Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AGRP,Agouti-related protein,40516,0.221298335551447,0.00454834621702211,0.212383576966083,0.23021309413681,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCN1,CCN family member 1,40280,0.322273910592126,0.00663495944012093,0.309269390089489,0.335278431094763,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,F7,Coagulation factor VII,40376,0.103175507758628,0.00260340604722171,0.0980728319060734,0.108278183611183,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGFBP1,Fibroblast growth factor-binding protein 1,40411,0.129936281298276,0.00269991424812507,0.124644449371951,0.135228113224601,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LCAT,Phosphatidylcholine-sterol acyltransferase,37987,0.0855582712304178,0.00189267734570607,0.0818486236328339,0.0892679188280017,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LDLR,Low-density lipoprotein receptor,40356,0.368297050271702,0.00377790452522556,0.36089235740226,0.375701743141144,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MFGE8,Lactadherin,40332,0.162657758083184,0.00362550744485022,0.155551763491278,0.169763752675091,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPY,Pro-neuropeptide Y,40489,0.300630163278812,0.00559831120771975,0.289657473311681,0.311602853245942,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLA2G7,Platelet-activating factor acetylhydrolase,40332,0.183722166140084,0.00246654750926243,0.17888773302193,0.188556599258238,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PROC,Vitamin K-dependent protein C,40372,0.0948171805672489,0.00217421726517559,0.0905557147275047,0.099078646406993,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TFPI,Tissue factor pathway inhibitor,40309,0.126967144110564,0.00265396803277629,0.121765366766322,0.132168921454805,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,40403,0.141180312653774,0.00367002048947858,0.133987072494396,0.148373552813152,1.16722552011169e-308
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMOC1,SPARC-related modular calcium-binding protein 1,40489,0.107432386627549,0.00288653507986307,0.101774777871017,0.11308999538408,6.94331175747026e-291
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLA2G10,Group 10 secretory phospholipase A2,40228,-0.194388251355951,0.00524299528701484,-0.2046645221185,-0.184111980593402,1.41883427143593e-288
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HHEX,Hematopoietically-expressed homeobox protein HHEX,37942,0.242936069837334,0.00656004853045802,0.230078374717636,0.255793764957031,5.47317922973499e-286
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RARRES2,Retinoic acid receptor responder protein 2,40424,0.142170591334931,0.00404790580699708,0.134236695953216,0.150104486716645,2.23502267817155e-260
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL27,C-C motif chemokine 27,40359,0.183171841608674,0.00522459152566962,0.172931642218361,0.193412040998986,1.86971419452359e-259
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APCS,Serum amyloid P-component,37882,0.108042018663473,0.00314545359234884,0.10187692962247,0.114207107704477,6.64407244741433e-248
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FURIN,Furin,40411,0.0996406077083952,0.00296813472824505,0.0938230636410349,0.105458151775755,8.50729306051324e-239
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAMR1,Inactive serine protease PAMR1,40332,0.0813536212188185,0.00246483098026891,0.0765225524974914,0.0861846899401456,4.00331107846909e-231
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERBB3,Receptor tyrosine-protein kinase erbB-3,40311,0.055090498055233,0.00167278014895005,0.0518118489632909,0.0583691471471751,3.81514652012965e-230
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TTR,Transthyretin,37871,0.073976860097005,0.00224525334542523,0.0695761635399716,0.0783775566540385,5.25389559486703e-229
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GHR,Growth hormone receptor,37671,0.0832844988953412,0.00253424928672748,0.0783173702933554,0.0882516274973271,9.29546717366778e-228
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL23,C-C motif chemokine 23,40422,0.118364682151466,0.0036167682391175,0.111275816402796,0.125453547900137,1.97490998317092e-227
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CFP,Properdin,38013,0.0620961068595195,0.00192544873403332,0.0583222273408142,0.0658699863782248,6.33252144700729e-220
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LPL,Lipoprotein lipase,40359,-0.12989600419691,0.00405314808899246,-0.137840174451335,-0.121951833942485,1.92798655110684e-218
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CES1,Liver carboxylesterase 1,40352,0.213471874174694,0.00673353561850057,0.200274144362432,0.226669603986955,6.11691369753505e-214
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTH,Parathyroid hormone,37572,0.21270012607184,0.00696702984736635,0.199044747571001,0.226355504572678,8.03258222370888e-198
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,40330,0.278036046854288,0.00913574739208556,0.2601299819658,0.295942111742775,8.95273398087025e-198
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NRP1,Neuropilin-1,40424,-0.0758535165242642,0.00249612038168633,-0.0807459124723694,-0.070961120576159,3.06164835164697e-197
NMR metabolomics,X23503.Total Lipids in Medium VLDL,INHBC,Inhibin beta C chain,40332,0.114698176555162,0.00377681414438949,0.107295620832159,0.122100732278166,5.76806345085574e-197
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMAD1,Mothers against decapentaplegic homolog 1,39980,0.215782943430195,0.0071273090248869,0.201813417741416,0.229752469118973,1.11518161112152e-195
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJB1,DnaJ homolog subfamily B member 1,40305,0.231810596779632,0.00779263474512034,0.216537032679196,0.247084160880068,2.85745992140114e-189
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNTN3,Contactin-3,40332,0.0920746009361846,0.00310467278922803,0.0859894422692977,0.0981597596030716,3.59836104504014e-188
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC39A5,Zinc transporter ZIP5,40341,0.140382961732316,0.00475450612450442,0.131064129728287,0.149701793736344,1.39455180296528e-186
NMR metabolomics,X23503.Total Lipids in Medium VLDL,P4HB,Protein disulfide-isomerase,40266,0.100839014590665,0.00343224283020564,0.094111818643462,0.107566210537868,8.79973638025494e-185
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDKN1A,Cyclin-dependent kinase inhibitor 1,40305,0.271320502465329,0.00931494564591603,0.253063208999334,0.289577795931325,9.54257840305309e-182
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINA5,Plasma serine protease inhibitor,37835,0.085063458124102,0.00291613772375092,0.0793478281855502,0.0907790880626538,2.08416234294286e-181
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCHE,Cholinesterase,37748,0.0729244529869563,0.00250619343304706,0.0680123138581841,0.0778365921157286,1.63764451381737e-180
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40516,0.0667041952687143,0.00230423409365785,0.0621878964451449,0.0712204940922837,1.16224911662341e-179
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL6,C-X-C motif chemokine 6,40516,0.199708768031953,0.00691029255898221,0.186164594616348,0.213252941447558,4.39732288138061e-179
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINA4,Kallistatin,37781,0.0604663855848635,0.00212580728728906,0.0562998033017769,0.06463296786795,7.95838716512478e-173
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VPS37A,Vacuolar protein sorting-associated protein 37A,40305,0.199282663111199,0.00703876271323082,0.185486688193267,0.213078638029131,4.53990648721127e-172
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGFBP3,Fibroblast growth factor-binding protein 3,37942,0.0927027820837688,0.00326776911347276,0.0862979546213622,0.0991076095461754,5.21821838973733e-172
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GCG,Pro-glucagon,39980,0.313405500798545,0.011091919037614,0.291665339484821,0.335145662112268,2.56228083220532e-171
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLKB1,Plasma kallikrein,37721,0.0630979582256454,0.00223830851838119,0.0587108735296183,0.0674850429216725,7.44476740730307e-170
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINF2,Alpha-2-antiplasmin,37755,0.033981500173759,0.00120597035459937,0.0316177982787442,0.0363452020687738,1.00410556624494e-169
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPIND1,Heparin cofactor 2,37981,0.0683224886602624,0.00242964294840765,0.0635603884813834,0.0730845888391413,3.84624305831568e-169
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAMP2,Lysosome-associated membrane glycoprotein 2,39887,0.04604268507948,0.0016456145225734,0.0428172806152361,0.0492680895437239,4.437423491782e-168
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PROS1,Vitamin K-dependent protein S,38013,0.062315843591096,0.00223069605247444,0.0579436793282461,0.0666880078539459,5.04379640965887e-167
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DSG2,Desmoglein-2,40332,-0.0668322630656231,0.00240000301811057,-0.0715362689811198,-0.0621282571501264,1.15927347972113e-166
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CFH,Complement factor H,37301,0.0572718808748808,0.00205084891870884,0.0532522169942115,0.0612915447555501,1.15962229328629e-166
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SYAP1,Synapse-associated protein 1,37671,0.13966025326336,0.00501940041898818,0.129822228442143,0.149498278084577,1.24992956121601e-165
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40489,0.0857387247339871,0.00309261110520515,0.079677206967785,0.0918002425001892,2.78165257760305e-165
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CFI,Complement factor I,38013,0.0491506516475343,0.00178685535641228,0.0456484151489663,0.0526528881461024,3.93384928521726e-162
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNCA,Alpha-synuclein,37671,0.277327399037728,0.0101229862538982,0.257486345980088,0.297168452095369,9.09245684102435e-161
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DEFB4A_DEFB4B,Beta-defensin 4A,40141,0.35983220520848,0.0131942061119353,0.333971561229087,0.385692849187873,4.80135951031351e-160
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHMP6,Charged multivesicular body protein 6,37990,0.13514624144828,0.00495800068089919,0.125428560113718,0.144863922782843,2.55115462581032e-159
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD4,T-cell surface glycoprotein CD4,40309,0.0740067936064787,0.00272099989245538,0.0686736338172662,0.0793399533956913,2.99181882809055e-159
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOM,Apolipoprotein M,40372,0.0642726886023251,0.00238511509098154,0.0595978630240013,0.0689475141806489,1.93492777226614e-156
NMR metabolomics,X23503.Total Lipids in Medium VLDL,F10,Coagulation factor X,37987,0.062273096545743,0.00230974882428572,0.057745988850143,0.066800204241343,5.38755904574167e-156
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VMO1,Vitelline membrane outer layer protein 1 homolog,40305,0.16201439769532,0.00602187022166132,0.150211532060864,0.173817263329776,6.07382914588792e-156
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMPRSS15,Enteropeptidase,40305,0.220105984581899,0.00821204605877711,0.204010374306696,0.236201594857102,8.26805835707209e-155
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPM,Carboxypeptidase M,40415,0.0813685406175033,0.00305715447604837,0.0753765178444485,0.0873605633905581,9.4211211183036e-153
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADIPOQ,Adiponectin,38013,-0.157756153664602,0.00591919887684548,-0.169357783463219,-0.146154523865984,1.40927369013185e-152
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGFBP3,Insulin-like growth factor-binding protein 3,40403,0.0644509924736271,0.00242674807398178,0.0596945662486228,0.0692074186986314,4.07179141050435e-152
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATRN,"Attractin, Isoform 2",38013,0.0387454970193448,0.00145751635229167,0.0358887649688531,0.0416022290698365,7.96491583578299e-152
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KDR,Vascular endothelial growth factor receptor 2,40411,0.0593356548722604,0.00225631744450619,0.0549132726810283,0.0637580370634925,3.03751771380252e-149
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL4A1,Collagen alpha-1(IV) chain,40359,-0.09297402871928,0.00353765430545857,-0.0999078311579788,-0.0860402262805812,4.69045132432822e-149
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AGR3,Anterior gradient protein 3,39963,0.135791797128349,0.0053203139910725,0.125363981705847,0.146219612550851,8.61675011098864e-141
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SOST,Sclerostin,40330,0.0880860526805866,0.00345400302172204,0.0813162067580114,0.0948558986031618,1.23152814243023e-140
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FLI1,Friend leukemia integration 1 transcription factor,39980,0.247708326196487,0.00971645216309301,0.228664079956825,0.266752572436149,1.76647402469943e-140
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGSF9,Protein turtle homolog A,37990,0.179579832671898,0.00710443896163672,0.16565513230709,0.193504533036706,8.71861061929599e-138
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDHR5,Cadherin-related family member 5,40359,0.0875937591505217,0.00348144219902997,0.080770132440423,0.0944173858606204,5.15090926934549e-137
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40471,0.117105223693972,0.00466803820756742,0.10795586880714,0.126254578580804,2.93351117668658e-136
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPR37,Prosaposin receptor GPR37,40042,0.150334342990971,0.00600833215183406,0.138558011973376,0.162110674008566,1.67973770874038e-135
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,40228,0.165512491659256,0.00662386109317331,0.152529723916637,0.178495259401876,3.52200922322947e-135
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37901,0.31123392039084,0.0124671306507373,0.286798344315395,0.335669496466286,1.68023344471388e-134
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SORT1,Sortilin,40330,0.0803416125444395,0.0032491368588028,0.073973304301186,0.086709920787693,1.73373517148441e-132
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LATS1,Serine/threonine-protein kinase LATS1,37598,0.186580258846345,0.00753969422414555,0.17180245816702,0.201358059525671,3.50266517738601e-132
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STAB2,Stabilin-2,37998,0.0617972724381657,0.00249860993947576,0.0568999969567932,0.0666945479195381,3.97556091847226e-132
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,40042,0.185746239888013,0.00753043837911228,0.170986580664953,0.200505899111073,8.21690059058391e-132
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLAT,Tissue-type plasminogen activator,40490,0.107885831721116,0.00438798420863934,0.0992853826721833,0.116486280770049,4.63126783736835e-131
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NCS1,Neuronal calcium sensor 1,40489,0.0629042339966119,0.00255894687451065,0.0578886981225711,0.0679197698706528,5.16364737713216e-131
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRAP1,Proline-rich acidic protein 1,37998,0.0931896350149118,0.00378484530747277,0.0857713382122652,0.100607931817558,5.47581850160358e-131
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPB2,Carboxypeptidase B2,37981,0.0491226229299995,0.00199822918264318,0.0452060937320189,0.0530391521279801,1.37542460952005e-130
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AFM,Afamin,38013,0.0408660254153634,0.0016671150969722,0.0375984798252979,0.0441335710054289,7.04996220281168e-130
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL22,C-C motif chemokine 22,40204,0.112760973706376,0.00460714015006335,0.103730979012251,0.1217909684005,7.13616437233398e-130
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GRP,Gastrin-releasing peptide,37628,0.119040309653666,0.00486515953669944,0.109504596961735,0.128576022345597,2.4418536826502e-129
NMR metabolomics,X23503.Total Lipids in Medium VLDL,F9,Coagulation factor IX,40372,0.0392629573636363,0.00160798161493556,0.0361113133983626,0.04241460132891,2.63146769434335e-129
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRIP2,Cysteine-rich protein 2,40228,0.0788404336306242,0.00323873488348183,0.0724925132589998,0.0851883540022486,1.59768844181638e-128
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMAD2,Mothers against decapentaplegic homolog 2,37900,0.147849269757543,0.00607122779978564,0.135949663269963,0.159748876245123,3.20108463125037e-128
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUMB,Protein numb homolog,37598,0.180705832446419,0.00746610114569282,0.166072274200862,0.195339390691977,1.18199023496481e-126
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNAPIN,SNARE-associated protein Snapin,37959,0.123997538956538,0.00512926836121048,0.113944172968566,0.134050904944511,1.96487412401895e-126
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRCP,Lysosomal Pro-X carboxypeptidase,40443,0.0662951165137362,0.00276185751444888,0.0608818757854164,0.071708357242056,4.10554985435849e-125
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NAA80,N-alpha-acetyltransferase 80,37572,0.254921401238851,0.0106399041326794,0.234067189138799,0.275775613338902,3.39699648756636e-124
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MEGF9,Multiple epidermal growth factor-like domains protein 9,40490,0.0447555628982083,0.00187969872523615,0.0410713533967454,0.0484397723996711,3.57963982889259e-123
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENO3,Beta-enolase,37628,0.120763061807959,0.0050807130410426,0.110804864247516,0.130721259368403,2.58061098328544e-122
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSRC1,Proline/serine-rich coiled-coil protein 1,39980,0.124560501119657,0.00525315415847848,0.114264318969039,0.134856683270275,4.01592010583024e-122
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOC1,Apolipoprotein C-I,37981,0.0767452393392761,0.00324597171323513,0.0703831347813352,0.0831073438972169,3.90152522139425e-121
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL17,C-X-C motif chemokine 17,40516,0.087621870044514,0.00371264881526696,0.0803450783665908,0.0948986617224373,4.302516064464e-121
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAT2,Linker for activation of T-cells family member 2,40305,0.258289558940717,0.0109617097624802,0.236804607806256,0.279774510075178,1.08964709100969e-120
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERP44,Endoplasmic reticulum resident protein 44,40280,0.0541030023894749,0.0022966704927782,0.0496015282236296,0.0586044765553201,1.25130139823618e-120
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GUSB,Beta-glucuronidase,40419,0.123167045018979,0.00523926667139255,0.11289808234305,0.133436007694908,3.64404964085174e-120
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FN1,Fibronectin,38013,0.0550167269242954,0.00234866005971312,0.0504133532072577,0.0596201006413331,5.43260899347713e-119
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCN2,Ficolin-2,40291,0.0860041226039646,0.00367908544692467,0.0787931151279922,0.093215130079937,7.55823620943015e-119
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCSK9,Proprotein convertase subtilisin/kexin type 9,40536,0.0817732892884861,0.00350722899164761,0.0748991204648567,0.0886474581121154,2.79497885783797e-118
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GSTA3,Glutathione S-transferase A3,39980,0.158127511143649,0.00678761333813472,0.144823789000904,0.171431233286393,5.04210865969563e-118
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANGPTL2,Angiopoietin-related protein 2,40377,0.0832312368354747,0.00357591846832527,0.0762224366375571,0.0902400370333922,7.22913888575393e-118
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39980,0.140628657934613,0.00604305504990185,0.128784270036805,0.152473045832421,8.93054250262348e-118
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KYNU,Kynureninase,40516,0.0929263406044377,0.00400053555846538,0.0850852909098455,0.10076739029903,2.0071011504107e-117
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GSTA1,Glutathione S-transferase A1,40333,0.171513675199902,0.00741579715690786,0.156978712772363,0.186048637627441,2.00905570812363e-116
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGSF8,Immunoglobulin superfamily member 8,40359,0.0617620557817398,0.00268008148664003,0.0565090960679253,0.0670150154955542,1.28715048189941e-115
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMAD5,Mothers against decapentaplegic homolog 5,40305,0.0426318754360656,0.00185475349153563,0.0389965585926557,0.0462671922794754,4.94204630095959e-115
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37671,0.0436088270678263,0.00190450258647588,0.0398760019983336,0.047341652137319,7.90343825465372e-114
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERBB2,Receptor tyrosine-protein kinase erbB-2,40411,0.0496218121056534,0.00217723526940506,0.0453544309776195,0.0538891932336873,3.56705507253158e-113
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EEF1D,Elongation factor 1-delta,37990,0.187235900245057,0.00821332936694236,0.17113777468585,0.203334025804264,6.53772828209257e-113
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNAP29,Synaptosomal-associated protein 29,40411,0.186035823023632,0.0081840504141543,0.16999508421189,0.202076561835375,1.33331944096147e-112
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AP1G2,AP-1 complex subunit gamma-like 2,37900,0.161836195092295,0.00714778068320451,0.147826544953214,0.175845845231376,2.0237195704048e-111
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DTYMK,Thymidylate kinase,37990,0.139626459896791,0.0062118824089058,0.127451170375335,0.151801749418246,7.00832028863713e-110
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINF1,Pigment epithelium-derived factor,37790,0.0520802485403429,0.00232601593391052,0.0475212573098783,0.0566392397708075,4.93553704831663e-109
NMR metabolomics,X23503.Total Lipids in Medium VLDL,YES1,Tyrosine-protein kinase Yes,40305,0.227651392172458,0.0101927427821569,0.20767361631943,0.247629168025485,8.07397577413768e-109
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BTD,Biotinidase,38013,0.0412785768053738,0.00185447648353944,0.0376438028976365,0.0449133507131111,7.81289048740292e-108
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MLN,Promotilin,40341,0.177035208242775,0.00797253597434542,0.161409037733058,0.192661378752492,1.30586495832e-107
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANGPTL3,Angiopoietin-related protein 3,40355,0.0722587384934272,0.00325923796689224,0.0658706320783184,0.078646844908536,2.78035042002391e-107
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGFR2,Fibroblast growth factor receptor 2,40411,0.0425378216723176,0.00192131197082695,0.0387720502094968,0.0463035931351384,5.28890379674137e-107
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37628,0.0515835069474025,0.00232972625067489,0.0470172434960797,0.0561497703987253,1.0999918768979e-106
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD300LG,CMRF35-like molecule 9,40332,-0.0746163141013502,0.00338742997430401,-0.0812556768509861,-0.0679769513517144,6.0376198683322e-106
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ABL1,Tyrosine-protein kinase ABL1,40305,0.134023980344083,0.00610567830982605,0.122056850856824,0.145991109831342,3.13157989652186e-105
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IPCEF1,Interactor protein for cytohesin exchange factors 1,40203,0.174970437863292,0.00799197286213735,0.159306171053503,0.190634704673082,1.09007720003371e-104
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37990,0.0571434239754598,0.00260708565255151,0.0520335360964588,0.0622533118544607,1.13262847262093e-104
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TJAP1,Tight junction-associated protein 1,40411,0.162248150643092,0.00741638107276353,0.147712043740475,0.176784257545708,1.47240620675663e-104
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UPB1,Beta-ureidopropionase,37990,0.179592762319489,0.00819990955078548,0.16352093959995,0.195664585039029,1.6141771509517e-104
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GLA,Alpha-galactosidase A,37642,0.0711171268363544,0.00324995461956197,0.0647472157820129,0.0774870378906959,2.70409909046587e-104
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EHBP1,EH domain-binding protein 1,37990,0.146275870374534,0.00670203419845563,0.133139883345561,0.159411857403507,8.09686387276454e-104
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL17,C-C motif chemokine 17,40333,0.177046967173552,0.00813627242171942,0.161099873226982,0.192994061120122,1.78703252682718e-103
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37942,0.0784432384121097,0.00361042473038818,0.0713668059405489,0.0855196708836705,6.58175597087907e-103
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NOTCH3,Neurogenic locus notch homolog protein 3,40536,-0.0673720005820178,0.00310926110544996,-0.0734661523486997,-0.0612778488153358,1.19794360395875e-102
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMBP,Protein AMBP,40470,0.0389551556355753,0.00179973763890226,0.0354276698633269,0.0424826414078237,1.9832722850697e-102
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FYB1,FYN-binding protein 1,40311,0.177453592807802,0.00821546863894716,0.161351274275466,0.193555911340138,5.2830999507005e-102
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIMP4,Metalloproteinase inhibitor 4,40332,-0.0788759304037671,0.00365570395878114,-0.0860411101629781,-0.0717107506445561,8.6757727524239e-102
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYH9,Myosin-9,37998,0.217348013280677,0.0100897548402677,0.197572093793752,0.237123932767602,3.15301216213169e-101
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGFBP2,Insulin-like growth factor-binding protein 2,40497,-0.122600060535537,0.00571080998859649,-0.133793248113186,-0.111406872957888,8.07902440199802e-101
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37901,0.0575791903443643,0.00269083607819528,0.0523051516311016,0.0628532290576271,6.375001258178e-100
NMR metabolomics,X23503.Total Lipids in Medium VLDL,YTHDF3,YTH domain-containing family protein 3,40044,0.162621652219731,0.00762331708510817,0.147679950732919,0.177563353706543,1.50547910518507e-99
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",40341,0.182603226824998,0.00856596572765051,0.165813933998803,0.199392519651193,1.92990257970985e-99
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SARG,Specifically androgen-regulated gene protein,37931,0.207782211121694,0.00976045863531578,0.188651712196475,0.226912710046912,6.16777017900457e-99
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBP5,Retinol-binding protein 5,40305,0.10518334025565,0.00497728242105105,0.09542786671039,0.11493881380091,8.85106676956029e-98
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDHR2,Cadherin-related family member 2,40305,0.146004251990337,0.00691420460679968,0.132452410961009,0.159556093019664,1.23354130290431e-97
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAPK9,Mitogen-activated protein kinase 9,40341,0.0814803174460394,0.00386287562513677,0.0739090812207713,0.0890515536713074,1.98226176813296e-97
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,40042,0.103252385989365,0.0049008543754472,0.0936467114134882,0.112858060565241,3.50526899937484e-97
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HEG1,Protein HEG homolog 1,37671,0.0500696012105678,0.00237517068898952,0.0454142666601483,0.0547249357609873,4.72029310982913e-97
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CES2,Cocaine esterase,40305,0.101142488780841,0.00481776200130484,0.0916996752582837,0.110585302303399,1.5375764720086e-96
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SELPLG,P-selectin glycoprotein ligand 1,40341,0.0521582743252099,0.00248942101827813,0.0472790091293848,0.0570375395210351,3.58353305717565e-96
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DKK1,Dickkopf-related protein 1,40471,0.112283414282071,0.00536731702540078,0.101763472912286,0.122803355651857,6.74463009088514e-96
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL13RA1,Interleukin-13 receptor subunit alpha-1,40109,0.0390271935403337,0.0018659712448228,0.035369889900481,0.0426844971801863,7.92469073812668e-96
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL16,Pro-interleukin-16,40516,0.0759015711694615,0.00363269438956943,0.0687814901659055,0.0830216521730176,1.13299616595982e-95
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CREG1,Protein CREG1,40145,0.067766052037578,0.0032460819013712,0.0614037315108904,0.0741283725642655,1.74089843437632e-95
NMR metabolomics,X23503.Total Lipids in Medium VLDL,THPO,Thrombopoietin,40042,0.0715401275186916,0.00343759144018023,0.0648024482959383,0.0782778067414449,6.67087249178893e-95
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACY1,Aminoacylase-1,40359,0.110477626299616,0.00535151047593122,0.0999886657667906,0.120966586832441,1.8427682042515e-93
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADH1B,All-trans-retinol dehydrogenase,37671,0.136737329472933,0.00664842497503786,0.123706416521859,0.149768242424007,1.51729488376519e-92
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MTSS1,Protein MTSS 1,37901,0.204323043158317,0.00996489324176345,0.184791852404461,0.223854233912174,5.00426698690652e-92
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,40305,0.0764228755716473,0.00373802049611047,0.0690963553992708,0.0837493957440238,1.01640218546675e-91
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL5,C-X-C motif chemokine 5,40309,0.210967795887139,0.0103305099872865,0.190719996312058,0.231215595462221,1.60501682137119e-91
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DAB2,Disabled homolog 2,40489,0.202581014762028,0.00992569356005081,0.183126655384329,0.222035374139728,1.98136217444292e-91
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TARBP2,RISC-loading complex subunit TARBP2,39961,0.145115358237544,0.00711179458796247,0.131176240845138,0.159054475629951,2.38746795196983e-91
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37922,0.153773010158476,0.00754311617709344,0.138988502451372,0.168557517865579,5.24089413954972e-91
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NTproBNP,N-terminal prohormone of brain natriuretic peptide,40359,-0.179840852150792,0.00883635731808602,-0.197160112494241,-0.162521591807344,6.34569636740603e-91
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,40228,0.0994802442873635,0.00489201406729708,0.0898918967154612,0.109068591859266,9.11703817537583e-91
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FTCD,Formimidoyltransferase-cyclodeaminase,37920,0.152410957204461,0.00749244070834505,0.137725773416105,0.167096140992818,1.25095530615862e-90
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SKAP1,Src kinase-associated phosphoprotein 1,40192,0.134292581733828,0.00660990205856179,0.121337173699047,0.147247989768609,1.32043814732615e-90
NMR metabolomics,X23503.Total Lipids in Medium VLDL,F11R,Junctional adhesion molecule A,40332,0.103343645280178,0.00508934965142631,0.0933685199633821,0.113318770596973,1.60541299293458e-90
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL16,C-C motif chemokine 16,40536,0.0966357259467304,0.00476181548084476,0.0873025676042747,0.105968884289186,1.97019403081528e-90
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37628,0.154165239974408,0.0075955921730643,0.139277879315202,0.169052600633614,3.2751069849297e-90
NMR metabolomics,X23503.Total Lipids in Medium VLDL,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",40305,0.177379114582232,0.00875338914332712,0.160222471861311,0.194535757303153,3.69343990049004e-90
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40536,0.0521677694922743,0.00257542326527527,0.0471199398923348,0.0572155990922138,4.17414773178296e-90
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37959,0.174771617672567,0.00862038742492616,0.157875658319712,0.191667577025422,4.72697691830977e-90
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37714,0.203626696519675,0.0100431004136269,0.183942219708967,0.223311173330384,4.89429685367886e-90
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KAZN,Kazrin,37901,0.189429037642828,0.00934610192581552,0.17111067786823,0.207747397417427,5.38806361508635e-90
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP6V1G1,V-type proton ATPase subunit G 1,37628,0.131807255288241,0.00650975059789873,0.119048144116359,0.144566366460122,8.60278617777064e-90
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AXIN1,Axin-1,40341,0.170949655937952,0.0084639149474508,0.154360382640948,0.187538929234956,1.36954731789936e-89
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TXLNA,Alpha-taxilin,40228,0.162085808371122,0.008033606183734,0.146339940251003,0.177831676491241,2.13136312071502e-89
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FAM20A,Pseudokinase FAM20A,37990,0.0513984703882007,0.00254624734669499,0.0464078255886785,0.0563891151877229,2.66686872808965e-89
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DAAM1,Disheveled-associated activator of morphogenesis 1,37671,0.150709199470439,0.00747752866676452,0.13605324328358,0.165365155657297,5.26383510253943e-89
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPD52L2,Tumor protein D54,37671,0.195472075043309,0.00971701562352243,0.176426724421205,0.214517425665413,1.11828444229648e-88
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJA2,DnaJ homolog subfamily A member 2,40471,0.148528097862348,0.00739576066563031,0.134032406957713,0.163023788766983,1.28121686385132e-88
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BANK1,B-cell scaffold protein with ankyrin repeats,40341,0.191307475827919,0.00954846476637657,0.172592484885821,0.210022466770017,3.31561300866643e-88
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40516,0.0524591304330023,0.00262252962580993,0.0473189723664149,0.0575992884995898,6.0589152502908e-88
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NOS3,"Nitric oxide synthase, endothelial",39961,0.0986151145994715,0.0049359315979261,0.0889406886675364,0.108289540531407,1.06073782478045e-87
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD63,CD63 antigen,40203,0.0938462850536105,0.00470049518573677,0.0846333144895664,0.103059255617655,1.33751188676618e-87
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GCC1,GRIP and coiled-coil domain-containing protein 1,37942,0.192881797235149,0.00966353571549871,0.173941267232771,0.211822327237526,2.23948812343249e-87
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGFBP1,Insulin-like growth factor-binding protein 1,40500,-0.210582085393348,0.0105630054721096,-0.231285576118682,-0.189878594668013,2.26780502212396e-87
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37959,0.151003821687659,0.00757136437352648,0.136163947515547,0.165843695859771,3.02646956838757e-87
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ASGR1,Asialoglycoprotein receptor 1,40228,0.0526365958490033,0.00264482467372204,0.0474527394885081,0.0578204522094985,4.58995450300883e-87
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OTUD7B,OTU domain-containing protein 7B,37959,0.113319003193785,0.005690792412869,0.102165050064561,0.124472956323008,5.564179735241e-87
NMR metabolomics,X23503.Total Lipids in Medium VLDL,F2,Prothrombin,38013,0.0264056318183083,0.00132626835359105,0.0238061458452699,0.0290051177913468,5.82874458315324e-87
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB11FIP3,Rab11 family-interacting protein 3,37990,0.191846646320093,0.00964123749313605,0.172949820833546,0.210743471806639,7.27261056196202e-87
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37562,0.121935044355187,0.0061390439671532,0.109902518179567,0.133967570530807,1.60923804143132e-86
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPD1,Glycerol-3-phosphate dehydrogenase,37900,0.0914090340940053,0.00460408432115655,0.0823850288245385,0.100433039363472,1.75868363887075e-86
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLXNA4,Plexin-A4,40341,0.147394335942972,0.00743806048349852,0.132815737395315,0.161972934490629,2.37526635647644e-86
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1S,Complement C1s subcomponent,38013,0.0370502087714705,0.00186963631266703,0.0333857215986431,0.0407146959442979,3.51927985302418e-86
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,40305,0.0809415792138192,0.00409734133230958,0.0729107902024924,0.088972368225146,7.86482203306422e-86
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CANT1,Soluble calcium-activated nucleotidase 1,40312,0.0361312343513903,0.00183181758612848,0.0325408718825785,0.0397215968202021,1.41349946254228e-85
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARHGEF12,Rho guanine nucleotide exchange factor 12,40341,0.184166306163648,0.00934144610079902,0.165857071806082,0.202475540521214,1.68375950256941e-85
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GHRL,Appetite-regulating hormone,40359,0.139879968316587,0.00710648291332969,0.12595126180646,0.153808674826713,3.08455896721184e-85
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SORD,Sorbitol dehydrogenase,40417,0.118533404197764,0.00602633868428547,0.106721780376565,0.130345028018964,4.02168042435422e-85
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MINK1,Misshapen-like kinase 1,37942,0.164232084119773,0.00834441032690228,0.147877039879045,0.180587128360501,4.80727493241061e-85
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATG16L1,Autophagy-related protein 16-1,37901,0.150109408789339,0.00762703498080825,0.135160420226955,0.165058397351723,4.88994197641888e-85
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNF41,E3 ubiquitin-protein ligase NRDP1,39980,0.118616551024744,0.00603625155095055,0.106785497984881,0.130447604064608,6.12385577387558e-85
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DPY30,Protein dpy-30 homolog,40414,0.105234700673646,0.00535810058487933,0.0947328235272822,0.115736577820009,7.01901434309208e-85
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDLIM7,PDZ and LIM domain protein 7,40422,0.220751971974062,0.011258391223247,0.198685525176498,0.242818418771627,1.30969829993179e-84
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC1B,C-type lectin domain family 1 member B,40471,0.170010217115698,0.00867960944562318,0.152998182602277,0.18702225162912,1.92611377109525e-84
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL18R1,Interleukin-18 receptor 1,40516,0.057478623052569,0.00293491835921907,0.0517261830684996,0.0632310630366384,2.02390773861666e-84
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PHACTR2,Phosphatase and actin regulator 2,37959,0.201336232135829,0.010270749967068,0.181205562200376,0.221466902071283,2.16650071644686e-84
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NOMO1,Nodal modulator 1,40332,0.0417784299041916,0.00213392060500975,0.0375959455183725,0.0459609142900107,2.33688530612721e-84
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEP20,Centrosomal protein 20,39980,0.12984596767184,0.00663645349659992,0.116838518818504,0.142853416525176,3.13539173820235e-84
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HBEGF,Proheparin-binding EGF-like growth factor,40434,0.127365364766143,0.00652635214987828,0.114573714552382,0.140157014979905,7.64830840204273e-84
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MTSS2,Protein MTSS 2,37900,0.172241545497534,0.00886189921164406,0.154872223042712,0.189610867952357,5.22993974413089e-83
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BPIFB1,BPI fold-containing family B member 1,40261,-0.107799050272471,0.00555268664745248,-0.118682316101478,-0.0969157844434639,5.44306214364012e-83
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AAMDC,Mth938 domain-containing protein,37628,0.093727692241979,0.00483641944860265,0.0842483101227178,0.10320707436124,1.60983050224382e-82
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VEGFC,Vascular endothelial growth factor C,40411,0.097348985097324,0.00503557245903358,0.0874792630776182,0.10721870711703,2.50861498656629e-82
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GP1BA,Platelet glycoprotein Ib alpha chain,40283,0.0560442106371666,0.00290507896172365,0.0503502558721883,0.061738165402145,5.48652748392716e-82
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MASP1,Mannan-binding lectin serine protease 1,40192,0.041387397056093,0.00214717874235451,0.0371789267210782,0.0455958673911078,7.59411328920475e-82
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37901,0.0468616451545042,0.00243107228525104,0.0420967434754121,0.0516265468335962,1.07395641957189e-81
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARF6,ADP-ribosylation factor 6,37901,0.182573179372236,0.00947400573236925,0.164004128136792,0.20114223060768,1.18344593481774e-81
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CES3,Carboxylesterase 3,40305,0.119140182672877,0.00618899702577685,0.107009748502354,0.131270616843399,1.19713949885201e-81
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AP3S2,AP-3 complex subunit sigma-2,37942,0.0809753501537505,0.00420229246509884,0.0727388569221568,0.0892118433853443,1.21113695267594e-81
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLIN1,Perilipin-1,39961,0.0616297032313245,0.00320159369167305,0.0553545795956453,0.0679048268670037,1.26940988663632e-81
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL13,C-X-C motif chemokine 13,40471,0.109863344926824,0.0057173153924628,0.0986574067575971,0.121069283096051,2.24103049082813e-81
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C9,Complement component C9,37987,-0.0841751814804755,0.00439085771330168,-0.0927812625985468,-0.0755691003624041,7.66186328476199e-81
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBPMS2,RNA-binding protein with multiple splicing 2,37628,0.177642248264414,0.00926748348240701,0.159477980638896,0.195806515889932,8.53051382721958e-81
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCLY,Selenocysteine lyase,40434,0.082283728140815,0.0042996752925891,0.0738563645673403,0.0907110917142896,9.88486618571291e-81
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPC5,Glypican-5,40228,0.0967808050080043,0.00505742029510931,0.0868682612295901,0.106693348786419,1.03057099392223e-80
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SELP,P-selectin,40403,0.0991022566097604,0.00519493818729526,0.0889201777626617,0.109284335456859,3.08199735640466e-80
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFE2,Transcription factor NF-E2 45 kDa subunit,37628,0.128805622270786,0.00674640502561662,0.115582668420578,0.142028576120995,3.51418886764858e-80
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LEFTY2,Left-right determination factor 2,40453,0.0893547548589426,0.0046859916128341,0.0801702112977877,0.0985392984200974,3.57089200205636e-80
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ELN,Elastin,37990,0.0605055137177321,0.00316991869159174,0.0542924730822123,0.0667185543532519,3.61869869343038e-80
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,40160,0.0790398366155435,0.00415252487555925,0.0709008878594474,0.0871787853716396,7.03739414514659e-80
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF21,Fibroblast growth factor 21,40453,0.200825787099627,0.0105645316745847,0.180119305017441,0.221532269181814,1.07524997965613e-79
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BECN1,Beclin-1,37628,0.104500194562967,0.00549752998116359,0.0937250357998867,0.115275353326048,1.67226895924546e-79
NMR metabolomics,X23503.Total Lipids in Medium VLDL,F13B,Coagulation factor XIII B chain,37934,0.0442519181181462,0.00232945927959105,0.0396861779301477,0.0488176583061446,1.97567551332981e-79
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINC1,Antithrombin-III,37981,0.0252162252454342,0.00132875203128519,0.0226118712641152,0.0278205792267532,2.80160849998944e-79
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZBTB16,Zinc finger and BTB domain-containing protein 16,39980,0.11962688224995,0.00631352922484456,0.107252364969255,0.132001399530645,3.60156600266518e-79
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CMIP,C-Maf-inducing protein,37900,0.140425859428741,0.00740609924483492,0.125909904908865,0.154941813948618,3.85949828384555e-79
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SHBG,Sex hormone-binding globulin,37987,-0.09221847289309,0.00486450713579927,-0.101752906879257,-0.0826840389069235,4.05111722219241e-79
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CIRBP,Cold-inducible RNA-binding protein,37901,0.162936956131801,0.00859671129328854,0.146087401996955,0.179786510266646,4.42823761066182e-79
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNIP1,TNFAIP3-interacting protein 1,37942,0.151380255570502,0.0079931542071383,0.135713673324511,0.167046837816493,5.76819263797135e-79
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DOK2,Docking protein 2,40359,0.20563492201597,0.0108795032563046,0.184311095633613,0.226958748398327,8.14551396517736e-79
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GGT1,Glutathione hydrolase 1 proenzyme,40303,0.0822802403831739,0.00437008039030058,0.0737148828181848,0.090845597948163,3.16869989914048e-78
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37860,0.184045589084214,0.0097732860497326,0.164889948426738,0.20320122974169,4.23021285782299e-78
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLTP,Phospholipid transfer protein,40461,-0.0579339119657392,0.00308544858252374,-0.0639813911874857,-0.0518864327439927,8.05189661949297e-78
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCTN1,Dynactin subunit 1,40489,0.111375679626382,0.00593247669877825,0.0997480252967766,0.123003333955987,8.41954902658801e-78
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCR,Breakpoint cluster region protein,40341,0.154130352370677,0.00821296664102222,0.138032937754274,0.170227766987081,9.78123309839695e-78
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TGFBI,Transforming growth factor-beta-induced protein ig-h3,40273,0.0457548547038722,0.00243885297306711,0.0409747028766607,0.0505350065310837,1.0992958009028e-77
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD6,T-cell differentiation antigen CD6,40502,0.0898817467642197,0.00479504302659172,0.0804834624320999,0.0992800310963394,1.43826183894543e-77
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPP1R9B,Neurabin-2,40516,0.158721677831154,0.00846776257366091,0.142124863186778,0.175318492475529,1.44898942301744e-77
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KHK,Ketohexokinase,37628,0.109021991181044,0.00581191212799847,0.097630643410167,0.120413338951921,1.68546575016383e-77
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GAS6,Growth arrest-specific protein 6,40429,-0.0434403688245507,0.00231998872914709,-0.047987546733679,-0.0388931909154224,2.10819244195022e-77
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERBIN,Erbin,40305,0.173016936212179,0.00924294584232389,0.154900762361224,0.191133110063134,2.37027868894686e-77
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TCTN3,Tectonic-3,37990,0.0493075390931055,0.00263358345200387,0.0441457155271779,0.0544693626590331,3.05315947336178e-77
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLXNB3,Plexin-B3,40310,0.0786346071210019,0.00420776160423353,0.0703873943767042,0.0868818198652996,4.17030227239581e-77
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTBS,Di-N-acetylchitobiase,37819,0.0454952191795162,0.00244440028079999,0.0407041946291482,0.0502862437298842,2.36186006866303e-76
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LECT2,Leukocyte cell-derived chemotaxin-2,37990,0.10945619377002,0.00588800181498355,0.0979157102126519,0.120996677327387,3.44801568601585e-76
NMR metabolomics,X23503.Total Lipids in Medium VLDL,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37628,0.0958531864669186,0.00516099676063367,0.0857376328160767,0.105968740117761,4.98797726436737e-76
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NT5E,5'-nucleotidase,40411,0.0967738110610209,0.00522412774539635,0.0865345206800441,0.107013101441998,8.17683046613605e-76
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IRAK1,Interleukin-1 receptor-associated kinase 1,40044,0.115401701655466,0.00622954830473925,0.103191786978177,0.127611616332755,8.4549119760658e-76
NMR metabolomics,X23503.Total Lipids in Medium VLDL,USO1,General vesicular transport factor p115,40305,0.151240910423075,0.00818045830397062,0.135207212147292,0.167274608698857,1.60107298419343e-75
NMR metabolomics,X23503.Total Lipids in Medium VLDL,S100A4,Protein S100-A4,40411,0.0963262916886961,0.00521102305312878,0.0861126865045637,0.106539896872828,1.66969509612974e-75
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUCB2,Nucleobindin-2,40447,0.0619216327376068,0.00335267957778594,0.0553503807651463,0.0684928847100672,2.21529435476085e-75
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDGFC,Platelet-derived growth factor C,39980,0.0495322877064431,0.00268166112554201,0.0442762319003807,0.0547883435125054,2.27626634537651e-75
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IKBKG,NF-kappa-B essential modulator,40341,0.153188872769097,0.00829877681632641,0.136923270209097,0.169454475329097,2.69146944299338e-75
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37901,0.180982280056881,0.00982720971565246,0.161720949014202,0.20024361109956,8.04174715016522e-75
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF4B,Eukaryotic translation initiation factor 4B,40228,0.0983253039755003,0.00535144710870216,0.087836467642444,0.108814140308557,1.28201780802902e-74
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NCK2,Cytoplasmic protein NCK2,40422,0.172561948403207,0.00942537752735823,0.154088208449585,0.191035688356829,4.07376560780731e-74
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACP5,Tartrate-resistant acid phosphatase type 5,40419,0.0525986707857098,0.00287491440508373,0.0469638385517457,0.0582335030196739,5.10126693038605e-74
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SDC4,Syndecan-4,40359,0.0746889862969401,0.00408315572914372,0.0666860010678184,0.0826919715260618,5.49317612456008e-74
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZFYVE19,Abscission/NoCut checkpoint regulator,37901,0.15029375144663,0.00820943973001876,0.134203249575794,0.166384253317467,5.70073413653918e-74
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SUGP1,SURP and G-patch domain-containing protein 1,37901,0.0653793817522026,0.00357743046718582,0.0583676180365184,0.0723911454678868,1.00937784674424e-73
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRHBP,Corticotropin-releasing factor-binding protein,40357,0.0462263401201523,0.0025323136891193,0.0412630052894784,0.0511896749508261,1.07498064625436e-73
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNAP23,Synaptosomal-associated protein 23,40359,0.143149694370998,0.00784364995445242,0.127776140460271,0.158523248281725,1.1586885423758e-73
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEP85,Centrosomal protein of 85 kDa,39980,0.103755838594871,0.00568719392722233,0.0926089384975152,0.114902738692227,1.36022270833314e-73
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLA2,Src-like-adapter 2,37959,0.169202040893886,0.0093073057727008,0.150959721579393,0.18744436020838,5.55166751968482e-73
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD99L2,CD99 antigen-like protein 2,40332,0.0389546469416032,0.00214745702011845,0.0347456311821711,0.0431636627010354,8.37753091775289e-73
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLIP2,CAP-Gly domain-containing linker protein 2,40341,0.183008853826484,0.0100897783591114,0.163232888242625,0.202784819410342,8.65036090073795e-73
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINH1,Serpin H1,37714,0.21057822398744,0.0116212442380595,0.187800585280843,0.233355862694037,1.65303276351231e-72
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37714,0.173775832620057,0.00959066803644064,0.154978123268633,0.19257354197148,1.67806414727272e-72
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCBP2,Poly(rC)-binding protein 2,37959,0.117362643539497,0.00647973744008456,0.104662358156931,0.130062928922063,1.83324590635787e-72
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,40411,0.15566760655492,0.00860673960216092,0.138798396934684,0.172536816175155,2.14154327977276e-72
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL5,C-C motif chemokine 5,40403,0.163068427317969,0.00903775250978683,0.145354432398786,0.180782422237151,4.65522218615926e-72
NMR metabolomics,X23503.Total Lipids in Medium VLDL,THOP1,Thimet oligopeptidase,40288,0.0487516555681175,0.00270350467211196,0.0434527864107781,0.0540505247254569,5.65094133004799e-72
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARHGAP45,Rho GTPase-activating protein 45,37671,0.133978529830095,0.00742889520355437,0.119417895231129,0.148539164429062,7.52979463596034e-72
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,40411,0.0561473367072647,0.00311849676494205,0.0500350830479783,0.0622595903665512,9.18691846601427e-72
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STAT5B,Signal transducer and activator of transcription 5B,40305,0.223806308198482,0.012436067385459,0.199431616122983,0.248181000273982,1.07111219451315e-71
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MXRA8,Matrix remodeling-associated protein 8,37671,-0.0495845303006888,0.00275392446045475,-0.0549822222431801,-0.0441868383581975,1.27248857911286e-71
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RTBDN,Retbindin,40305,0.047557285430179,0.00264463272921284,0.0423738052809218,0.0527407655794361,1.37158700976217e-71
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCN2,CCN family member 2,40358,0.0934512874796307,0.00519806913575567,0.0832630719735496,0.103639502985712,1.47691162477128e-71
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40516,0.162296078121816,0.00902830657768357,0.144600597229556,0.179991559014076,1.49856154267093e-71
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFKBIE,NF-kappa-B inhibitor epsilon,39980,0.0805387207485662,0.0044798476049603,0.071758219442844,0.0893192220542884,1.53783217856671e-71
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLSCR3,Phospholipid scramblase 3,37919,0.0972367401323288,0.00540710844396408,0.0866388075821592,0.107834672682498,1.80674788697332e-71
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FABP5,Fatty acid-binding protein 5,40432,0.112019058460596,0.00624336107054585,0.0997820707623261,0.124256046158866,2.76677278241467e-71
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BID,BH3-interacting domain death agonist,40341,0.108415194715888,0.00604884381836652,0.0965594608318898,0.120270928599887,3.89045633060784e-71
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37562,0.120282950676731,0.00670865191147343,0.107133992930243,0.133431908423219,4.88115774349616e-71
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CKB,Creatine kinase B-type,37998,-0.097928118129452,0.00547125587642602,-0.108651779647247,-0.087204456611657,7.88900850995814e-71
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFX1,Transcriptional repressor NF-X1,37562,0.10986083510587,0.00614311473284182,0.0978203302295002,0.12190133998224,1.09255835961445e-70
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SDCCAG8,Serologically defined colon cancer antigen 8,37900,0.184375630598421,0.0103170044178723,0.164154301939392,0.204596959257451,1.29718529143932e-70
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37990,0.117100479647492,0.00655809639546719,0.104246610712376,0.129954348582608,1.67134259170979e-70
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL3,C-X-C motif chemokine 3,40350,0.149940482371493,0.00840634536097883,0.133464045463975,0.166416919279012,1.78522612359055e-70
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CMC1,COX assembly mitochondrial protein homolog,37990,0.145138746754337,0.00813076335605199,0.129202450576475,0.161075042932199,1.83361899768516e-70
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPPC,C-type natriuretic peptide,40341,0.0693539659139694,0.00389462733288259,0.0617204963415195,0.0769874354864192,2.96963166285652e-70
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJB6,DnaJ homolog subfamily B member 6,37557,0.135609533155356,0.00763447860649507,0.120645955086626,0.150573111224086,9.00552994541808e-70
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,40422,0.166198833455364,0.00936900582396498,0.147835582040393,0.184562084870336,9.73896022305501e-70
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD2AP,CD2-associated protein,40359,0.102122909706924,0.00577268459869454,0.0908084478934829,0.113437371520365,2.28156408064062e-69
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LEP,Leptin,40359,0.10198878963354,0.0057677449023696,0.0906840096248957,0.113293569642185,2.62702089348706e-69
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGF2R,Cation-independent mannose-6-phosphate receptor,40332,0.036632745495242,0.00207192413900248,0.0325717741827971,0.0406937168076868,2.73019300482959e-69
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37901,0.163808863404825,0.00927214299075554,0.145635463142944,0.181982263666706,4.54941461316033e-69
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AHSG,Alpha-2-HS-glycoprotein,37987,0.0431833179849617,0.00244539972844753,0.0383903345172046,0.0479763014527189,5.14691920249836e-69
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FOXO1,Forkhead box protein O1,40341,0.134689688655753,0.00764269392486499,0.119710008563017,0.149669368748488,7.36877022086554e-69
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PON2,Serum paraoxonase/arylesterase 2,40042,0.0547536527150658,0.00310709806816589,0.0486637405014607,0.060843564928671,7.74243105821698e-69
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFSF11,Tumor necrosis factor ligand superfamily member 11,40341,0.0967303707417796,0.00549369464311463,0.0859627292412749,0.107498012242284,9.6902832436503e-69
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPHA1,Ephrin type-A receptor 1,40400,0.0542286681553634,0.00308265426530344,0.0481866657953687,0.0602706705153582,1.27091674121073e-68
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RGCC,Regulator of cell cycle RGCC,37959,0.119052483654782,0.00676494808098042,0.10579318541606,0.132311781893504,1.47185592995091e-68
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL1RL2,Interleukin-1 receptor-like 2,40044,0.0643929204895714,0.00366268345294273,0.0572140609218036,0.0715717800573391,1.58290369082794e-68
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AGRN,Agrin,40422,0.052429347997545,0.00299728554287819,0.0465546683335037,0.0583040276615862,7.04104919181912e-68
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GDF2,Growth/differentiation factor 2,40359,0.0564352402654847,0.00322878236539321,0.050106826829314,0.0627636537016553,8.92996843682954e-68
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL1RN,Interleukin-1 receptor antagonist protein,40313,0.0869458049880896,0.00497830617969262,0.077188324875892,0.0967032851002871,1.13815163636353e-67
NMR metabolomics,X23503.Total Lipids in Medium VLDL,F11,Coagulation factor XI,37810,0.0478064862342533,0.00273757218826966,0.0424408447452448,0.0531721277232619,1.53720472847745e-67
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BACH1,Transcription regulator protein BACH1,40341,0.114231902295794,0.00656079577030788,0.101372742585991,0.127091062005598,2.85150694225943e-67
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MMP10,Stromelysin-2,40341,-0.094195216337988,0.00541551784737608,-0.104809631318845,-0.0835808013571309,3.86250509328121e-67
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,40403,-0.0589233108111843,0.00339109212105152,-0.0655698513684453,-0.0522767702539233,5.1976547334757e-67
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37990,0.101411025071052,0.00583437266667356,0.089975654644372,0.112846395497732,6.04820954933636e-67
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK10,Kallikrein-10,40354,0.0616634281563555,0.00355257543544733,0.0547003803028787,0.0686264760098323,7.16532637856631e-67
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GIGYF2,GRB10-interacting GYF protein 2,37959,0.118841810614251,0.00684852486840976,0.105418701872168,0.132264919356334,9.90907274991976e-67
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCXR,L-xylulose reductase,40411,0.0818269066008488,0.00472383729967882,0.0725681854934784,0.0910856277082193,1.30181458393778e-66
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RILPL2,RILP-like protein 2,37990,0.152309446040053,0.00879411834835039,0.135072974077286,0.16954591800282,1.74385321348496e-66
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSNK2A1,Casein kinase II subunit alpha,37959,-0.0708979896304691,0.00409498067129459,-0.0789241517462065,-0.0628718275147317,1.94090048493755e-66
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEC31A,Protein transport protein Sec31A,37628,0.119689148086459,0.00691474215100916,0.106136253470481,0.133242042702437,2.16819444681964e-66
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TREM2,Triggering receptor expressed on myeloid cells 2,40357,0.0785802536078014,0.0045464554411344,0.069669200943178,0.0874913062724249,2.51099131575063e-66
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLG,Plasminogen,37705,0.0350554614131727,0.00202639079151954,0.0310837354617944,0.039027187364551,2.53665614351922e-66
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TACC3,Transforming acidic coiled-coil-containing protein 3,40305,0.181059427936376,0.0104799111449098,0.160518802092353,0.201600053780399,2.84341489153617e-66
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,40228,0.147881911498455,0.00856257539492267,0.131099263724407,0.164664559272503,3.17459653939752e-66
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL13,C-C motif chemokine 13,40483,0.108800922157053,0.0063010799551326,0.0964508054449934,0.121151038869113,3.30719171615913e-66
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SRPK2,SRSF protein kinase 2,40341,0.129012130915951,0.00747292745699073,0.114365193100249,0.143659068731652,3.52846469250538e-66
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAXX,Protein PAXX,37671,0.0707573501442522,0.00409633373467766,0.062728536024284,0.0787861642642204,3.96743935223477e-66
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PBLD,Phenazine biosynthesis-like domain-containing protein,39961,0.0784344362706886,0.00454796218167485,0.0695204303946059,0.0873484421467712,4.94354385236323e-66
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,40192,0.173961105005612,0.0101014755151961,0.154162212995828,0.193759997015397,7.36560523665568e-66
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37942,0.10736580921797,0.00623342919475729,0.0951482879962454,0.119583330439694,8.82103565334094e-66
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FKBPL,FK506-binding protein-like,37901,0.0917967592571275,0.00533119825621593,0.0813476106749443,0.102245907839311,9.71316258222549e-66
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HEXIM1,Protein HEXIM1,40341,0.126974296134641,0.00738362148537153,0.112502398023313,0.141446194245969,1.10346184611501e-65
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TBCC,Tubulin-specific chaperone C,40228,0.12627845870088,0.00735075166673151,0.111870985434086,0.140685931967674,1.50510792920932e-65
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LZTFL1,Leucine zipper transcription factor-like protein 1,37671,0.110552890576059,0.00643937520756793,0.0979317151692261,0.123174065982892,2.34244929275079e-65
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GIT1,ARF GTPase-activating protein GIT1,37598,0.151842703963138,0.00884526772224508,0.134505979227538,0.169179428698739,2.43278258564547e-65
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GH1,Somatotropin,40330,-0.270764400440092,0.0158206390687388,-0.30177285301482,-0.239755947865364,4.42483406934654e-65
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APPL2,DCC-interacting protein 13-beta,37671,0.172784859838158,0.0100915983096091,0.153005327151324,0.192564392524992,5.13235554969049e-65
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39980,0.0953197275362067,0.00557185761980917,0.0843988866013808,0.106240568471033,5.1541940171117e-65
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37901,0.138191295642972,0.00808440799617612,0.122345855970467,0.154036735315477,8.00771989093753e-65
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEMA3F,Semaphorin-3F,40359,0.0398807614296606,0.00233695657787103,0.0353003265370334,0.0444611963222878,1.01374765828465e-64
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SKAP2,Src kinase-associated phosphoprotein 2,40422,0.160890279410806,0.00943322662193491,0.142401155231813,0.179379403589798,1.18429183005222e-64
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HCLS1,Hematopoietic lineage cell-specific protein,40516,0.0862186231372041,0.00505636662121865,0.0763081445596155,0.0961291017147926,1.26130995116174e-64
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LGALS1,Galectin-1,40359,0.0518398794814855,0.0030409530914902,0.0458796114221647,0.0578001475408063,1.37207128351337e-64
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGA5,Integrin alpha-5,40332,0.0383729775783662,0.0022511623158622,0.0339606994392763,0.0427852557174561,1.40775063857947e-64
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PHLDB1,Pleckstrin homology-like domain family B member 1,37901,0.0817499806634918,0.00480588698898323,0.0723304421650846,0.0911695191618989,3.22468157751289e-64
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37663,0.0699066753068204,0.00411251210254529,0.0618461515858316,0.0779671990278092,4.03954090718567e-64
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VNN1,Pantetheinase,37987,0.11126936474543,0.00654685341255753,0.0984375320568171,0.124101197434043,4.0709057958558e-64
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TANK,TRAF family member-associated NF-kappa-B activator,40044,0.106924618598101,0.00630259388810651,0.0945715345774121,0.11927770261879,5.57153479555407e-64
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",40277,0.1597990179906,0.00942334731608987,0.141329257251064,0.178268778730137,6.18514482041526e-64
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MITD1,MIT domain-containing protein 1,40228,0.148169086781018,0.00874390741991842,0.131031028237978,0.165307145324058,7.63506234783805e-64
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,40341,0.153627515190925,0.00908813613822298,0.135814768360008,0.171440262021842,1.5049994549996e-63
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VAMP8,Vesicle-associated membrane protein 8,37598,0.135805576966866,0.00802796695857015,0.120070761728069,0.151540392205664,1.59395351797133e-63
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EZR,Ezrin,40471,0.0361608661033001,0.00213973113601481,0.0319669930767111,0.0403547391298892,1.60453756203168e-63
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WASF1,Wiskott-Aldrich syndrome protein family member 1,40042,0.140739696765183,0.00833251651332438,0.124407964399068,0.157071429131299,1.9390496406958e-63
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNMBP,Dynamin-binding protein,40228,0.0941548349497333,0.00557569837240529,0.0832264661398189,0.105083203759648,2.03380617093817e-63
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TBC1D23,TBC1 domain family member 23,40305,0.136873254022311,0.0081060242222141,0.120985446546771,0.15276106149785,2.06450760459352e-63
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HJV,Hemojuvelin,37959,0.0704272929052017,0.00416791227739794,0.0622581848415018,0.0785964009689017,2.10042969073726e-63
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IST1,IST1 homolog,37812,0.1530423596737,0.00905744150191539,0.135289774329946,0.170794945017454,2.15746444466545e-63
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AP3B1,AP-3 complex subunit beta-1,37901,0.116584049862555,0.00690692960267189,0.103046467841318,0.130121631883792,2.85976014140033e-63
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARHGEF1,Rho guanine nucleotide exchange factor 1,37942,0.138884156792911,0.0082313817196056,0.122750648622484,0.155017664963338,3.18506639778379e-63
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37959,0.164217493359863,0.009740742452911,0.145125638152157,0.183309348567568,3.98921891182426e-63
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ORM1,Alpha-1-acid glycoprotein 1,37950,0.0302627086769657,0.00179510226618712,0.0267443082352389,0.0337811091186924,4.0156674205706e-63
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DLK1,Protein delta homolog 1,40536,0.0806273435406439,0.00479113448920074,0.0712367199418104,0.0900179671394773,5.22299823348495e-63
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37959,0.117096266095515,0.00695416347827496,0.103466105678096,0.130726426512934,5.60451896839661e-63
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RABEP1,Rab GTPase-binding effector protein 1,37671,0.120216980455405,0.00713883395314585,0.106224865907239,0.134209095003571,5.63734878492571e-63
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37959,0.0996851874620186,0.00593730396963523,0.0880480716815336,0.111322303242504,1.25252576710828e-62
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD36,Platelet glycoprotein 4,37598,0.0674433910253905,0.00401748668477383,0.0595691171232338,0.0753176649275472,1.35077092090471e-62
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ASAH2,Neutral ceramidase,40228,0.0797496643026351,0.0047561500225926,0.0704276102583536,0.0890717183469166,1.46306939872798e-62
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAPGEF2,Rap guanine nucleotide exchange factor 2,37714,0.0799841338996522,0.00476737102258462,0.0706400866953863,0.089328181103918,1.573761619382e-62
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37628,0.0700518739041014,0.00417732549065543,0.0618643159424168,0.0782394318657861,1.80853622310446e-62
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCAMP3,Secretory carrier-associated membrane protein 3,40305,0.129041199269027,0.00771470260473028,0.113920382163756,0.144162016374298,2.86395263410388e-62
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPL,N-acetylneuraminate lyase,37990,0.0652025562423927,0.00390078842137058,0.0575570109365064,0.072848101548279,4.25235312991505e-62
NMR metabolomics,X23503.Total Lipids in Medium VLDL,USP8,Ubiquitin carboxyl-terminal hydrolase 8,40042,0.145669615981408,0.00872730424200772,0.128564099667073,0.162775132295743,5.23828894149864e-62
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDLIM5,PDZ and LIM domain protein 5,37959,0.178713264350673,0.0107044321617019,0.157732577313737,0.199693951387608,5.92196332106071e-62
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SUSD1,Sushi domain-containing protein 1,40042,0.074318097579416,0.00445595450582505,0.0655844267479989,0.0830517684108331,6.47358561535278e-62
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEP43,Centrosomal protein 43,39934,0.103855413858962,0.00624002315576923,0.0916249684736542,0.11608585924427,1.15912189398302e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MSRA,Mitochondrial peptide methionine sulfoxide reductase,40411,0.109418107989457,0.00658189020442045,0.0965176031887925,0.122318612790121,1.53450082913921e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AHNAK,Neuroblast differentiation-associated protein AHNAK,37628,0.0470575184565901,0.00283032303873021,0.0415100853006788,0.0526049516125013,1.90090095046821e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STK11,Serine/threonine-protein kinase STK11,40042,0.10957915077071,0.00659835780997778,0.0966463694631534,0.122511932078266,2.0875179704627e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDGFB,Platelet-derived growth factor subunit B,40422,0.128613027236523,0.00774590849372369,0.113431046588824,0.143795007884221,2.13227371238615e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OPHN1,Oligophrenin-1,37942,0.16049770882108,0.00966871700629531,0.141547023488741,0.179448394153418,2.83597988998253e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AKT1S1,Proline-rich AKT1 substrate 1,39961,0.101262818644457,0.00611963184489626,0.0892683402284603,0.113257297060454,5.58588210332915e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,YOD1,Ubiquitin thioesterase OTU1,37562,0.0953882850496818,0.00576252741969467,0.0840937313070803,0.106682838792283,6.29570517460511e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BTN3A2,Butyrophilin subfamily 3 member A2,40341,0.0564651036552835,0.00341430693468344,0.0497730620633039,0.063157145247263,6.3308857336913e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HMOX2,Heme oxygenase 2,39961,0.0682592425589505,0.00413240523209494,0.0601597283040444,0.0763587568138566,8.98717969801764e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DAG1,Dystroglycan,40422,0.0706496626154664,0.00427886473007693,0.0622630877445156,0.0790362374864172,9.69294048984869e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNST,Consortin,40359,0.160879766992036,0.00974744262921277,0.141774779438779,0.179984754545293,1.08231414720264e-60
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FUOM,Fucose mutarotase,37671,0.0932333107857213,0.00564479555877462,0.0821695114905231,0.10429711008092,1.12686906663796e-60
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAK4,Serine/threonine-protein kinase PAK 4,39961,0.091300883206004,0.00554070734150139,0.0804410968166613,0.102160669595347,1.71866843726139e-60
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDNF,Cerebral dopamine neurotrophic factor,40305,0.048219219345765,0.00293196255398088,0.0424725727399625,0.0539658659515676,2.82450375315846e-60
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,40305,0.0457519314226477,0.00278317089409774,0.0402969164702161,0.0512069463750793,3.17848036719696e-60
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NIT2,Omega-amidase NIT2,37936,0.112413751864484,0.00683545146769295,0.0990162669878059,0.125811236741162,3.46740108467582e-60
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNPY4,Protein canopy homolog 4,40305,0.111144660768453,0.0067656286776038,0.0978840285603499,0.124405292976557,3.79550718241799e-60
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDHD2,Phospholipase DDHD2,37959,0.0984241818848925,0.00598719735165972,0.0866892750756395,0.110159088694146,3.84864054979023e-60
NMR metabolomics,X23503.Total Lipids in Medium VLDL,METAP2,Methionine aminopeptidase 2,40453,0.0874434441596346,0.0053254501389333,0.0770055618873253,0.0978813264319438,4.27078335127026e-60
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AZI2,5-azacytidine-induced protein 2,37959,0.0818421897701501,0.00498415674547003,0.0720732425490289,0.0916111369912714,5.20207848088572e-60
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL10,C-X-C motif chemokine 10,40422,0.100032219481491,0.00610444855153539,0.0880675003204818,0.111996938642501,7.31972171545682e-60
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VPS53,Vacuolar protein sorting-associated protein 53 homolog,40305,0.112833059376654,0.00688664363771358,0.0993352378467352,0.126330880906572,7.67728369959505e-60
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37671,0.072033352359244,0.00439385572468173,0.0634213951388678,0.0806453095796202,8.19257974548779e-60
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SYTL4,Synaptotagmin-like protein 4,37990,0.108565614436948,0.00662634262677884,0.0955779828884611,0.121553245985434,9.35249796755004e-60
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,40359,0.124266455540193,0.00759122524902186,0.10938765405211,0.139145257028275,9.68135042849974e-60
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COMMD1,COMM domain-containing protein 1,37628,0.0912568817569999,0.00557020028889613,0.0803392891907635,0.102174474323236,9.83407778320422e-60
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDCD5,Programmed cell death protein 5,40471,0.0863604048475059,0.00527632139712479,0.0760188149091413,0.0967019947858705,9.95544067650269e-60
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,40379,0.0394376430655658,0.00241141223453402,0.0347112750858791,0.0441640110452525,1.23512057570172e-59
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SH2B3,SH2B adapter protein 3,39980,0.144530826293003,0.00883736876569971,0.127209583512232,0.161852069073775,1.27226525157149e-59
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37990,0.11407245316028,0.00697209703410574,0.100407142973433,0.127737763347127,1.34741897051927e-59
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MPRIP,Myosin phosphatase Rho-interacting protein,37863,0.064280362942714,0.00392942360199913,0.0565786926827957,0.0719820332026323,1.42142641580902e-59
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MME,Neprilysin,40305,0.120075142044356,0.00735932867012141,0.105650857850918,0.134499426237794,2.31115258507368e-59
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL18A1,Collagen alpha-1(XVIII) chain,40391,0.0341727371719141,0.0020947569032019,0.0300670136416384,0.0382784607021898,2.39507959962203e-59
NMR metabolomics,X23503.Total Lipids in Medium VLDL,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37900,0.106742848080884,0.00654391281870239,0.0939167789562272,0.119568917205541,3.01273271014935e-59
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FABP4,"Fatty acid-binding protein, adipocyte",40536,0.0722963380579862,0.00443725888703504,0.0635993106393975,0.0809933654765749,3.29583132264965e-59
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FAM13A,Protein FAM13A,37901,0.0994147442551998,0.00609725513636377,0.0874641241879268,0.111365364322473,3.36750552608194e-59
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYDGF,Myeloid-derived growth factor,37990,0.148056764359042,0.00908596903869292,0.130248265043204,0.16586526367488,3.90372911245972e-59
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRELD2,Protein disulfide isomerase CRELD2,40396,0.0762091424769483,0.00468224062841115,0.0670319508452625,0.0853863341086342,4.35942536449566e-59
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37959,0.116514225279807,0.00716996076081476,0.10246110218861,0.130567348371004,8.02093722765475e-59
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANXA11,Annexin A11,40312,0.0989373992137249,0.00609582283442773,0.0869895864582466,0.110885211969203,9.15114338846929e-59
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRKL,Crk-like protein,40374,0.155985981928484,0.00963003490750611,0.137111113509772,0.174860850347196,1.53328150166392e-58
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STC1,Stanniocalcin-1,40471,0.0606592830263236,0.00374622601395505,0.0533166800389717,0.0680018860136755,1.6703847873333e-58
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BIRC2,Baculoviral IAP repeat-containing protein 2,39980,0.0928221440374317,0.00573742140157367,0.0815767980903473,0.104067489984516,2.15088343103111e-58
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BRAP,BRCA1-associated protein,37778,0.159920227624171,0.00990696580336745,0.140502574649571,0.179337880598771,4.57523471252428e-58
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OGFR,Opioid growth factor receptor,40305,0.0482239577172763,0.00299032611360697,0.0423629185346067,0.054084996899946,4.79976766548987e-58
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAT,Linker for activation of T-cells family member 1,40516,0.110213738808009,0.00683514251127273,0.0968168594859142,0.123610618130103,4.89371947988107e-58
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MARS1,"Methionine--tRNA ligase, cytoplasmic",37642,0.124901310648543,0.00774062150735934,0.109729692494119,0.140072928802967,5.12866571896148e-58
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GFER,FAD-linked sulfhydryl oxidase ALR,39980,0.0935731423942022,0.00580705576669697,0.0821913130914761,0.104954971696928,6.03028123263054e-58
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GTPBP2,GTP-binding protein 2,37572,0.116725617035689,0.00723867874975866,0.102537806686162,0.130913427385216,6.10570067734926e-58
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39980,0.12006559504002,0.00745336872364646,0.105456992341673,0.134674197738367,6.50820441412417e-58
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HYOU1,Hypoxia up-regulated protein 1,40536,0.0314899713088111,0.00195803605020432,0.0276522206504106,0.0353277219672116,9.55548368169524e-58
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DOK1,Docking protein 1,37942,0.198419493392812,0.0123402563333895,0.174232590979368,0.222606395806255,1.22752790319756e-57
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STAMBP,STAM-binding protein,40192,0.0941155952871142,0.00585785288938671,0.0826342036239162,0.105596986950312,1.25696689697127e-57
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRIM21,E3 ubiquitin-protein ligase TRIM21,40341,0.116138236183999,0.00725203856119187,0.101924240604063,0.130352231763935,2.83762679419794e-57
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TGFB1,Transforming growth factor beta-1 proprotein,40502,0.0549061348157441,0.00342960253758321,0.048184113842081,0.0616281557894072,3.04422659521626e-57
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DBNL,Drebrin-like protein,40422,0.1335521522496,0.0083485330080723,0.117189027553778,0.149915276945422,3.7220749355509e-57
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF19,Fibroblast growth factor 19,40422,0.110655880016247,0.00693306284018119,0.0970670768494918,0.124244683183002,6.62046069959099e-57
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WASHC3,WASH complex subunit 3,37942,0.108287023319028,0.00678882913381477,0.0949809182167513,0.121593128421305,9.28866754623898e-57
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39886,0.0792042640857472,0.00497301182998802,0.0694571608989707,0.0889513672725238,1.16694179917526e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRIM5,Tripartite motif-containing protein 5,40341,0.122616238551559,0.00770638478233417,0.107511724378184,0.137720752724934,1.45338755154981e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIA1,Nucleolysin TIA-1 isoform p40,39836,0.173520914861687,0.010905904701166,0.152145341647402,0.194896488075973,1.50784502891626e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPART,Spartin,37671,0.111208903958726,0.00698777174985465,0.0975128713290112,0.124904936588441,1.67365379908486e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDC27,Cell division cycle protein 27 homolog,39980,0.0876118013902369,0.00551114149931573,0.076809964051578,0.0984136387288957,1.8468775071218e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNX15,Sorting nexin-15,37671,0.0780270552987757,0.00490809069045053,0.0684071975454927,0.0876469130520587,2.18956467664651e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPON2,Spondin-2,40267,-0.0496368604052234,0.00312563907727358,-0.0557631129966797,-0.0435106078137672,2.35554853964384e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TWF2,Twinfilin-2,37998,0.119192574374562,0.00750406310214222,0.104484610694363,0.133900538054761,2.64518289027851e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HS1BP3,HCLS1-binding protein 3,37628,0.128614484435945,0.00809636383300692,0.112745611323251,0.144483357548638,2.65964021080974e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37671,0.090850979869335,0.00572404497990186,0.0796318517087274,0.102070108029943,3.27992931881942e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,A1BG,Alpha-1B-glycoprotein,38013,0.0251688471509949,0.00158676031842722,0.0220587969268775,0.0282788973751122,3.72456816773739e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STAT2,Signal transducer and activator of transcription 2,37598,0.110460478374104,0.00696302197762281,0.0968129552979633,0.124108001450245,3.73797944411891e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EREG,Proepiregulin,40192,0.115204001648383,0.00727212145091143,0.100950643604596,0.129457359692169,4.33927897598883e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EVI5,Ecotropic viral integration site 5 protein homolog,37598,0.128734346768051,0.00814373159669867,0.112772632838522,0.144696060697581,8.96697423596285e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FETUB,Fetuin-B,40372,0.0482616250012098,0.00305626531741222,0.0422713449790819,0.0542519050233378,9.4982342923e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRADD,Death domain-containing protein CRADD,40192,0.109438917629586,0.00693927046972076,0.0958379475089332,0.123039887750239,1.31378192742386e-55
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37900,0.11770680560185,0.00746793278304862,0.103069657347075,0.132343953856625,1.79110449524101e-55
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRKG1,cGMP-dependent protein kinase 1,37671,0.178697924136055,0.0113386834554188,0.156474104563434,0.200921743708676,1.87264140763346e-55
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",40305,0.0625125627748869,0.003969769611379,0.0547318143365841,0.0702933112131898,1.89041722867366e-55
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHMP1A,Charged multivesicular body protein 1a,40228,0.113254559437533,0.00719920328710362,0.0991441209948097,0.127364997880256,2.42139056174495e-55
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRAF2,TNF receptor-associated factor 2,40341,0.10114984719492,0.0064463445558399,0.0885150118654741,0.113784682524367,4.51152414300135e-55
NMR metabolomics,X23503.Total Lipids in Medium VLDL,QDPR,Dihydropteridine reductase,40290,0.0620162800109908,0.00396358988719576,0.0542476438320871,0.0697849161898945,9.02307537312689e-55
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",40182,0.0581251975851959,0.00371484270908121,0.0508441058753968,0.0654062892949951,9.0457294940465e-55
NMR metabolomics,X23503.Total Lipids in Medium VLDL,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37901,0.209030832767135,0.0133557396511776,0.182853583050827,0.235208082483443,9.93189536310955e-55
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PACS2,Phosphofurin acidic cluster sorting protein 2,37562,0.0880965255083585,0.00562817645599107,0.077065299654616,0.099127751362101,9.94499279269384e-55
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEMA4D,Semaphorin-4D,40471,0.0422420568855225,0.00270196615368625,0.0369462032242975,0.0475379105467476,1.08613745800476e-54
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GORASP2,Golgi reassembly-stacking protein 2,37901,0.0663563873757568,0.00424521652486063,0.05803576298703,0.0746770117644836,1.35522605288322e-54
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LYN,Tyrosine-protein kinase Lyn,40305,0.118622529740702,0.00759843008297263,0.103729606778076,0.133515452703329,1.54935458026779e-54
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HDGFL2,Hepatoma-derived growth factor-related protein 2,37942,0.0881767730366758,0.00564640865702797,0.0771098120689009,0.0992437340044506,1.68695254013754e-54
NMR metabolomics,X23503.Total Lipids in Medium VLDL,XPNPEP2,Xaa-Pro aminopeptidase 2,40411,0.124046774952133,0.00796562811894536,0.108434143839,0.139659406065266,2.79669152855451e-54
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MPHOSPH8,M-phase phosphoprotein 8,40042,0.105406362353429,0.00676888578971872,0.0921393462055806,0.118673378501278,2.88264824041456e-54
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TOP2B,DNA topoisomerase 2-beta,37598,0.111535232807816,0.00716630043585393,0.0974892839535427,0.12558118166209,3.89424002617815e-54
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OGA,Protein O-GlcNAcase,37901,0.0989798555705157,0.00636123188608782,0.0865118410737836,0.111447870067248,4.03927991941194e-54
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IDUA,Alpha-L-iduronidase,40489,0.0636561423470473,0.00409463289476002,0.0556306618733176,0.0716816228207769,4.18752862635624e-54
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39980,0.118856389302501,0.00766042630212982,0.103841953750327,0.133870824854676,6.90017235240318e-54
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP5IF1,"ATPase inhibitor, mitochondrial",40422,0.155034836096534,0.0100025974269001,0.13542974513981,0.174639927053259,8.62114689909154e-54
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,37391,0.0491839844130013,0.00317597388025486,0.0429590756077018,0.0554088932183008,1.29925201735261e-53
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIFBP,KIF-binding protein,40305,0.115095006211569,0.00746106007339428,0.100471328467717,0.129718683955422,2.66559247505399e-53
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CASC3,Protein CASC3,37572,0.0572979910066038,0.00371781441120554,0.050011074760641,0.0645849072525667,3.9837039257607e-53
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GP1BB,Platelet glycoprotein Ib beta chain,37562,0.0946486106476586,0.00614199075693634,0.0826103087640634,0.106686912531254,4.08840884674415e-53
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NHLRC3,NHL repeat-containing protein 3,37370,0.0445781780899807,0.00289346223899822,0.0389069921015441,0.0502493640784172,4.38465956361494e-53
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBM17,Splicing factor 45,37959,0.10645139068986,0.00691290828344111,0.0929020904543156,0.120000690925405,4.69561125938755e-53
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EDAR,Tumor necrosis factor receptor superfamily member EDAR,40341,0.127858465590456,0.00832362750460732,0.111544155681426,0.144172775499486,7.17973851049628e-53
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TAX1BP1,Tax1-binding protein 1,37942,0.0892727430717444,0.00581048458536394,0.0778841932844311,0.100661292859058,7.98011331966765e-53
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSO,Cathepsin O,40516,0.0418279043159329,0.00272436262317402,0.0364881535745119,0.047167655057354,7.98630238585742e-53
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNCG,Gamma-synuclein,40228,0.0929546030422516,0.00606790470774285,0.0810615098150756,0.104847696269428,1.36345791779649e-52
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ICA1,Islet cell autoantigen 1,40044,0.110013595717565,0.00718336546974914,0.095934199396857,0.124092992038274,1.463751189662e-52
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAVS,Mitochondrial antiviral-signaling protein,39980,0.128670998277507,0.00840317740293234,0.11220077056776,0.145141225987254,1.53419227891054e-52
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPP1R2,Protein phosphatase inhibitor 2,40359,0.109834569521548,0.00717584838007838,0.0957699066965945,0.123899232346502,1.64651363310378e-52
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ESM1,Endothelial cell-specific molecule 1,40357,-0.046917879007019,0.00306741411716985,-0.0529300106766719,-0.0409057473373661,1.93234173368851e-52
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAX,Protein max,39961,0.144845739708482,0.00947370259056491,0.126277282630975,0.163414196785989,2.17349358295413e-52
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIMP3,Metalloproteinase inhibitor 3,40422,0.182437016472789,0.0119417376339937,0.159031210710161,0.205842822235416,2.54078095182861e-52
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPY,Pancreatic prohormone,40337,0.139582405028589,0.00913926468305077,0.12166944624981,0.157495363807369,2.72915064808568e-52
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FIS1,Mitochondrial fission 1 protein,40354,0.106632599903866,0.00699177950571709,0.092928712072661,0.120336487735072,3.78366810118532e-52
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C2,Complement C2,40372,0.0330911146382673,0.00217052423296343,0.028836887141659,0.0373453421348756,4.10479269873626e-52
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINE1,Plasminogen activator inhibitor 1,40536,0.0930446875373538,0.00611118428613831,0.0810667663365227,0.105022608738185,5.53328767369847e-52
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MED18,Mediator of RNA polymerase II transcription subunit 18,39980,0.10557603638552,0.00693540679841853,0.0919826390606193,0.11916943371042,5.92277233853334e-52
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAP2,Microtubule-associated protein 2,37942,0.0632208953238432,0.00415527815129494,0.0550765501473051,0.0713652405003812,7.61710890692681e-52
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ISM1,Isthmin-1,40341,0.0534962038697201,0.00353379029464629,0.0465699748922133,0.0604224328472268,2.06142007680553e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD22,B-cell receptor CD22,40516,0.0561715539904477,0.00371320011611689,0.0488936817628586,0.0634494262180368,2.40727671052646e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNASE4,Ribonuclease 4,37575,0.0375034907136096,0.00247728717791683,0.0326480078448926,0.0423589735823266,2.43167529911429e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37671,0.0803594489916148,0.00530925550314252,0.0699533082054555,0.0907655897777742,2.53284472344538e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL7,C-C motif chemokine 7,40341,0.0832998909013451,0.0055110536169564,0.0724982258121106,0.0941015559905797,2.92749520550494e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37714,0.067569781417339,0.00447018246686839,0.0588082237822769,0.076331339052401,3.40684179738824e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DGKA,Diacylglycerol kinase alpha,37598,0.0744271421662217,0.00492816242369535,0.0647679438157789,0.0840863405166646,4.18714140854559e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C3,Complement C3,37360,0.0642607512095521,0.00426437178224463,0.0559025825163526,0.0726189199027515,6.98819217011847e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BAG4,BAG family molecular chaperone regulator 4,37598,0.0664455597471129,0.00441386478993691,0.0577943847588365,0.0750967347353892,8.63025190197942e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VASP,Vasodilator-stimulated phosphoprotein,37987,0.0981872786806736,0.00654035595915197,0.0853681810007357,0.111006376360611,1.55013698996767e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39980,0.0604922227483042,0.00403268734716585,0.0525881555478591,0.0683962899487493,1.64612191077293e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB27B,Ras-related protein Rab-27B,37990,0.111548575537425,0.00743401983728414,0.096977896656348,0.126119254418502,1.72902639431957e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GFRA1,GDNF family receptor alpha-1,40453,0.03781677574755,0.00252320747830491,0.0328712890900724,0.0427622624050277,1.94654131125441e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MVK,Mevalonate kinase,40044,0.104029622613252,0.00694483050536662,0.0904177548227336,0.117641490403771,2.24209343951567e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,40228,0.105919880479495,0.00707145322845902,0.0920598321517152,0.119779928807275,2.25168657294919e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLUL1,Clusterin-like protein 1,40338,-0.0617121079265548,0.00412091009203363,-0.0697890917069407,-0.0536351241461689,2.34679748018761e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RWDD1,RWD domain-containing protein 1,40471,0.0873728073103444,0.00583568068359002,0.075934873170508,0.0988107414501809,2.44448291612515e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARSB,Arylsulfatase B,40305,0.074468912862962,0.00497677739722311,0.0647144291644047,0.0842233965615193,2.81164019155914e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FAM172A,Cotranscriptional regulator FAM172A,37628,0.0838287435854203,0.0056006063138737,0.0728515552102279,0.0948059319606128,3.08250866788975e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MTDH,Protein LYRIC,37598,0.124157618544175,0.0083010259189119,0.107887607743108,0.140427629345242,3.62886047567139e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GOLM2,Protein GOLM2,40471,0.0303746514312091,0.00203313006896329,0.026389716496041,0.0343595863663771,3.94609890892321e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LBR,Delta(14)-sterol reductase LBR,40471,0.0886700495349549,0.00594041694649107,0.0770268323198324,0.100313266750077,4.80250121941766e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39980,0.115732872568223,0.0077608682166984,0.100521570863494,0.130944174272951,6.06972850933036e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NT5C1A,Cytosolic 5'-nucleotidase 1A,37942,0.0430751640341985,0.0028875004385303,0.0374156631746791,0.0487346648937179,6.30930411669289e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37942,0.130650482078164,0.00876225579404297,0.113476460721839,0.147824503434488,7.01606736421914e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37628,0.0946791618925794,0.00635085301976198,0.0822314899738459,0.107126833811313,7.43745700998476e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LGALS8,Galectin-8,40471,0.0815105339272034,0.00547309942061545,0.0707832590627972,0.0922378087916097,7.89250784153369e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DRG2,Developmentally-regulated GTP-binding protein 2,40305,0.0757562989594081,0.00508723023874766,0.0657853276914627,0.0857272702273535,8.13074642926596e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATOX1,Copper transport protein ATOX1,40411,0.0966611611519851,0.00649949779354699,0.083922145476633,0.109400176827337,1.07625645403187e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TP53,Cellular tumor antigen p53,39980,0.0580761344763732,0.00390541840516721,0.0504215144022454,0.0657307545505009,1.12274403790736e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DTNB,Dystrobrevin beta,37878,0.0563019028939579,0.0037864827655944,0.0488803966733928,0.0637234091145229,1.29603557845675e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37959,0.107854202789259,0.00725918472627194,0.0936262007257657,0.122082204852752,1.52772666454208e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIGLEC7,Sialic acid-binding Ig-like lectin 7,40359,0.0374622911192374,0.0025245277519458,0.0325142167254236,0.0424103655130511,1.74769118437822e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MGLL,Monoglyceride lipase,40396,0.115933936111228,0.00781268850074662,0.100621066649765,0.131246805572692,1.74824027618113e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DLG4,Disks large homolog 4,37942,0.0943467646848758,0.00635557335266814,0.0818898409136462,0.106803688456105,1.84799996370544e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ASPSCR1,Tether containing UBX domain for GLUT4,37959,0.0918708667808416,0.00619148778270328,0.0797355507267432,0.10400618283494,2.02987175299971e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ST13,Hsc70-interacting protein,37671,0.0766579053576744,0.00516642798663888,0.0665317065038622,0.0867841042114866,2.08631776223052e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SH3GLB2,Endophilin-B2,37942,0.0900626718044055,0.00607137189283029,0.0781627828944581,0.101962560714353,2.16323948294778e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPING1,Plasma protease C1 inhibitor,37981,0.0250223311965606,0.0016882068499011,0.0217134457707544,0.0283312166223667,2.57832294975023e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD69,Early activation antigen CD69,40288,0.117864451640925,0.00796299544178503,0.102256980575026,0.133471922706824,3.0550206598817e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BPIFB2,BPI fold-containing family B member 2,37951,0.0909908977547977,0.00615934991309272,0.078918571925136,0.103063223584459,5.2924128363095e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUDC,Nuclear migration protein nudC,40516,0.0846021993021541,0.00573060495538814,0.0733702135895933,0.0958341850147148,5.29737695183483e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIRT2,NAD-dependent protein deacetylase sirtuin-2,40305,0.119674032784541,0.00810922175290497,0.103779958148847,0.135568107420235,5.79339203404863e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GASK1A,Golgi-associated kinase 1A,37562,0.0581686435318261,0.00393925541284915,0.0504477029226418,0.0658895841410105,5.96294071831067e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39980,0.132089907378298,0.00895803820754619,0.114532152491508,0.149647662265089,7.04929630697051e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,YJU2,Splicing factor YJU2,37900,0.0427993870671209,0.00290333595067522,0.0371088486037974,0.0484899255304443,8.38977089140568e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GYS1,"Glycogen [starch] synthase, muscle",40042,0.124252494260189,0.00843580810917233,0.107718310366211,0.140786678154167,8.9076841794683e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OTUD6B,Deubiquitinase OTUD6B,37901,0.0786671292542523,0.00533956433524934,0.0682015831571637,0.089132675351341,9.5059541109381e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MOCS2,Molybdopterin synthase catalytic subunit,37671,0.0898522074358141,0.00609878210517711,0.077898594509667,0.101805820361961,9.6589085157484e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",40280,0.101012304126408,0.00686093341966974,0.0875648746238557,0.114459733628961,9.66368099616291e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GLB1,Beta-galactosidase,40228,0.0544590626180855,0.00370114087906131,0.0472048264951254,0.0617132987410457,1.09967873966705e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDH2,Cadherin-2,40359,0.0469542558719723,0.00319287063514898,0.0406962294270803,0.0532122823168643,1.23111057498912e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NAGK,N-acetyl-D-glucosamine kinase,37608,0.0755213924826518,0.00513245715521425,0.0654617764584318,0.0855810085068717,1.26666040829058e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C4BPB,C4b-binding protein beta chain,40411,0.0549800918440117,0.00374099236141209,0.047647746815644,0.0623124368723794,1.40661747598338e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DIABLO,"Diablo homolog, mitochondrial",40314,0.145761978472799,0.00991837072452743,0.126321971852725,0.165201985092872,1.42315256081208e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GRAP2,GRB2-related adapter protein 2,40359,0.16873677399504,0.0114879720730598,0.146220348731843,0.191253199258238,1.59653494384016e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RTN4R,Reticulon-4 receptor,40489,0.0450623387903908,0.0030690348653052,0.0390470304543926,0.051077647126389,1.71256391915336e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FLT4,Vascular endothelial growth factor receptor 3,40411,0.0442385026100073,0.00301453961532295,0.0383300049639743,0.0501470002560402,1.92674909977593e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MMP7,Matrilysin,40015,0.0642308962385927,0.00437710343398971,0.0556517735079728,0.0728100189692125,1.9839510322775e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LPP,Lipoma-preferred partner,37562,0.0894510756753437,0.00609964271627316,0.0774957759514483,0.101406375399239,2.60684735167966e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LGALS9,Galectin-9,40350,0.0426890192846195,0.00291387114400546,0.0369778318423688,0.0484002067268702,2.76920328789081e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MPI,Mannose-6-phosphate isomerase,40305,0.114001026003324,0.00778225441460319,0.0987478073507015,0.129254244655946,2.83322280118269e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VAV3,Guanine nucleotide exchange factor VAV3,37541,0.132462985584314,0.00903987219990221,0.114744836072506,0.150181135096122,3.0962133251449e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IRAK4,Interleukin-1 receptor-associated kinase 4,40341,0.138743269350318,0.00947667507552236,0.120168986202294,0.157317552498342,3.19276457058811e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIAE,Sialate O-acetylesterase,40374,0.0621330863015817,0.00424457784453063,0.0538137137263016,0.0704524588768617,3.29506291558712e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGL1,Fibrinogen-like protein 1,37987,-0.0834117586895622,0.00569706590116551,-0.0945780078558466,-0.0722455095232778,3.58061314422628e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFNLR1,Interferon lambda receptor 1,40341,0.0495946785492565,0.00339218246336937,0.0429460009210526,0.0562433561774605,4.28043370328078e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,40305,0.0585223275127184,0.0040084544126966,0.050665756863833,0.0663788981616037,5.7746288774116e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UBXN1,UBX domain-containing protein 1,37671,0.0914961307862302,0.00626690783535917,0.0792129914289262,0.103779270143534,6.63573380265553e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37901,0.0672689918795907,0.00462087538729854,0.0582120761204856,0.0763259076386959,1.20277310179629e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EHD3,EH domain-containing protein 3,37628,0.154515133569102,0.0106216135242636,0.133696771061546,0.175333496076659,1.42085893991732e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMED8,Protein TMED8,37901,0.135353871670365,0.00931350972395577,0.117099392611412,0.153608350729318,1.71257313273261e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,40333,0.0804821310806645,0.00554243027094978,0.0696189677496029,0.091345294411726,1.79457381636168e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SAMD9L,Sterile alpha motif domain-containing protein 9-like,40341,0.0947773785392907,0.00653337978309292,0.0819719541644285,0.107582802914153,2.20869199009927e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EGFR,Epidermal growth factor receptor,40536,0.0215143453615002,0.00148375443878534,0.0186061866614809,0.0244225040615195,2.41190100281786e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39980,0.0760567041430395,0.00525270918774065,0.0657613941350678,0.0863520141510111,3.31378041689917e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPRY2,Protein sprouty homolog 2,40044,0.120883295504538,0.00835006602045931,0.104517166104438,0.137249424904639,3.42951702441761e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,40305,0.0363061055889667,0.00251097273660655,0.0313845990252178,0.0412276121527155,4.38590845739611e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CACYBP,Calcyclin-binding protein,37642,0.134507713961785,0.00929776894477649,0.116284086830023,0.152731341093547,4.50992415399195e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DUSP13,Dual specificity protein phosphatase 13 isoform A,37900,0.0539578467472077,0.00373078917878401,0.0466454999567911,0.0612701935376244,4.68856027805554e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CETN3,Centrin-3,37901,0.100682946956852,0.00696420615998191,0.0870331028832879,0.114332791030417,5.08274784591621e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HARS1,"Histidine--tRNA ligase, cytoplasmic",40332,0.101390592054744,0.00701976907338132,0.087631844670917,0.115149339438572,5.46274334985209e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TXNDC5,Thioredoxin domain-containing protein 5,40471,0.0876980761909942,0.00607523652062826,0.0757906126105628,0.0996055397714255,6.11118817621316e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GMPR,GMP reductase 1,40516,0.0667695399438941,0.00462662489156089,0.0577013551564348,0.0758377247313535,6.43594471445436e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PMVK,Phosphomevalonate kinase,39951,0.145055226745554,0.0100543734419474,0.125348654799337,0.16476179869177,7.03447747250486e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC4G,C-type lectin domain family 4 member G,40341,0.0430702849618141,0.00298595021669546,0.037217822537091,0.0489227473865372,7.19467363860886e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,40341,0.131505520891057,0.00912037442438255,0.113629587019267,0.149381454762847,7.77699693137342e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,XIAP,E3 ubiquitin-protein ligase XIAP,37598,0.0753645605128754,0.00522431658603345,0.0651249000042499,0.085604221021501,8.11705100560685e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KYAT1,Kynurenine--oxoglutarate transaminase 1,40340,0.0738415725647327,0.00513363793192025,0.063779642218169,0.0839035029112964,1.28225805341697e-46
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GMPR2,GMP reductase 2,37671,0.0883926478984969,0.00615128992308293,0.0763361196492543,0.100449176147739,1.79286993439932e-46
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NSFL1C,NSFL1 cofactor p47,40471,0.0867688859327628,0.0060436213601035,0.07492338806696,0.0986143837985657,1.86774850189571e-46
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GOLGA3,Golgin subfamily A member 3,37959,0.102061546400869,0.00710567489329909,0.0881344236100026,0.115988669191735,1.93024837325015e-46
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SHMT1,"Serine hydroxymethyltransferase, cytosolic",40396,0.113423044425769,0.00790572753455362,0.0979278184580438,0.128918270393494,2.16499717544577e-46
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSD,Cathepsin D,39243,0.051890639505879,0.00362135886677045,0.0447927761270089,0.0589885028847491,2.93894687763578e-46
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GP5,Platelet glycoprotein V,37671,0.0466804260349666,0.00325760282919795,0.0402955244897387,0.0530653275801946,3.16759706480669e-46
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TBCB,Tubulin-folding cofactor B,40228,0.131253023077318,0.00917518816043185,0.113269654282872,0.149236391871765,3.94510090215278e-46
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD40,Tumor necrosis factor receptor superfamily member 5,40350,0.064029808648941,0.00447760653578696,0.0552536998387986,0.0728059174590835,4.22610127429717e-46
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUB1,NEDD8 ultimate buster 1,40341,0.108176515556498,0.0075696948389271,0.0933399136722007,0.123013117440795,4.82174545006644e-46
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",40341,0.12460147440018,0.00873616994450489,0.10747858130895,0.141724367491409,7.17132610793725e-46
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DPP4,Dipeptidyl peptidase 4,40068,0.0386727107101462,0.00271205723655053,0.0333570785265072,0.0439883428937852,7.58479009647562e-46
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PKD2,Polycystin-2,37562,0.0772786917061408,0.00541674030534747,0.0666618807076597,0.0878955027046218,7.77888292424425e-46
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STXBP1,Syntaxin-binding protein 1,37959,0.100079118816686,0.00701642252857497,0.086326930660679,0.113831306972693,7.94100784419231e-46
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMN,Protein amnionless,40044,0.0615789443582224,0.00432097499584629,0.0531098333663637,0.0700480553500812,8.54753887419252e-46
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39961,0.145301839642328,0.0101959858945886,0.125317707288935,0.165285971995722,8.61190215620269e-46
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COCH,Cochlin,37990,0.0602702527749108,0.00423051719106887,0.0519784390804158,0.0685620664694058,1.00778817489997e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGA2,Integrin alpha-2,37671,0.0437452754348482,0.00307279754630417,0.037722592244092,0.0497679586256043,1.18564917227153e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ELAC1,Zinc phosphodiesterase ELAC protein 1,37959,0.110243170250644,0.00775104566970937,0.0950511207380138,0.125435219763274,1.40665570068437e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRIM40,E3 ubiquitin ligase TRIM40,37572,0.0929191117969286,0.00653310552329588,0.0801142249712687,0.105723998622589,1.44210609278519e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUDT5,ADP-sugar pyrophosphatase,40332,0.0671819363489576,0.00473059849714642,0.0579099632945506,0.0764539094033646,1.7010745891836e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCPEP1,Retinoid-inducible serine carboxypeptidase,37563,0.063604191571546,0.00447678159767305,0.0548296996401068,0.0723786835029852,1.78783412443529e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,B4GAT1,"Beta-1,4-glucuronyltransferase 1",40332,0.0310606758526569,0.00218908921175588,0.0267700609976153,0.0353512907076984,2.034717090547e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNF5,E3 ubiquitin-protein ligase RNF5,37628,0.0945642009341379,0.00666108597889562,0.0815084724155025,0.107619929452773,2.0805489990815e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BGLAP,Osteocalcin,37998,0.117378383477276,0.00828391829359715,0.101141903621826,0.133614863332727,2.98081158960184e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NACC1,Nucleus accumbens-associated protein 1,37900,0.0706617780024968,0.00498765825142908,0.0608859678296958,0.0804375881752978,3.08656599870411e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37671,0.107944692482482,0.00762217791857052,0.0930052237620838,0.12288416120288,3.37253397599621e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL11,Eotaxin,40516,0.0482959561586903,0.00341270117310933,0.041607061859396,0.0549848504579846,3.40048468066397e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTX3,Pentraxin-related protein PTX3,40341,-0.0631025206405061,0.00445913616113982,-0.0718424275163402,-0.0543626137646721,3.44979106599772e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNAP25,Synaptosomal-associated protein 25,37541,0.0601336994148549,0.00424899696455157,0.0518056653643338,0.0684617334653759,3.88038468251194e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BIN2,Bridging integrator 2,40332,0.116235882613077,0.00822600064748273,0.100112921344011,0.132358843882144,4.63286080107687e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RRAS,Ras-related protein R-Ras,37572,0.16736060155484,0.0118465928383985,0.144141279591579,0.190579923518101,5.50593410761263e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EGF,Pro-epidermal growth factor,40324,0.13136352919305,0.00931190637803798,0.113112192692096,0.149614865694004,6.41943415244524e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TDRKH,Tudor and KH domain-containing protein,39961,0.108935242251594,0.00772159949939896,0.0938009072327718,0.124069577270416,6.43980582493642e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SUGT1,Protein SGT1 homolog,39980,0.103830816188239,0.00738469051770269,0.089356822773542,0.118304809602937,1.25120035979214e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAPKAPK2,MAP kinase-activated protein kinase 2,37714,0.0934821767493572,0.00664592871814233,0.0804561564617983,0.106508197036916,1.28394640698374e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERP29,Endoplasmic reticulum resident protein 29,37671,0.151088999100366,0.0107493929070655,0.130020189002517,0.172157809198214,1.48954510801586e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37900,0.0607151551123807,0.00432856987514406,0.0522311581570984,0.0691991520676631,2.20121258208577e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL7,Interleukin-7,40341,0.0819067007016073,0.00584386776713772,0.0704527198780174,0.0933606815251973,2.29157862155601e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37671,0.132094991574792,0.00942264808178375,0.113626601334495,0.150563381815088,2.48098150518529e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PF4,Platelet factor 4,37934,0.123765374755896,0.00882967764683704,0.106459206568096,0.141071542943697,2.51183149178687e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CASP7,Caspase-7,37942,0.106479367849661,0.00759790280538552,0.0915874783511049,0.121371257348216,2.6054205071828e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VEGFA,Vascular endothelial growth factor A,40456,0.0744802602078367,0.00532739627486528,0.0640385635091007,0.0849219569065726,3.72287187139365e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",40332,0.0579866265950677,0.00415076489756094,0.0498511273958483,0.0661221257942871,4.32711072432e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,40305,0.0488809913143645,0.00349943770115658,0.0420220934200976,0.0557398892086314,4.4449838204599e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39980,0.0992736684997669,0.00710679604077452,0.0853443482598488,0.113202988739685,4.46389249248281e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NIT1,Deaminated glutathione amidase,37628,0.0628126571861423,0.00450134976791366,0.0539900116410315,0.0716353027312531,6.09340539587838e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SH2D1A,SH2 domain-containing protein 1A,40341,0.0692850568944045,0.00497084305574088,0.0595422045051524,0.0790279092836566,6.72191924594899e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FAP,Prolyl endopeptidase FAP,40536,0.0341852284153164,0.00245277681866383,0.0293777858507353,0.0389926709798975,6.76073064930499e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPOCK1,Testican-1,40228,0.0318313269032131,0.00228557311190054,0.0273516036038881,0.0363110502025382,7.88440441774504e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPIB,Peptidyl-prolyl cis-trans isomerase B,40338,0.118817216390646,0.00853259263968829,0.102093334816857,0.135541097964435,8.06834433778984e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40489,0.079665879183632,0.005721487089822,0.0684517644875809,0.0908799938796832,8.14900986177204e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BAG6,Large proline-rich protein BAG6,40042,0.045326010386089,0.00325846105668838,0.0389394267149798,0.0517125940571983,1.00172254948693e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MESD,LRP chaperone MESD,40332,0.152484351167207,0.0109724810682851,0.130978288273368,0.173990414061045,1.19011115997289e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NEXN,Nexilin,37987,0.0861890361685762,0.00619946364733331,0.074038087419803,0.0983399849173495,1.21751291865714e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,40305,0.119038061821487,0.00857088260051696,0.102239131924474,0.135836991718501,1.33622189157142e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,37225,0.136067722249729,0.00979532776744173,0.116868879825543,0.155266564673914,1.48718765587852e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,F12,Coagulation factor XII,38013,0.0526468751585156,0.00379213517082875,0.0452142902236912,0.0600794600933399,1.59006929463583e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KRT18,"Keratin, type I cytoskeletal 18",40305,0.0968005419214305,0.00698401394801826,0.0831118745833147,0.110489209259546,1.97497946267411e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TALDO1,Transaldolase,37966,0.0560949638575568,0.00405117125279505,0.0481546682020785,0.0640352595130351,2.63438932043621e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD244,Natural killer cell receptor 2B4,40516,0.0334260367926969,0.00241572515698347,0.0286912154850093,0.0381608581003845,2.70607338035967e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD207,C-type lectin domain family 4 member K,40029,0.0481972633560874,0.00348712648100808,0.0413624954533115,0.0550320312588632,3.40177519651079e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD226,CD226 antigen,37598,0.052631616568372,0.00380766058336816,0.0451686018249704,0.0600946313117736,3.73252363857431e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37959,0.0596059363893345,0.00432248985283768,0.0511338562777726,0.0680780165008963,5.74342690018637e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINB9,Serpin B9,40228,0.041990138125765,0.00304752549880988,0.0360169881480977,0.0479632881034324,6.09193014009054e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRIM58,E3 ubiquitin-protein ligase TRIM58,37900,0.108402425971725,0.00786852502168196,0.0929801169292283,0.123824735014222,6.88042768365181e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LACTB2,Endoribonuclease LACTB2,40359,0.0823802964483902,0.0059850369136267,0.0706496240976818,0.0941109687990985,7.3496173205799e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37628,0.127654038350862,0.00929729270188825,0.109431344655161,0.145876732046563,1.31426592604636e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HAO1,Hydroxyacid oxidase 1,40489,0.162051308880092,0.0118267824290658,0.138870815319123,0.185231802441061,1.7121819997452e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HTRA2,"Serine protease HTRA2, mitochondrial",40411,0.076280686320685,0.00556927333061799,0.0653649105926738,0.0871964620486963,1.84666195166396e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARHGEF10,Rho guanine nucleotide exchange factor 10,37959,0.115361175067658,0.00842417270372477,0.0988497965683577,0.131872553566959,2.11413680899955e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPKOW,G-patch domain and KOW motifs-containing protein,39961,0.0332079381773735,0.0024289593480611,0.0284471778551738,0.0379686984995733,2.63667335543874e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATXN2L,Ataxin-2-like protein,37959,0.0599175684643695,0.00438067964552825,0.0513314363591341,0.0685037005696048,2.6403087549528e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOL1,Apolipoprotein L1,37987,0.0807297917708964,0.00591003653343029,0.069146120165373,0.0923134633764197,3.36122240972222e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,YWHAQ,14-3-3 protein theta,37671,0.0914509082899066,0.00669762676323269,0.0783235598339705,0.104578256745843,3.67935132315534e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,40377,0.0279614842883798,0.00204914841410033,0.0239451533967431,0.0319778151800164,3.71074006733305e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINB6,Serpin B6,40433,0.0739393423691339,0.00541887712229551,0.0633183432094347,0.0845603415288331,3.73623443407371e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSPB1,Heat shock protein beta-1,40116,0.0838022335321086,0.00615057332615925,0.0717471098128364,0.0958573572513807,4.93011829692686e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPARC,SPARC,40411,0.0874613383092961,0.00642195896348452,0.0748742987408664,0.100048377877726,5.29369186360003e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTF1,Cardiotrophin-1,40042,0.104440007555773,0.00767288190087887,0.0894011590300506,0.119478856081496,5.93626135562913e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DTD1,D-aminoacyl-tRNA deacylase 1,37671,0.107797023862829,0.00792706363134823,0.0922599791453865,0.123334068580272,7.79984916156547e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STK24,Serine/threonine-protein kinase 24,39961,0.0762592074721108,0.00561110876604641,0.0652614342906599,0.0872569806535618,7.88741126273762e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FARSA,Phenylalanine--tRNA ligase alpha subunit,37572,0.084240790849228,0.00619700704443496,0.0720946570421354,0.0963869246563205,8.36388704315935e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,THTPA,Thiamine-triphosphatase,37884,0.109255582221947,0.00803979229670986,0.0934975893203956,0.125013575123498,8.7466670729937e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KRT5,"Keratin, type II cytoskeletal 5",39961,0.0602869244874878,0.00443986796288911,0.0515847832802251,0.0689890656947505,9.30116937602428e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1R,Complement C1r subcomponent,38013,0.0245640630074036,0.00180878250110238,0.021018849305243,0.0281092767095643,9.80390839052022e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EGLN1,Egl nine homolog 1,40341,0.06528440834569,0.00481400474988719,0.0558489590359111,0.0747198576554689,1.15757912202509e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TBC1D5,TBC1 domain family member 5,40341,0.0964202155285984,0.0071101956075736,0.0824842321377541,0.110356198919443,1.16560085478452e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,40044,0.0672539142281941,0.00496287573209438,0.0575266777932891,0.076981150663099,1.33705164072024e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAMDC4,Apical endosomal glycoprotein,37900,0.0670568857177736,0.0049574934668663,0.0573401985227156,0.0767735729128315,2.03866899018839e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CERT,Ceramide transfer protein,39961,0.0755561934266412,0.00558943726883282,0.0646008963797289,0.0865114904735535,2.11047740436072e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDIA4,Protein disulfide-isomerase A4,37998,0.074240313673611,0.00548974936985794,0.0634804049086894,0.0850002224385325,2.11083036882828e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,38013,0.0331403324574338,0.00245117440382201,0.0283360306259426,0.0379446342889249,2.20362388039772e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39976,0.0954424662475837,0.00706690651805818,0.0815913294721897,0.109293603022978,2.48228034619534e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMAD3,Mothers against decapentaplegic homolog 3,37900,0.062103249201998,0.00460478670853007,0.0530778672532791,0.071128631150717,3.46999695850265e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AFP,Alpha-fetoprotein,40182,0.0850602764765335,0.0063172020168315,0.0726785605235437,0.0974419924295232,4.25256783690356e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,JPT2,Jupiter microtubule associated homolog 2,37901,0.107090129359329,0.00796326600434024,0.0914821279908217,0.122698130727835,5.81580091379694e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HGF,Hepatocyte growth factor,40516,0.0416976165644672,0.00310677616566977,0.0356083352797544,0.0477868978491799,7.51019217045233e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL1R2,Interleukin-1 receptor type 2,40330,0.0237228150937141,0.00177095355671578,0.0202517461225512,0.0271938840648771,1.06846083572446e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STIP1,Stress-induced-phosphoprotein 1,40307,0.0795023690923238,0.00594023776846619,0.0678595030661301,0.0911452351185175,1.25116480364957e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STX8,Syntaxin-8,40341,0.0592810017796106,0.00443335036046487,0.0505916350730995,0.0679703684861218,1.46803593558275e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCL2L1,Bcl-2-like protein 1,37942,0.120989267378105,0.00905979872239581,0.103232061882209,0.138746472874001,2.01267704021051e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MANF,Mesencephalic astrocyte-derived neurotrophic factor,40422,0.143553060101114,0.010771286394469,0.122441338767955,0.164664781434273,2.63379210634661e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUDT16,U8 snoRNA-decapping enzyme,37880,0.105972539867295,0.00795229679113231,0.0903860381566755,0.121559041577914,2.94280490845968e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CASP2,Caspase-2,40341,0.0816893107379014,0.00613376073719825,0.0696671396929928,0.09371148178281,2.99066832078308e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,F2R,Proteinase-activated receptor 1,40396,0.0693809778549143,0.00521079891143893,0.059167811988494,0.0795941437213347,3.11221771754472e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LSP1,Lymphocyte-specific protein 1,40341,0.0482673359575206,0.00362537590460842,0.0411615991844881,0.0553730727305531,3.16317018862286e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CIAPIN1,Anamorsin,40411,0.0770512013028878,0.00579049988884837,0.065701821520745,0.0884005810850306,3.47479472748898e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCDH9,Protocadherin-9,37901,0.0409048134477271,0.00307288064701871,0.0348819673795704,0.0469276595158838,3.5601766823661e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCTD,Deoxycytidylate deaminase,37671,0.114165214052271,0.00857814591952041,0.0973520480500111,0.130978380054531,3.72723560024413e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,40396,0.0923870347991672,0.0069475600978626,0.0787698170073565,0.106004252590978,3.90140285122057e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC3B,Tetranectin,37681,0.0254576259187542,0.00191416178170295,0.0217058688266164,0.029209383010892,4.20804130698166e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RABGAP1L,Rab GTPase-activating protein 1-like,40044,0.0725940857462653,0.00546203111826597,0.061888504754464,0.0832996667380666,4.33229942977167e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSIP1,PC4 and SFRS1-interacting protein,40341,0.0747464496942966,0.00562602566675254,0.0637194393874616,0.0857734600011316,4.5756814835452e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FHIT,Bis(5'-adenosyl)-triphosphatase,39961,0.0909157235160963,0.00684766701193224,0.0774942961727091,0.104337150859483,5.21138977702959e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37900,0.130207404999207,0.0098051808124253,0.110989250606853,0.14942555939156,5.43849082314897e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37990,0.0895767615437604,0.00674857017097101,0.0763495640086573,0.102803959078864,5.86407746412028e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MICALL2,MICAL-like protein 2,37572,0.0826103033090232,0.00622398845133393,0.0704112859444087,0.0948093206736377,6.01526808868048e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEP170,Centrosomal protein of 170 kDa,37628,0.0929740675048124,0.00701965052693179,0.0792155524720261,0.106732582537599,8.67990323858171e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37959,0.119043706866788,0.00899115860876828,0.101421035993602,0.136666377739974,9.10792176127114e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37628,0.0931394249839787,0.0070406135313731,0.0793398224624875,0.10693902750547,1.07031279972371e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37714,0.0797597226024256,0.00603598567475367,0.0679291906799085,0.0915902545249428,1.29565423779066e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMOC2,SPARC-related modular calcium-binding protein 2,40422,0.0458858499589393,0.00347528439198352,0.0390742925506516,0.052697407367227,1.35077878396611e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYO9B,Unconventional myosin-IXb,40044,0.0794875186597347,0.00602187441635885,0.0676846448036714,0.0912903925157981,1.43411086804515e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VSNL1,Visinin-like protein 1,37942,0.0449011776276302,0.00340303719066966,0.0382312247339177,0.0515711305213427,1.65898593585677e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PENK,Proenkephalin-A,37671,0.0369521327401633,0.00280221899371377,0.0314597835124843,0.0424444819678423,1.85614910668299e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39853,0.105878806795821,0.00803929381108286,0.0901217909260987,0.121635822665544,2.12787298976036e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STX4,Syntaxin-4,40305,0.0713945471367744,0.005422084455525,0.0607672616039454,0.0820218326696034,2.17697677763625e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ESYT2,Extended synaptotagmin-2,37942,0.0975612372609341,0.00740752104518204,0.0830424960123773,0.112079978509491,2.2676255912831e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLPBP,Pyridoxal phosphate homeostasis protein,40359,0.0810086524278694,0.00615960338517361,0.0689358297929292,0.0930814750628097,2.67155139446154e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMTN,Smoothelin,37905,0.115103276788069,0.008748527403753,0.097956163076713,0.132250390499425,2.71610762033121e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSPA1A,Heat shock 70 kDa protein 1A,40400,0.0849069157709431,0.00646561166012453,0.072234316917099,0.0975795146247871,3.44437248428577e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK13,Kallikrein-13,40032,0.0517041366680123,0.00393794483779154,0.0439857647859409,0.0594225085500837,3.59103322170423e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DFFA,DNA fragmentation factor subunit alpha,40516,0.0808366908774553,0.00616137661077529,0.0687603927203357,0.0929129890345749,4.02427634656137e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGBP1,Immunoglobulin-binding protein 1,37959,0.0729624475285364,0.00556076166027289,0.0620633546744015,0.0838615403826712,4.33088808933729e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPI,Glucose-6-phosphate isomerase,37987,0.055790710997794,0.00425317003531609,0.0474544977285744,0.0641269242670135,4.5280157260013e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,40397,0.130876055961564,0.00998612451786864,0.111303251906542,0.150448860016587,4.85480236242306e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJB14,DnaJ homolog subfamily B member 14,37901,0.076550586099037,0.00583922184558658,0.0651057112816874,0.0879954609163867,5.02421970239046e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL16,C-X-C motif chemokine 16,40517,0.0282429269969902,0.00215554662036373,0.0240180556210773,0.0324677983729031,5.05396398254221e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VPS4B,Vacuolar protein sorting-associated protein 4B,37900,0.112168259104265,0.00857281479767695,0.0953655421008179,0.128970976107712,7.00439063398257e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPBP,Platelet basic protein,37934,0.0997537660660172,0.00762425086665746,0.0848102343673685,0.114697297764666,7.03440794299737e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CASP3,Caspase-3,40536,0.104334438807592,0.00798405168007366,0.0886856975146474,0.119983180100536,7.92503358245493e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GNPDA2,Glucosamine-6-phosphate isomerase 2,37671,0.043253468410195,0.00330990029520427,0.0367660638315946,0.0497408729887954,8.733994919317e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AP2B1,AP-2 complex subunit beta,37572,0.0581434191105831,0.00444936690932757,0.049422659968301,0.0668641782528651,8.78282849943959e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37990,0.0732986612905215,0.00561245592960818,0.0622982476684895,0.0842990749125535,9.55365679571894e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINE2,Glia-derived nexin,37990,0.0761711844444758,0.005832552247979,0.064739382038437,0.0876029868505147,9.59484450495964e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GP6,Platelet glycoprotein VI,40311,0.104132957650913,0.00798419167823556,0.0884839419615717,0.119781973340255,1.11034021832401e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RP2,Protein XRP2,40305,0.0489101474917797,0.00375126313732766,0.0415576717426175,0.0562626232409419,1.1708802833676e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINB1,Leukocyte elastase inhibitor,40287,0.105206809568718,0.00807162977755845,0.0893864152047038,0.121027203932733,1.23655875363157e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL24,C-C motif chemokine 24,40396,0.0980112562179911,0.00752148045175102,0.0832691545325591,0.112753357903423,1.28664167716036e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRYZL1,Quinone oxidoreductase-like protein 1,37628,0.110318748290772,0.00847024156817958,0.0937170748171404,0.126920421764404,1.5398223285817e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACE2,Angiotensin-converting enzyme 2,40042,0.0576441804793213,0.00443855745632176,0.0489446078649307,0.066343753093712,2.28871591636101e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CST3,Cystatin-C,40372,0.0330473357810923,0.00254531065029513,0.0280585269065139,0.0380361446556708,2.37297457277881e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHM,Rab proteins geranylgeranyltransferase component A 1,37572,0.072276644861671,0.00556449302228554,0.0613702385379913,0.0831830511853506,2.43726215739824e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SETMAR,Histone-lysine N-methyltransferase SETMAR,40182,0.0351833690202725,0.0027105827325705,0.0298706268644343,0.0404961111761106,2.49980520536831e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GLOD4,Glyoxalase domain-containing protein 4,40328,0.0427985643135185,0.00329845965431,0.0363335833910709,0.0492635452359661,2.64473064417828e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GMFG,Glia maturation factor gamma,37990,0.0845011981861431,0.00651528908588672,0.0717312315778051,0.0972711647944811,3.07126487369032e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRRC59,Leucine-rich repeat-containing protein 59,37990,0.0553264096385152,0.00426945380247601,0.0469582801856622,0.0636945390913682,3.53945145580354e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MGMT,Methylated-DNA--protein-cysteine methyltransferase,40341,0.143971448182365,0.0111253546061704,0.122165753154271,0.165777143210459,4.12428443553907e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37990,0.105383654709062,0.00815765347803077,0.0893946538921214,0.121372655526002,5.94087960296265e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37900,0.0452929774797087,0.00350712187353219,0.0384190186075856,0.0521669363518318,6.25972530574399e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FNDC1,Fibronectin type III domain-containing protein 1,37942,0.0537904274838337,0.00416923434423488,0.0456187281691333,0.061962126798534,7.36666440865824e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VASH1,Tubulinyl-Tyr carboxypeptidase 1,40341,0.0947582096245058,0.00735310040518005,0.0803461328303529,0.109170286418659,8.25761214245083e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SFRP1,Secreted frizzled-related protein 1,40178,0.0510406545570009,0.00396147643474851,0.0432761607448938,0.058805148369108,8.57462458384767e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HAVCR1,Hepatitis A virus cellular receptor 1,40470,0.0715097784417046,0.00555102206222421,0.0606297751997452,0.0823897816836641,8.72514053885535e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NRGN,Neurogranin,37987,0.106013704520378,0.00822957351688251,0.0898837404272879,0.122143668613467,9.46675030812396e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF4E,Eukaryotic translation initiation factor 4E,37598,0.106723022625257,0.00829332329821729,0.0904681089607513,0.122977936289763,1.14200026419026e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37990,0.103484675342671,0.00804618138787487,0.0877141598224363,0.119255190862906,1.23354733812438e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AKT2,RAC-beta serine/threonine-protein kinase,37959,0.146693604825026,0.0114063990522655,0.124337062682585,0.169050146967466,1.24605502515759e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MCEMP1,Mast cell-expressed membrane protein 1,37598,0.10805103118044,0.00840308199435624,0.091580990471502,0.124521071889378,1.29845848929553e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GGH,Gamma-glutamyl hydrolase,40077,0.039928200597661,0.00310982891682309,0.0338329359206877,0.0460234652746342,1.52780983098936e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IMPACT,Protein IMPACT,37942,0.0663292105171624,0.00516857247581035,0.0561988084645741,0.0764596125697507,1.77049098782943e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BLMH,Bleomycin hydrolase,40536,0.0375578141995482,0.00293112379133479,0.031812811568532,0.0433028168305644,2.10079141618879e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANG,Angiogenin,40309,0.0400710982111406,0.00312804275304871,0.0339401344151652,0.0462020620071161,2.20073316716261e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RFC4,Replication factor C subunit 4,37900,0.0238948803508614,0.0018665649727045,0.0202364130043606,0.0275533476973622,2.65389119784255e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMEM106A,Transmembrane protein 106A,37900,0.0813840115974974,0.00636724079736531,0.0689042196346614,0.0938638035603334,3.41575807353622e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40471,0.0662454657855906,0.0052013582004815,0.0560508037126468,0.0764401278585343,5.6239372533345e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AKT3,RAC-gamma serine/threonine-protein kinase,39897,0.0662522877277643,0.00520282373320695,0.0560547532106786,0.0764498222448499,5.87751492465848e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37598,0.0923459709825272,0.00724954339840717,0.0781368659216492,0.106555076043405,5.99742415785006e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCDH7,Protocadherin-7,37901,0.0403903145398519,0.0031715956582618,0.0341739870496588,0.046606642030045,6.1727909855171e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MIA,Melanoma-derived growth regulatory protein,40411,0.0427416212721502,0.00335964478687781,0.0361567174898697,0.0493265250544307,6.73685866543588e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPP3R1,Calcineurin subunit B type 1,40228,0.0477658387932553,0.00375505690946406,0.0404059272507058,0.0551257503358049,6.91301220613286e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COMT,Catechol O-methyltransferase,39877,0.0981816205518433,0.00771890807636867,0.0830525607221607,0.113310680381526,7.04757952010464e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB33A,Ras-related protein Rab-33A,37562,0.0772385611818798,0.00607291925048652,0.0653356394509262,0.0891414829128334,7.7008173477559e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRDX5,"Peroxiredoxin-5, mitochondrial",40516,0.0799540639241318,0.00629614520214992,0.0676136193279179,0.0922945085203456,9.00986519797797e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SFTPA2,Pulmonary surfactant-associated protein A2,39980,0.0573832144848338,0.00451908831555645,0.0485258013863431,0.0662406275833244,9.24439161823357e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FOXJ3,Forkhead box protein J3,37598,0.0504723161910918,0.00397366861207543,0.042683925711424,0.0582607066707596,9.51220945852257e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLA2G4A,Cytosolic phospholipase A2,40422,0.100254721574327,0.00789958128399717,0.084771542257693,0.115737900890962,9.96092746477341e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRIM1,Cysteine-rich motor neuron 1 protein,40422,-0.0237424975920961,0.00187084613193201,-0.0274093560106829,-0.0200756391735094,1.00067729144236e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37671,0.0704697662988888,0.00555224568931597,0.0595873647478295,0.0813521678499481,1.07045512692946e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GIPC3,PDZ domain-containing protein GIPC3,37901,0.11278213886039,0.00889235016974997,0.0953531325276797,0.1302111451931,1.19018110437942e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDGFA,Platelet-derived growth factor subunit A,40536,0.0826345437591095,0.00652038767821653,0.0698545839098051,0.0954145036084139,1.24507528052105e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIT1,Signaling threshold-regulating transmembrane adapter 1,40044,0.0640986197612862,0.00505834849828517,0.0541842567046473,0.0740129828179252,1.28353219087101e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NT5C3A,Cytosolic 5'-nucleotidase 3A,40312,0.102104467307555,0.00806796617413024,0.0862912536062599,0.11791768100885,1.56571515640587e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,REEP4,Receptor expression-enhancing protein 4,37959,0.0713980375624245,0.00564602791700134,0.0603318228451019,0.0824642522797472,1.90080033211851e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNM3,Dynamin-3,37959,0.0629389656034353,0.00498257574652871,0.053173117140239,0.0727048140666316,2.26358109220866e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MZT1,Mitotic-spindle organizing protein 1,39980,0.0604713572098005,0.00479070230044843,0.0510815807009216,0.0698611337186794,2.38927562279784e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UROD,Uroporphyrinogen decarboxylase,37671,0.0806535929975236,0.00639426673998385,0.0681208301871552,0.0931863558078919,2.88050420784309e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MIF,Macrophage migration inhibitory factor,40307,0.0788425100995838,0.00625644774235369,0.0665798725245706,0.0911051476745971,3.07874308878783e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CBLN4,Cerebellin-4,40489,0.0360173267181815,0.00286169484501038,0.0304084048219611,0.0416262486144018,3.73643670753199e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37990,0.11182320747413,0.0088986371901333,0.0943818785814682,0.129264536366791,5.13672915000025e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA5A,"Carbonic anhydrase 5A, mitochondrial",40042,0.10466092545454,0.00833346947239956,0.0883273252886368,0.120994525620443,5.29265572854302e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DYNLT1,Dynein light chain Tctex-type 1,37572,0.0926133553658895,0.00737333015295497,0.0781616282660977,0.107065082465681,5.60005122345035e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TXNDC9,Thioredoxin domain-containing protein 9,37942,0.060639988744677,0.00482927738967904,0.0511746050609061,0.070105372428448,5.79990236431837e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SELE,E-selectin,40536,0.0569065442273261,0.00453452727157178,0.0480188707750454,0.0657942176796068,5.88781118543105e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FADD,FAS-associated death domain protein,40359,0.0868139761926933,0.00692902586508224,0.0732330854971321,0.100394866888254,7.64683752242989e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39980,0.0770879251586097,0.00616584957605934,0.0650028599895334,0.089172990327686,1.075934753164e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CETN2,Centrin-2,39961,0.0763125907502489,0.00610892963140165,0.0643390886727017,0.0882860928277961,1.22568192971395e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PARP1,Poly [ADP-ribose] polymerase 1,40341,0.0613942266311992,0.00491583023763343,0.0517591993654377,0.0710292538969608,1.25867926676395e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRIM24,Transcription intermediary factor 1-alpha,37687,0.0729195434128448,0.00584262679907633,0.0614679948866552,0.0843710919390344,1.50977690407479e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSME1,Proteasome activator complex subunit 1,40216,0.0424676736943316,0.00342578639255428,0.0357531323649252,0.049182215023738,3.98091489210008e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMNDC1,Survival of motor neuron-related-splicing factor 30,37901,0.0650817357029766,0.00525105667029943,0.0547896646291897,0.0753738067767635,4.37584141222073e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HPGDS,Hematopoietic prostaglandin D synthase,39980,0.0423187192543028,0.00341688639230841,0.0356216219253783,0.0490158165832272,4.60339560625173e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL18,C-C motif chemokine 18,40172,0.0789865410507395,0.00638056301323836,0.0664806375447923,0.0914924445566867,4.92988535043364e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PGF,Placenta growth factor,40516,0.029507187118454,0.00238464803762914,0.0248332769647009,0.0341810972722071,5.22955721789628e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRYBB1,Beta-crystallin B1,37990,0.0729291007844674,0.00589136394749144,0.0613820274473842,0.0844761741215506,5.25217277154472e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA13,Carbonic anhydrase 13,40173,0.116177415053208,0.00940347804878344,0.0977465980775925,0.134608232028824,6.66910510644142e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAP3,Cytosol aminopeptidase,40044,0.0551263379031576,0.00446472325645281,0.0463754803205101,0.0638771954858051,7.34915609013222e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GGCT,Gamma-glutamylcyclotransferase,37978,0.0542614601961246,0.00439606018082669,0.0456451822417043,0.0628777381505449,8.15974645338051e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,40228,0.106416604164054,0.0086259472491233,0.0895097475557721,0.123323460772335,8.30457552057034e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DBN1,Drebrin,37598,0.0580010210351091,0.00470970095367505,0.048770007165906,0.0672320349043121,1.16442604609958e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DBI,Acyl-CoA-binding protein,40270,0.0881431485073781,0.00716292663548005,0.0741038123018372,0.102182484712919,1.21916011210435e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,POMC,Pro-opiomelanocortin,37628,0.0762888249831532,0.00620256787357597,0.0641317919509443,0.0884458580153621,1.40934628838497e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATXN3,Ataxin-3,37942,0.0696313679122932,0.00566595872454363,0.0585260888121877,0.0807366470123987,1.5793618519875e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDC26,Anaphase-promoting complex subunit CDC26,37879,0.0786491440100295,0.00640846095761139,0.0660885605331112,0.0912097274869478,1.94135529915092e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37959,0.0528085127613031,0.0043038903204981,0.0443728877331268,0.0612441377894793,2.00280225381974e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BRSK2,Serine/threonine-protein kinase BRSK2,37959,0.0438129521069826,0.0035722355801131,0.0368113703699609,0.0508145338440043,2.13133016148572e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FRMD4B,FERM domain-containing protein 4B,37562,0.0787052513896339,0.00641879894708961,0.0661244054533383,0.0912860973259296,2.24379749912079e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MUC13,Mucin-13,39961,0.0558488137058651,0.00456589055680912,0.0468996682145193,0.064797959197211,3.02527864330467e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRDX6,Peroxiredoxin-6,40489,-0.0663923278051993,0.00543453217684931,-0.077044010871824,-0.0557406447385747,3.58917385496413e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL8,C-C motif chemokine 8,40470,0.0669816621640598,0.00548291753699943,0.0562351437915409,0.0777281805365787,3.60486497690198e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDC37,Hsp90 co-chaperone Cdc37,40411,0.0928005084939071,0.00760110861282797,0.0779023356127643,0.10769868137505,3.96028156042876e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37628,0.0525592183314485,0.00430426277695404,0.0441228632886186,0.0609955733742785,4.15200764072343e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IQGAP2,Ras GTPase-activating-like protein IQGAP2,40305,0.0604236391865033,0.00495124046890083,0.0507192078674577,0.0701280705055489,4.22246135385721e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39939,0.0641359593956867,0.00525711161309596,0.0538320206340186,0.0744398981573548,4.46387396158437e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPCDC,Phosphopantothenoylcysteine decarboxylase,40471,0.0522254503262328,0.00428572953206503,0.0438254204433853,0.0606254802090802,5.22683099158369e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEPTIN9,Septin-9,40305,0.0311748171892285,0.00255857728828088,0.026160005704198,0.0361896286742591,5.33966251204466e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PARK7,Parkinson disease protein 7,40332,0.0590692898556698,0.00486128206918014,0.0495411770000767,0.0685974027112629,8.00999839487623e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARL13B,ADP-ribosylation factor-like protein 13B,37562,0.0769829086881699,0.00633826196324724,0.0645599152402053,0.0894059021361345,9.17406024253901e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,INPP1,Inositol polyphosphate 1-phosphatase,40305,0.0593611925549713,0.00489008628550996,0.0497766234353717,0.0689457616745708,9.25524497296722e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37865,0.0345101118072507,0.00284519116836393,0.0289335371172574,0.040086686497244,1.10899734320016e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TSC22D1,TSC22 domain family protein 1,37959,0.0741795126079036,0.00611736070414564,0.0621894856277782,0.0861695395880291,1.14963719713123e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,JAM3,Junctional adhesion molecule C,37671,0.0558308026792296,0.0046039883266667,0.0468069855589629,0.0648546197994964,1.15198957645394e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGSF3,Immunoglobulin superfamily member 3,40305,0.0379666777968325,0.00313718706536017,0.0318177911487266,0.0441155644449384,1.4467434706024e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PNMA1,Paraneoplastic antigen Ma1,37628,0.0615172549424462,0.00508521231652195,0.0515502388020632,0.0714842710828292,1.64305885872623e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PALM2,Paralemmin-2,37942,0.0406431593377925,0.00336058996927892,0.0340564029980058,0.0472299156775792,1.69215801066067e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TADA3,Transcriptional adapter 3,37900,0.0427911751797649,0.00353919989474209,0.0358543433860704,0.0497280069734594,1.76548103717077e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PXN,Paxillin,39961,0.0568629459882972,0.00470599455516686,0.0476391966601701,0.0660866953164242,1.8341978719292e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGB1BP2,Integrin beta-1-binding protein 2,40042,0.121302028538884,0.0100441888686956,0.101615418356241,0.140988638721527,1.97415473120165e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CASP10,Caspase-10,39961,0.0787539818404426,0.00652779235040447,0.0659595088336498,0.0915484548472354,2.29675622945104e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SDHB,Succinate dehydrogenase,37901,0.0780222222300005,0.00647321314747319,0.065334724460953,0.0907097199990479,2.77266628870119e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMSB10,Thymosin beta-10,40332,0.0829855613076327,0.00689409905106584,0.0694731271675437,0.0964979954477218,3.16082923540489e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37990,0.0438037298738566,0.00364336086174113,0.036662742584844,0.0509447171628692,3.97240050355546e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADD1,Alpha-adducin,37671,0.0767312829069984,0.00638262222628603,0.0642213433434778,0.089241222470519,4.05711088173429e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARHGAP25,Rho GTPase-activating protein 25,39980,0.064830287068962,0.00539515814568194,0.0542557771034254,0.0754047970344986,4.08747177611883e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37608,0.0879135380096847,0.00731508097631018,0.0735759792961167,0.102251096723253,4.25311368768942e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPPB,Natriuretic peptides B,40042,-0.140206499463979,0.0116773414604395,-0.163094088726441,-0.117318910201518,4.58345001554825e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCARF1,Scavenger receptor class F member 1,40536,0.0461500655519355,0.00384420187575138,0.0386154298754628,0.0536847012284082,4.62473379872104e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CFB,Complement factor B,37770,0.0357460443563405,0.00298219538732169,0.02990094139719,0.041591147315491,6.17831875124969e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BAG3,BAG family molecular chaperone regulator 3,40203,0.0431518387771541,0.00360757073717045,0.0360810001323,0.0502226774220082,7.84655190456007e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40471,-0.0491352892722798,0.00411125634404734,-0.0571933517066126,-0.041077226837947,8.79949805875479e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRSS2,Trypsin-2,40403,0.0543840665515986,0.00455481429658744,0.0454566305302872,0.06331150257291,1.01057903240281e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP6AP2,Renin receptor,39980,0.0452334798486434,0.00379043871132092,0.0378042199744544,0.0526627397228324,1.09929202257689e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB2B,Ras-related protein Rab-2B,37900,0.0666369559778945,0.00558476231697568,0.0556908218366221,0.0775830901191668,1.17919599151022e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BDNF,Brain-derived neurotrophic factor,37998,0.0897430106109488,0.00752154698156473,0.0750007785270819,0.104485242694816,1.18253169555873e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLMAP,Sarcolemmal membrane-associated protein,37901,0.0903186892521018,0.00757096566316611,0.0754795965522962,0.105157781951907,1.21199936236055e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BTC,Probetacellulin,39980,0.0815062392770988,0.0068508265217483,0.0680786192944721,0.0949338592597254,1.69234411532383e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD1C,T-cell surface glycoprotein CD1c,40411,0.0258661422466842,0.00217603449761075,0.0216011146313671,0.0301311698620013,1.89941163205899e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,40044,0.0473957700038502,0.00398719956254505,0.0395808588612619,0.0552106811464385,1.9099226035195e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANKRD54,Ankyrin repeat domain-containing protein 54,39980,0.0624944661571071,0.00525752106253879,0.0521897248745311,0.0727992074396832,1.91933446399971e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CYB5R2,NADH-cytochrome b5 reductase 2,37746,0.060183870873592,0.00506318800352181,0.0502600223866892,0.0701077193604947,2.02890156409337e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DXO,Decapping and exoribonuclease protein,37942,0.0494690615826586,0.00416653477866585,0.0413026534164735,0.0576354697488437,2.37054584907379e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANGPT1,Angiopoietin-1,40263,0.0914381036195745,0.0077045494853047,0.0763371866283773,0.106539020610772,2.37943514707922e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LGALS3,Galectin-3,40374,0.0318760458449119,0.00268781913958852,0.0266079203313184,0.0371441713585054,2.6293960059231e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,40341,0.128499666204915,0.0108398816594027,0.107253498152486,0.149745834257345,2.79492705296518e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRELD1,Protein disulfide isomerase CRELD1,37671,0.0405182307663281,0.00342159554030421,0.0338119035073319,0.0472245580253244,3.44663421774963e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ABRAXAS2,BRISC complex subunit Abraxas 2,37562,0.0723235258237386,0.00611313681969228,0.0603417776571418,0.0843052739903355,3.93966328870503e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PEBP1,Phosphatidylethanolamine-binding protein 1,40332,0.0628132023860738,0.00531315896998622,0.0523994108049008,0.0732269939672468,4.08724944556794e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTRB1,Chymotrypsinogen B,40332,0.0571488702427046,0.00483705214224173,0.0476682480439108,0.0666294924414984,4.4591554788291e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCRG1,Scrapie-responsive protein 1,37990,0.0295124052445242,0.00249759608000133,0.0246171169277216,0.0344076935613268,4.61964850396314e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB6A,Ras-related protein Rab-6A,40341,0.0512896754363738,0.00434252314682516,0.0427783300685965,0.0598010208041511,4.66176850409743e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD84,SLAM family member 5,40341,0.033019271879707,0.00279939285966107,0.0275324618747713,0.0385060818846427,5.62077762731871e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GGACT,Gamma-glutamylaminecyclotransferase,37990,0.0759961798143683,0.00644366646065724,0.0633665935514801,0.0886257660772565,6.01220511670731e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FXYD5,FXYD domain-containing ion transport regulator 5,40044,0.0707587212843532,0.00602156817851305,0.0589564476544676,0.0825609949142388,9.51265069829563e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LIPF,Gastric triacylglycerol lipase,37628,0.0639139462798822,0.00543707669390503,0.0532572759598284,0.0745706165999361,9.56495665447928e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MSR1,Macrophage scavenger receptor types I and II,40471,0.0477416718197927,0.00406324869421682,0.0397777043791277,0.0557056392604576,9.57447668665561e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFSF14,Tumor necrosis factor ligand superfamily member 14,40228,0.0614138912497456,0.00523288441967876,0.0511574377871752,0.0716703447123159,1.12661790131966e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TP53I3,Quinone oxidoreductase PIG3,37419,0.0572338648114152,0.00488003811817654,0.0476689900997892,0.0667987395230412,1.32024759964097e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FSHB,Follitropin subunit beta,37628,0.0744916340871164,0.00635966771563944,0.0620266853644631,0.0869565828097697,1.5645250894171e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJB2,DnaJ homolog subfamily B member 2,37671,0.0580493273674064,0.00495785765330715,0.0483319263669244,0.0677667283678884,1.64858018698483e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL26,C-C motif chemokine 26,40341,0.0945012547511995,0.0080764039209791,0.0786715030660805,0.110331006436319,1.69793182189937e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFAT5,Nuclear factor of activated T-cells 5,37598,0.093346933258864,0.007977535583305,0.0777109635155862,0.108982903002142,1.79924924846285e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGA6,Integrin alpha-6,40341,0.0564773298183519,0.00483108070420093,0.0470084116381181,0.0659462479985857,1.91933144962831e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SRP14,Signal recognition particle 14 kDa protein,40305,0.0630028816059448,0.00539141579877692,0.052435706640342,0.0735700565715475,2.02741639152613e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANXA3,Annexin A3,40442,0.0741839335248389,0.00635856665469547,0.0617211428816358,0.086646724168042,2.52408882669873e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GZMA,Granzyme A,40516,0.0371921050272233,0.00319840410883425,0.0309232329739082,0.0434609770805385,3.94213826892328e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,40384,-0.0322562129090798,0.00277937717874412,-0.0377037921794183,-0.0268086336387414,5.14687610866003e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37628,0.0477345921070708,0.00411666668770235,0.0396659253991742,0.0558032588149674,6.14096587597914e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TBCA,Tubulin-specific chaperone A,37671,0.0918946064407491,0.00792598892898751,0.0763596681399336,0.107429544741565,6.23134650454535e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,40414,0.0613007594305681,0.00529265607598371,0.0509271535216401,0.0716743653394962,6.73947575469336e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARFIP1,Arfaptin-1,37959,0.0722958289493972,0.00624917471120846,0.0600474465154287,0.0845442113833658,8.27892348521831e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCARA5,Scavenger receptor class A member 5,40471,0.0308022259632158,0.00266395395549685,0.025580876210442,0.0360235757159897,8.44817235108278e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VCAM1,Vascular cell adhesion protein 1,40372,-0.0283723568731815,0.00245618274998187,-0.033186475063146,-0.0235582386832171,9.63044949275533e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37628,0.102436755855168,0.00887674826943757,0.0850383292470708,0.119835182463266,1.16557745729132e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL3,C-C motif chemokine 3,40341,0.0644979548498726,0.00559264090024319,0.0535363786853959,0.0754595310143492,1.19621188643987e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCGB3A2,Secretoglobin family 3A member 2,40396,-0.08878903528213,0.00770272559123272,-0.103886377440946,-0.0736916931233138,1.27592435411865e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCRN1,Secernin-1,40341,0.0588042517753048,0.00511242515578914,0.0487838984699581,0.0688246050806515,1.69766709485108e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SRC,Proto-oncogene tyrosine-protein kinase Src,40385,0.124992140103054,0.0108792871755278,0.10366873723902,0.146315542967089,1.97458018321617e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RGS10,Regulator of G-protein signaling 10,37959,0.0624341055396664,0.00545125114411939,0.0517496532971924,0.0731185577821404,3.12586280664189e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PARD3,Partitioning defective 3 homolog,37714,0.0773816145270989,0.00675676273721478,0.0641383595621579,0.0906248694920398,3.16963650297458e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITPA,Inosine triphosphate pyrophosphatase,37562,0.0708931899219691,0.00619416304083838,0.0587526303619259,0.0830337494820123,3.45855312707522e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MEP1A,Meprin A subunit alpha,37901,0.0712074196110767,0.00622826369021125,0.0590000227782626,0.0834148164438907,3.9431169801761e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37562,0.0424906751896535,0.00372105234596926,0.0351974125915538,0.0497839377877533,4.66116226547988e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37575,0.037106719359052,0.00325150204220141,0.0307337753563372,0.0434796633617667,5.03580712998669e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ABHD14B,Protein ABHD14B,40171,0.060662492297913,0.00532282421401264,0.0502297568384482,0.0710952277573778,5.6958018037571e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RILP,Rab-interacting lysosomal protein,40434,0.0623832386349059,0.00547474305620474,0.0516527422447447,0.0731137350250672,5.79731643090393e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFT20,Intraflagellar transport protein 20 homolog,37572,0.0447651630515747,0.00392993972587351,0.0370624811888626,0.0524678449142868,6.42250126485225e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39961,0.0663186282913309,0.00582500538890966,0.054901617729068,0.0777356388535938,6.51698921148153e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PKN3,Serine/threonine-protein kinase N3,37714,0.0798751290380901,0.00702433090642417,0.0661074404614988,0.0936428176146815,7.99549731364521e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPPED1,Serine/threonine-protein phosphatase CPPED1,40471,0.0681189894492501,0.00599316387611293,0.0563723882520687,0.0798655906464314,8.02306729476611e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNM1,Dynamin-1,37901,0.117357959996759,0.0103273301897951,0.0971163928247604,0.137599527168757,8.65608740723723e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PALM,Paralemmin-1,37824,0.0303033399631406,0.00266845011889637,0.0250731777301037,0.0355335021961775,9.45899560289469e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",40042,0.0906767232120793,0.00798764082973554,0.0750209471857977,0.106332499238361,9.47157779301497e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADGRF5,Adhesion G protein-coupled receptor F5,37990,0.0308736449070044,0.00271921795208463,0.0255439777209185,0.0362033120930902,9.67049364191901e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LARP1,La-related protein 1,37900,0.0655674606785124,0.00577660957980638,0.0542453059020919,0.0768896154549329,1.00664441265638e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AIF1,Allograft inflammatory factor 1,39980,0.054395108201336,0.00479754720187822,0.0449919156856547,0.0637983007170173,1.11153255924862e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEMIP2,Cell surface hyaluronidase,37598,0.0349110779997963,0.00307819355057596,0.0288778186406675,0.0409443373589252,1.12374404523974e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCT5,T-complex protein 1 subunit epsilon,39980,0.0468520391506165,0.00413359834854385,0.0387501863874706,0.0549538919137625,1.15864355408166e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANGPTL7,Angiopoietin-related protein 7,40489,0.0380998752922921,0.00336416257206854,0.0315061166510378,0.0446936339335465,1.27541244886706e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37900,0.0362035749427868,0.00319687819340605,0.029937693683711,0.0424694562018627,1.34862102203703e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TTF2,Transcription termination factor 2,37572,0.0501573297277313,0.00443363061994862,0.041467413712632,0.0588472457428306,1.55171354640214e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FUS,RNA-binding protein FUS,39960,0.0405179822946661,0.00358527027345123,0.0334908525587017,0.0475451120306305,1.68747694162109e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HPSE,Heparanase,37848,0.0954485640092314,0.00845071342999389,0.0788851656864433,0.112011962332019,1.89299401106701e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,40379,0.0304668322100957,0.00270148240665801,0.025171926693046,0.0357617377271454,2.18268887277951e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TST,Thiosulfate sulfurtransferase,39923,0.0778090185461711,0.00690595439617162,0.0642733479296748,0.0913446891626675,2.48579315913288e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SUOX,"Sulfite oxidase, mitochondrial",37959,0.0631943832776925,0.00561226641086072,0.0521943411124055,0.0741944254429795,2.7904206959151e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37598,0.0580585659975214,0.00516301913770385,0.0479390484876219,0.068178083507421,3.32838992890826e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APP,Amyloid-beta precursor protein,40309,0.0683940970525328,0.00608642721036448,0.0564646997202184,0.0803234943848472,3.45361592091288e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ROBO2,Roundabout homolog 2,40471,0.0237693098880948,0.00211776363197313,0.0196184931694275,0.0279201266067622,4.00293378235014e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FAS,Tumor necrosis factor receptor superfamily member 6,40490,0.0326752350239255,0.00291180988757983,0.026968087644269,0.038382382403582,4.09969890360564e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MDH1,"Malate dehydrogenase, cytoplasmic",37928,0.0415729891939187,0.00370353427284773,0.0343140620191371,0.0488319163687002,4.12803864703203e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARAF,Serine/threonine-protein kinase A-Raf,37714,0.0686306237373488,0.00611669507212895,0.056641901395976,0.0806193460787215,4.38711579605619e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1RL,Complement C1r subcomponent-like protein,37993,0.0197952314070503,0.00176536998777769,0.016335106231006,0.0232553565830946,4.72285854362862e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPRC5C,G-protein coupled receptor family C group 5 member C,37900,0.058792701631567,0.00524364299116673,0.0485151613688802,0.0690702418942538,4.77992117344084e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD40LG,CD40 ligand,40516,0.0779669179124805,0.00695725616796469,0.0643306958232698,0.0916031400016913,4.85215536734711e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AK2,"Adenylate kinase 2, mitochondrial",37942,0.107612410920328,0.00960073379060914,0.088794972690734,0.126429849149922,4.96172922664513e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CGA,Glycoprotein hormones alpha chain,40332,0.0912618376356346,0.00815040186540627,0.0752870499794383,0.107236625291831,5.40283652161238e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL1,Growth-regulated alpha protein,40329,0.0988590870345088,0.00883912890434826,0.0815343943819862,0.116183779687031,6.24654626379543e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDCP1,CUB domain-containing protein 1,40228,0.049400504647007,0.00441799932646409,0.0407412259671374,0.0580597833268766,6.44180205655157e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37671,0.0421023995217273,0.00376674444793798,0.0347195804037689,0.0494852186396857,7.08767275751813e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37598,0.0497191177654612,0.00445140932721898,0.040994355484112,0.0584438800468104,7.77064528699189e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPA1,Carboxypeptidase A1,40536,0.0579556211903526,0.00519695776341809,0.0477695839740531,0.068141658406652,8.94384420610665e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CALB2,Calretinin,39961,0.0319868462641152,0.00286823271096956,0.0263651101506149,0.0376085823776156,8.99685160985797e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CFHR4,Complement factor H-related protein 4,37973,0.0745824509308926,0.00668577585276245,0.0614783302594782,0.087686571602307,8.99921925397011e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ELOA,Elongin-A,40305,0.0515579193894138,0.00463714852250715,0.0424691082852998,0.0606467304935278,1.30169650362175e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB10,Ras-related protein Rab-10,37990,0.0542761338258606,0.00488401387175971,0.0447034666372116,0.0638488010145097,1.44112627832141e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MTIF3,"Translation initiation factor IF-3, mitochondrial",37901,0.0881670602626621,0.00794709528728601,0.0725907534995815,0.103743367025743,1.7779238446872e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DPT,Dermatopontin,40536,0.0266889203656292,0.00240671490709196,0.021971759147729,0.0314060815835294,1.7920743686163e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39980,0.0532641436054493,0.00480373152700152,0.0438488298125263,0.0626794573983723,1.83314878287338e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NECAP2,Adaptin ear-binding coat-associated protein 2,37562,0.0682863062709066,0.00616403115531022,0.0562048052064986,0.0803678073353146,2.13947564755802e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPCAM,Epithelial cell adhesion molecule,40358,-0.100405770782231,0.00907081694114873,-0.118184571986882,-0.0826269695775792,2.24909468212432e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DTX3,Probable E3 ubiquitin-protein ligase DTX3,40305,0.0240889941331581,0.00217747166561225,0.0198211496685581,0.0283568385977581,2.41268314660872e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CORO1A,Coronin-1A,39990,0.0904972691345311,0.00818797907537553,0.0744488301467951,0.106545708122267,2.71903500492628e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ALDH1A1,Retinal dehydrogenase 1,40332,0.053035355739374,0.00480038448390944,0.0436266021509115,0.0624441093278365,2.83684089927699e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACRBP,Acrosin-binding protein,37900,0.0380310079403236,0.00344698502544461,0.0312749172904522,0.044787098590195,3.49400651766809e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRP11,Low-density lipoprotein receptor-related protein 11,40359,0.0353878414584281,0.00320876791350045,0.0290986563479672,0.0416770265688889,3.5234698710276e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDZD2,PDZ domain-containing protein 2,37562,0.0616172829218651,0.00560432826135495,0.0506327995296094,0.0726017663141208,5.3768811554146e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSAP,Prosaposin,37901,0.0284515267585405,0.00258923298203394,0.023376630113754,0.0335264234033271,5.7145902210144e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TREML2,Trem-like transcript 2 protein,40332,0.0334825923035085,0.00304831018702545,0.0275079043369386,0.0394572802700784,5.75368522430203e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FOXO3,Forkhead box protein O3,39980,0.0968098819212932,0.00881919640109166,0.0795242569751536,0.114095506867433,6.23292884530906e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IMPA1,Inositol monophosphatase 1,40228,0.060832430734484,0.00554563261050223,0.0499629908178996,0.0717018706510684,6.76121594114761e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KCTD5,BTB/POZ domain-containing protein KCTD5,37716,0.0421832582660162,0.00384489924251617,0.0346472557506846,0.0497192607813479,6.92549825707303e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NID1,Nidogen-1,40355,0.0392847626984919,0.00359425880642443,0.0322400154379,0.0463295099590838,1.04111229330985e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AKR1B1,Aldo-keto reductase family 1 member B1,39980,0.0762262878101286,0.00698562230166528,0.0625344680988646,0.0899181075213925,1.27409817347742e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD5,T-cell surface glycoprotein CD5,40470,0.0331209656931269,0.00303796099527833,0.0271665621423814,0.0390753692438725,1.40365617094638e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BLNK,B-cell linker protein,37598,0.0380568502927566,0.00349440569519881,0.0312078151301669,0.0449058854553463,1.67121407419711e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37671,0.0667518546425003,0.00613671544773175,0.0547238923649461,0.0787798169200545,1.92925183642114e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL4,C-C motif chemokine 4,40376,0.0668212746335478,0.00614989640258733,0.0547674776844767,0.078875071582619,2.10169529525904e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MARCO,Macrophage receptor MARCO,40359,0.0262301984696296,0.00241513258888478,0.0214965385954154,0.0309638583438437,2.21148230015194e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37628,0.0521735851545023,0.00480393434392623,0.0427578738404069,0.0615892964685977,2.31903578425492e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD164,Sialomucin core protein 24,40332,0.0261929579877339,0.00241329271386612,0.0214629042685563,0.0309230117069115,2.39109333857433e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37901,0.0640500710729755,0.00591772126538073,0.0524513373928293,0.0756488047531217,3.45045614637483e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,40228,0.0443324946278825,0.00409735680816793,0.0363016752838734,0.0523633139718916,3.45646959454094e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PYY,Peptide YY,37562,0.0937152842651078,0.00866307768771225,0.0767356519971918,0.110694916533024,3.69239449292428e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAEP,Glycodelin,40228,-0.129253855346879,0.0119784565810179,-0.152731630245674,-0.105776080448084,4.74287275434973e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LONP1,"Lon protease homolog, mitochondrial",37628,0.0850356810964501,0.00789169616884674,0.0695679566055105,0.10050340558739,5.83012334685132e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SULT2A1,Bile salt sulfotransferase,40341,0.0521144021633931,0.00484278604934942,0.0426225415066682,0.0616062628201179,6.49488313747212e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNASEH2A,Ribonuclease H2 subunit A,37959,0.0484687723710364,0.00450431092956664,0.0396403229490857,0.057297221792987,6.79477963452303e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39980,0.0641822103101974,0.0059667280254186,0.052487423380377,0.0758769972400179,6.8555799418286e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ASGR2,Asialoglycoprotein receptor 2,37987,0.0253131697294747,0.00235432637933721,0.0206986900259737,0.0299276494329756,7.46245024488905e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MCAM,Cell surface glycoprotein MUC18,40403,-0.0331914632268011,0.00309010600043739,-0.0392480709876584,-0.0271348554659438,8.05181229271961e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJC9,DnaJ homolog subfamily C member 9,37901,0.0751951075298904,0.00700784670209356,0.061459727993787,0.0889304870659937,9.42968849553227e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FST,Follistatin,40396,0.0506355098392457,0.00472334294710096,0.0413777576629278,0.0598932620155636,1.00838944476261e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGFBP2,Fibroblast growth factor-binding protein 2,37998,0.0484750039156142,0.00453685190984427,0.0395827741723195,0.057367233658909,1.53074694096317e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPB1,Carboxypeptidase B,40536,0.0545476466422071,0.00511882061962436,0.0445147582277434,0.0645805350566709,1.99644919869479e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37959,0.0880350837722654,0.00826720396324333,0.0718313640043084,0.104238803540222,2.24934420402072e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRRN1,Leucine-rich repeat neuronal protein 1,40044,0.03735045748817,0.00350975891130318,0.0304713300220158,0.0442295849543242,2.34282401753421e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNDP1,Beta-Ala-His dipeptidase,40403,0.0441919873383995,0.00415378783619688,0.0360505631794537,0.0523334114973454,2.40577626835406e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANXA4,Annexin A4,40279,0.0693285428484913,0.00652094491887285,0.0565474908075005,0.082109594889482,2.60415194841814e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJC21,DnaJ homolog subfamily C member 21,37942,0.0363617068144732,0.00342573457636704,0.0296472670447939,0.0430761465841526,3.24504554963909e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSS,Cathepsin S,37057,0.0239088083861393,0.00225297776940266,0.0194929719581101,0.0283246448141685,3.37690727855886e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL18,Interleukin-18,40292,0.0456567071568867,0.00430536702371678,0.0372181877904018,0.0540952265233716,3.47228790024998e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGAL,Integrin alpha-L,37598,0.042177646001873,0.00397626776348355,0.0343841611854452,0.0499711308183007,3.51457647902929e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF2,Fibroblast growth factor 2,40341,0.0636920527386835,0.00602259441476052,0.0518877676857529,0.0754963377916142,4.72434710940526e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WAS,Wiskott-Aldrich syndrome protein,40044,0.0655667009783433,0.00621088641213536,0.053393363610558,0.0777400383461286,5.78494575435027e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C19orf12,Protein C19orf12,39961,0.0596985610627262,0.00565925092906212,0.0486064292417645,0.070790692883688,6.29504572090617e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C7,Complement component C7,37678,-0.0302875019786429,0.00287222658709945,-0.0359170660893578,-0.024657937867928,6.79042205820664e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MOG,Myelin-oligodendrocyte glycoprotein,40489,0.031124654869626,0.00295324841559257,0.0253362879750646,0.0369130217641875,6.92969092306533e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MCFD2,Multiple coagulation factor deficiency protein 2,40291,0.0413010735967196,0.00392268615233508,0.0336126087381428,0.0489895384552964,7.74839706284544e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FRZB,Secreted frizzled-related protein 3,40176,0.0255249384141279,0.00242659662515389,0.0207688090288263,0.0302810677994295,8.61781353531563e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",40305,0.0309056777062372,0.00293959738465699,0.0251440668323095,0.0366672885801649,9.09312329848235e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNER,Delta and Notch-like epidermal growth factor-related receptor,40319,0.023396095178135,0.00223272938763827,0.019019945578364,0.027772244777906,1.31201284067712e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSL,Cathepsin L1,40359,0.0230481370981316,0.00220364177904571,0.018728999211202,0.0273672749850612,1.61048284549764e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,40341,0.0581698763078901,0.00556351306033736,0.0472653907096288,0.0690743619061513,1.6711951410921e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCDC134,Coiled-coil domain-containing protein 134,37900,0.0467951469879897,0.00447514049577467,0.0380238716162714,0.0555664223597081,1.71015155761985e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNX9,Sorting nexin-9,40359,0.0652130072663152,0.00624282469224331,0.0529770708695183,0.0774489436631121,1.84616234786015e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37671,0.0844397320450488,0.00809915811169484,0.068565382146127,0.100314081943971,2.37219924990503e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37901,0.0432234913467959,0.00414849990574054,0.0350924315315444,0.0513545511620473,2.53354858490415e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37671,0.0272628536127316,0.00261991153136717,0.022127827011252,0.0323978802142112,2.91364129148173e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATG4A,Cysteine protease ATG4A,39980,0.0563413097989064,0.00541656672563381,0.0457248390166641,0.0669577805811487,2.94931493005819e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GSR,"Glutathione reductase, mitochondrial",37944,0.0209158754994936,0.00201716677019074,0.0169622286299197,0.0248695223690674,4.26528625767265e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37990,0.0698563416984251,0.0067413055810814,0.0566433827595055,0.0830693006373446,4.55968916251864e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LGALS3BP,Galectin-3-binding protein,38013,0.0278842176641209,0.00269761134744312,0.0225968994231324,0.0331715359051094,5.95522976870826e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAD23B,UV excision repair protein RAD23 homolog B,39980,0.044795683903327,0.00433643925705365,0.0362962629595018,0.0532951048471521,6.20550523296055e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACAN,Aggrecan core protein,40224,0.0266476478264133,0.00258210867754497,0.0215867148184251,0.0317085808344014,6.8590175364709e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL11,C-X-C motif chemokine 11,40471,0.0745870676851369,0.0072294283601024,0.0604173880993362,0.0887567472709376,7.05288583508536e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFNAR1,Interferon alpha/beta receptor 1,37901,0.0248301955448817,0.00240789005304193,0.0201107310409195,0.0295496600488439,7.69471699252264e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENO2,Gamma-enolase,40471,0.0616541364467185,0.0059820532256551,0.0499293121244345,0.0733789607690025,7.8720476790175e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FMNL1,Formin-like protein 1,39961,0.0562392094487329,0.00545805262205501,0.0455414263095051,0.0669369925879607,8.13551904503632e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSZ,Cathepsin Z,40345,0.0290948632311832,0.00282461193829684,0.0235586238321215,0.034631102630245,8.39031603900721e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MFAP5,Microfibrillar-associated protein 5,40536,0.038390351075321,0.0037278703512207,0.0310837251869284,0.0456969769637136,8.57220361340337e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZNRD2,Protein ZNRD2,37901,0.0637653799733595,0.00619866016632917,0.0516160060473543,0.0759147538993647,9.96329661030697e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPK1,Thiamin pyrophosphokinase 1,37990,0.025338861030699,0.00246852933323438,0.0205005435375596,0.0301771785238384,1.25035144660333e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL6R,Interleukin-6 receptor subunit alpha,40273,0.0314277436488245,0.00306260915954519,0.0254250296961159,0.0374304576015331,1.25168999752e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC27A4,Long-chain fatty acid transport protein 4,39961,0.062149242441367,0.00605759622367742,0.0502763538429593,0.0740221310397747,1.28271821663405e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VWC2,Brorin,40167,0.0362953586781994,0.0035405110055557,0.0293559571073103,0.0432347602490886,1.39332483408345e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLAMF6,SLAM family member 6,39980,0.0354672374047344,0.00345978132723917,0.0286860660033456,0.0422484088061232,1.39848595908132e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPM1F,Protein phosphatase 1F,37990,0.0487622826294185,0.00476495195091813,0.039422976805619,0.058101588453218,1.72288513265939e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPRM,Receptor-type tyrosine-protein phosphatase mu,40324,0.0226599957469993,0.00221738707521208,0.0183139170795836,0.027006074414415,1.93586999615961e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",40341,0.0765644216275576,0.00749363120609371,0.0618769044636139,0.0912519387915012,1.97492801917071e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DYNLT3,Dynein light chain Tctex-type 3,37900,0.0404602710569498,0.0039653599070058,0.0326881656392185,0.0482323764746812,2.34774266964628e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GET3,ATPase GET3,37990,0.0522014356249828,0.00511690092546384,0.0421723098110737,0.0622305614388919,2.38473249614866e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CELA3A,Chymotrypsin-like elastase family member 3A,40522,0.0511695739007561,0.00502465658213849,0.0413212469997647,0.0610179008017475,2.77879570946857e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DMD,Dystrophin,37628,0.0482194997237581,0.00473805454930703,0.0389329128071163,0.0575060866403998,3.08548391990976e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPDC1,Neural proliferation differentiation and control protein 1,40359,0.0286654614186044,0.00281887484995884,0.0231404667126851,0.0341904561245237,3.23028756254478e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MMP3,Stromelysin-1,40332,-0.0446870171813028,0.00439884329726997,-0.0533087500439519,-0.0360652843186536,3.58908803795492e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK7,Kallikrein-7,37352,0.0358486451376863,0.00353355894790323,0.028922869599796,0.0427744206755767,4.28636579909489e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37562,0.0259207910717358,0.00255624289060666,0.0209105550061467,0.0309310271373249,4.49498860856541e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1QA,Complement C1q subcomponent subunit A,40442,-0.0209327510511388,0.00206877059431786,-0.0249875414160018,-0.0168779606862758,5.40437127547589e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD274,Programmed cell death 1 ligand 1,40228,0.0319901254727348,0.00316462437273213,0.0257874617021799,0.0381927892432898,5.9818225192612e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DARS1,"Aspartate--tRNA ligase, cytoplasmic",40192,0.068186699974561,0.0067499212891033,0.0549568542479185,0.0814165457012035,6.41199438011349e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADGRD1,Adhesion G-protein coupled receptor D1,37671,0.0336069702019401,0.00332604144023071,0.0270879289790879,0.0401260114247923,6.46438267789653e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAMP1,Lysosome-associated membrane glycoprotein 1,37621,0.0263753840810833,0.00261205892519925,0.0212557485876928,0.0314950195744738,6.91953715906509e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37901,0.0708035688489793,0.00701456483086159,0.0570550217804906,0.084552115917468,7.15748716407097e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRSS8,Prostasin,40293,0.0370258831709003,0.00367142343384112,0.0298298932405717,0.0442218731012289,7.60566975474189e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPRR,Receptor-type tyrosine-protein phosphatase R,37942,0.0327520633525322,0.00325178094659916,0.0263785726971979,0.0391255540078666,8.91182941389812e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EGFL7,Epidermal growth factor-like protein 7,39980,0.0369536865128963,0.00367408773092919,0.0297524745602751,0.0441548984655175,1.00204337457104e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPXM1,Probable carboxypeptidase X1,40411,0.0628933194590238,0.0062539098842576,0.0506356560858789,0.0751509828321687,1.01053178881123e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MEP1B,Meprin A subunit beta,40359,0.108086152258574,0.0107677899868784,0.0869812838842926,0.129191020632856,1.22113214898185e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TREML1,Trem-like transcript 1 protein,37987,0.0481772235041375,0.0048054335956068,0.0387585736567482,0.0575958733515269,1.42208910032312e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LTBP3,Latent-transforming growth factor beta-binding protein 3,39980,0.0493147766567158,0.00493462840029327,0.039642904992141,0.0589866483212906,1.91337533012059e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL2,C-C motif chemokine 2,40203,0.0481020889853205,0.00481705365384331,0.0386606638237876,0.0575435141468534,2.06474122679341e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RASSF2,Ras association domain-containing protein 2,39980,0.0499381732307852,0.00500475894115377,0.0401288457061239,0.0597475007554466,2.23434761187764e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OCLN,Occludin,37959,0.0396141709090936,0.00397079746976605,0.0318314078683522,0.0473969339498351,2.32960465785273e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TSNAX,Translin-associated protein X,37562,0.0358976218092894,0.00360370391993787,0.0288343621262112,0.0429608814923676,2.72322283029648e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OPLAH,5-oxoprolinase,37628,0.0617624693667929,0.00620263009077244,0.049605314388879,0.0739196243447069,2.8271848010807e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCS,Copper chaperone for superoxide dismutase,40228,0.0436812787417699,0.00439825412959295,0.0350607006477677,0.0523018568357721,3.5512770132168e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HRG,Histidine-rich glycoprotein,37934,0.028520369904355,0.0028723983699568,0.0228904690992396,0.0341502707094703,3.73455843609371e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDT,D-dopachrome decarboxylase,37998,0.0369961446531849,0.00372758294503328,0.0296900820809197,0.0443022072254501,3.88850250160966e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GNAS,Neuroendocrine secretory protein 55,37959,0.081506482888115,0.00822130596237595,0.0653927232018581,0.0976202425743719,4.33660013365448e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRG2,Bone marrow proteoglycan,37998,-0.0471754669687075,0.00475889418204309,-0.0565028995655119,-0.037848034371903,4.37503724666444e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ASPN,Asporin,37990,0.0245852374172693,0.00248718983536937,0.0197103453399454,0.0294601294945933,5.79867047868024e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VWA1,von Willebrand factor A domain-containing protein 1,40453,0.0377291414778483,0.00381800176028949,0.0302458580276809,0.0452124249280157,5.80275247861329e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACYP1,Acylphosphatase-1,37622,0.0595520654421147,0.00602683828075491,0.047739462411835,0.0713646684723943,6.03921689446666e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MRI1,Methylthioribose-1-phosphate isomerase,37572,0.062018666200944,0.00628535749232428,0.0496993655159884,0.0743379668858996,6.94043751851497e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FXN,"Frataxin, mitochondrial",40489,0.0663045090439685,0.0067295702080567,0.0531145514361774,0.0794944666517597,7.74645001196916e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GRK5,G protein-coupled receptor kinase 5,40042,0.0471191793034584,0.00479235477684883,0.0377261639408347,0.0565121946660821,9.53141962628902e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMOTL2,Angiomotin-like protein 2,37855,0.0431119652202665,0.00438674625950478,0.0345139425516371,0.0517099878888959,1.02011153113758e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HNMT,Histamine N-methyltransferase,40147,0.0414782600128401,0.00422436485512332,0.0331985048967983,0.0497580151288818,1.08609519367218e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40536,0.020408100060233,0.0020820914338253,0.0163272008499354,0.0244889992705305,1.28052398597496e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CFHR5,Complement factor H-related protein 5,37785,0.0373312925390965,0.00380903102526684,0.0298655917295735,0.0447969933486195,1.3324798497449e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HPCAL1,Hippocalcin-like protein 1,40516,0.0653593460786141,0.00667211445695052,0.0522820017429911,0.0784366904142371,1.35643013177534e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C8B,Complement component C8 beta chain,38013,0.0272707823350175,0.00278486764552065,0.0218124417497971,0.032729122920238,1.4406846376434e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEBPB,CCAAT/enhancer-binding protein beta,40042,0.0336962690074702,0.00344272910473015,0.0269485199621991,0.0404440180527413,1.47731979769194e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HGFAC,Hepatocyte growth factor activator,37849,0.0257172066137753,0.00264028106569075,0.0205422557250214,0.0308921575025292,2.40659863435543e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBKS,Ribokinase,39991,0.0439589051670989,0.00452489606929263,0.0350901088712854,0.0528277014629125,3.01382492922059e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD72,B-cell differentiation antigen CD72,37671,0.0374248815954065,0.00386035494322311,0.0298585859066892,0.0449911772841238,3.76437637188749e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCN1,Ficolin-1,37967,0.0497593285981196,0.00514069524525619,0.0396835659174175,0.0598350912788218,4.34679340962735e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLRD1,Natural killer cells antigen CD94,40516,0.0401325302920275,0.00415033755903823,0.0319978686763126,0.0482671919077424,4.65764317857773e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37998,0.0547005418873463,0.00565740936428044,0.0436120195333566,0.065789064241336,4.81901882095087e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MSTN,Growth/differentiation factor 8,40042,0.0448869676670796,0.00465795339587175,0.0357573790111709,0.0540165563229882,6.44567130240783e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCTN6,Dynactin subunit 6,39961,0.0620384687784296,0.00645015387773233,0.0493961671780742,0.074680770378785,7.71350497723762e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTP4A3,Protein tyrosine phosphatase type IVA 3,37598,0.0466018696916616,0.00484482761285231,0.037106007570471,0.0560977318128521,7.8523557205109e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,40044,0.0366102681758793,0.00381531663909256,0.0291322475632579,0.0440882887885007,9.58036693912195e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37942,0.0666307753226987,0.00695226840147654,0.0530043292558047,0.0802572213895928,1.09413927758715e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGF1R,Insulin-like growth factor 1 receptor,40305,0.0191130826380033,0.00200040593719542,0.0151922870011002,0.0230338782749063,1.4181780190604e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MEGF10,Multiple epidermal growth factor-like domains protein 10,40357,0.0331825761357982,0.00347784450141162,0.0263660009130314,0.039999151358565,1.61313646828619e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39980,0.0534631687340109,0.0056085522833745,0.0424704062585969,0.0644559312094249,1.75896576231473e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37901,0.0895144645497287,0.00939944516042819,0.0710915520352895,0.107937377064168,1.95856266782721e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PMM2,Phosphomannomutase 2,37562,0.0525694522373016,0.00552432176757377,0.041741781572857,0.0633971229017462,2.1100400825394e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIF22,Kinesin-like protein KIF22,37562,0.106114441204754,0.0111709572517775,0.0842193649912705,0.128009517418238,2.47856736004192e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C5,Complement C5,38013,0.0132269555164685,0.00139436939538195,0.0104939915015199,0.0159599195314171,2.79515815394583e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRSS27,Serine protease 27,40314,0.0349030988137124,0.00368269876879649,0.0276850092268713,0.0421211884005536,2.96208922537824e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LTBP2,Latent-transforming growth factor beta-binding protein 2,40536,-0.0272036313907173,0.00287398060787867,-0.0328366333821595,-0.0215706293992751,3.31783333125856e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MATN2,Matrilin-2,40379,0.025513931619346,0.00269970620915527,0.0202225074494017,0.0308053557892903,3.82598036397777e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCRL1,Fc receptor-like protein 1,40359,0.038612722555389,0.00409726174565513,0.030582089533905,0.046643355576873,4.92520699217607e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STK4,Serine/threonine-protein kinase 4,40359,0.0735747684158577,0.00781919829450028,0.0582491397586371,0.0889003970730782,5.65149196182921e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UNC79,Protein unc-79 homolog,37482,0.048526348519007,0.00516504780625518,0.0384028548187468,0.0586498422192671,6.65336895862698e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLU,Clusterin,38013,0.0282888072614899,0.00301827162263913,0.0223729948811172,0.0342046196418626,8.18612519949146e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TSPYL1,Testis-specific Y-encoded-like protein 1,37598,0.0346964341950181,0.00370707290532666,0.0274305713005779,0.0419622970894583,9.29292088318848e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHAD,Chondroadherin,37671,0.0458771285191939,0.00490490772385929,0.0362635093804296,0.0554907476579581,9.8435731936965e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FUT8,"Alpha-(1,6)-fucosyltransferase",40228,0.0499087873933183,0.00534076338589083,0.0394408911569722,0.0603766836296643,1.04050800708522e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WDR46,WD repeat-containing protein 46,37900,0.0302967825279216,0.00324395994907945,0.0239386210277259,0.0366549440281173,1.11845447286262e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRL,Prolactin,40471,-0.0649352400126502,0.00698573870850396,-0.0786272878813179,-0.0512431921439824,1.65147670879739e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BOLA2_BOLA2B,BolA-like protein 2,37628,0.0474993958653484,0.00510872111101752,0.037486302487754,0.0575124892429427,1.65804133373845e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PON3,Serum paraoxonase/lactonase 3,40422,-0.0231306166643697,0.00249150889990445,-0.0280139741081824,-0.018247259220557,1.84160013699609e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IMMT,MICOS complex subunit MIC60,37900,0.0375780779467279,0.00405142367377672,0.0296372875461255,0.0455188683473303,2.03816162413721e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NAA10,N-alpha-acetyltransferase 10,37562,0.0435023319324473,0.00469080491343445,0.0343083543021157,0.0526963095627788,2.07079499457439e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCARB2,Lysosome membrane protein 2,40011,0.0260628974132642,0.0028128791595623,0.0205496542605221,0.0315761405660064,2.1895959537487e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DSCAM,Down syndrome cell adhesion molecule,37959,0.0296957460632359,0.00321070487372597,0.023402764510733,0.0359887276157388,2.60185884061081e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAMA4,Laminin subunit alpha-4,40422,0.0275701699999194,0.00298458084349374,0.0217203915466717,0.0334199484531671,2.83331935588567e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37562,0.0566828740566237,0.00613503404014793,0.0446582073379338,0.0687075407753137,2.86090298664526e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EFCAB2,Dynein regulatory complex protein 8,37714,0.0292706283057928,0.00316946616095111,0.0230584746303286,0.035482781981257,2.96486612377339e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CALCA,Calcitonin,40192,0.0461206225590159,0.00501279790064261,0.0362955386737564,0.0559457064442754,3.99861016044721e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37572,0.0451513392854295,0.00491194434748028,0.0355239283643682,0.0547787502064909,4.42327717997739e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",40305,0.0582111694955306,0.006339384056959,0.045785976743891,0.0706363622471702,4.7238174244066e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ASAH1,Acid ceramidase,37882,0.0386436459267241,0.00420805040777764,0.0303958671274799,0.0468914247259683,4.78634102894835e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAM,Peptidyl-glycine alpha-amidating monooxygenase,40432,0.0233483452528275,0.00254361758136095,0.01836285479336,0.028333835712295,4.86456713909072e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FOLR2,Folate receptor beta,40471,-0.0246221412197326,0.00268249453521129,-0.0298798305087468,-0.0193644519307185,4.87969884352672e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD83,CD83 antigen,40341,0.0281025752421792,0.00306184268825672,0.0221013635731961,0.0341037869111624,4.90686963568415e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,THBD,Thrombomodulin,40359,0.0231675664482515,0.00252561655419915,0.0182173580020212,0.0281177748944818,5.1516922175708e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TLR3,Toll-like receptor 3,40516,0.0508478465315773,0.00554435873863573,0.0399809034038513,0.0617147896593033,5.23887757566069e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AGXT,Serine--pyruvate aminotransferase,40359,0.0640718173781745,0.00699043927411886,0.0503705564009016,0.0777730783554475,5.51567158274791e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BRK1,Protein BRICK1,39961,0.0369274236407904,0.00403024685107005,0.029028139812693,0.0448267074688877,5.69017481582269e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ING1,Inhibitor of growth protein 1,39925,0.0372839467756575,0.00406970701514623,0.0293073210259709,0.0452605725253441,5.75696975992403e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGAV,Integrin alpha-V,40489,0.0136500339058235,0.00149132385195461,0.0107270391559925,0.0165730286556546,6.19336721949045e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FABP6,Gastrotropin,40017,0.0465504782614721,0.00509066146313024,0.0365727817937368,0.0565281747292074,6.73096274088553e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SWAP70,Switch-associated protein 70,37901,0.0293187332792897,0.00320736578244436,0.0230322963456987,0.0356051702128806,7.05911876131225e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STX16,Syntaxin-16,39980,0.0490697622576561,0.00538274012755683,0.0385195916076447,0.0596199329076674,8.72074179007449e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ICAM1,Intercellular adhesion molecule 1,40291,0.023634552509063,0.00259614467328528,0.0185461089494239,0.0287229960687022,9.75086439481681e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BAP18,Chromatin complexes subunit BAP18,37942,0.0537707317233874,0.00590610515348243,0.0421947656225618,0.065346697824213,9.88975203941569e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPQ,Carboxypeptidase Q,37986,0.0303040751087369,0.00333178378830157,0.0237737788836658,0.036834371333808,1.07157839026267e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BRDT,Bromodomain testis-specific protein,37562,0.0309077196366253,0.00340307211557775,0.0242376982900929,0.0375777409831577,1.21345607338374e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENTR1,Endosome-associated-trafficking regulator 1,37628,0.047179708851576,0.00519546847472897,0.0369965906411072,0.0573628270620448,1.22786429694749e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PECAM1,Platelet endothelial cell adhesion molecule,40332,0.024735389183665,0.00272510498882086,0.0193941834055761,0.0300765949617539,1.24633508175307e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STXBP3,Syntaxin-binding protein 3,39980,0.0365211714569411,0.00402591860880432,0.0286303709836847,0.0444119719301976,1.31191323205281e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGA,Fibrinogen alpha chain,37698,0.0254510736047138,0.00280612357823497,0.0199510713913733,0.0309510758180543,1.35783920574562e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IDS,Iduronate 2-sulfatase,40516,0.00713457874752584,0.000787642588506961,0.0055907992740522,0.00867835822099948,1.47668767345634e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACP6,Lysophosphatidic acid phosphatase type 6,40453,0.0545404675461494,0.006026598015701,0.0427283354353755,0.0663525996569234,1.59171361087361e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BOLA1,BolA-like protein 1,37541,0.0451920710712895,0.00500089089343745,0.0353903249201521,0.0549938172224269,1.83704357636203e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA4,Carbonic anhydrase 4,40536,-0.0191694563951727,0.00212594825395951,-0.0233363149729333,-0.015002597817412,2.14894587688196e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCDC80,Coiled-coil domain-containing protein 80,40359,0.0287910263514348,0.00319808591978556,0.0225227779486551,0.0350592747542145,2.44982488388942e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSG1,Pregnancy-specific beta-1-glycoprotein 1,40228,-0.0956544161979319,0.0106505970478637,-0.116529586411745,-0.074779245984119,2.97751035958056e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD276,CD276 antigen,40357,-0.0294176471461389,0.00327575848748377,-0.0358381337816071,-0.0229971605106708,2.99452046853626e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSPB6,Heat shock protein beta-6,40489,0.0298173163527534,0.00332160892728508,0.0233069628552746,0.0363276698502322,3.09203249920034e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAGR1,PAXIP1-associated glutamate-rich protein 1,37628,0.036452875279168,0.00406550677009221,0.0284844820097872,0.0444212685485487,3.47278829247568e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COX6B1,Cytochrome c oxidase subunit 6B1,37990,0.0264353757533411,0.00295126083201379,0.0206509045225941,0.0322198469840881,3.75598238722613e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMOT,Angiomotin,37671,0.0340661485344145,0.00380410839333607,0.0266100960834758,0.0415222009853532,3.84312899853993e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ASS1,Argininosuccinate synthase,37562,0.0655983295997759,0.00733922154644464,0.0512134553687444,0.0799832038308074,4.48493357697275e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAMB1,Laminin subunit beta-1,37628,0.0240034814464462,0.00269112400356228,0.0187288783994642,0.0292780844934283,5.29493145116305e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,REN,Renin,40359,-0.0578504392603507,0.00649313097775101,-0.0705769759767427,-0.0451239025439587,5.67300057665501e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD46,Membrane cofactor protein,40250,0.0232229015615339,0.00261004048671947,0.0181072222075638,0.0283385809155041,6.31956312653164e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL5RA,Interleukin-5 receptor subunit alpha,40341,-0.0446667772360835,0.00502358172636349,-0.0545129974197559,-0.034820557052411,6.67100003053041e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37714,0.0707503895936114,0.00795610707830505,0.0551564197201335,0.0863443594670893,6.73379894915533e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VGF,Neurosecretory protein VGF,37959,0.0247246943144107,0.00278076963726054,0.0192743858253801,0.0301750028034414,6.79630849019104e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD8A,T-cell surface glycoprotein CD8 alpha chain,40471,0.0391128838817577,0.00440231071590191,0.03048435487859,0.0477414128849255,7.08367597854355e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SH3BP1,SH3 domain-binding protein 1,37901,0.0378630168030571,0.00426242327218255,0.0295086671895793,0.0462173664165349,7.32602239360531e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37598,0.0363507555777602,0.00409578140263074,0.0283230240286039,0.0443784871269164,7.87682635433485e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERI1,3'-5' exoribonuclease 1,37714,0.0271590337271614,0.00306608343658296,0.0211495101914588,0.033168557262864,9.18033743173829e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACOT13,Acyl-coenzyme A thioesterase 13,37901,0.0914036214342061,0.0103326651323156,0.0711515977748676,0.111655645093545,1.01820942807445e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TSHB,Thyrotropin subunit beta,40359,0.0674871084127887,0.00763450255275514,0.0525234834093886,0.0824507334161888,1.05818025837408e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37628,-0.0292567767966524,0.00331368337068629,-0.0357515962031976,-0.0227619573901073,1.18731581894739e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LGMN,Legumain,40422,0.0285033251143874,0.00323041967572055,0.0221717025499752,0.0348349476787997,1.22331388684494e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPMT,Thiopurine S-methyltransferase,39980,0.0594331559751539,0.00674264229890539,0.0462175770692994,0.0726487348810085,1.32753589545806e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MANSC1,MANSC domain-containing protein 1,40411,-0.021975266984928,0.00249783585588049,-0.0268710252624538,-0.0170795087074023,1.53680773421704e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPPK1,Epiplakin,37628,0.0590206292901344,0.00670729721517765,0.0458743267483862,0.0721669318318826,1.54412723013166e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENAH,Protein enabled homolog,40044,0.0378644744678077,0.00431179331240973,0.0294133595754846,0.0463155893601308,1.77658019351434e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NID2,Nidogen-2,40332,0.0588846416986661,0.00671844436984773,0.0457164907337646,0.0720527926635677,2.06076763945618e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,40228,0.0277541110506002,0.00316863851371347,0.0215435795637218,0.0339646425374786,2.16701348244839e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39980,0.0381697682864084,0.00436235998280883,0.0296195427201031,0.0467199938527137,2.35388980537938e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STX6,Syntaxin-6,39980,0.0548517642160854,0.00627526981201731,0.0425522353845315,0.0671512930476393,2.54499327794123e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPHS1,Nephrin,37598,0.0277137310903634,0.00316996736712368,0.021500595050801,0.0339268671299258,2.55217790055925e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37959,0.0465336265585142,0.00532840078823142,0.0360899610135806,0.0569772921034478,2.76535695706036e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MDK,Midkine,40352,0.0402750955098828,0.00461543728055996,0.0312288384399853,0.0493213525797803,2.89188033900674e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPAG1,Sperm-associated antigen 1,37959,0.0458025898775361,0.00525042437402213,0.0355117581044527,0.0560934216506195,3.00711103361992e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SF3B4,Splicing factor 3B subunit 4,40305,0.0582250834005592,0.00668224379767536,0.0451278855571155,0.0713222812440029,3.23622372134092e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TCL1A,T-cell leukemia/lymphoma protein 1A,40215,0.0746852287297354,0.00858969683909052,0.057849422925118,0.0915210345343528,3.8138359032715e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAN2B2,Epididymis-specific alpha-mannosidase,37990,0.0472622602045497,0.00543644365795457,0.0366068306349587,0.0579176897741406,3.91127186057898e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL15A1,Collagen alpha-1(XV) chain,37998,0.0205426046402982,0.00236488097926422,0.0159074379209403,0.0251777713596561,4.16074472453635e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CASP8,Caspase-8,40434,0.0488434227379733,0.00563489568792746,0.0377990271896355,0.0598878182863111,4.81255975682602e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ABCA2,ATP-binding cassette sub-family A member 2,37562,0.0293327746340619,0.00338372459169784,0.0227006744343341,0.0359648748337897,4.87607202013676e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCN4,CCN family member 4,40489,0.0322809702445955,0.00372743357573493,0.024975200436155,0.0395867400530359,5.14365548652962e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTGES2,Prostaglandin E synthase 2,37484,0.043143284643635,0.00499099354259191,0.0333609373001549,0.0529256319871152,6.04417357893887e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ECE1,Endothelin-converting enzyme 1,39961,0.0278032858626886,0.00321833426303556,0.0214953507071389,0.0341112210182383,6.2148431118034e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL25,C-C motif chemokine 25,40516,0.0383655664948268,0.00445000263545077,0.0296435613293433,0.0470875716603103,7.21810118893903e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LY75,Lymphocyte antigen 75,40341,0.0305486869302926,0.00354543107465711,0.0235996420239647,0.0374977318366206,7.5536684335253e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NTRK2,BDNF/NT-3 growth factors receptor,40359,0.0202135360186428,0.00234711113468379,0.0156131981946626,0.0248138738426231,7.83777190526593e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39980,0.0343016025850093,0.00399056933235298,0.0264800866935975,0.0421231184764211,9.05764695848922e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLF4,Krueppel-like factor 4,37541,0.0306743472139238,0.00356814992119672,0.0236807733683783,0.0376679210594694,9.12739877799256e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,37337,0.0387026042681409,0.00450479423910544,0.0298732075594942,0.0475320009767876,9.57072544259963e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",40044,0.0563626343282493,0.00656214880594679,0.0435008226685936,0.069224445987905,9.58842782261604e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SOD1,Superoxide dismutase [Cu-Zn],39978,0.0383036294158713,0.00446308761301461,0.0295559776943626,0.0470512811373799,1.01680454810553e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,40341,0.0291517992893735,0.00341048642730848,0.0224672458918489,0.0358363526868981,1.36849684280504e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STX7,Syntaxin-7,37598,0.0392762655060448,0.00459651362449999,0.0302670988020249,0.0482854322100648,1.4284310969514e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPINT2,Kunitz-type protease inhibitor 2,40422,0.0326033009715485,0.00381774007655282,0.025120530421505,0.040086071521592,1.46235865927929e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37942,0.0372638951170196,0.00436512199692605,0.0287082560030445,0.0458195342309946,1.52700797008262e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37942,0.030109293960544,0.00352754742635702,0.0231953010048842,0.0370232869162037,1.54366418025758e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC5A,C-type lectin domain family 5 member A,40314,-0.0219563795142109,0.00257328559457843,-0.0270000192795846,-0.0169127397488372,1.56105582452477e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BMPER,BMP-binding endothelial regulator protein,37671,0.017476350307183,0.00204957054810902,0.0134591920328893,0.0214935085814766,1.66612939459137e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ALCAM,CD166 antigen,40536,0.0150473696079549,0.00176567238520886,0.0115866517329455,0.0185080874829643,1.70302061145596e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NBN,Nibrin,40044,0.0395354098457011,0.00464095652720552,0.0304391350523783,0.0486316846390239,1.75769098307733e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAGED1,Melanoma-associated antigen D1,39980,0.0377362496922983,0.00443007585588874,0.0290533010147564,0.0464191983698403,1.7675774848367e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CR1,Complement receptor type 1,37959,0.0281418059702995,0.0033057534666046,0.0216625291757545,0.0346210827648446,1.87261743900699e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DENR,Density-regulated protein,37598,0.0446897100834783,0.00525893541323041,0.0343821966735467,0.05499722349341,2.1375067798843e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,40359,0.0494604848964704,0.00582671909132804,0.0380401154774674,0.0608808543154733,2.27445123918124e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37628,0.0706988180527731,0.00832939250016888,0.0543732087524421,0.0870244273531041,2.32782546404691e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PQBP1,Polyglutamine-binding protein 1,39980,0.0426417087369008,0.00502733489222122,0.0327881323481472,0.0524952851256544,2.41143423500475e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STAM,Signal transducing adapter molecule 1,37900,0.0290524261509175,0.00342571154467242,0.0223380315233596,0.0357668207784755,2.47010706011527e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NGRN,Neugrin,37942,0.0170364731391211,0.00200916212213295,0.0130985153797405,0.0209744308985017,2.49708613683607e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LBP,Lipopolysaccharide-binding protein,40403,-0.0447312479029066,0.00530047609654459,-0.0551201810521341,-0.0343423147536792,3.46935070588069e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARHGAP1,Rho GTPase-activating protein 1,39980,0.0352487039435773,0.0041802019000643,0.0270555082194513,0.0434418996677033,3.68432770639311e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP6V1F,V-type proton ATPase subunit F,39925,0.0508092391369485,0.00602943232717493,0.0389915517756856,0.0626269264982114,3.8595492792818e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTN,Pleiotrophin,40042,0.0385143393855266,0.00457608819767201,0.0295452065180894,0.0474834722529637,4.21488093879938e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TREH,Trehalase,37998,0.0570288077738094,0.00678896361113943,0.0437224390959761,0.0703351764516426,4.89630758905746e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRG1,Leucine-rich alpha-2-glycoprotein,38013,-0.0195713836750991,0.00233310405072694,-0.0241442676145239,-0.0149984997356743,5.40388773786108e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FAM3C,Protein FAM3C,40330,0.0225776949155332,0.00270143116481686,0.0172828898324921,0.0278724999985742,6.92069140509122e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",40192,0.0725700258048911,0.00868546423935739,0.0555465158957506,0.0895935357140315,7.063338577032e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCT,Secretin,37572,0.0349355525188788,0.00420036755399147,0.0267028321130555,0.0431682729247021,9.88402858052092e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NEK7,Serine/threonine-protein kinase Nek7,37714,0.0575322734244119,0.0069206307607691,0.0439678371333044,0.0710967097155193,1.02202157926668e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPHB4,Ephrin type-B receptor 4,40536,-0.0186265925021172,0.00224268753670313,-0.0230222600740554,-0.0142309249301791,1.07255262558971e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RPE,Ribulose-phosphate 3-epimerase,37714,0.0528732027661021,0.00637740494469824,0.0403734890744936,0.0653729164577107,1.23341287519232e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPINK2,Serine protease inhibitor Kazal-type 2,37671,0.0287197886965017,0.00347020666088848,0.0219181836411602,0.0355213937518431,1.39394805179552e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PVALB,Parvalbumin alpha,40417,0.0851385663779328,0.0102928879953265,0.0649645059070928,0.105312626848773,1.42508534876683e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37900,0.041271652122291,0.00499420003298409,0.0314830200576422,0.0510602841869398,1.54079178258435e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPP1,Tripeptidyl-peptidase 1,40255,0.0335291230417087,0.0040698807662953,0.02555215673977,0.0415060893436475,1.88153490242847e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DKK4,Dickkopf-related protein 4,40203,0.034193666850706,0.00415739734166087,0.0260451680610507,0.0423421656403613,2.10690471067634e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TXN,Thioredoxin,37819,0.0333203726099759,0.00406505982896033,0.0253528553452136,0.0412878898747381,2.69272486691878e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37959,0.0510306659995119,0.00623159871381203,0.0388167325204403,0.0632445994785835,2.8685494713758e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANGPT2,Angiopoietin-2,40489,-0.0288917546079346,0.00352976316379478,-0.0358100904089724,-0.0219734188068969,2.92146129353967e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HMOX1,Heme oxygenase 1,40184,-0.0349868406112833,0.00427482721552775,-0.0433655019537176,-0.0266081792688489,2.94481888418589e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL17D,Interleukin-17D,40044,0.02552947992993,0.00312520090484008,0.0194040861564434,0.0316548737034166,3.34865319613041e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,XRCC4,DNA repair protein XRCC4,39961,0.0277673682650992,0.00339915597856142,0.0211050225471189,0.0344297139830796,3.35017160269757e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GRPEL1,"GrpE protein homolog 1, mitochondrial",40305,0.0446252110383315,0.00546395570747599,0.0339158578516785,0.0553345642249844,3.39215321886576e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C7orf50,Uncharacterized protein C7orf50,37942,0.016352482179987,0.00200273973109444,0.0124271123070419,0.0202778520529321,3.49631171334782e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGB6,Integrin beta-6,40044,0.0224591726668549,0.00275228870449307,0.0170646868060485,0.0278536585276614,3.59861347361301e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PER3,Period circadian protein homolog 3,37598,0.0878655248816204,0.0107851307488141,0.0667266686139447,0.109004381149296,4.06857108319111e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL24A1,Collagen alpha-1(XXIV) chain,37901,0.0407911918178624,0.00502088453373218,0.0309502581317473,0.0506321255039774,4.88949047194843e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC4A,C-type lectin domain family 4 member A,40341,-0.0254509257382833,0.00313432879363014,-0.0315942101737984,-0.0193076413027682,4.99890369422241e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCTN2,Dynactin subunit 2,40305,0.0695198542949943,0.00856791242371389,0.0527267459445151,0.0863129626454736,5.2552789410878e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD74,HLA class II histocompatibility antigen gamma chain,40471,0.0256617698396589,0.00316594181685481,0.0194565238786234,0.0318670158006943,5.62602049894713e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTGDS,Prostaglandin-H2 D-isomerase,40234,0.0217947454240363,0.00269191769571834,0.0165185867404284,0.0270709041076443,6.07283163210674e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MZB1,Marginal zone B- and B1-cell-specific protein,40405,-0.0375981220772741,0.00464593937572649,-0.046704163253698,-0.0284920809008501,6.25372909267391e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SORCS2,VPS10 domain-containing receptor SorCS2,39980,0.0265224996915751,0.00327806889473497,0.0200974846578946,0.0329475147252556,6.35807765744029e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PNLIP,Pancreatic triacylglycerol lipase,37987,0.044529425875976,0.0055044903871833,0.0337406247170968,0.0553182270348553,6.48983842626789e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSTB,Cystatin-B,40097,0.0308568001274735,0.00381517898034285,0.0233790493260015,0.0383345509289455,6.51184938289255e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMS,Spermine synthase,37541,0.0471541024310828,0.00583551229691278,0.0357164983291337,0.0585917065330318,7.01040846088749e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL12A_IL12B,Interleukin-12,40305,0.0576724652388105,0.00714197635119648,0.0436741915904654,0.0716707388871556,7.22069768663115e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,40450,0.0223189428911953,0.00276695114202061,0.0168957186528349,0.0277421671295557,7.75851179079118e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SV2A,Synaptic vesicle glycoprotein 2A,37572,0.045512284442181,0.00564162012780565,0.034454708991682,0.0565698598926801,7.81220444583118e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPINK6,Serine protease inhibitor Kazal-type 6,40489,0.039610969864946,0.00492046648125268,0.0299668555616908,0.0492550841682013,8.83792664238363e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BMP6,Bone morphogenetic protein 6,40024,0.0310555622417801,0.00385846733418247,0.0234929662667825,0.0386181582167778,8.9694000353854e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],40305,0.0418764254434434,0.00520541286317292,0.0316738162316244,0.0520790346552623,9.24669596358257e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLAMF7,SLAM family member 7,40341,-0.0421958427686982,0.00526091282876444,-0.0525072319130765,-0.0318844536243199,1.12486922970674e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANGPTL4,Angiopoietin-related protein 4,40396,-0.0332522909815262,0.00415458895660533,-0.0413952853364726,-0.0251092966265797,1.28941612650188e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ESAM,Endothelial cell-selective adhesion molecule,40536,0.0227744202909268,0.00284933445132297,0.0171897247663338,0.0283591158155199,1.40696536034509e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLSTN3,Calsyntenin-3,37942,0.0222991837187813,0.00278982981737181,0.0168311172767326,0.0277672501608301,1.42311530870095e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARSA,Arylsulfatase A,40332,0.0324159131142488,0.00405883633472782,0.0244605938981823,0.0403712323303154,1.48270862507529e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,40228,0.0214518628421547,0.00268600610618325,0.0161872908740355,0.0267164348102738,1.48306546319439e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37564,0.0208224671545098,0.00260882577074848,0.0157091686438427,0.0259357656651768,1.56472825341488e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APRT,Adenine phosphoribosyltransferase,40216,0.0352564761449489,0.00442006188460145,0.02659315485113,0.0439197974387677,1.60859547007427e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GBP1,Guanylate-binding protein 1,37931,0.0468317858736149,0.00587333707516202,0.0353200452062973,0.0583435265409325,1.66432774911204e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MENT,Protein MENT,37671,-0.0157673384815948,0.00197809758218989,-0.019644409742687,-0.0118902672205027,1.70299862843185e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDIA3,Protein disulfide-isomerase A3,37671,0.0185745454295922,0.00233177949362636,0.0140042576220846,0.0231448332370999,1.77490900794263e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39925,0.0346066232471736,0.00435314232416932,0.0260744642918017,0.0431387822025454,1.99630328110745e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLIT2,Slit homolog 2 protein,39961,0.0380145754203163,0.00478717666411107,0.0286317091586587,0.047397441681974,2.14370277259038e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,REPS1,RalBP1-associated Eps domain-containing protein 1,37598,0.028414560626815,0.00357905228703105,0.0213996181442342,0.0354295031093959,2.20052192074195e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GIP,Gastric inhibitory polypeptide,37628,0.0373905173424187,0.00471517523851205,0.0281487738749351,0.0466322608099023,2.37055351633091e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FAM3B,Protein FAM3B,40305,0.0260819520284664,0.00329013762474967,0.0196332822839571,0.0325306217729758,2.38756808365366e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLITRK6,SLIT and NTRK-like protein 6,40042,-0.0246834795551682,0.00311400899232478,-0.0307869371801248,-0.0185800219302117,2.40400177633064e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNRPB2,U2 small nuclear ribonucleoprotein B'',37942,0.0284370896573424,0.00360532666318024,0.0213706493975091,0.0355035299171757,3.31855123088158e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37901,0.083782575421739,0.0106224044448639,0.0629626627098057,0.104602488133672,3.32393909311224e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OXT,Oxytocin-neurophysin 1,40471,0.0949009526148644,0.0120403839861077,0.0713018000020934,0.118500105227635,3.43097564021426e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,S100A13,Protein S100-A13,37598,0.0251117368067332,0.00318535575490644,0.0188684395271166,0.0313550340863498,3.43336881012808e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DSG4,Desmoglein-4,40250,0.0364732972512166,0.00464053177970266,0.0273778549629994,0.0455687395394338,4.09676197292783e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NOTCH1,Neurogenic locus notch homolog protein 1,40536,0.0111024637060099,0.00141356505553339,0.0083318761971645,0.0138730512148554,4.27496368317316e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,40400,0.0372484283181241,0.00474586780489266,0.0279465274205345,0.0465503292157137,4.47271137593227e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRYGD,Gamma-crystallin D,37942,0.0686429886776349,0.0087556825018401,0.0514818509740283,0.0858041263812415,4.84896456898148e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LGALS7_LGALS7B,Galectin-7,40270,0.0287261049838835,0.00366498586390229,0.021542732690635,0.0359094772771319,4.86834356215655e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HDGF,Hepatoma-derived growth factor,40471,0.0681735585524272,0.00870121780393254,0.0511191716567194,0.085227945448135,4.98332463689695e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PODXL,Podocalyxin,40305,0.0108564681322802,0.00138598629393223,0.00813993499617308,0.0135730012683874,5.06284971892121e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MMP12,Macrophage metalloelastase,40346,0.0369231122754884,0.00471862585475185,0.0276746056001748,0.046171618950802,5.39564227634332e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD200R1,Cell surface glycoprotein CD200 receptor 1,40291,0.0246161774323625,0.00314694484250216,0.0184481655410582,0.0307841893236667,5.51447723333059e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,40332,0.0256368000299395,0.00328262331053941,0.0192028583412823,0.0320707417185968,6.08155033303618e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNF,Tumor necrosis factor,40014,0.0283238886646099,0.00362921467217953,0.021210627907138,0.0354371494220817,6.3563682161007e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,INSR,Insulin receptor,37598,0.012043837481562,0.00154403618015805,0.00901752656845217,0.0150701483946717,6.64393035550651e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LEPR,Leptin receptor,40359,-0.0217751723478839,0.00279247454885899,-0.0272484224636475,-0.0163019222321202,6.68787570169833e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FLT3LG,Fms-related tyrosine kinase 3 ligand,40516,0.0233635766188132,0.00300172545417035,0.0174801947286393,0.0292469585089871,7.48903863068296e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ELOB,Elongin-B,37562,0.0285436236154501,0.00367228521378592,0.0213459445964297,0.0357413026344705,8.25300003976484e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDH5,Cadherin-5,40536,-0.0214819044737097,0.00276625250514984,-0.0269037593838034,-0.016060049563616,8.60609690639923e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CASP9,Caspase-9,37598,0.0442722542425178,0.00570718777369427,0.033086166206077,0.0554583422789586,9.31473423632485e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPXM2,Inactive carboxypeptidase-like protein X2,37990,0.0177697992626289,0.00229453098638182,0.0132725185293206,0.0222670799959373,1.02823569085246e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CST5,Cystatin-D,40070,0.0389203948088297,0.00503301123341965,0.0290556927913272,0.0487850968263322,1.11403692835439e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCG2,Secretogranin-2,40392,0.022701993837155,0.0029392109556642,0.0169411403640532,0.0284628473102568,1.19561678614337e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37901,0.0559399938505977,0.00724347081900703,0.0417427910453439,0.0701371966558515,1.21808993468712e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCRL5,Fc receptor-like protein 5,40332,-0.0393875672838495,0.00510229530750394,-0.0493880660865572,-0.0293870684811418,1.2363878309927e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FSTL1,Follistatin-related protein 1,37628,-0.0158558546171667,0.00205382130024602,-0.0198813443656489,-0.0118303648686845,1.24525874973446e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCRIB,Protein scribble homolog,37628,0.0654994417487708,0.00849078953082678,0.0488574942683504,0.0821413892291913,1.30494771542194e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PZP,Pregnancy zone protein,38013,0.0458816283157021,0.00595038948992469,0.0342188649154497,0.0575443917159545,1.33827157109773e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RGMB,RGM domain family member B,40471,0.0182352928272501,0.00236570012579544,0.0135985205806911,0.0228720650738092,1.35060620948645e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CYTL1,Cytokine-like protein 1,37998,0.016120552686703,0.00209945537660133,0.0120056201485644,0.0202354852248416,1.72039111959084e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37901,0.0295130979627797,0.00384454744130923,0.0219777849778136,0.0370484109477458,1.74590183033072e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GLO1,Lactoylglutathione lyase,40042,0.0414064957644073,0.00539855538703842,0.030825327205812,0.0519876643230026,1.82237532387352e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERMAP,Erythroid membrane-associated protein,37598,0.0312079175275101,0.00410144159029192,0.023169092010538,0.0392467430444823,2.94967262163688e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSE,Cathepsin E,37671,0.03575666830746,0.00470508706766898,0.0265346976548288,0.0449786389600912,3.17074226415453e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,POSTN,Periostin,37998,-0.0262592389347806,0.00345700704510517,-0.0330349727431867,-0.0194835051263745,3.25543262810571e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37901,-0.022827463502661,0.00300686057121597,-0.0287209102222443,-0.0169340167830777,3.36258408202445e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APLP1,Amyloid-like protein 1,40359,-0.0359196634070591,0.00473810890624126,-0.045206356863292,-0.0266329699508262,3.61738706055327e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,XCL1,Lymphotactin,40489,0.0389149469193598,0.00513698925063831,0.0288464479881087,0.0489834458506109,3.77393420218292e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37572,0.0377529706236896,0.0049862858680376,0.0279798503223359,0.0475260909250433,3.93980369029282e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IDO1,"Indoleamine 2,3-dioxygenase 1",37628,0.0447863380964182,0.00591650610587292,0.0331899861289073,0.0563826900639291,3.98835748906614e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLTA,Clathrin light chain A,40042,0.0326062360947133,0.00432181399764612,0.0241354806593269,0.0410769915300997,4.78779964292928e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOA2,Apolipoprotein A-II,37987,-0.0326936142959181,0.0043411207394636,-0.0412022109452667,-0.0241850176465694,5.34780660497188e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LACRT,Extracellular glycoprotein lacritin,37863,0.0366139598145058,0.00486164501081681,0.0270851355933049,0.0461427840357068,5.34914262616907e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37990,0.0226798738743414,0.00301366891834045,0.0167730827943941,0.0285866649542887,5.57580963567595e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL1R1,Interleukin-1 receptor type 1,40303,-0.0152739361744367,0.00203552024660844,-0.0192635558577893,-0.0112843164910842,6.53286521287385e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GLRX,Glutaredoxin-1,40260,0.0386891978837517,0.00515833753139616,0.0285788563222153,0.0487995394452882,6.70379953593833e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37628,0.0342940137856637,0.00458295109109548,0.0253114296471166,0.0432765979242109,7.72739489318447e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDGFRA,Platelet-derived growth factor receptor alpha,40359,-0.0194011174380852,0.00259444515916506,-0.0244862299500487,-0.0143160049261217,7.94258321177387e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FBP1,"Fructose-1,6-bisphosphatase 1",40359,0.0492662522964977,0.00659523215480762,0.0363395972730747,0.0621929073199206,8.43664699037271e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SRPX,Sushi repeat-containing protein SRPX,37990,-0.0222903034501318,0.00298489988976558,-0.0281407072340724,-0.0164398996661913,8.66027122459237e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,XG,Glycoprotein Xg,40458,0.0203500317090673,0.00272805352235523,0.0150030468052511,0.0256970166128836,9.1272264530488e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMIGO2,Amphoterin-induced protein 2,40305,0.0153189754997716,0.00205603427205752,0.0112891483265388,0.0193488026730043,9.75989202311204e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37901,0.0693293688226716,0.00930677088356618,0.0510880978908819,0.0875706397544613,9.9516833016143e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPRC,Receptor-type tyrosine-protein phosphatase C,37998,0.0152143995545187,0.00204338459382594,0.0112093657506199,0.0192194333584175,1.02261814503396e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL10RB,Interleukin-10 receptor subunit beta,40422,0.0192886166124558,0.00259312318856882,0.0142060951628609,0.0243711380620507,1.07108888345704e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL20,C-C motif chemokine 20,40516,0.0600076422255179,0.00808187787347788,0.0441671615935013,0.0758481228575346,1.18464267105977e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COLEC12,Collectin-12,40357,0.0172761080489871,0.00232751201699895,0.0127141844956692,0.0218380316023051,1.20681261187093e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WASF3,Wiskott-Aldrich syndrome protein family member 3,39961,0.056735015339123,0.00764631141678132,0.0417482449622316,0.0717217857160144,1.23261966518657e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37990,0.0206743042105611,0.00278750373402662,0.0152107968918689,0.0261378115292533,1.27134026986129e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37598,0.0302932185884284,0.00408741291394716,0.022281889277092,0.0383045478997648,1.32663257905176e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EDF1,Endothelial differentiation-related factor 1,37959,0.0469831578199734,0.00635138959496581,0.0345344342138404,0.0594318814261064,1.47170075191705e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGB1,Integrin beta-1,40333,0.0147514277937001,0.00199514154255183,0.0108409503702985,0.0186619052171017,1.49944307695828e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOB,Apolipoprotein B-100,37987,0.0150809818421468,0.00203945344235477,0.0110836530951314,0.0190783105891621,1.50143829280143e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ECI2,Enoyl-CoA delta isomerase 2,37562,0.0424454174930181,0.00574225918869408,0.0311905894831777,0.0537002455028585,1.53675368227458e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37594,0.0260457698028187,0.00352808492446556,0.0191307233508662,0.0329608162547712,1.64798038594159e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GRN,Progranulin,40262,0.0162851231901567,0.00221160149111815,0.0119503842675651,0.0206198621127483,1.87976632873584e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37959,0.0447947168143497,0.00609079747878785,0.0328567537559255,0.0567326798727739,2.02691964582504e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MILR1,Allergin-1,40044,-0.0334722081398516,0.00455738396607479,-0.0424046807133582,-0.024539735566345,2.16563439211852e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHCHD6,MICOS complex subunit MIC25,37900,0.0194430645108942,0.0026478562124521,0.0142532663344881,0.0246328626873003,2.20952809635882e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RANBP1,Ran-specific GTPase-activating protein,37628,0.0355722227143016,0.00484895220514596,0.0260682763922155,0.0450761690363877,2.32829417401719e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SORBS1,Sorbin and SH3 domain-containing protein 1,37959,0.0265360032191664,0.00362283155474402,0.0194352533718681,0.0336367530664647,2.53075744709975e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSNK1D,Casein kinase I isoform delta,37598,0.0426079729578845,0.00582397381464921,0.031192984281172,0.0540229616345969,2.70355884518859e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,40359,0.0325211631614579,0.00444686561147568,0.0238053065629656,0.0412370197599503,2.73118256278715e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZHX2,Zinc fingers and homeoboxes protein 2,37942,0.0201010226471454,0.00275178284123215,0.0147075282783304,0.0254945170159604,2.93416607681891e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAMP3,Lysosome-associated membrane glycoprotein 3,40502,0.0338484721071003,0.00463634914146935,0.0247612277898204,0.0429357164243803,2.99748352218406e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK6,Kallikrein-6,40387,0.0202273066964618,0.00277667667688921,0.014785020409759,0.0256695929831647,3.37427508323779e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINA9,Serpin A9,40228,0.0477476561979673,0.00657404163364766,0.0348625345960179,0.0606327777999167,3.96109054618611e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37628,0.0275116856096504,0.00378944470981594,0.0200843739784112,0.0349389972408897,4.08541203783938e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AREG,Amphiregulin,40305,-0.0327314364152688,0.00451566447143443,-0.0415821387792803,-0.0238807340512574,4.41100387427808e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPC2,NPC intracellular cholesterol transporter 2,37815,0.0205107230257147,0.00282940012595972,0.0149650987788336,0.0260563472725957,4.42459053735836e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37598,0.0401783783436585,0.00554502177963122,0.0293101356555813,0.0510466210317357,4.53706940813514e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AK1,Adenylate kinase isoenzyme 1,40359,0.0421754274297171,0.00582314463097481,0.0307620639530065,0.0535887909064278,4.59904790237527e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TAFA5,Chemokine-like protein TAFA-5,40305,0.0236839758359581,0.00327220331377445,0.0172704573409602,0.030097494330956,4.76471464599555e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COPB2,Coatomer subunit beta',37562,0.0286042804541927,0.00395460061327017,0.0208532632521832,0.0363552976562022,4.98062159691737e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLITRK2,SLIT and NTRK-like protein 2,40489,0.0249598509961703,0.00345471850635715,0.0181886027237103,0.0317310992686303,5.24186698322816e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINI2,Serpin I2,37901,0.0367085310033362,0.00511033806652647,0.0266922683929444,0.0467247936137281,7.16853585129261e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGHMBP2,DNA-binding protein SMUBP-2,37562,0.0365189325848846,0.00508918118215927,0.0265441374678524,0.0464937277019167,7.57522521497405e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MMP1,Interstitial collagenase,39757,0.0607241378348781,0.00847169006280381,0.0441196253117827,0.0773286503579736,7.96432494539393e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CBLIF,Cobalamin binding intrinsic factor,40330,0.0475512534518775,0.00665152397654943,0.0345142664578406,0.0605882404459144,9.126841862339e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DSC2,Desmocollin-2,40177,-0.0219675010298844,0.00307344845251363,-0.0279914599968111,-0.0159435420629577,9.22502454335063e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD93,Complement component C1q receptor,39725,-0.0205046993984457,0.00287414286981492,-0.0261380194232829,-0.0148713793736085,1.01729301653556e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AGER,Advanced glycosylation end product-specific receptor,40311,0.0263261952091552,0.00369325450654185,0.0190874163763331,0.0335649740419772,1.06085695984034e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL2A1,Collagen alpha-1(II) chain,37628,0.0535415065079621,0.00751137835578055,0.0388192049306322,0.068263808085292,1.07099431042096e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMARCA2,Probable global transcription activator SNF2L2,39961,0.0474571622349068,0.00668413726935281,0.0343562531869753,0.0605580712828383,1.30200948281873e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL19,C-C motif chemokine 19,40471,0.084504557435274,0.0119390972020824,0.0611039269191926,0.107905187951355,1.52349277506921e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNX2,Sorting nexin-2,37900,0.0504017050493166,0.00712270241942593,0.0364412083072418,0.0643622017913914,1.55492606102113e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRYM,Ketimine reductase mu-crystallin,37541,0.0497992702576153,0.00704023591862454,0.0360004078571112,0.0635981326581194,1.5872767363326e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLB,Beta-klotho,39961,-0.0475039811672004,0.00671681118995884,-0.0606689310995198,-0.0343390312348811,1.58782034771981e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIMP1,Metalloproteinase inhibitor 1,40167,0.0180936799820313,0.00256305188694912,0.013070098283611,0.0231172616804516,1.74185999582999e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GC,Vitamin D-binding protein,38013,0.0167451074228124,0.00237329985997145,0.0120934396972684,0.0213967751483565,1.80169284440945e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C2orf69,UPF0565 protein C2orf69,37572,0.038907618026037,0.00551428041533786,0.0280996284119748,0.0497156076400992,1.80235957846475e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EFNA4,Ephrin-A4,40203,0.0189413022061662,0.00268647989980224,0.0136758016025538,0.0242068028097786,1.85545042429855e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DAPK2,Death-associated protein kinase 2,37598,0.0337128103862726,0.00478725695463002,0.0243297867551978,0.0430958340173475,1.9863886728608e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VSIG4,V-set and immunoglobulin domain-containing protein 4,40309,-0.0250255462290096,0.00355619922115625,-0.0319956967024758,-0.0180553957555433,2.04229552754514e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SGSH,N-sulphoglucosamine sulphohydrolase,37790,0.0360370411889018,0.00512166194935167,0.0259985837681725,0.046075498609631,2.07196571569503e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSDE1,Cold shock domain-containing protein E1,37562,0.0751305253458913,0.0107118847530981,0.054135231229819,0.0961258194619637,2.43387662161131e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,40228,0.0350651821601948,0.00501099905322694,0.02524362401587,0.0448867403045196,2.70779931163446e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,40042,-0.0193481203565838,0.00276739628717858,-0.0247722170794538,-0.0139240236337138,2.83096457132173e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL31RA,Interleukin-31 receptor subunit alpha,37544,0.0258562213605024,0.00370456486959024,0.0185952742161055,0.0331171685048992,3.10375594470675e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL28A1,Collagen alpha-1(XXVIII) chain,37572,0.0463347961814679,0.00663884897068123,0.0333226521989326,0.0593469401640031,3.10818253176269e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRH,Corticoliberin,39947,0.0552968218373594,0.00792842833839658,0.0397571022941021,0.0708365413806167,3.19376675860628e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LTA,Lymphotoxin-alpha,40341,0.0255955201887991,0.00367078959241989,0.0184007725876561,0.0327902677899421,3.23032626285264e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GRSF1,G-rich sequence factor 1,37402,0.0503205450980254,0.00722100414559587,0.0361673769726575,0.0644737132233933,3.35520141965643e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPL,Periplakin,37598,0.0210049084541033,0.00301749923306155,0.0150906099573027,0.026919206950904,3.53819896634416e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37598,0.0274462342158167,0.00395187518047732,0.0197005588620812,0.0351919095695522,3.95929744748212e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNX5,Sorting nexin-5,37628,0.0190088175514684,0.00273736601448432,0.0136435801630791,0.0243740549398576,3.98457366213438e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA12,Carbonic anhydrase 12,40305,-0.0204048635503771,0.00294646793705467,-0.0261799407070042,-0.0146297863937499,4.52101500550547e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TF,Serotransferrin,38013,0.0137704701164897,0.00199147906804275,0.00986717114312588,0.0176737690898535,4.89859331527913e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37942,0.0543702241704411,0.00787173919486053,0.0389416153485144,0.0697988329923677,5.17131642480049e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSMG3,Proteasome assembly chaperone 3,40341,0.0322550704067872,0.00467122920766427,0.0230994611597652,0.0414106796538092,5.20869773459426e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MCTS1,Malignant T-cell-amplified sequence 1,37901,0.0164118477719851,0.00237820597733194,0.0117505640564145,0.0210731314875557,5.39745207531087e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BPIFA2,BPI fold-containing family A member 2,37150,-0.0697564798666281,0.0101446591283529,-0.0896400117581997,-0.0498729479750565,6.43575852597452e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYOM3,Myomesin-3,37671,-0.056463952240522,0.0082328064818678,-0.0726002529449829,-0.0403276515360611,7.27279664155038e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CABP2,Calcium-binding protein 2,37572,0.040952622725321,0.00598315683683888,0.0292256353251168,0.0526796101255252,8.00698820357859e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINI1,Neuroserpin,37642,0.0199474287943514,0.00291514712561334,0.0142337404281492,0.0256611171605535,8.11553824628945e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL8,Interleukin-8,40209,0.0423017231077514,0.00618307416141947,0.0301828977513693,0.0544205484641336,8.12336364227201e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CARHSP1,Calcium-regulated heat-stable protein 1,39961,0.0329070236744453,0.00481109029179046,0.023477286702536,0.0423367606463546,8.22531946811782e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ECM1,Extracellular matrix protein 1,37655,0.0230887453184034,0.00338382922474875,0.0164564400378959,0.029721050598911,9.28791958215854e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WFDC1,WAP four-disulfide core domain protein 1,37653,0.0337876149093225,0.00497795023571309,0.0240308324473249,0.0435443973713202,1.19003405950765e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CFHR2,Complement factor H-related protein 2,37911,0.0353837521652251,0.0052218636000528,0.0251488995091216,0.0456186048213286,1.28619379610384e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AHCY,Adenosylhomocysteinase,40359,0.0417960919907714,0.0061756138421378,0.0296918888601813,0.0539002951213615,1.35205890720389e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DGKZ,Diacylglycerol kinase zeta,40044,0.0216177458962541,0.00319869014044638,0.0153483132209792,0.027887178571529,1.44557392572632e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DEFB103A_DEFB103B,Beta-defensin 103,37539,0.0254092240207918,0.00376838801198474,0.0180231835173017,0.0327952645242819,1.61961202235201e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DKK3,Dickkopf-related protein 3,40536,-0.0180882047032025,0.00268324825569664,-0.0233473712843679,-0.0128290381220371,1.62469978856123e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BGN,Biglycan,39956,-0.0747204131821068,0.0110865341970204,-0.0964500202082668,-0.0529908061559468,1.64259875550483e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ICOSLG,ICOS ligand,40305,0.0117515402472441,0.00174410044942327,0.00833310336637453,0.0151699771281137,1.66248268505825e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37628,0.0210080602532293,0.00312193559223787,0.0148890664924431,0.0271270540140156,1.77679085243943e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMFR,E3 ubiquitin-protein ligase AMFR,39961,0.039527439315439,0.00588851877201071,0.027985942522298,0.05106893610858,1.97780285525723e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37990,0.020450191574425,0.00305011283802513,0.0144719704118957,0.0264284127369542,2.09774107090339e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTGR1,Prostaglandin reductase 1,37990,0.0485810674319616,0.00725242708353688,0.0343663103482293,0.0627958245156939,2.1874546264654e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GALNT7,N-acetylgalactosaminyltransferase 7,40305,0.0129146328061077,0.0019288970892308,0.00913399451121534,0.0166952711010001,2.22387599307476e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FEN1,Flap endonuclease 1,39980,0.0377434209559943,0.00565247132106977,0.0266645771666976,0.0488222647452911,2.51589081254778e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL12B,Interleukin-12 subunit beta,40516,0.0329793910691976,0.00494597721972563,0.0232852757185354,0.0426735064198598,2.67907511478191e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOD,Apolipoprotein D,37345,-0.0271292877288532,0.00406996033735417,-0.0351064099900674,-0.019152165467639,2.74058111161506e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37959,0.0288513491028612,0.00433186043280357,0.0203609026545662,0.0373417955511562,2.83906119115227e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PBK,Lymphokine-activated killer T-cell-originated protein kinase,37482,-0.0184256975799137,0.00276681670710013,-0.02384865832583,-0.0130027368339975,2.85726223878262e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRRC25,Leucine-rich repeat-containing protein 25,40305,0.0235864044662863,0.0035427002569389,0.016642711962686,0.0305300969698865,2.87185991905638e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADA,Adenosine deaminase,40516,0.0205512196246185,0.00309973720017387,0.0144757347122777,0.0266267045369593,3.46412597146224e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GFAP,Glial fibrillary acidic protein,39959,0.0282031934166855,0.00427606792640034,0.0198221002809408,0.0365842865524302,4.37269223994841e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLA2G15,Phospholipase A2 group XV,40411,0.0154476921632018,0.00234535767990975,0.0108507911105787,0.0200445932158249,4.64396559548509e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD302,CD302 antigen,40305,0.0180539606114877,0.00274375867804712,0.0126761936025154,0.0234317276204601,4.85158130065848e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAMTSL4,ADAMTS-like protein 4,37628,0.0141059948789085,0.00214619738756732,0.00989944799927657,0.0183125417585405,5.13217238538531e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PKD1,Polycystin-1,37990,0.0155234963825283,0.00236355335139241,0.0108909318137992,0.0201560609512574,5.29060392458334e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37990,0.0324587593770019,0.00494316644405207,0.0227701531466598,0.042147365607344,5.34303267694062e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MDM1,Nuclear protein MDM1,37572,0.0187590786367265,0.00286204884427907,0.0131494629019395,0.0243686943715135,5.79460516980381e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NAP1L4,Nucleosome assembly protein 1-like 4,37879,0.0249056429086618,0.00380646649542257,0.0174449685776335,0.03236631723969,6.24912084936557e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPTX1,Neuronal pentraxin-1,40332,0.0235028228566669,0.00359842091880126,0.0164499178558165,0.0305557278575174,6.71251322091095e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",40411,-0.0206767746961374,0.00316742289857156,-0.0268849235773377,-0.0144686258149372,6.86876076623778e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FASLG,Tumor necrosis factor ligand superfamily member 6,40516,0.0217181384957138,0.00332821158439234,0.0151948437903048,0.0282414332011228,6.98176164268099e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MTUS1,Microtubule-associated tumor suppressor 1,37714,0.033000584782201,0.00505946449131161,0.0230840343792302,0.0429171351851717,7.16317622751664e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDC,Aromatic-L-amino-acid decarboxylase,40330,-0.0288977335251174,0.00443117794762474,-0.0375828423024619,-0.0202126247477729,7.17307101035647e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANXA2,Annexin A2,37441,0.0424523396166186,0.0065329758891404,0.0296477068739034,0.0552569723593338,8.42746996237742e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EBI3_IL27,Interleukin-27,40453,-0.0184539714127053,0.00284468397914844,-0.0240295520118362,-0.0128783908135744,9.00254152328036e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFIC,Nuclear factor 1 C-type,37959,0.0258257914358537,0.00398595689520401,0.0180133159212538,0.0336382669504535,9.54108354920616e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MST1,Hepatocyte growth factor-like protein,37787,0.0362456194050995,0.00562345791433168,0.0252236418930094,0.0472675969171896,1.19237246985105e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40489,0.0148733789035689,0.00230871777318748,0.0103482920681215,0.0193984657390164,1.2105357017095e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CAPG,Macrophage-capping protein,40185,0.0340723754075293,0.00529049689612572,0.0237030014911229,0.0444417493239357,1.22697857924939e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD34,Hematopoietic progenitor cell antigen CD34,40408,0.014198769803365,0.00221252691430995,0.0098622170513175,0.0185353225554125,1.42487632518736e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCER2,Low affinity immunoglobulin epsilon Fc receptor,40332,0.0283478234779257,0.00443187084003973,0.0196613566314478,0.0370342903244035,1.63578750086398e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LETM1,Mitochondrial proton/calcium exchanger protein,37959,0.0303439117200942,0.00474824327000762,0.0210373549108793,0.0396504685293091,1.70710454625874e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TCOF1,Treacle protein,37990,0.0176342740202207,0.0027608522447139,0.0122230036205815,0.02304554441986,1.74407443380691e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AFAP1,Actin filament-associated protein 1,37671,0.0493409871708875,0.0077383232487409,0.0341738736033553,0.0645081007384196,1.87590393085626e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGR,Tyrosine-protein kinase Fgr,39961,0.0320708529854631,0.00504691006476669,0.0221789092585204,0.0419627967124058,2.14868477004014e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPM1A,Protein phosphatase 1A,39980,0.0179820498019543,0.00283360842840841,0.0124281772822738,0.0235359223216348,2.27127269033904e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPR,Nucleoprotein TPR,37562,0.0272378300318012,0.00429788461389581,0.0188139761885654,0.035661683875037,2.41173024864674e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DMP1,Dentin matrix acidic phosphoprotein 1,37628,-0.0367842814097921,0.00580436855759584,-0.04816084378268,-0.0254077190369043,2.41372345958824e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL17RB,Interleukin-17 receptor B,40126,-0.0308209522235632,0.00487465341049477,-0.040375272908133,-0.0212666315389935,2.63995702950092e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCRL2,Fc receptor-like protein 2,40442,0.0280245160526486,0.00443873338293699,0.0193245986220921,0.0367244334832051,2.79755978069617e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRTAC1,Cartilage acidic protein 1,40536,0.0167625100926895,0.00266907179482083,0.0115311293748407,0.0219938908105383,3.46648361313088e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBP2,Retinol-binding protein 2,40305,-0.0435478639775218,0.00694420669505314,-0.057158509099826,-0.0299372188552177,3.67776561915375e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLPS,Colipase,40311,0.0392181437577468,0.00625479328317133,0.026958748922731,0.0514775385927626,3.70167233328119e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HIP1R,Huntingtin-interacting protein 1-related protein,37910,0.0234357248584634,0.00374921491826436,0.0160872636186652,0.0307841860982615,4.20587297405304e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDX58,Antiviral innate immune response receptor RIG-I,39980,0.0325836972756892,0.00521935321290455,0.0223537649783962,0.0428136295729821,4.40802747324567e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPR15L,Protein GPR15L,37901,0.0343926780721185,0.00551003081964627,0.0235930176656118,0.0451923384786252,4.4546915504541e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LYZL2,Lysozyme-like protein 2,37482,0.0204914470525057,0.0032846900448648,0.0140534545645707,0.0269294395404407,4.55540239198511e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF23,Fibroblast growth factor 23,40469,0.0349789871209074,0.00562269294542278,0.0239585089478787,0.045999465293936,5.06142940641437e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MEPE,Matrix extracellular phosphoglycoprotein,40357,0.0150479623703424,0.00242462719137011,0.010295693075257,0.0198002316654278,5.55910840719578e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPRR3,Small proline-rich protein 3,37942,0.0403279800064503,0.00650315849795521,0.0275817893504581,0.0530741706624425,5.7635910763968e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,THBS2,Thrombospondin-2,40332,-0.0202488429803267,0.00326583946468052,-0.0266498883311005,-0.0138477976295529,5.77873805872514e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,40396,0.0500880975435822,0.00808233092958035,0.0342467289216047,0.0659294661655597,5.88763134961172e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1QL2,Complement C1q-like protein 2,37598,0.0243151092513757,0.00393318500992906,0.0166060666319148,0.0320241518708367,6.51505130973959e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LCP1,Plastin-2,37998,0.0265323577805715,0.00430253965980981,0.0180993800473443,0.0349653355137988,7.17236999478428e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENSA,Alpha-endosulfine,37900,0.0296818493742071,0.00482405884852946,0.0202266940310893,0.0391370047173248,7.82483153516519e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOE,Apolipoprotein E,38013,0.0420901846022676,0.00684934571997334,0.0286654669911199,0.0555149022134154,8.21303379120665e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD101,Immunoglobulin superfamily member 2,37901,0.0238789657626909,0.00388648618287552,0.0162614528442548,0.0314964786811269,8.26865705256463e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHRDL1,Chordin-like protein 1,40396,0.0170682041037214,0.00278135074588168,0.0116167566417933,0.0225196515656495,8.62669905936024e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPA2,Carboxypeptidase A2,40398,0.0358511547958933,0.00584339669937645,0.0243980972651155,0.0473042123266712,8.69910713725107e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDH17,Cadherin-17,40359,-0.0378669957956876,0.00617405621317385,-0.0499681459735083,-0.0257658456178669,8.81408378007454e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RPL14,60S ribosomal protein L14,37628,0.0231620274646863,0.00377683611015208,0.0157594286887882,0.0305646262405844,8.8896787988347e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPTX2,Neuronal pentraxin-2,37998,-0.0182898105494106,0.00298513742079506,-0.0241406798941689,-0.0124389412046523,9.20570331951038e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SFTPD,Pulmonary surfactant-associated protein D,40359,0.0369804815967817,0.00605440057084975,0.0251138564779162,0.0488471067156472,1.03212954601005e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FES,Tyrosine-protein kinase Fes/Fps,39980,0.0264922483898814,0.00433787031025508,0.0179900225817814,0.0349944741979814,1.03809060387048e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37900,0.0205930249663192,0.00337633006761565,0.0139754180337925,0.0272106318988458,1.09500155383873e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37598,0.0390935813580883,0.00641137379422327,0.0265272887214107,0.0516598739947659,1.1073427795784e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ROBO1,Roundabout homolog 1,40379,0.0133767206465922,0.00219433643695685,0.0090758212301568,0.0176776200630277,1.11248505940413e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GCLM,Glutamate--cysteine ligase regulatory subunit,37562,0.0254750769792238,0.00418252663766043,0.0172773247694094,0.0336728291890382,1.15466187807028e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCRL3,Fc receptor-like protein 3,40044,0.0304151674832164,0.00499780592886342,0.0206194678626441,0.0402108671037887,1.1869458373869e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAMTOR5,Ragulator complex protein LAMTOR5,37900,0.022734642144805,0.00374616164747638,0.0153921653157513,0.0300771189738587,1.32347248471208e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TFPI2,Tissue factor pathway inhibitor 2,40357,0.0220456580578831,0.00363314314499424,0.0149246974936943,0.0291666186220718,1.32507117172848e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39925,0.0261001068444446,0.00430125625098361,0.0176696445925167,0.0345305690963725,1.32516224512402e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",40310,0.0348632116848571,0.00575177032041364,0.0235897418568464,0.0461366815128679,1.38082174885241e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37628,0.0379685094748543,0.0062649494994696,0.0256892084558938,0.0502478104938147,1.39432444227167e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37714,0.0410505082846336,0.00677532663733663,0.0277708680754538,0.0543301484938134,1.40834394896221e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37628,0.0430606430617915,0.00711749697434821,0.029110348992069,0.057010937131514,1.48799599354951e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,40403,0.0227433141649964,0.00376741530578236,0.015359180165663,0.0301274481643298,1.60635077649541e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PVR,Poliovirus receptor,40471,0.020206275900811,0.00335051909301839,0.0136392584784949,0.026773293323127,1.66745439244543e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CIT,Citron Rho-interacting kinase,37572,0.0248609125018947,0.00412285628717638,0.016780114179029,0.0329417108247604,1.6834268324836e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DSG3,Desmoglein-3,40419,0.0184076926641698,0.0030546511809545,0.012420576349499,0.0243948089788406,1.7163410312616e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UMOD,Uromodulin,40502,-0.0297629237195904,0.00493911766005792,-0.039443594333304,-0.0200822531058769,1.71784046749729e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WARS,"Tryptophan--tRNA ligase, cytoplasmic",40332,0.0208141606123187,0.00345492276723138,0.0140425119885452,0.0275858092360922,1.73384629061238e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,40042,0.0314979799126899,0.00523344295782947,0.0212404317153441,0.0417555281100357,1.79877714108777e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39980,0.0440471154941427,0.00732032543764064,0.029699277636367,0.0583949533519183,1.81561933670751e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NXPH3,Neurexophilin-3,37598,0.0166670779133343,0.00277569723814893,0.0112267113265624,0.0221074445001062,1.96807492883906e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGFBP4,Insulin-like growth factor-binding protein 4,40063,0.0231906401233954,0.0038683084964414,0.0156087554703702,0.0307725247764205,2.07925027204096e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SFRP4,Secreted frizzled-related protein 4,37671,0.0228523384266768,0.00382111275953128,0.0153629574179955,0.0303417194353581,2.28132388104225e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL14,C-C motif chemokine 14,40309,0.0211999489542244,0.00355472243402426,0.0142326929835368,0.0281672049249119,2.51546008138864e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINB8,Serpin B8,40516,0.0296248815978721,0.00497205259486268,0.0198796585119412,0.0393701046838029,2.60231901583173e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COMP,Cartilage oligomeric matrix protein,40198,0.0183926325579911,0.00308695203180377,0.0123422065756557,0.0244430585403265,2.60490805412894e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJB8,DnaJ homolog subfamily B member 8,40042,0.0318826508466886,0.005361318031721,0.0213744675045155,0.0423908341888618,2.79289632858253e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MTPN,Myotrophin,40042,0.0179792463639882,0.00302497547109033,0.0120502944406512,0.0239081982873253,2.84774250446509e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37714,0.0200415422910765,0.00337648660627327,0.0134236285427809,0.0266594560393721,3.0004791339948e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,40228,0.0377263972722039,0.00636226633653013,0.0252563552526048,0.0501964392918029,3.09805171119609e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GSTT2B,Glutathione S-transferase theta-2B,37942,0.129054142299778,0.0218125671354615,0.0863015107142732,0.171806773885282,3.36827520147317e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,40044,0.019474262183773,0.00329975673880224,0.0130067389757207,0.0259417853918254,3.6717647304228e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RARRES1,Retinoic acid receptor responder protein 1,39980,0.0188807146929738,0.00320053204966173,0.0126076718756368,0.0251537575103108,3.72765873636236e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VIPR1,Vasoactive intestinal polypeptide receptor 1,37628,-0.0140345556238817,0.00238301839659029,-0.0187052716811987,-0.00936383956656473,3.97042095674969e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40516,0.0200299188680635,0.00340281877117199,0.0133603940765664,0.0266994436595606,4.02869745604705e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPC1,Glypican-1,40489,0.015741833363046,0.00267833677805802,0.0104922932780523,0.0209913734480398,4.24856729748293e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PEPD,Xaa-Pro dipeptidase,37987,0.0138523991400366,0.00235917874840894,0.00922840879315511,0.0184763894869181,4.41451591076624e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTRC,Chymotrypsin-C,40360,0.0335646245934387,0.00571811636903698,0.0223571165101262,0.0447721326767512,4.44801990995852e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CBS,Cystathionine beta-synthase,37628,0.0271771715564983,0.00463838948927795,0.0180859281575135,0.0362684149554831,4.76262886873854e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37598,0.0190259039975112,0.00325255787615055,0.0126508905602561,0.0254009174347663,5.04720181583803e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VWF,von Willebrand factor,40536,-0.0381147894182592,0.00651745101789957,-0.0508889934133424,-0.025340585423176,5.06821376647458e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLGN,Calmegin,37572,0.0237736305184153,0.00406673346881124,0.0158028329195453,0.0317444281172853,5.15883386564175e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINA3,Alpha-1-antichymotrypsin,37958,0.00786552835363873,0.00134692876630047,0.00522554797168981,0.0105055087355877,5.35288125394039e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37628,0.0152317473666835,0.00261088774185701,0.0101144073926437,0.0203490873407232,5.540695129081e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RELT,Tumor necrosis factor receptor superfamily member 19L,40332,0.014522524158697,0.00249288296746131,0.0096364735424728,0.0194085747749211,5.8010771050703e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD300LF,CMRF35-like molecule 1,40489,0.0321866659035763,0.0055398935928568,0.0213284744615769,0.0430448573455756,6.36649192771974e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NADK,NAD kinase,40359,0.0283454318033393,0.00487917637136157,0.0187822461154706,0.037908617491208,6.38679372130014e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",40341,0.0239260967191326,0.00411944053418998,0.0158519932721203,0.032000200166145,6.43955317188285e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,REG4,Regenerating islet-derived protein 4,40379,0.0256670643816687,0.00443366546666567,0.0169770800670039,0.0343570486963334,7.20835266145326e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BAX,Apoptosis regulator BAX,39934,0.0471401921638979,0.00815618132035714,0.0311540767759979,0.0631263075517979,7.62787397354475e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCGB1A1,Uteroglobin,40384,0.0298588553140467,0.00517252660972271,0.0197207031589902,0.0399970074691032,7.95162367210493e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPTLC1,Serine palmitoyltransferase 1,37942,0.0189425820905744,0.00328118101990371,0.0125114672915632,0.0253736968895857,7.95397103343419e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYL3,Myosin light chain 3,37628,-0.0359778274443682,0.00624971338710406,-0.0482272656830922,-0.0237283892056443,8.76774275980252e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPME1,Protein phosphatase methylesterase 1,40305,0.0321294338428993,0.00559151373981755,0.0211700669128569,0.0430888007729417,9.2998631539076e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GDF15,Growth/differentiation factor 15,40536,-0.0225231341719954,0.00392089982281409,-0.030208097824711,-0.0148381705192797,9.39265953534263e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRSS53,Serine protease 53,37942,0.0192456628954243,0.0033572327345157,0.0126654867357736,0.0258258390550751,1.01021796212401e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL32,Interleukin-32,40341,-0.0223001162543264,0.00389501315416235,-0.0299343420364846,-0.0146658904721682,1.05116405782474e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37562,0.0442735485983396,0.00774570622540295,0.0290919643965498,0.0594551328001294,1.11513425299744e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LTB,Lymphotoxin-beta,37900,0.018508346883637,0.00324082239407768,0.0121563349912448,0.0248603587760293,1.14688792258172e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCAM,Basal cell adhesion molecule,40332,-0.0123403107425878,0.00216138650113533,-0.016576628284813,-0.00810399320036251,1.15373469095824e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LMOD1,Leiomodin-1,37959,-0.0189122371196824,0.00331281496589464,-0.0254053544528359,-0.0124191197865289,1.16160818692753e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GDNF,Glial cell line-derived neurotrophic factor,39961,0.0199006115384677,0.00349897484066375,0.0130426208507667,0.0267586022261686,1.31195231725635e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NAGA,Alpha-N-acetylgalactosaminidase,37567,0.0309155507392353,0.00544450707705325,0.0202443168682109,0.0415867846102596,1.38925733865502e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD14,Monocyte differentiation antigen CD14,40048,0.0214857619343371,0.00378917731519027,0.0140589743965641,0.02891254947211,1.45075969591016e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TGFA,Protransforming growth factor alpha,40341,0.0247357812427714,0.00437041374847973,0.0161697702957511,0.0333017921897917,1.54142803717927e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADM,Pro-adrenomedullin,40489,0.0138942193734452,0.00245604017800804,0.00908038062454949,0.018708058122341,1.56523274812245e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ODAM,Odontogenic ameloblast-associated protein,39934,0.0276804881976691,0.00489841326625784,0.0180795981958037,0.0372813781995345,1.62412679826802e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDA,Cytidine deaminase,37970,0.0236304753208398,0.00418822196425209,0.0154215602709057,0.0318393903707739,1.71334628278164e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACVRL1,Serine/threonine-protein kinase receptor R3,40203,0.0124518954436749,0.00220964639215869,0.00812098851504383,0.0167828023723059,1.7780461089525e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDCD1,Programmed cell death protein 1,40455,0.0224588714086736,0.00399312456444208,0.0146323472623671,0.03028539555498,1.89283416803838e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINA7,Thyroxine-binding globulin,38013,0.00961175899061437,0.00170894220589526,0.00626223226705966,0.0129612857141691,1.8984271633381e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRTG,Protogenin,40489,0.0128084146035189,0.00229701450195919,0.00830626617967891,0.0173105630273589,2.49919643926472e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RABEPK,Rab9 effector protein with kelch motifs,39980,0.0305657731566145,0.00548958946365512,0.0198061778078505,0.0413253685053786,2.62022051253977e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VIT,Vitrin,37990,0.0187016322060592,0.00336917425007433,0.0120980506759135,0.0253052137362048,2.89701934366848e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AARSD1,Alanyl-tRNA editing protein Aarsd1,40305,0.0281406430785643,0.00508156240358913,0.0181807807675296,0.038100505389599,3.11173629126341e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC14A,C-type lectin domain family 14 member A,40332,-0.0158910436561685,0.00287016559386219,-0.0215165682201384,-0.0102655190921986,3.13235273966891e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GOT1,"Aspartate aminotransferase, cytoplasmic",37998,0.0203047007353418,0.0036772922177726,0.0130972079885075,0.0275121934821761,3.42022966552926e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSPA2,Heat shock-related 70 kDa protein 2,37900,0.0167135711108024,0.00303724003219496,0.0107605806477003,0.0226665615739046,3.80470400999032e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRSS22,Brain-specific serine protease 4,37598,0.0177865647551948,0.00323564106389112,0.0114447082699682,0.0241284212404214,3.93339192895573e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSPG4,Chondroitin sulfate proteoglycan 4,37998,-0.016569122185029,0.00301514115976653,-0.0224787988581714,-0.0106594455118866,3.97080536637572e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,S100P,Protein S100-P,40042,0.0268102326561657,0.00489212967635604,0.0172216584905079,0.0363988068218236,4.31245521966332e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C2CD2L,Phospholipid transfer protein C2CD2L,39925,0.0218735186092822,0.00400220592011641,0.014029195005854,0.0297178422127104,4.69098876610492e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITM2A,Integral membrane protein 2A,40341,-0.0294437215416734,0.00539674453588939,-0.0400213408320166,-0.0188661022513302,4.94736725722481e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINA12,Serpin A12,39903,0.0568520248299033,0.0104271215830146,0.0364148665271946,0.077289183132612,5.04792487362042e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD28,T-cell-specific surface glycoprotein CD28,39980,0.0179062073296698,0.00328465569993282,0.0114682821578014,0.0243441325015381,5.07169961055611e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,37482,0.0332466785480724,0.00610081551504278,0.0212890801385886,0.0452042769575563,5.14165628487286e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRISP3,Cysteine-rich secretory protein 3,37875,-0.0134624164953425,0.00247068487374241,-0.0183049588478777,-0.00861987414280742,5.15877396718618e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANGPTL1,Angiopoietin-related protein 1,40136,0.0146540328408935,0.00269500686318414,0.00937181938905255,0.0199362462927344,5.48491370315398e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSH,Pro-cathepsin H,40013,0.0358837580838755,0.00660676804877211,0.0229344927082822,0.0488330234594688,5.67645143545724e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DHPS,Deoxyhypusine synthase,37900,0.0204435025674435,0.00376371578473247,0.0130666196293678,0.0278203855055191,5.67795795451057e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",40306,-0.0343307108000414,0.00632181598417245,-0.0467214701290194,-0.0219399514710633,5.70191527465599e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GNLY,Granulysin,40332,0.0251420996590343,0.0046322820897825,0.0160628267630606,0.034221372555008,5.79597719763794e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPRH,Receptor-type tyrosine-protein phosphatase H,37901,0.0237910671884363,0.00438709812271671,0.0151923548679115,0.032389779508961,5.96322502877312e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40470,0.0145033966540479,0.00268403680998277,0.00924268450648165,0.0197641088016141,6.6258766005683e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,40228,0.0344636666481752,0.00638411918223007,0.0219507930510042,0.0469765402453461,6.82313576494685e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39980,0.0252074191918436,0.00467016672968392,0.0160538924016631,0.034360945982024,6.85519438165548e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VAMP5,Vesicle-associated membrane protein 5,40042,0.0275257324847632,0.00511361602558637,0.0175030450746139,0.0375484198949125,7.43839177485744e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFNGR2,Interferon gamma receptor 2,40228,0.0253536319121987,0.00471191985959067,0.016118268987401,0.0345889948369964,7.52375683749467e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SFTPA1,Pulmonary surfactant-associated protein A1,39980,0.0288095729920618,0.00535823038132641,0.018307441444662,0.0393117045394615,7.69622953773715e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NCAN,Neurocan core protein,40471,0.0182350892595548,0.00340089140805851,0.0115693420997602,0.0249008364193495,8.35132440854119e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD163,Scavenger receptor cysteine-rich type 1 protein M130,40403,0.0207672352795705,0.00388173748762839,0.0131590298038188,0.0283754407553221,8.91759290161606e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TDP1,Tyrosyl-DNA phosphodiesterase 1,37900,0.0320831797267862,0.00600525164219631,0.0203128865080814,0.043853472945491,9.31571844471695e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATXN2,Ataxin-2,37541,0.0559882216214534,0.0105370971800298,0.0353355111485949,0.0766409320943118,1.09339551924769e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSMD9,26S proteasome non-ATPase regulatory subunit 9,40305,0.0265976048220298,0.00501259559458137,0.0167729174566503,0.0364222921874093,1.13468296067299e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FABP2,"Fatty acid-binding protein, intestinal",40359,-0.0373833177827912,0.00704807215872483,-0.0511975392138919,-0.0235690963516905,1.14778029981029e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLRK1,NKG2-D type II integral membrane protein,37942,0.0223289450921145,0.00421444356175692,0.0140686357110709,0.030589254473158,1.18792516510107e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HLA_E,,40341,0.0139288016143024,0.0026292516084645,0.00877546846171194,0.0190821347668928,1.18880107259706e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LUZP2,Leucine zipper protein 2,37900,0.0215083013319419,0.0040858373209161,0.0135000601829463,0.0295165424809375,1.43036948407225e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA9,Carbonic anhydrase 9,40489,-0.0216130413732234,0.00410763465005144,-0.0296640052873242,-0.0135620774591226,1.44585169155107e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF16,Fibroblast growth factor 16,37598,0.0235267375633852,0.00450219477171019,0.0147024358108332,0.0323510393159371,1.76232670328599e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCGB3A1,Secretoglobin family 3A member 1,37671,-0.0119408316587903,0.0022869182425017,-0.0164231914140937,-0.00745847190348699,1.80304178918836e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,REG3G,Regenerating islet-derived protein 3-gamma,37900,0.019237311161759,0.00369014822801255,0.0120046206348544,0.0264700016886636,1.88407244145095e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHGA,Chromogranin-A,37998,-0.0430167609167566,0.00825510147944373,-0.0591967598164663,-0.0268367620170468,1.90654707846002e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,40379,0.0156902591479236,0.00301727957544373,0.0097763911800539,0.0216041271157933,2.01609356575497e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGFBP6,Insulin-like growth factor-binding protein 6,40291,0.0137394569837296,0.00264474561271512,0.00855575558280799,0.0189231583846512,2.0725657310239e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GAS2,Growth arrest-specific protein 2,37714,0.0253888329682132,0.00489202078336332,0.0158004722328211,0.0349771937036053,2.1357601276942e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LXN,Latexin,40183,-0.0313856299183122,0.00605862167850143,-0.043260528408175,-0.0195107314284494,2.24234504073775e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPM3,Tropomyosin alpha-3 chain,37562,-0.0201718616452892,0.00389370482481366,-0.027803523101924,-0.0125402001886544,2.24412756397521e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PFDN2,Prefoldin subunit 2,39961,0.026511523615611,0.00513439958811079,0.0164481004229138,0.0365749468083081,2.4535914024591e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP6V1G2,V-type proton ATPase subunit G 2,37562,0.0478804934427797,0.00928347776932666,0.0296848770148995,0.06607610987066,2.53777968573022e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GBA,Lysosomal acid glucosylceramidase,37572,0.0249178897490583,0.0048382296237452,0.0154349596865177,0.0344008198115989,2.63967060920537e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MFAP4,Microfibril-associated glycoprotein 4,37671,-0.0147518215704311,0.0028674094656402,-0.0203719441230859,-0.00913169901777627,2.7185578140666e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LYPD3,Ly6/PLAUR domain-containing protein 3,40284,0.0163687335457335,0.00318245110693169,0.0101311293761474,0.0226063377153196,2.72977481426054e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSBP1,Heat shock factor-binding protein 1,37628,0.0448922654481034,0.00873125305749572,0.0277790094554118,0.062005521440795,2.76370780795351e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNASE3,Eosinophil cationic protein,40288,0.0507047053932053,0.00990792461688296,0.0312851731441147,0.0701242376422959,3.13083047510536e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39961,0.0141333057159624,0.00277021763386162,0.00870367915359361,0.0195629322783312,3.40273689051952e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRDX1,Peroxiredoxin-1,39953,-0.0414443832932846,0.00814543569068723,-0.0574094372470316,-0.0254793293395376,3.65992059920969e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADGRG1,Adhesion G-protein coupled receptor G1,40305,-0.0253787152962283,0.00499234676478945,-0.0351637149552156,-0.015593715637241,3.74714206682441e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37572,0.0482102887336105,0.00950979975302733,0.0295710812176769,0.0668494962495441,4.04216617304123e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TSPAN1,Tetraspanin-1,40042,0.0141182247833074,0.00278743615370705,0.00865484992204154,0.0195815996445732,4.13171244462146e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40516,0.0176148576025096,0.00347871036496001,0.010796585287188,0.0244331299178312,4.15927912628286e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRKD2,Serine/threonine-protein kinase D2,37562,0.0219691066494482,0.00434928886048235,0.0134445004829028,0.0304937128159936,4.44957492859131e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,YAP1,Transcriptional coactivator YAP1,37942,0.0122870397868483,0.00243448556707122,0.00751544807538874,0.0170586314983079,4.54459490270076e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ICAM5,Intercellular adhesion molecule 5,40359,0.0203061474379041,0.00402380107984326,0.0124194973214113,0.0281927975543969,4.54919628074888e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40516,0.0160309262926002,0.00318289387723125,0.009792454293227,0.0222693982919735,4.79039244114687e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MSLN,Mesothelin,40271,0.024866533689076,0.00494501170625436,0.0151743107448175,0.0345587566333346,4.99454158977559e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CX3CL1,Fractalkine,40228,-0.0156684176422571,0.00312212525177068,-0.0217877831357276,-0.00954905214878653,5.26405586305976e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCL2,Apoptosis regulator Bcl-2,37901,0.0247773127918077,0.00494375139085435,0.0150875600657332,0.0344670655178822,5.45961500560726e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BST2,Bone marrow stromal antigen 2,40471,0.0244391295689964,0.00488402373906418,0.0148664430404306,0.0340118160975622,5.67796139751845e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCN5,CCN family member 5,40332,0.0178441442330148,0.00358040590786536,0.0108265486535987,0.0248617398124309,6.29932055656414e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TYRO3,Tyrosine-protein kinase receptor TYRO3,40359,0.0128284422295367,0.00257551226417511,0.0077804381917535,0.0178764462673199,6.39434762976255e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CALCB,Calcitonin gene-related peptide 2,37942,0.018127806154214,0.0036493177606306,0.010975143343378,0.0252804689650499,6.86694344141193e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL1B,Interleukin-1 beta,39946,0.0254779195408017,0.00514608364860508,0.0153915955895357,0.0355642434920677,7.46350232229827e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CGREF1,Cell growth regulator with EF hand domain protein 1,40359,0.0189773002170033,0.00383392620986133,0.0114628048456752,0.0264917955883315,7.50367994176313e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37628,0.0166681141749458,0.00337265831275476,0.0100577038819464,0.0232785244679451,7.82236937414859e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DGCR6,Protein DGCR6,37541,0.0204177865220788,0.00415775467106132,0.0122685873667986,0.028566985677359,9.18135908444799e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCARF2,Scavenger receptor class F member 2,40471,-0.0133134280438133,0.00271228321405914,-0.0186295031433692,-0.00799735294425741,9.26462098575333e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40489,0.0139615377591578,0.00284606590454572,0.00838324858624823,0.0195398269320674,9.40761071941719e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37959,-0.0169629025481615,0.00345930908893971,-0.0237431483624833,-0.0101826567338397,9.52136248634911e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GFRA2,GDNF family receptor alpha-2,40305,0.00949630511589942,0.00193864594653197,0.00569655906069675,0.0132960511711021,9.75624402342105e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NXPH1,Neurexophilin-1,39961,0.016888273370717,0.00344779434267775,0.0101305964590686,0.0236459502823653,9.76522428054301e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL6ST,Interleukin-6 receptor subunit beta,40359,0.00778354790284975,0.00159385228364026,0.00465959742691484,0.0109074983787847,1.05241482529965e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNTN2,Contactin-2,40489,0.0199149633866781,0.00409268503087117,0.0118933007261706,0.0279366260471856,1.14967580249516e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GIMAP8,GTPase IMAP family member 8,37482,0.0230573926085493,0.00474121120976527,0.0137646186374093,0.0323501665796892,1.16860197243242e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCDHB15,Protocadherin beta-15,37900,-0.0179177698339549,0.00368683141125263,-0.02514395940001,-0.0106915802678997,1.18748030216904e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37990,0.0117559090657223,0.00242148620220506,0.00700979610940034,0.0165020220220442,1.21833946718642e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RSPO3,R-spondin-3,40489,0.012654518985515,0.00260811503570798,0.00754261351552735,0.0177664244555026,1.23384295197108e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DUSP3,Dual specificity protein phosphatase 3,39961,0.0374412729271482,0.00775547505758696,0.0222405418142778,0.0526420040400186,1.39420472191976e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GAL,Galanin peptides,40422,0.027484868726627,0.0056944509087469,0.0163237449454831,0.0386459925077709,1.40164014184575e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TEK,Angiopoietin-1 receptor,40411,0.00947274083550232,0.001964145180353,0.00562301628201044,0.0133224653889942,1.42840439424543e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DPP7,Dipeptidyl peptidase 2,40251,0.0254953171971267,0.00528788026171833,0.0151310718841588,0.0358595625100946,1.43836066634665e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD86,T-lymphocyte activation antigen CD86,37901,0.0128925465416188,0.00267400359175815,0.00765149950177284,0.0181335935814648,1.44085577446086e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA7,Carbonic anhydrase 7,37714,-0.0154951585306187,0.00321785173335044,-0.0218021479279855,-0.00918816913325183,1.48547305706058e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIF1C,Kinesin-like protein KIF1C,37562,0.0165853092425093,0.00344632905167425,0.00983050430122781,0.0233401141837909,1.50747969628977e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HEPACAM2,HEPACAM family member 2,37942,-0.0179096243302378,0.00372196960245777,-0.0252046847510551,-0.0106145639094206,1.51145286337168e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANPEP,Aminopeptidase N,40370,0.0124022701853288,0.00257935124737312,0.00734674174047745,0.0174577986301801,1.53618130916583e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEBPA,CCAAT/enhancer-binding protein alpha,37598,0.0169644690496933,0.00352884315548189,0.0100479364649488,0.0238810016344378,1.54618644516292e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HEPH,Hephaestin,37990,0.0109809635751717,0.00229059511930841,0.0064913971413272,0.0154705300090162,1.65280394084583e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PGA4,Pepsin A-4,37987,0.0298020045202971,0.00621799789531731,0.0176147286454752,0.041989280395119,1.66166027606546e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FABP9,Fatty acid-binding protein 9,40341,0.02443081494167,0.00510092838982508,0.0144329952976128,0.0344286345857271,1.68719234070912e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSF,Cathepsin F,40411,0.0174782821266109,0.00365071314312523,0.0103228843660855,0.0246336798871364,1.70271702093975e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CREBZF,CREB/ATF bZIP transcription factor,37482,-0.0115907401938721,0.00242133648851759,-0.0163365597113666,-0.0068449206763776,1.71222412773845e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BSG,Basigin,40502,0.00881363432450567,0.00184230841152609,0.00520270983791453,0.0124245588110968,1.7335414153529e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL22RA1,Interleukin-22 receptor subunit alpha-1,40044,0.0190795664656691,0.00398864295853025,0.0112618262669498,0.0268973066643883,1.73868328949042e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CWC15,Spliceosome-associated protein CWC15 homolog,37835,0.0256272697701244,0.00536598337458938,0.0151099423559292,0.0361445971843195,1.80823658649845e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TOR1AIP1,Torsin-1A-interacting protein 1,37628,0.0218848177143767,0.0046026078499711,0.0128637063284334,0.0309059291003201,2.00672967072589e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LHB,Lutropin subunit beta,39980,0.0368074627147414,0.00775370303679197,0.0216102047626291,0.0520047206668537,2.08213482204098e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,S100A11,Protein S100-A11,40207,0.0194666289232591,0.0041010685059513,0.0114285346515946,0.0275047231949237,2.08557667267728e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BRD1,Bromodomain-containing protein 1,37714,-0.013469492813141,0.00283789817753884,-0.0190317732411172,-0.0079072123851649,2.09343672521731e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RHOC,Rho-related GTP-binding protein RhoC,40152,0.0503070290529057,0.0106005005282483,0.029530048017539,0.0710840100882724,2.09594863997295e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADGRG2,Adhesion G-protein coupled receptor G2,40359,0.011620096537958,0.00245078658816975,0.00681655482514532,0.0164236382507708,2.14113156760644e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GBP4,Guanylate-binding protein 4,39961,0.0213329367267225,0.00450779947550763,0.0124976497547275,0.0301682236987174,2.23783530191592e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNC,Tenascin,40403,-0.0203922652920138,0.00430972696196864,-0.0288393301374724,-0.0119452004465553,2.24574478047503e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC28A1,Sodium/nucleoside cotransporter 1,37482,0.0256326438313076,0.00545326162115303,0.0149442510538477,0.0363210366087675,2.62280012914058e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CILP,Cartilage intermediate layer protein 1,37998,0.023097614754677,0.00492137577813142,0.0134517182295394,0.0327435112798145,2.71432242151875e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD59,CD59 glycoprotein,39665,0.00963799606551041,0.00205811074120656,0.00560409901274554,0.0136718931182753,2.85241687619971e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYOM2,Myomesin-2,37562,-0.0201537393779152,0.00430991404831818,-0.0286011709126189,-0.0117063078432116,2.95248802973076e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCDH1,Protocadherin-1,40475,0.00929084472927934,0.00198756205044843,0.00539522311040041,0.0131864663481583,2.97081241797841e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",40044,0.0247176735843347,0.00529406087425965,0.0143413142707858,0.0350940328978836,3.05274941119984e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RCOR1,REST corepressor 1,40042,0.0190748450229058,0.00409043381870499,0.011057594738244,0.0270920953075676,3.13788051035298e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCSK7,Proprotein convertase subtilisin/kexin type 7,37900,0.0193021374080298,0.00414305861574247,0.0111817425211745,0.027422532294885,3.20935789595336e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDIA5,Protein disulfide-isomerase A5,37482,0.0261608736361364,0.00562659923001409,0.0151327391453088,0.0371890081269641,3.36007839412027e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK8,Kallikrein-8,39801,0.0150744426168947,0.00324509453188609,0.00871405733439794,0.0214348278993914,3.42399318229758e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NME3,Nucleoside diphosphate kinase 3,40379,0.0101382952310852,0.00218510374216635,0.00585549189643911,0.0144210985657312,3.51639698600882e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMPRSS11D,Transmembrane protease serine 11D,37921,0.0163731734060004,0.00352978968509114,0.00945478562322176,0.023291561188779,3.54131785882676e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,THBS4,Thrombospondin-4,40355,0.0190528629431726,0.00411332813639261,0.0109907397958431,0.0271149860905021,3.65051107718023e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOBR,Apolipoprotein B receptor,37628,-0.0179300511454678,0.0038761590797085,-0.0255273229416965,-0.0103327793492391,3.76841744875791e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRELP,Prolargin,40357,0.00978085749986565,0.00211647574882127,0.00563256503217595,0.0139291499675553,3.8434788495222e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TACSTD2,Tumor-associated calcium signal transducer 2,38484,-0.013183915966291,0.00286008808770629,-0.0187896886181953,-0.0075781433143867,4.06965278565364e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NECTIN2,Nectin-2,40330,0.0121462512521279,0.00263533735120164,0.00698099004377273,0.0173115124604832,4.07774476532194e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MNAT1,CDK-activating kinase assembly factor MAT1,37714,0.0181238810427375,0.00393566998400368,0.0104099678740903,0.0258377942113847,4.16238995091388e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RPS10,40S ribosomal protein S10,37562,-0.0178217564921857,0.0038796761701649,-0.0254259217857089,-0.0102175911986625,4.3968116180485e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,40305,0.0188452153706604,0.00410624958053213,0.0107969661928174,0.0268934645485034,4.47935467235031e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNF149,E3 ubiquitin-protein ligase RNF149,37628,0.0126818297653643,0.00276953945949406,0.00725353242475595,0.0181101271059727,4.71393520718483e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIAA1549L,UPF0606 protein KIAA1549L,37714,-0.0121769544842273,0.00265978841408063,-0.0173901397758253,-0.00696376919262926,4.73332721635828e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCN4B,Sodium channel subunit beta-4,37628,0.0175456106993889,0.00383356744573517,0.010031818505748,0.0250594028930299,4.76374680562643e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EFNA1,Ephrin-A1,40303,0.0113678397707365,0.00249141484741606,0.00648466666980103,0.016251012871672,5.08534433217022e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL34,Interleukin-34,39934,0.0149741207557212,0.00328179781106173,0.00854179704604024,0.0214064444654022,5.08685617104058e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFASC,Neurofascin,40516,0.0113148280588132,0.00248356472034483,0.00644704120693737,0.0161826149106891,5.2550150531234e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37901,-0.0125361016501025,0.00275695211638817,-0.0179397277982233,-0.00713247550198167,5.48683872401736e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OBP2B,Odorant-binding protein 2b,40184,-0.0275025117775158,0.00604997368408874,-0.0393604601983298,-0.0156445633567019,5.5111439097147e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD27,CD27 antigen,40411,-0.0168285075175583,0.00371351849320746,-0.0241070037642449,-0.00955001127087167,5.89389533572068e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL28,C-C motif chemokine 28,40278,0.0246630098098491,0.00544267571458255,0.0139953654092673,0.0353306542104309,5.90193382639438e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD300A,CMRF35-like molecule 8,37671,0.0122394622221449,0.00270445756726488,0.00693872539030569,0.017540199053984,6.07318276946696e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLSTN2,Calsyntenin-2,40516,-0.0161128074479199,0.00356262023220823,-0.023095543103048,-0.00913007179279176,6.14808918975824e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GM2A,Ganglioside GM2 activator,37714,0.0158739188839238,0.00351619000011044,0.00898218648370733,0.0227656512841403,6.40061946222618e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MUC16,Mucin-16,40305,0.077198197545829,0.0171089671701172,0.0436646218923994,0.110731773199259,6.46355260995859e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DLL4,Delta-like protein 4,37628,0.0347996207634266,0.00771462772082918,0.0196789504306014,0.0499202910962518,6.51227572404017e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SYT1,Synaptotagmin-1,37942,0.0161297727188635,0.00357933067576377,0.00911428459436649,0.0231452608433605,6.65019587838029e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACRV1,Acrosomal protein SP-10,37598,0.0145162313110559,0.00323091172768688,0.0081836443247896,0.0208488182973222,7.08521760235574e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGSF21,Immunoglobulin superfamily member 21,37628,0.0160629396565823,0.00357660114673231,0.00905280140898693,0.0230730779041776,7.14522364751628e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL1RL1,Interleukin-1 receptor-like 1,40490,-0.018557639272072,0.00413422345207921,-0.0266607172381472,-0.0104545613059967,7.21294652634246e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37598,0.0176877432930748,0.00394507393902159,0.00995539837259248,0.0254200882135571,7.40496330776356e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL6A3,Collagen alpha-3(VI) chain,40536,0.0139910952812209,0.00312768679859543,0.0078608291559739,0.020121361406468,7.75477898266929e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,40403,-0.0180252981362612,0.00403967983942963,-0.0259430706215432,-0.0101075256509791,8.17306175525109e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PIGR,Polymeric immunoglobulin receptor,40154,0.0142881193891909,0.00320995081444324,0.00799661579288218,0.0205796229854997,8.59816312084571e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37998,-0.0157283134559929,0.00354341389357397,-0.0226734046873979,-0.00878322222458797,9.11996304784881e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRUNE2,Protein prune homolog 2,37714,0.011999212506962,0.00270446361338525,0.00669846382472693,0.0172999611891971,9.20341887957701e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AGT,Angiotensinogen,37987,0.00980226447794243,0.00221453234790008,0.00546178107605827,0.0141427478798266,9.65970591491481e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,40286,0.0724581518915017,0.0163962800167979,0.0403214430585779,0.104594860724425,9.97332518316893e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TDGF1,Teratocarcinoma-derived growth factor 1,39961,0.0573575065016753,0.0130197361729953,0.0318388236026045,0.082876189400746,1.06283024048443e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BTN2A1,Butyrophilin subfamily 2 member A1,40422,0.0103615173075671,0.00235688109505487,0.00574203036125958,0.0149810042538747,1.10831214795671e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FAM171B,Protein FAM171B,37900,0.0111331283324747,0.00253456615120396,0.00616537867611491,0.0161008779888344,1.12901952858833e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EXTL1,Exostosin-like 1,37562,0.0192282120243836,0.00437973984047028,0.0106439219370618,0.0278125021117053,1.14099737440876e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATXN10,Ataxin-10,39961,0.0290224538079473,0.00662206267205546,0.0160432109707186,0.042001696645176,1.17992695118182e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB37,Ras-related protein Rab-37,40044,0.0332299653604027,0.00761468523980062,0.0183051822903935,0.0481547484304119,1.28566949080607e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SUSD2,Sushi domain-containing protein 2,40332,-0.0114027001338959,0.00261377208496605,-0.0165256934204293,-0.00627970684736243,1.29368339086959e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VSIG10,V-set and immunoglobulin domain-containing protein 10,37900,0.0142206159281045,0.00326103651775884,0.00782898435329722,0.0206122475029119,1.30572072477351e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGB1BP1,Integrin beta-1-binding protein 1,39980,0.0165107503388009,0.00379373410227415,0.00907503149834355,0.0239464691792582,1.3569478913866e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CST1,Cystatin-SN,36179,0.0415967487179765,0.00955902177779374,0.0228610660335008,0.0603324314024522,1.36310375958797e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHRM1,Muscarinic acetylcholine receptor M1,37572,-0.0149939003392882,0.00345032471949947,-0.0217565367895071,-0.00823126388906919,1.39909129711151e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NCAM2,Neural cell adhesion molecule 2,40332,-0.0107051379382784,0.00246436785229866,-0.0155352989287838,-0.005874976947773,1.40799211064314e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNPY2,Protein canopy homolog 2,40042,0.0241101323252798,0.00558343602108261,0.0131665977239578,0.0350536669266017,1.58312011744864e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SAA4,Serum amyloid A-4 protein,38013,0.0128807446943049,0.00298615839375799,0.00702787424253923,0.0187336151460705,1.61838993314683e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPPP3,Tubulin polymerization-promoting protein family member 3,39961,0.0155473011104414,0.00362370286187106,0.0084448435011741,0.0226497587197087,1.79394966571746e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC4A1,Band 3 anion transport protein,37998,-0.0181283997121824,0.00422610516940563,-0.0264115658442174,-0.00984523358014734,1.8021720747867e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GART,Trifunctional purine biosynthetic protein adenosine-3,37959,0.0105425440873216,0.00245899887673023,0.00572290628893035,0.0153621818857128,1.82086891676494e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GGT5,Glutathione hydrolase 5 proenzyme,40228,0.00885068996267887,0.0020703050162487,0.00479289213083142,0.0129084877945263,1.92203392348936e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MPO,Myeloperoxidase,40332,0.0181584156313495,0.00426711264288113,0.00979487485130254,0.0265219564113966,2.0984040790344e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NCF2,Neutrophil cytosol factor 2,40324,0.0321921797152474,0.0075852329163964,0.0173251231991105,0.0470592362313844,2.2075865153137e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,38013,-0.00759583484437251,0.00178982371194394,-0.0111038893197826,-0.0040877803689624,2.21127483348037e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,40332,-0.0140408210235509,0.00331320178628923,-0.0205346965246778,-0.00754694552242397,2.26953667818547e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACTN2,Alpha-actinin-2,37562,-0.0212548383935113,0.00501546903595572,-0.0310851577039845,-0.011424519083038,2.27207337850931e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CFC1,Cryptic protein,39980,0.0178441337282712,0.00421540722231957,0.00958193557252489,0.0261063318840176,2.31842804470192e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37562,0.0189574393178928,0.00448145362417302,0.0101737902145136,0.0277410884212719,2.35070970998682e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PREB,Prolactin regulatory element-binding protein,40044,0.0114494509969163,0.00270908663982896,0.00613964118285158,0.0167592608109811,2.38901838092766e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP6V1D,V-type proton ATPase subunit D,40305,0.0101512764085029,0.00240228287775364,0.00544280196810577,0.0148597508489001,2.39553488839741e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA2,Carbonic anhydrase 2,40291,0.0271532936095953,0.0064485373848476,0.014514160335294,0.0397924268838966,2.55909629341949e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL3A1,Collagen alpha-1(III) chain,37998,-0.00890011338411095,0.0021141704107161,-0.0130438873891145,-0.00475633937910738,2.57311524204939e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERBB4,Receptor tyrosine-protein kinase erbB-4,40411,-0.0093493678745045,0.00222213511971422,-0.0137047527091444,-0.00499398303986463,2.59759532567901e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL17C,Interleukin-17C,40044,-0.0269211387926801,0.00641461312471065,-0.039493780517113,-0.0143484970682472,2.72157991315219e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLASP1,CLIP-associating protein 1,37482,0.027472403945675,0.00654978846925469,0.0146348185459358,0.0403099893454142,2.7541039422562e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MNDA,Myeloid cell nuclear differentiation antigen,40333,0.0370847870657883,0.00884403923481605,0.0197504701655489,0.0544191039660278,2.76542882398079e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TINAGL1,Tubulointerstitial nephritis antigen-like,40325,0.00854222886107619,0.00203932964832978,0.00454514275034981,0.0125393149718026,2.82018256535476e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37901,0.0150427593921855,0.00360515352650916,0.00797665848022752,0.0221088603041434,3.03074103803308e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CALB1,Calbindin,40305,0.0161264038411045,0.00387256666638191,0.00853617317499599,0.0237166345072131,3.14005552896086e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FOSB,Protein fosB,39961,0.0148938839981167,0.00357671024111228,0.00788353192553662,0.0219042360706967,3.14232392638219e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPNMB,Transmembrane glycoprotein NMB,39957,0.0107110766868716,0.00257924798691974,0.00565575063250887,0.0157664027412343,3.30202856716618e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYOM1,Myomesin-1,37541,0.0178125724445259,0.00428937784437794,0.00940539186954511,0.0262197530195066,3.30634122987143e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ULBP2,UL16-binding protein 2,40228,0.014114819707424,0.00340543969208637,0.00744015791093473,0.0207894815039133,3.41906440583415e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRTAP,Cartilage-associated protein,37572,0.018358595943887,0.00443884492866255,0.00965845988370836,0.0270587320040656,3.55776325382253e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,40359,0.0219649191404665,0.00531815560228002,0.0115413341599976,0.0323885041209353,3.64337161729771e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINA6,Corticosteroid-binding globulin,38013,0.00671949507678944,0.0016340888316929,0.00351668096667136,0.00992230918690752,3.94431035554454e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDGFRB,Platelet-derived growth factor receptor beta,40536,0.0130281598133831,0.00317619740996201,0.00680281288985751,0.0192535067369086,4.11947368612943e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFYA,Nuclear transcription factor Y subunit alpha,37562,0.0144323942222172,0.00352393484704297,0.00752548192201302,0.0213393065224215,4.23726098714343e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,40228,0.0140144051962896,0.00342411308380545,0.00730314355203092,0.0207256668405483,4.28210758582128e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37959,0.027145873023241,0.00664179821630457,0.014127948519284,0.0401637975271979,4.39273637108942e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPSAB1,Tryptase alpha/beta-1,40498,0.0196552493074468,0.00481117045027922,0.0102253552248995,0.029085143389994,4.42268399592813e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPON1,Spondin-1,40379,0.0122535795462239,0.00300090236466724,0.0063718109114761,0.0181353481809717,4.4617873146987e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EP300,Histone acetyltransferase p300,37598,0.0111498229654362,0.00273398200634857,0.00579121823299299,0.0165084276978794,4.56461689436205e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLC,Galectin-10,40333,-0.0244334747404454,0.00600090892725641,-0.036195256237868,-0.0126716932430229,4.6911752597443e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL12RB1,Interleukin-12 receptor subunit beta-1,40044,0.0140572133289264,0.00347514140978297,0.00724593616575176,0.020868490492101,5.25578737393632e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,40044,0.01552005140924,0.00384129802836388,0.00799110727364682,0.0230489955448332,5.36354998605316e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGLC2,Immunoglobulin lambda constant 2,37978,-0.00896953322502896,0.00222196161300581,-0.0133245779865204,-0.00461448846353757,5.44922325430863e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD300E,CMRF35-like molecule 2,40436,0.0146820756662763,0.00364537287362802,0.00753714483396536,0.0218270064985872,5.66113103645594e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL2RA,Interleukin-2 receptor subunit alpha,40208,-0.0148117986266656,0.00367773011758713,-0.0220201496571363,-0.00760344759619479,5.66542521665996e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FLT1,Vascular endothelial growth factor receptor 1,40272,0.00847623729339863,0.00211471419302448,0.00433139747507065,0.0126210771117266,6.14588353299761e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LMNB2,Lamin-B2,37942,0.0100224167229251,0.00250052488998042,0.00512138793856352,0.0149234455072867,6.15317339408197e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL4R,Interleukin-4 receptor subunit alpha,40341,-0.0132565297992372,0.00331361676729402,-0.0197512186631335,-0.0067618409353409,6.34623235474525e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,S100A12,Protein S100-A12,40139,0.0279098653236371,0.00698121191076668,0.0142266899785344,0.0415930406687397,6.42119654859768e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,37541,0.0225257321534277,0.00566805244908883,0.0114163493532136,0.0336351149536419,7.10078217250286e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DIPK2B,Divergent protein kinase domain 2B,37671,0.00968570633315814,0.00244375476312712,0.00489594699742899,0.0144754656688873,7.42619811766584e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCN3,CCN family member 3,40522,0.0121703094141192,0.00308002920357677,0.00613345217510878,0.0182071666531297,7.80399322162153e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSF3,Granulocyte colony-stimulating factor,40044,0.0175579114244842,0.00446227970058622,0.00881184321133523,0.0263039796376332,8.36478538267155e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,JAM2,Junctional adhesion molecule B,40471,0.00935106105971866,0.00238264414024639,0.00468107854483573,0.0140210435746016,8.72163850443829e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENO1,Alpha-enolase,40299,0.0283240210345312,0.0072298810400906,0.0141534541959536,0.0424945878731087,8.97979268099726e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VSIG2,V-set and immunoglobulin domain-containing protein 2,37900,0.0205514412302858,0.0052497309081908,0.0102619686502318,0.0308409138103397,9.09401979395088e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NEO1,Neogenin,37959,0.00761840922165038,0.00195140719903859,0.00379365111153474,0.011443167331766,9.50523711400031e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAYN,Layilin,40192,-0.0122389028989432,0.00314005472057978,-0.0183934101512796,-0.00608439564660686,9.75243701460803e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BMP4,Bone morphogenetic protein 4,40203,-0.0161050570370493,0.0041498182396607,-0.0242387007867843,-0.00797141328731433,0.000104491788204103
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37900,0.015625761346079,0.00403096879306274,0.00772506251167601,0.0235264601804819,0.00010650478583413
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZBP1,Z-DNA-binding protein 1,37598,0.0142815626409102,0.00368699095086629,0.00705506037721225,0.0215080649046081,0.000107803103734709
NMR metabolomics,X23503.Total Lipids in Medium VLDL,POF1B,Protein POF1B,37598,-0.0164740171268486,0.00425380266874291,-0.0248114703575847,-0.0081365638961125,0.000108124782540508
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCAN,Brevican core protein,40228,0.0118553021313165,0.00306331779991275,0.00585119924348754,0.0178594050191455,0.000109235050117507
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EGFLAM,Pikachurin,37901,0.0108879832205041,0.00281547071239925,0.00536966062420152,0.0164063058168066,0.000110611411938901
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLXNB2,Plexin-B2,40472,0.00822252100333067,0.00212692970962955,0.00405373877245676,0.0123913032342046,0.00011111217492445
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPHX2,Bifunctional epoxide hydrolase 2,40042,0.0221326974900018,0.00572553440625176,0.0109106500537484,0.0333547449262553,0.000111260120028362
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSC,Dipeptidyl peptidase 1,40349,0.0150033142954213,0.00388346769692618,0.00739171760944601,0.0226149109813966,0.000112272264702237
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CST6,Cystatin-M,39992,0.0167912743177343,0.00435932645494546,0.00824699446604124,0.0253355541694274,0.000117721115919837
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40489,0.0118608100250328,0.0030860475243698,0.00581215687726798,0.0179094631727976,0.00012182638769193
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD80,T-lymphocyte activation antigen CD80,37990,0.0119569084394786,0.0031117637971675,0.00585785139703029,0.0180559654819269,0.000122350576121043
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SSH3,Protein phosphatase Slingshot homolog 3,37482,0.0102818989149354,0.00267863939394454,0.00503176570280414,0.0155320321270667,0.000124384275001289
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAMTSL2,ADAMTS-like protein 2,37998,0.010826732502993,0.00282495443146814,0.00528982181731548,0.0163636431886706,0.000127403483925463
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ROBO4,Roundabout homolog 4,37628,-0.00626275449217111,0.00163555630010046,-0.009468444840368,-0.00305706414397422,0.000129193586354169
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AHNAK2,Protein AHNAK2,37628,0.00996199534498676,0.00261880938621578,0.00482912894800383,0.0150948617419697,0.000143011516526662
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GBP2,Guanylate-binding protein 2,40044,0.0206134995464811,0.00543803288815036,0.00995495508570638,0.0312720440072558,0.000150839471552075
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSV,Cathepsin L2,40444,0.0146730761566105,0.00387609098308454,0.00707593782976485,0.0222702144834562,0.000153938843172155
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NTF3,Neurotrophin-3,40341,0.012066778439037,0.00319092824984587,0.00581255906933905,0.0183209978087349,0.000156401331215056
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SBSN,Suprabasin,37977,-0.0116105583410713,0.00307246301555447,-0.017632585851558,-0.00558853083058451,0.00015819297151862
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ALPP,"Alkaline phosphatase, placental type",40305,0.0354522509760078,0.00940871154478539,0.0170111763482284,0.0538933256037871,0.000165140741715299
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NEFL,Neurofilament light polypeptide,39903,0.0147114997226387,0.0039059545191564,0.0070558288650922,0.0223671705801853,0.00016621357864997
NMR metabolomics,X23503.Total Lipids in Medium VLDL,THY1,Thy-1 membrane glycoprotein,40471,-0.00962806379080702,0.00255683474880919,-0.014639459898473,-0.00461666768314101,0.000166731373599582
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,40228,-0.00972243859825604,0.00258838930059319,-0.0147956816274187,-0.00464919556909338,0.000173151721726258
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NAAA,N-acylethanolamine-hydrolyzing acid amidase,40159,0.0202873613243567,0.00540909950296541,0.00968552629854448,0.0308891963501689,0.000177046502665899
NMR metabolomics,X23503.Total Lipids in Medium VLDL,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37628,0.0125392631688448,0.0033433439503162,0.00598630902622506,0.0190922173114646,0.000177227127950778
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RPA2,Replication protein A 32 kDa subunit,37598,0.0111774919576091,0.00299080868575693,0.00531550693352551,0.0170394769816927,0.000186808982588158
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37562,0.012226072666981,0.00327650123312381,0.00580413025005836,0.0186480150839037,0.000191191053441265
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LPCAT2,Lysophosphatidylcholine acyltransferase 2,40305,0.0126402807012956,0.00339631012962063,0.00598351284723917,0.019297048555352,0.000198516064215648
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TGFBR2,TGF-beta receptor type-2,40411,0.0107200652541416,0.00288083727493679,0.00507362419526547,0.0163665063130177,0.000198987855738433
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF5,Eukaryotic translation initiation factor 5,37562,0.015498675027982,0.00416874023993777,0.00732794415770396,0.02366940589826,0.000201776776317724
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAG3,Lymphocyte activation gene 3 protein,40305,-0.0139440650000709,0.00375604689293894,-0.0213059169102312,-0.0065822130899106,0.00020598094054894
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAEA,E3 ubiquitin-protein transferase MAEA,39980,0.0137334031226259,0.00371101596115699,0.00645981183875823,0.0210069944064936,0.000215737701774532
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VASN,Vasorin,40116,0.00926600723103656,0.00250576699589185,0.00435470391908853,0.0141773105429846,0.000218156338009797
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PROCR,Endothelial protein C receptor,37562,-0.012501252106965,0.003391199123613,-0.0191480023892464,-0.0058545018246835,0.000228383187213052
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOF,Apolipoprotein F,37987,0.00811125266097522,0.00220665032278466,0.00378621802831728,0.0124362872936332,0.000238001557715806
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NECTIN1,Nectin-1,37598,0.0107513617861565,0.00292693961802377,0.00501456013482987,0.0164881634374831,0.000240441611235278
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37628,-0.00895760844837425,0.00244068987504188,-0.0137413606034563,-0.00417385629329216,0.000243399905635175
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,40434,0.0113082028838442,0.00308346437820306,0.00526461270256622,0.0173517930651222,0.000245853681168134
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UROS,Uroporphyrinogen-III synthase,37572,0.0233421996079978,0.00643109459273791,0.0107372542062315,0.0359471450097641,0.000284957424595665
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VEGFB,Vascular endothelial growth factor B,37598,0.00947541802452876,0.00261304387884827,0.00435385202198616,0.0145969840270714,0.000288710949504338
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LY96,Lymphocyte antigen 96,40228,-0.011496796065434,0.00317157946628387,-0.0177130918193504,-0.00528050031151761,0.000289934082379036
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINA1,Alpha-1-antitrypsin,37779,-0.00268908628828235,0.000743264319194284,-0.00414588435390314,-0.00123228822266155,0.000298054526323397
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXADR,Coxsackievirus and adenovirus receptor,40341,0.0174588788221347,0.00484440482163987,0.00796384537172058,0.0269539122725489,0.000314403799179531
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD109,CD109 antigen,40332,-0.0109755529960257,0.00305107606046697,-0.0169556620745409,-0.00499544391751042,0.000322547797237115
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40471,0.0236930872401609,0.00659049460293414,0.01077571781841,0.0366104566619118,0.000325316833286997
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBM19,Probable RNA-binding protein 19,37562,-0.0157999659813133,0.00439482223399628,-0.024413817559946,-0.00718611440268061,0.000325417534698856
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNX18,Sorting nexin-18,37901,0.0149196000357496,0.00416129074996622,0.00676347016581586,0.0230757299056834,0.000337844948727468
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPTP,Ceramide-1-phosphate transfer protein,37562,-0.0132564323691179,0.00370141880390443,-0.0205112132247705,-0.00600165151346517,0.000342934206909221
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MRPL46,"39S ribosomal protein L46, mitochondrial",39961,0.00903307928192973,0.00252493347762568,0.00408420966578339,0.0139819488980761,0.00034788465058966
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40536,0.0228963914606957,0.00640073880694122,0.0103509433990909,0.0354418395223005,0.000348383163055323
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CELA2A,Chymotrypsin-like elastase family member 2A,37998,0.0192444817466463,0.00538899602280617,0.00868204954194617,0.0298069139513463,0.000356757776030954
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SAT2,Thialysine N-epsilon-acetyltransferase,37714,0.0223892000237521,0.00627841726971441,0.0100835021751119,0.0346948978723924,0.000363667059593946
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUP50,Nuclear pore complex protein Nup50,37562,-0.0116079227005894,0.00326218677048303,-0.0180018087707361,-0.00521403663044261,0.000374544955244215
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CR2,Complement receptor type 2,40403,0.0150817071497817,0.00424054098199843,0.00677024682506474,0.0233931674744986,0.000376841972179484
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NELL2,Protein kinase C-binding protein NELL2,40422,0.00915778920657533,0.00257763055051811,0.00410563332755983,0.0142099450855908,0.000382262206875227
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCDH17,Protocadherin-17,40359,-0.0112881789141542,0.00317984747431554,-0.0175206799638126,-0.00505567786449573,0.000386471706736481
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPTXR,Neuronal pentraxin receptor,40359,0.0109795062623791,0.00309799456470783,0.00490743691555178,0.0170515756092065,0.000395132042540834
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WFDC2,WAP four-disulfide core domain protein 2,39535,0.0123149493319551,0.00347603933451685,0.00550191223630209,0.0191279864276082,0.000397082481256982
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RANBP2,E3 SUMO-protein ligase RanBP2,37541,-0.0107813823549278,0.00304632922751539,-0.016752187640858,-0.00481057706899762,0.000402826493944582
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDKL5,Cyclin-dependent kinase-like 5,37541,-0.0175532821179334,0.00497440123986544,-0.0273031085480696,-0.00780345568779709,0.000419002633651899
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EDA2R,Tumor necrosis factor receptor superfamily member 27,40489,-0.0113837907123516,0.00323850599266289,-0.0177312624579709,-0.00503631896673238,0.000440740381595027
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DPP10,Inactive dipeptidyl peptidase 10,40341,0.010909637087812,0.0031090846332958,0.00481583120655224,0.0170034429690718,0.000451115860643963
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLAU,Urokinase-type plasminogen activator,40332,0.00939975271854853,0.00268134141378899,0.00414432354752211,0.014655181889575,0.000456808619691378
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FABP3,"Fatty acid-binding protein, heart",37990,0.0152319477942785,0.00434640338252705,0.0067129971645255,0.0237508984240315,0.000458952874176656
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FUCA1,Tissue alpha-L-fucosidase,40437,0.0259371425190726,0.00740397473229323,0.0114253520437779,0.0404489329943674,0.000461068165820365
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TSC1,Hamartin,37598,0.0244440068593849,0.00699360301264708,0.0107365449545967,0.0381514687641732,0.000475276256686781
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TGFB2,Transforming growth factor beta-2 proprotein,37900,0.0169205546316197,0.00484632112302683,0.00742176523048716,0.0264193440327523,0.00048199709889826
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLAMF1,Signaling lymphocytic activation molecule,40044,-0.0189442059480426,0.00544006380953471,-0.0296067310147307,-0.0082816808813546,0.000498395413326438
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NRP2,Neuropilin-2,40332,-0.00923332126091681,0.00265235702697397,-0.0144319410337858,-0.00403470148804783,0.000500558802334471
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MATN3,Matrilin-3,40203,-0.00994143301339938,0.00285688145746979,-0.0155409206700402,-0.00434194535675859,0.000503107993667915
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNASE6,Ribonuclease K6,37917,0.00937863644051041,0.00269624144599777,0.00409400320635478,0.014663269674666,0.000505989198290996
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,40305,-0.00631304935404695,0.00181627835274976,-0.00987295492543648,-0.00275314378265742,0.000510664361844165
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EFHD1,EF-hand domain-containing protein D1,37959,0.011031527693701,0.00317512044143798,0.00480829162848259,0.0172547637589195,0.000513669618776942
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CAT,Catalase,37786,0.0172534911015778,0.00498013243547064,0.00749243152805532,0.0270145506751002,0.000532958561253075
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDX25,ATP-dependent RNA helicase DDX25,37572,-0.0124188762757474,0.00359696791673619,-0.0194689333925503,-0.00536881915894445,0.000556971414659978
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK4,Kallikrein-4,40489,-0.0191596963614868,0.00555434673846027,-0.030046215968869,-0.00827317675410468,0.000563078277814803
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TDO2,"Tryptophan 2,3-dioxygenase",37572,0.0122734329016659,0.00355818205870664,0.00529939606660091,0.0192474697367309,0.000563693595843652
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39980,-0.0102154573011908,0.00296494692935426,-0.0160267532827252,-0.00440416131965646,0.000571701638385824
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSF3R,Granulocyte colony-stimulating factor receptor,37598,0.00990111992670807,0.00287505953157325,0.00426600324482449,0.0155362366085916,0.000575395708850982
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLITRK1,SLIT and NTRK-like protein 1,37598,0.0101605635716887,0.00295437930388151,0.00436998013608099,0.0159511470072965,0.000585346777622103
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37901,0.00674993640327763,0.00196540614876837,0.00289774035169162,0.0106021324548636,0.000595719518526703
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GLYR1,Putative oxidoreductase GLYR1,37900,0.0190325938220654,0.00554640435092421,0.00816164129425397,0.0299035463498769,0.000602015451789616
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIRREL2,Kin of IRRE-like protein 2,39961,0.012600430115804,0.00367278877576397,0.00540176411530667,0.0197990961163014,0.000603477168288806
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSF2,Granulocyte-macrophage colony-stimulating factor,37562,0.0111876943885968,0.00327345871621485,0.00477171530481571,0.0176036734723779,0.000633449912149922
NMR metabolomics,X23503.Total Lipids in Medium VLDL,INHBB,Inhibin beta B chain,37671,0.0160385413022248,0.00471416317183959,0.00679878148541922,0.0252783011190304,0.000670429964740408
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LIFR,Leukemia inhibitory factor receptor,40341,-0.00759538267155859,0.00223599933043977,-0.0119779413592205,-0.00321282398389665,0.000683302154365128
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PI3,Elafin,40074,0.016534499791855,0.00488613718258483,0.00695767091398874,0.0261113286697213,0.000716236331301662
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPHB6,Ephrin type-B receptor 6,40192,0.00962730629984375,0.00285283218115255,0.00403575522478476,0.0152188573749027,0.000740884305141782
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NME1,Nucleoside diphosphate kinase A,37598,-0.0067913839218961,0.00201386024562975,-0.0107385500033304,-0.00284421784046179,0.000747523736846313
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZBTB17,Zinc finger and BTB domain-containing protein 17,40042,0.0125100685532116,0.00372160306742513,0.00521572654105832,0.0198044105653648,0.000777141689631839
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LGALS4,Galectin-4,40357,-0.0161598953986566,0.00481669743469788,-0.0256006223706644,-0.00671916842664871,0.00079557971571667
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NINJ1,Ninjurin-1,39980,0.0172714667129381,0.00514875660904903,0.00717990375920205,0.0273630296666742,0.000797009467065958
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CYB5A,Cytochrome b5,37482,0.0225662086148397,0.00673774815984081,0.0093602222215517,0.0357721950081277,0.000812689251489829
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ICAM3,Intercellular adhesion molecule 3,40536,-0.0077102971238762,0.00230270630865028,-0.0122236014888308,-0.00319699275892165,0.000814769625036
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRTN3,Myeloblastin,39897,-0.014376793866547,0.0042936879472672,-0.0227924222431907,-0.00596116548990329,0.000814869425113566
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,40422,0.0126485832340475,0.00378596525705704,0.00522809133021565,0.0200690751378793,0.0008369459809231
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HAVCR2,Hepatitis A virus cellular receptor 2,40332,-0.0104966320782543,0.0031420693155714,-0.0166550879367742,-0.00433817621973434,0.000837676511221626
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIAA1549,UPF0606 protein KIAA1549,37714,0.0216371936305725,0.00649111081454269,0.00891461643406884,0.0343597708270762,0.000860394987228505
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYL4,Myosin light chain 4,37628,-0.0160470386798207,0.00481470594551272,-0.0254838623330257,-0.00661021502661581,0.000861757865030457
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTHRC1,Collagen triple helix repeat-containing protein 1,37998,-0.00845046714517782,0.00254090178946526,-0.0134306346525297,-0.00347029963782591,0.000884074876113889
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GIMAP7,GTPase IMAP family member 7,37671,-0.00985078402029435,0.00296733210425776,-0.0156667549446396,-0.00403481309594914,0.00090343668324915
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WASL,Neural Wiskott-Aldrich syndrome protein,37598,-0.0190293410206353,0.00573369763284272,-0.030267388381007,-0.00779129366026358,0.000906313042207201
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC13A1,Solute carrier family 13 member 1,37900,0.01884350922206,0.00568548787089372,0.00769995299510832,0.0299870654490117,0.000921101093638391
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB39B,Ras-related protein Rab-39B,37562,0.0270925586118392,0.00817612100844036,0.0110673614352961,0.0431177557883823,0.000923460742037994
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRR4,Proline-rich protein 4,37577,-0.0208618752377365,0.00630595968530676,-0.0332215562209378,-0.00850219425453529,0.000941236947151349
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD248,Endosialin,37998,-0.0120894388262369,0.00366382539140119,-0.0192705365933832,-0.00490834105909056,0.000970461790523856
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",40434,-0.0221429030005703,0.00671395480741885,-0.0353022544231112,-0.00898355157802935,0.000975742738242726
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BRD3,Bromodomain-containing protein 3,37562,0.0146176966762792,0.00444409615027365,0.00590726822174286,0.0233281251308156,0.00100723321595462
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD79B,B-cell antigen receptor complex-associated protein beta chain,40516,-0.0132479529880049,0.00403013841596569,-0.0211470242832977,-0.00534888169271216,0.00101398788109022
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPRF,Receptor-type tyrosine-protein phosphatase F,40536,0.00867398947538842,0.00264225754589937,0.00349516468542566,0.0138528142653512,0.00103002659087183
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LIF,Leukemia inhibitory factor,39961,0.0157916814031823,0.00481590827818401,0.00635250117794163,0.025230861628423,0.00104380667841462
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL11,Interleukin-11,40044,0.0191181968231274,0.00583973979665871,0.00767230682167635,0.0305640868245785,0.0010633914838265
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GUCA2A,Guanylin,40276,-0.00999670510749564,0.00305679420518662,-0.0159880217496614,-0.00400538846532985,0.00107654292413355
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDH6,Cadherin-6,40359,-0.0113052807345951,0.00346000179545922,-0.0180868842536952,-0.00452367721549508,0.00108762385143349
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LSM1,U6 snRNA-associated Sm-like protein LSm1,39980,0.0169890626926778,0.0052030916736819,0.00679100301226123,0.0271871223730943,0.0010962909181593
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ELAVL4,ELAV-like protein 4,37541,0.0260532559762658,0.00798243072307719,0.0104076917590345,0.0416988201934971,0.00110201102529329
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37714,0.0214335904103038,0.00656802149574994,0.00856026827863391,0.0343069125419737,0.00110391737983582
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFSF13,Tumor necrosis factor ligand superfamily member 13,40422,0.0078556676278854,0.00240953090283713,0.00313298705832463,0.0125783481974462,0.00111548044814452
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL9A2,Collagen alpha-2(IX) chain,37714,0.0137770470662563,0.00424746516449356,0.00545201534384889,0.0221020787886636,0.00118324478624917
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIMP2,Metalloproteinase inhibitor 2,37990,-0.00740595336961894,0.0022841040991483,-0.0118827974039496,-0.00292910933528827,0.00118819175591054
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GSAP,Gamma-secretase-activating protein,39980,0.0264684835095608,0.0081696090663172,0.0104560497395791,0.0424809172795425,0.00119835227920173
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEZ6L,Seizure 6-like protein,40411,0.0081005431846938,0.00250672905022848,0.00318735424624597,0.0130137321231416,0.00123383753078978
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERC2,ERC protein 2,37572,0.0227812928176077,0.00705384632973929,0.00895575401131871,0.0366068316238967,0.0012425695692792
NMR metabolomics,X23503.Total Lipids in Medium VLDL,INSL4,Early placenta insulin-like peptide,37900,-0.0160074683622227,0.00495718655617882,-0.0257235540123332,-0.00629138271211222,0.00124459482239467
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MRPL52,"39S ribosomal protein L52, mitochondrial",37460,0.00744424241926192,0.0023207083624071,0.002895654028944,0.0119928308095798,0.00134103660972599
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39961,0.0145101006489982,0.00452996343427859,0.00563137231781218,0.0233888289801842,0.00136213158950773
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GLP1R,Glucagon-like peptide 1 receptor,37541,-0.0112727447196102,0.00351989349022946,-0.01817173596046,-0.00437375347876048,0.0013652773426209
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSF1R,Macrophage colony-stimulating factor 1 receptor,37987,0.0115358485120776,0.00360320778128861,0.00447356126075195,0.0185981357634033,0.00137006378584977
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RGMA,Repulsive guidance molecule A,40471,-0.00903771113543866,0.00282438319342122,-0.0145735021945442,-0.00350192007633307,0.00137748663680937
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UBAC1,Ubiquitin-associated domain-containing protein 1,40305,0.0103796884198623,0.00324759737717441,0.0040143975606004,0.0167449792791241,0.00139565570324248
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BAMBI,BMP and activin membrane-bound inhibitor homolog,39980,0.00882135044009046,0.00276040795239027,0.00341095085340554,0.0142317500267754,0.00139786059645522
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIAA0319,Dyslexia-associated protein KIAA0319,37942,0.00905027879665871,0.0028387714396769,0.00348628677489199,0.0146142708184254,0.00143539379282175
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40471,-0.0134087885507875,0.0042117603152718,-0.0216638387687202,-0.00515373833285473,0.00145706711617834
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RLN1,Prorelaxin H1,37959,-0.0240380199598755,0.00755381993544683,-0.0388435070333513,-0.00923253288639971,0.00146474796457324
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MELTF,Melanotransferrin,37990,0.00849230557283227,0.00267164324578233,0.00325588481109889,0.0137287263345656,0.00148278929318778
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TCN1,Transcobalamin-1,37766,0.00960345244719542,0.00302426746611474,0.00367588821361053,0.0155310166807803,0.00149938060048704
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NMRK2,Nicotinamide riboside kinase 2,37482,-0.0126987002748906,0.00400399181613503,-0.0205465242345153,-0.00485087631526596,0.00152000194115781
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STX5,Syntaxin-5,37598,0.0121111208029904,0.00384003541971575,0.00458465138034758,0.0196375902256333,0.00161462199142165
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,40167,0.00927860837859986,0.00294781107659,0.00350089866848345,0.0150563180887163,0.00164909530795079
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VCAN,Versican core protein,40471,-0.00861420351717483,0.00274458311502702,-0.0139935864226278,-0.00323482061172187,0.00170053417188794
NMR metabolomics,X23503.Total Lipids in Medium VLDL,REG3A,Regenerating islet-derived protein 3-alpha,40536,-0.0173823816374922,0.00556052531070603,-0.028281011246476,-0.00648375202850836,0.00177497611838856
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANXA1,Annexin A1,37608,0.0118473993641962,0.00379360578419747,0.00441193202716917,0.0192828667012232,0.00179411190346014
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37942,0.0177482042296442,0.00569880625700044,0.00657854396592337,0.0289178644933651,0.00184722817441929
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPA4,Carboxypeptidase A4,37410,0.0125054396967213,0.00402077815680038,0.00462471450939259,0.0203861648840501,0.00187363918266263
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARTN,Artemin,40044,0.0126634696846227,0.00407181423259462,0.00468271378873728,0.0206442255805082,0.00187404739072672
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ICAM4,Intercellular adhesion molecule 4,40341,-0.0149763973330802,0.00481850434832429,-0.0244206658557958,-0.00553212881036457,0.00188626138843905
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRKCQ,Protein kinase C theta type,40044,0.0125672426569348,0.00405740038295197,0.00461473790634897,0.0205197474075207,0.00195597218815781
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37562,-0.0147873511489961,0.00478175873097523,-0.0241595982617076,-0.00541510403628469,0.00198928348071253
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYBPC1,"Myosin-binding protein C, slow-type",37990,-0.0178905005100344,0.00579327972927581,-0.029245328779415,-0.00653567224065382,0.00201816172690785
NMR metabolomics,X23503.Total Lipids in Medium VLDL,INSL5,Insulin-like peptide INSL5,37901,0.026522479040742,0.00859188314346167,0.00968238807955716,0.0433625700019269,0.00202651463346343
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BMP10,Bone morphogenetic protein 10,37671,0.00810390521562571,0.00262623429409446,0.00295648599920057,0.0132513244320509,0.00203458249162092
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DLL1,Delta-like protein 1,40411,-0.00824934689408764,0.00267352670623084,-0.0134894592383001,-0.00300923454987519,0.0020351174544459
NMR metabolomics,X23503.Total Lipids in Medium VLDL,S100A14,Protein S100-A14,37959,0.0151672507277262,0.00491957865696431,0.00552487656007618,0.0248096248953763,0.00205311580888546
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MRC1,Macrophage mannose receptor 1,37987,0.00795623581949807,0.00258484950723283,0.00288993078532172,0.0130225408536744,0.00208792867325237
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37942,0.0152496004636754,0.00495947680800616,0.00552902591998335,0.0249701750073675,0.00211036019609828
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",40305,0.00971126646559468,0.00316428438510642,0.00350926907078609,0.0159132638604033,0.00215121603096852
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACE,Angiotensin-converting enzyme,37987,-0.00715782802155054,0.00233730488516572,-0.0117389455964753,-0.00257671044662573,0.00219980124891269
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CKAP4,Cytoskeleton-associated protein 4,40457,0.00730681091689855,0.00238764708771567,0.00262702262497583,0.0119865992088213,0.00221514046548504
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CAPS,Calcyphosin,37942,0.0265694891794383,0.00868524478816419,0.00954640939463653,0.0435925689642401,0.00222399407580831
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDRG1,p53 and DNA damage-regulated protein 1,37572,0.0150817147693523,0.00493657599861869,0.00540602581205966,0.0247574037266449,0.0022543984965172
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37901,-0.0192921018452142,0.00632608552510798,-0.0316912294744258,-0.00689297421600253,0.00229583385575481
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPINK8,Serine protease inhibitor Kazal-type 8,37562,0.0108809520697308,0.00358630755161563,0.00385178926856417,0.0179101148708974,0.00241785795215081
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PMS1,PMS1 protein homolog 1,37572,0.0144620166076708,0.00476791246107566,0.00511690818396256,0.0238071250313791,0.0024245078533359
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37987,0.0131172911982116,0.00433316878553974,0.00462428037855375,0.0216103020178695,0.00247309504746455
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACTA2,"Actin, aortic smooth muscle",40042,-0.0120469855709186,0.00399068051689453,-0.0198687193840319,-0.00422525175780532,0.00254205223864814
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NGF,Beta-nerve growth factor,40228,0.00336418827344168,0.00111488055092992,0.00117902239361904,0.00554935415326433,0.0025524821449676
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNF43,E3 ubiquitin-protein ligase RNF43,37714,0.0163456503802852,0.00541680804038664,0.00572870662112734,0.026962594139443,0.00255285497773369
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MANSC4,MANSC domain-containing protein 4,37562,0.0182008204139647,0.00603364481575252,0.00637487657508977,0.0300267642528397,0.00256155162609767
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD300C,CMRF35-like molecule 6,40471,0.0093615268936707,0.0031124172509363,0.00326118908183555,0.0154618647055058,0.00263555242023426
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLURP1,Secreted Ly-6/uPAR-related protein 1,37919,0.0105155876484059,0.00349630092208263,0.00366283784112398,0.0173683374556879,0.00263777607426897
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CASP1,Caspase-1,39961,0.0184774829741808,0.00615187538743715,0.00641980721480399,0.0305351587335576,0.00267272861453381
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGAM,Integrin alpha-M,40332,-0.0086768073191875,0.00289240589388421,-0.0143459228712006,-0.00300769176717445,0.00270524308431871
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AKR1C4,Aldo-keto reductase family 1 member C4,40042,0.0151898664398472,0.00506593768749288,0.00526062857236116,0.0251191043073333,0.00271801251449025
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRISP2,Cysteine-rich secretory protein 2,40489,0.0167370515912608,0.00559549661762307,0.00576987822071955,0.027704224961802,0.00278337930978186
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAMTSL5,ADAMTS-like protein 5,37990,-0.0105849388975813,0.00354771004522603,-0.0175384505862243,-0.00363142720893829,0.00285389363395001
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC16A1,Monocarboxylate transporter 1,39961,0.0163081438382237,0.00549540533689467,0.00553714937791013,0.0270791382985372,0.00300596576945032
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRNN,Cornulin,39857,0.0180040473730209,0.00606939046172321,0.00610804206804338,0.0299000526779984,0.00301801852538534
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37562,-0.0112101060324363,0.00378022503419342,-0.0186193470994554,-0.00380086496541719,0.00302775109853482
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGFR4,Fibroblast growth factor receptor 4,37671,0.0144847550078746,0.00489599108212296,0.00488861248691358,0.0240808975288356,0.00309694922634062
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK11,Kallikrein-11,40260,0.00802574728931571,0.00271402515323146,0.00270625798898206,0.0133452365896494,0.00310968097107894
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRLF1,Cytokine receptor-like factor 1,40422,0.00708822419807285,0.00239831752250438,0.00238752185396428,0.0117889265421814,0.00312620028100551
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMEM25,Transmembrane protein 25,37959,-0.0118289349543226,0.00400978184553107,-0.0196881073715635,-0.00396976253708173,0.00318298895759289
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARHGAP5,Rho GTPase-activating protein 5,37482,0.0209137194928787,0.00709644521447511,0.00700468687250751,0.0348227521132499,0.00321369177235121
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,40411,0.0120595356588473,0.00409422840928848,0.00403484797664193,0.0200842233410528,0.00322902253862033
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNU13,NHP2-like protein 1,37562,0.0168543019912933,0.00572353294731133,0.00563617741456306,0.0280724265680235,0.00323796365433979
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCG3,Secretogranin-3,40379,-0.00895582164235957,0.00304400588668651,-0.0149220731802651,-0.00298957010445401,0.00326446281523198
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPR1,Atrial natriuretic peptide receptor 1,37562,-0.0108667955477923,0.00369938248242263,-0.0181175852133406,-0.00361600588224392,0.00331486559209334
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CENPF,Centromere protein F,37714,0.0146741844103227,0.00499567423501809,0.00488266290968723,0.0244657059109581,0.00331569555848397
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPO,Erythropoietin,40341,-0.0209876059348547,0.00714876658477784,-0.0349991884410193,-0.00697602342869017,0.00333126832749306
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTTG1,Securin,37714,0.0110983082701829,0.00378706226059915,0.00367566623940857,0.0185209503009572,0.00338901369585059
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FOLH1,Glutamate carboxypeptidase 2,37598,0.0289161755166444,0.00987457910815098,0.00956200046466846,0.0482703505686203,0.00341356308415146
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPTN,Neuroplastin,39980,0.0225272934289723,0.00772529458263786,0.0073857160470021,0.0376688708109425,0.00355008443210016
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TBC1D17,TBC1 domain family member 17,39961,0.0122654661985121,0.00420729462851025,0.00401916872663198,0.0205117636703922,0.00355871483793545
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SELENOP,Selenoprotein P,38013,0.00600353178444394,0.00206733715017535,0.00195155097010026,0.0100555125987876,0.00369031406187223
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL9A1,Collagen alpha-1(IX) chain,40341,0.0124942523366939,0.00430671029629353,0.00405310015595857,0.0209354045174292,0.00372350250461214
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GAST,Gastrin,37942,0.0344794126011759,0.0119013541110739,0.011152758543471,0.0578060666588807,0.00377235430271985
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VWC2L,von Willebrand factor C domain-containing protein 2-like,37959,0.0125006186365946,0.00432508598347348,0.00402345010898654,0.0209777871642026,0.00385537547415086
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCDH12,Protocadherin-12,37959,0.00675915301109886,0.00234348079997771,0.00216593064314255,0.0113523753790552,0.00392984005442228
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,40042,0.00921245516355635,0.00319841395224729,0.00294356381715167,0.015481346509961,0.00397813210570615
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NRXN3,Neurexin-3,37572,0.00920303007526126,0.00319682511883183,0.00293725284235087,0.0154688073081716,0.00399832569487281
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39757,0.0170895417719529,0.00595062498742328,0.00542631679660322,0.0287527667473025,0.00408584970670802
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMOD4,Tropomodulin-4,37482,-0.0110351921111126,0.00384518289365713,-0.0185717505826806,-0.00349863363954467,0.00411295515008403
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNTN5,Contactin-5,40367,0.00968998260818703,0.00338376131704179,0.00305781042678512,0.0163221547895889,0.00419308648302849
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TEF,Thyrotroph embryonic factor,37562,0.011289643830392,0.00395463834357817,0.00353855267697877,0.0190407349838052,0.00431334825366447
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRRC38,Leucine-rich repeat-containing protein 38,37572,0.0129399164845398,0.00453469863317312,0.00405190716352048,0.0218279258055591,0.00433035811959537
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGB7,Integrin beta-7,40489,0.0118364834006262,0.00415693326943219,0.00368889419253909,0.0199840726087133,0.00441328860948442
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KRT19,"Keratin, type I cytoskeletal 19",40310,-0.0176575541787441,0.00620839313767568,-0.0298260047285884,-0.00548910362889975,0.00445881185602008
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",40044,0.0311867052488886,0.0109848163899907,0.00965646512450676,0.0527169453732704,0.00453031806021664
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TLR4,Toll-like receptor 4,37598,0.00736345947071022,0.00260747947238647,0.00225279970483273,0.0124741192365877,0.00475032892680991
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37572,0.00937024883583817,0.00335074013971242,0.00280279816200184,0.0159376995096745,0.00517391593321029
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NTF4,Neurotrophin-4,39980,0.0104180558069592,0.00373167462072497,0.00310397355033824,0.0177321380635801,0.00524812398582175
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37942,-0.00665257929007879,0.00238664677974719,-0.0113304069783833,-0.0019747516017743,0.00532044052438225
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDR1,Epithelial discoidin domain-containing receptor 1,40471,0.00585582877503218,0.00210295195282695,0.00173404294749136,0.00997761460257301,0.00536607105177807
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NELL1,Protein kinase C-binding protein NELL1,40411,0.0107961542587815,0.0038789223345738,0.00319346648301688,0.0183988420345462,0.00538744498995119
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,40357,0.00752789404412396,0.00270477822057808,0.00222652873179094,0.012829259356457,0.00538918573603676
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VEGFD,Vascular endothelial growth factor D,40483,-0.00846094230492037,0.00304011765574436,-0.0144195729101793,-0.00250231169966143,0.0053905718391376
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MUC2,Mucin-2,37998,0.0230738403839552,0.00829865433583562,0.00680847788571733,0.039339202882193,0.00543616319438711
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37562,-0.0104174536130582,0.00375000161766739,-0.0177674567836863,-0.00306745044243013,0.00547746628519957
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,40442,0.00705237272037871,0.00254414055578484,0.00206585723104042,0.012038888209717,0.00557764527289535
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,40355,-0.0126114219490706,0.00455014513095024,-0.0215297064057331,-0.00369313749240816,0.00558373350189932
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39823,-0.0219008552527106,0.00790868727114034,-0.0374018823041457,-0.00639982820127553,0.00562589044143326
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DPP6,Dipeptidyl aminopeptidase-like protein 6,40305,-0.00825447252969018,0.00299643902169647,-0.0141274930122153,-0.0023814520471651,0.00588020650830913
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LYAR,Cell growth-regulating nucleolar protein,39980,0.0132143065194094,0.00480364852010945,0.00379915541999489,0.0226294576188239,0.00595025383478625
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYO6,Unconventional myosin-VI,37959,0.00941845434273056,0.00342817986660557,0.00269922180418364,0.0161376868812775,0.00601562653229563
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARID4B,AT-rich interactive domain-containing protein 4B,39961,0.0102716611576868,0.0037476226286343,0.00292632080556354,0.01761700150981,0.00613511481268837
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37598,0.022039424766589,0.00804892602026573,0.00626352976686819,0.0378153197663099,0.00618630212607596
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,37184,0.0122416410696812,0.0044708169693163,0.00347883980982125,0.0210044423295411,0.00618770694213426
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AHSP,Alpha-hemoglobin-stabilizing protein,40311,0.0218698253504053,0.00800520669097035,0.00617962023610342,0.0375600304647072,0.00630303435825073
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA1,Carbonic anhydrase 1,40003,0.0155422074507,0.00571002011711653,0.00435056802115159,0.0267338468802484,0.00649764963255202
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCN,Decorin,40042,-0.00566182382210883,0.00208337577619887,-0.00974524034345862,-0.00157840730075904,0.00658259248285714
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDA1,DET1- and DDB1-associated protein 1,37562,0.0101412391148706,0.00374247262043546,0.00280599277881708,0.0174764854509241,0.0067417462435782
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL10RA,Interleukin-10 receptor subunit alpha,40044,0.0148602289783519,0.00550627369445473,0.00406793253722061,0.0256525254194832,0.00696688449551046
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SDK2,Protein sidekick-2,37671,0.00942364061839255,0.00349206573994606,0.00257919176809827,0.0162680894686868,0.00697231498500702
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TFF3,Trefoil factor 3,40309,-0.0131362542822289,0.00487306941449295,-0.0226874703346351,-0.00358503822982275,0.00703184117074687
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FBLN2,Fibulin-2,37998,-0.00757697679849797,0.00282253250172562,-0.0131091405018802,-0.00204481309511575,0.0072735364258643
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TERF1,Telomeric repeat-binding factor 1,37598,-0.00728015985752314,0.002725739934926,-0.0126226101299781,-0.00193770958506817,0.00757428753561884
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPA33,Cell surface A33 antigen,40305,-0.0332141242615561,0.01244462594586,-0.0576055911154417,-0.00882265740767042,0.00761655207667433
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLMP,CXADR-like membrane protein,40489,0.00496877855263853,0.00186213631219011,0.00131899138074592,0.00861856572453114,0.00763079095214845
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOA4,Apolipoprotein A-IV,38013,0.00895528216398191,0.00336709252363445,0.0023557808176584,0.0155547835103054,0.0078314218412903
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MRPS16,"28S ribosomal protein S16, mitochondrial",37598,0.00705286400171327,0.00266261713224529,0.00183413442251249,0.012271593580914,0.00808635391129487
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40517,0.0065614805794987,0.00248185737040842,0.00169704013349819,0.0114259210254992,0.00820659736310313
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RALY,RNA-binding protein Raly,37900,0.0116513131464022,0.00441618555178363,0.00299558946490631,0.0203070368278982,0.00834137444447879
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBPMS,RNA-binding protein with multiple splicing,37598,0.0156165361271738,0.00592712568762951,0.00399936977941991,0.0272337024749276,0.0084296254702541
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCP2,Non-specific lipid-transfer protein,39980,0.0187728706183803,0.0071326156980259,0.00479294385024957,0.0327527973865111,0.00849739043340574
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UXS1,UDP-glucuronic acid decarboxylase 1,39980,0.0128816212329714,0.00491584408616738,0.00324656682408338,0.0225166756418595,0.00879046664854394
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37598,0.010502493147682,0.00400860617448586,0.00264562504568975,0.0183593612496743,0.00880343674433615
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HBQ1,Hemoglobin subunit theta-1,40489,-0.0140899459792265,0.00539610269703402,-0.0246663072654132,-0.0035135846930398,0.00903265817883919
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL7R,Interleukin-7 receptor subunit alpha,40332,-0.0125603932685225,0.00481201585632027,-0.0219919443469103,-0.00312884219013481,0.00905704294161098
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEMA3G,Semaphorin-3G,37671,0.0102939727287687,0.00395650684087652,0.00253921932065074,0.0180487261368867,0.00928438756767538
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC10A,C-type lectin domain family 10 member A,40228,-0.00856822539598247,0.0032967786693929,-0.0150299115879926,-0.0021065392039724,0.00935912425497618
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA14,Carbonic anhydrase 14,40489,0.00817858802509063,0.00315136263040153,0.00200191726950363,0.0143552587806776,0.00946069898634438
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMPD1,Sphingomyelin phosphodiesterase,40380,-0.0112417724544495,0.00433840548564869,-0.0197450472063209,-0.00273849770257803,0.00957229442480554
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL15,C-C motif chemokine 15,40536,0.0105126097918565,0.00405768045770579,0.00255955609475311,0.0184656634889598,0.00958415177301802
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCGB2A2,Mammaglobin-A,37562,-0.00761995750025444,0.0029433068525318,-0.0133888389312168,-0.00185107606929211,0.00963865051522258
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UNC5D,Netrin receptor UNC5D,37598,0.00633810603075978,0.00245285487789486,0.00153051047008586,0.0111457015914337,0.00977768408636049
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLIC5,Chloride intracellular channel protein 5,37572,-0.00763794698989906,0.00295973074083402,-0.0134390192419337,-0.00183687473786438,0.00987300436564019
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,40228,0.00601025938979258,0.0023311602442744,0.00144118531101476,0.0105793334685704,0.00993986629303407
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GRIK2,"Glutamate receptor ionotropic, kainate 2",37959,0.00995691545469879,0.00387105598321223,0.00236964572760283,0.0175441851817947,0.0101176566568753
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37562,0.0122748882439887,0.00478036135390023,0.00290537999034426,0.0216443964976332,0.0102463626258834
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ALPI,Intestinal-type alkaline phosphatase,37598,-0.0285147790384509,0.0111282172728393,-0.0503260848932159,-0.00670347318368593,0.010406634457587
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLSTN1,Calsyntenin-1,39961,0.0123014864355366,0.00481149276059398,0.00287096062477237,0.0217320122463008,0.0105768277119688
NMR metabolomics,X23503.Total Lipids in Medium VLDL,REG1A,Lithostathine-1-alpha,40274,-0.0113553042961312,0.00445233405103846,-0.0200818790361665,-0.00262872955609578,0.0107687790845742
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SATB1,DNA-binding protein SATB1,37959,0.00702783332324134,0.00275649864343213,0.00162509598211436,0.0124305706643683,0.0107971302803306
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL22,Interleukin-22,37900,-0.0152257819761457,0.00597397709786739,-0.0269347770879658,-0.00351678686432562,0.0108240247045692
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,40228,0.00950573666942971,0.00373725062983693,0.00218072543494933,0.0168307479039101,0.0109839313138536
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PNLIPRP2,Pancreatic lipase-related protein 2,40357,0.0679166794734589,0.0267048868414591,0.015575101264199,0.120258257682719,0.010992664993393
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMEM132A,Transmembrane protein 132A,37628,0.0146346808160407,0.00575435985474504,0.00335613550074045,0.025913226131341,0.0109945109747192
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC51B,Organic solute transporter subunit beta,37562,-0.0185830936590089,0.00730917138615109,-0.032909069575865,-0.00425711774215275,0.0110197064897173
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA11,Carbonic anhydrase-related protein 11,39980,0.00768835242175706,0.00302577751285951,0.00175782849655242,0.0136188763469617,0.0110647874304274
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEPTIN7,Septin-7,37714,0.0121793978559286,0.00480933853206742,0.00275309433307649,0.0216057013787808,0.0113383657555115
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LPO,Lactoperoxidase,39831,-0.0137176382868031,0.00541898340705201,-0.024338845764625,-0.00309643080898111,0.0113705557189978
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL9,C-X-C motif chemokine 9,40422,0.0155261837308396,0.00617907326929455,0.00341520012302231,0.0276371673386569,0.0119907430809559
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STX3,Syntaxin-3,37942,0.00888249678110766,0.00354181023474571,0.00194054872100608,0.0158244448412092,0.0121568382811634
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PEAR1,Platelet endothelial aggregation receptor 1,40536,0.00515553820047715,0.00206002812739261,0.00111788307078763,0.00919319333016667,0.0123364297712287
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WIF1,Wnt inhibitory factor 1,40489,0.00781076832521681,0.00312595157055833,0.00168390324692248,0.0139376334035111,0.012475430758992
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL18BP,Interleukin-18-binding protein,40403,0.00694178427631716,0.00278151756743786,0.00149000984413895,0.0123935587084954,0.0125815333159952
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MBL2,Mannose-binding protein C,37810,-0.0243150293002888,0.00975117696493151,-0.0434273361515545,-0.00520272244902299,0.0126593451579226
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39961,0.011341583271188,0.00455359949236036,0.0024165282661617,0.0202666382762143,0.0127600785485202
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37714,0.0151748629218385,0.00609358834940128,0.00323142975701202,0.0271182960866651,0.0127756759715772
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NTRK3,NT-3 growth factor receptor,40471,-0.0049564083764981,0.00199171924509896,-0.00886017809689206,-0.00105263865610414,0.012838130373299
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDCD1LG2,Programmed cell death 1 ligand 2,40305,0.00703541212988353,0.00282942299700713,0.00148974305574955,0.0125810812040175,0.0129102053960602
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SAG,S-arrestin,37541,-0.0120584706519237,0.00489589111719138,-0.0216544172416188,-0.00246252406222855,0.0137916254033109
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37562,-0.00717639011443041,0.00292143008342628,-0.0129023930779459,-0.00145038715091491,0.0140440249415597
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTRL,Chymotrypsin-like protease CTRL-1,37942,-0.0147510696960359,0.0060052782226282,-0.0265214150123872,-0.00298072437968465,0.0140481177353158
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37598,0.0139279234617026,0.0056705896636956,0.00281356772085927,0.025042279202546,0.0140555707039531
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LTA4H,Leukotriene A-4 hydrolase,40489,0.012990258905568,0.00529082181743682,0.00262024814339187,0.0233602696677442,0.0140894338845408
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37900,0.01131384914711,0.0046103450890831,0.00227757277250715,0.0203501255217129,0.0141397548360867
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CENPJ,Centromere protein J,37714,0.0164740827575226,0.00671560280634777,0.003311501257081,0.0296366642579643,0.0141756557552701
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NOP56,Nucleolar protein 56,37562,0.0248119357171536,0.0101623777014183,0.00489367542237373,0.0447301960119335,0.0146375624500839
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SULT1A1,Sulfotransferase 1A1,40471,-0.0286576180755422,0.0117404141150111,-0.0516688297409641,-0.0056464064101204,0.0146599399347397
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNASET2,Ribonuclease T2,40465,0.00586899060024704,0.0024078053312343,0.0011496921510278,0.0105882890494663,0.0148006140331723
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NEDD9,Enhancer of filamentation 1,37598,0.00738315240076571,0.00302912751378714,0.00144606247374291,0.0133202423277885,0.0148070520865438
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCN2B,Sodium channel subunit beta-2,37572,-0.00662143251199622,0.00272121508012386,-0.011955014069039,-0.00128785095495345,0.0149766836374949
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SOX9,Transcription factor SOX-9,37572,0.00605847927451728,0.00249012558856136,0.00117783312093702,0.0109391254280975,0.0149875078831507
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SH3GL3,Endophilin-A3,37643,0.0184433219621489,0.00759294271530983,0.00356115424014168,0.0333254896841562,0.0151534465765265
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD3D,T-cell surface glycoprotein CD3 delta chain,37541,-0.00762557033490175,0.00313942519214365,-0.0137788437115033,-0.00147229695830019,0.0151551464179608
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RCC1,Regulator of chromosome condensation,37900,0.0113523781271299,0.00467814275727706,0.00218321832286686,0.0205215379313929,0.0152505389016438
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSPN,Persephin,40341,0.0219546469357263,0.00907762462307802,0.00416250267449339,0.0397467911969592,0.0155938677719452
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TFF1,Trefoil factor 1,40261,-0.0171329605850956,0.00709891927046649,-0.03104684235521,-0.00321907881498131,0.0158131405824794
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NDRG1,Protein NDRG1,39961,0.015183939763285,0.00629467095893091,0.00284638468378043,0.0275214948427896,0.0158685668588677
NMR metabolomics,X23503.Total Lipids in Medium VLDL,QSOX1,Sulfhydryl oxidase 1,37761,0.00988963023542471,0.00410708515441126,0.00183974333277864,0.0179395171380708,0.0160561641310523
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNASE10,Inactive ribonuclease-like protein 10,37628,-0.0107458339948307,0.00447265341788973,-0.0195122346938945,-0.00197943329576679,0.0162943507854195
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39961,0.0121455323023455,0.00505850064341243,0.00223087104125718,0.0220601935634339,0.0163613980609536
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37998,-0.00567731922986857,0.0023692436608837,-0.0103210368052006,-0.00103360165453652,0.0165769007677134
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37714,0.0123351448425743,0.00514784951616715,0.00224535979088665,0.0224249298942619,0.0165809756571761
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HLA_DRA,,40288,-0.00788846021808401,0.00329377448874847,-0.014344258216031,-0.00143266222013701,0.0166336966823346
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GZMB,Granzyme B,40341,0.0137564827066878,0.00574714143015623,0.00249208550358161,0.025020879909794,0.0166944712273834
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTK7,Inactive tyrosine-protein kinase 7,39961,0.00844552957590092,0.00352944013016378,0.00152782692077992,0.0153632322310219,0.0167284915001301
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OLFM4,Olfactomedin-4,37177,0.0269500417153642,0.011284951635795,0.00483153650920599,0.0490685469215224,0.0169483947058171
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37714,0.0115955869301775,0.00486030578857929,0.00206938758456214,0.0211217862757929,0.0170572101116688
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DRAXIN,Draxin,40228,0.00943049544557386,0.00395979108395202,0.00166930492102791,0.0171916859701198,0.0172510874912618
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,37541,-0.0134058538196674,0.00563154945364243,-0.0244436907488065,-0.00236801689052821,0.0173038012690019
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37628,0.0134032626402221,0.00567030682452233,0.00228946126415834,0.0245170640162859,0.0181047985384292
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37562,0.0107525455532309,0.00455024310531137,0.00183406906682067,0.0196710220396412,0.0181387304115779
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AIF1L,Allograft inflammatory factor 1-like,37628,0.0125417829853606,0.00530746863514647,0.00213914446047351,0.0229444215102477,0.018139947621252
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,38013,0.0041058362468547,0.00173884081160546,0.000697708256107993,0.0075139642376014,0.0182275541892636
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37598,0.0067779708799038,0.00287932440008426,0.00113449505573864,0.012421446704069,0.0185865281433117
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GZMH,Granzyme H,40042,0.0159719469909132,0.00681682325670623,0.00261097340776901,0.0293329205740574,0.0191409072059502
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,40400,0.013642589237794,0.00583885525431725,0.0021984329393322,0.0250867455362558,0.0194765877620582
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA6,Carbonic anhydrase 6,40295,-0.0135995200792915,0.00582105530112023,-0.0250087884694871,-0.00219025168909579,0.0194899053882149
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDH23,Cadherin-23,37942,-0.00565324369059511,0.00241973915294004,-0.0103959324303576,-0.000910554950832624,0.0194900235522539
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MB,Myoglobin,40536,-0.0104687672882945,0.00448285719711832,-0.0192551673946464,-0.00168236718194259,0.019540556668585
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL14,C-X-C motif chemokine 14,40044,0.0131001530340276,0.00561932889005001,0.00208626840952955,0.0241140376585256,0.0197519894469434
NMR metabolomics,X23503.Total Lipids in Medium VLDL,L1CAM,Neural cell adhesion molecule L1,40411,0.0060218000629872,0.00258467276764429,0.000955841438404401,0.01108775868757,0.0198285278217199
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NAMPT,Nicotinamide phosphoribosyltransferase,39980,0.0109530647246535,0.00471177172330521,0.00171799214697527,0.0201881373023317,0.0201052764259315
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SELL,L-selectin,38013,0.00492658535854526,0.00211973880318499,0.000771897304302674,0.00908127341278784,0.0201322944259407
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,40042,0.00575469108998988,0.00247652070030367,0.000900710517394684,0.0106086716625851,0.020154370799902
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LY9,T-lymphocyte surface antigen Ly-9,40182,0.00607301797118552,0.00262137072601203,0.000935131348201937,0.0112109045941691,0.0205310213355566
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COMMD9,COMM domain-containing protein 9,37900,0.00831737023308527,0.00359413492486143,0.00127286578035686,0.0153618746858137,0.0206744451279349
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGB2,Integrin beta-2,40221,0.00605988714151755,0.00261942762790821,0.000925808990817454,0.0111939652922176,0.020711288832065
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLB1,"Phospholipase B1, membrane-associated",37942,0.0128362254464888,0.00555330154280142,0.00195175442259796,0.0237206964703795,0.0208225424369794
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GSTP1,Glutathione S-transferase P,39871,-0.0147668529663071,0.00639153907672626,-0.0272942695566906,-0.00223943637592366,0.020880528285111
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ART3,Ecto-ADP-ribosyltransferase 3,40403,-0.00700075149155508,0.00303238779203918,-0.0129442315639519,-0.00105727141915828,0.0209751930882703
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFNGR1,Interferon gamma receptor 1,40422,0.00429281699344776,0.0018692377291313,0.000629111044350424,0.0079565229425451,0.0216567523804758
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLAUR,Urokinase plasminogen activator surface receptor,40264,-0.00559087542318882,0.00243746897168592,-0.0103683146076932,-0.000813436238684412,0.021819542797671
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADA2,Adenosine deaminase 2,40258,-0.00876564208373253,0.00382600966430638,-0.016264621025773,-0.00126666314169202,0.0219726712550148
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD5L,CD5 antigen-like,37934,0.00976202459338877,0.00426547454626532,0.00140169448270875,0.0181223547040688,0.0221171880574056
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SOD2,"Superoxide dismutase [Mn], mitochondrial",40332,0.00774033681497779,0.00338529682890235,0.00110515503032917,0.0143755185996264,0.0222406189238261
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37677,-0.0137779931174932,0.00603584631253055,-0.0256082518900531,-0.00194773434493334,0.0224641696150997
NMR metabolomics,X23503.Total Lipids in Medium VLDL,F3,Tissue factor,40393,-0.00584652988870301,0.00256444700918988,-0.0108728460267152,-0.000820213750690844,0.0226303045440235
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37998,-0.0286393111260353,0.0126087484976515,-0.0533524581814322,-0.00392616407063843,0.0231393527041306
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,40365,-0.0102537373499393,0.00451841752764465,-0.0191098357041228,-0.00139763899575575,0.0232621696981508
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GFRAL,GDNF family receptor alpha-like,37477,-0.0128677868100288,0.00567496327284622,-0.0239907148248074,-0.00174485879525023,0.0233780800734484
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37900,0.0107197692587351,0.00473558509568927,0.00143802247118418,0.0200015160462861,0.0236107078046199
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VCPKMT,Protein-lysine methyltransferase METTL21D,37482,0.0184445267963087,0.00816870159235537,0.00243387167529215,0.0344551819173252,0.0239651977028257
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TTN,Titin,37562,-0.013594109603905,0.00602915452559675,-0.0254112524740746,-0.00177696673373537,0.024166774355365
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAMDC2,MAM domain-containing protein 2,37990,-0.0069846611228368,0.00310845579178016,-0.0130772344747259,-0.000892087770947687,0.0246568725898255
NMR metabolomics,X23503.Total Lipids in Medium VLDL,QPCT,Glutaminyl-peptide cyclotransferase,40373,0.00550401889421069,0.00245407555282923,0.000694030810665402,0.010314006977756,0.0249229365809581
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRIM26,Tripartite motif-containing protein 26,37482,0.0112189629543697,0.00505013582364862,0.00132069674001844,0.021117229168721,0.0263330756375398
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,37541,0.0116435070016556,0.00524701703473855,0.00135935361356809,0.0219276603897432,0.0264989285602439
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DUSP29,Dual specificity phosphatase 29,37572,-0.0135586804325609,0.00611660497413483,-0.0255472261818652,-0.00157013468325668,0.0266606565831672
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AOC1,Amiloride-sensitive amine oxidase [copper-containing],40044,0.011595619410927,0.00524523318604814,0.00131496236627263,0.0218762764555814,0.0270713122823927
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PADI4,Protein-arginine deiminase type-4,39934,0.0140420447771591,0.00635377081330637,0.00158865398307863,0.0264954355712396,0.0271174283794689
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCGN,Secretagogin,40044,-0.00886624207452323,0.00401267047045791,-0.0167310761966207,-0.00100140795242573,0.027150089499418
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SAT1,Diamine acetyltransferase 1,37562,-0.01059937448171,0.00479815549912588,-0.0200037592599967,-0.00119498970342326,0.0271882596236929
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCRLB,Fc receptor-like B,39980,0.0122273745813284,0.00557721155875706,0.00129603992616455,0.0231587092364922,0.0283667701667201
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPR158,Probable G-protein coupled receptor 158,37959,0.00738879647934694,0.00337685109944756,0.000770168324429729,0.0140074246342642,0.0286813626458795
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNF31,E3 ubiquitin-protein ligase RNF31,37598,0.0073923825463228,0.0033874469149694,0.000752986592982768,0.0140317784996628,0.0291059720318861
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,40228,0.0120437052424609,0.00554548460999178,0.00117455540687698,0.0229128550780448,0.02988530298961
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMBN,Ameloblastin,40044,-0.00589548171222984,0.00271496154270016,-0.0112168063359221,-0.000574157088537528,0.0299100175678883
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,37541,-0.0129743644671975,0.00597971917236241,-0.0246946140450279,-0.00125411488936721,0.0300453842083315
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VNN2,Vascular non-inflammatory molecule 2,40305,-0.00889698777764061,0.0041024418077782,-0.0169377737208859,-0.000856201834395337,0.0301198746309453
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHI3L1,Chitinase-3-like protein 1,40054,-0.014663111751621,0.00678900744857887,-0.0279695663508356,-0.00135665715240645,0.0308009040808727
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCND2,G1/S-specific cyclin-D2,37714,0.00724749434499438,0.00336178793611339,0.000658389990212145,0.0138365986997766,0.031113684781166
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOA1,Apolipoprotein A-I,38013,-0.00541316302141602,0.00252243486033302,-0.0103571353476687,-0.000469190695163297,0.0318901087728159
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37900,0.00888397091007211,0.00414377326268858,0.000762175315202491,0.0170057665049417,0.0320561572707646
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC4M,C-type lectin domain family 4 member M,37969,0.00941419500037664,0.00443508484053404,0.000721428712929921,0.0181069612878234,0.0338001430905932
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAPK13,Mitogen-activated protein kinase 13,37482,0.00803386692146191,0.00378927233914866,0.000606893136730533,0.0154608407061933,0.0340113271102244
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STOML2,"Stomatin-like protein 2, mitochondrial",37482,0.0176380010014444,0.00832229890089572,0.00132629515568874,0.0339497068472,0.0340783693831943
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PKLR,Pyruvate kinase PKLR,40374,-0.0128169436734797,0.00607106186016648,-0.024716224919406,-0.000917662427553432,0.0347746614160103
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FMR1,Synaptic functional regulator FMR1,39980,0.00677054309428743,0.0032110421161885,0.00047690054655797,0.0130641856420169,0.0350021013046188
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEMA6C,Semaphorin-6C,37598,0.00513413238572585,0.00244210148823984,0.000347613468775775,0.00992065130267593,0.0355423020147533
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37572,-0.00618557538242456,0.00294702961039566,-0.0119617534188001,-0.000409397346049053,0.0358431352512378
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDH15,Cadherin-15,40435,0.00844421826187668,0.00404491000926234,0.000516194643722502,0.0163722418800309,0.0368482967641719
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEZ6,Seizure protein 6 homolog,37572,-0.0059654933235595,0.00286758328003422,-0.0115859565524266,-0.000345030094692429,0.037515471594859
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37900,0.0180637727091654,0.00868973371008067,0.0010318946374073,0.0350956507809235,0.0376593648933524
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LCN15,Lipocalin-15,37959,-0.0121355230686851,0.00584074828938259,-0.023583389715875,-0.000687656421495226,0.0377526820610014
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AGBL2,Cytosolic carboxypeptidase 2,37541,0.0173131431189603,0.00835086145478104,0.00094545466758944,0.0336808315703311,0.0381716600358167
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37959,-0.0044840807405177,0.00216336557305468,-0.00872427726370487,-0.000243884217330538,0.0382159899169715
NMR metabolomics,X23503.Total Lipids in Medium VLDL,JCHAIN,Immunoglobulin J chain,40044,-0.0116869947611732,0.00564825705280241,-0.0227575785846659,-0.000616410937680448,0.0385500508660812
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLA2G2A,"Phospholipase A2, membrane associated",40293,-0.0108729360602033,0.00527784552391677,-0.0212175132870801,-0.000528358833326416,0.0394044361347024
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MMP9,Matrix metalloproteinase-9,40312,-0.0114565778028574,0.00558268411953183,-0.0223986386771398,-0.000514516928575027,0.0401702020944858
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRND,Prion-like protein doppel,37942,-0.0100644521357506,0.00491509687447843,-0.0196980420097284,-0.000430862261772915,0.0406125517552398
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STX1B,Syntaxin-1B,37572,0.00806782647363529,0.00394192629657586,0.0003416509323466,0.015794002014924,0.0407102757328383
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37562,-0.00717646917605995,0.00350812585190908,-0.0140523958458017,-0.000300542506318153,0.0408087246240902
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPRS,Receptor-type tyrosine-protein phosphatase S,40536,-0.00449407326928133,0.0022089995928504,-0.00882371247126811,-0.000164434067294546,0.0419237988748437
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NRCAM,Neuronal cell adhesion molecule,40359,0.00519323774202966,0.00255336973888412,0.000188633053816776,0.0101978424302425,0.0419806466127836
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYH4,Myosin-4,37562,-0.00887325716145884,0.00437075453581941,-0.0174399360516649,-0.000306578271252791,0.0423621444431476
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDX53,Probable ATP-dependent RNA helicase DDX53,37572,0.00657660975584862,0.00324475511046686,0.000216889739333578,0.0129363297723637,0.0426986360937079
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLSPN,Claspin,39925,0.00632289478795394,0.00312446817983786,0.00019893715547174,0.0124468524204361,0.0430211961963038
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF9,Fibroblast growth factor 9,37457,0.00753202849593755,0.00372893877836115,0.000223308490349698,0.0148407485015254,0.0434157555886606
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37562,-0.00899480164174629,0.00445321995505811,-0.0177231127536602,-0.000266490529832407,0.0434200594626223
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARHGAP30,Rho GTPase-activating protein 30,37714,0.006954174456713,0.00345344893742668,0.000185414539356704,0.0137229343740693,0.0440622844219327
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GHRHR,Growth hormone-releasing hormone receptor,39961,0.0102882180203408,0.00512144033982629,0.000250194954281245,0.0203262410864003,0.0445700813253283
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDH3,Cadherin-3,40471,0.00649977764200913,0.00323625205446885,0.000156723615250195,0.0128428316687681,0.0446146351149057
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYBPC2,"Myosin-binding protein C, fast-type",37628,-0.0151727445029541,0.0075625442897074,-0.0299953313107806,-0.000350157695127553,0.0448444806826194
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD7,T-cell antigen CD7,37567,0.00786143406066739,0.00393280784491119,0.00015313068464145,0.0155697374366933,0.0456357995050853
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SSB,Lupus La protein,39961,0.0110366985102289,0.00553029782298978,0.000197314777168887,0.0218760822432888,0.0459863478250513
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSB,Cathepsin B,40353,-0.00983147869761271,0.00492739466750605,-0.0194891722459246,-0.000173785149300861,0.0460305636091688
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCC,Netrin receptor DCC,37572,0.00426730179341147,0.00214278929377971,6.74347776032265e-05,0.0084671688092197,0.0464498774082183
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBFOX3,RNA binding protein fox-1 homolog 3,37959,0.00682490386485155,0.00342802896054425,0.000105967102184816,0.0135438406275183,0.046510680123824
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF12,Fibroblast growth factor 12,37598,0.00880485846703996,0.00442409655051169,0.000133629228037051,0.0174760877060429,0.046589048543207
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNPEP,Aspartyl aminopeptidase,37942,0.0108209618568566,0.00543826402037135,0.000161964376928787,0.0214799593367845,0.0466350688491083
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SOX2,Transcription factor SOX-2,37937,0.00424813052326265,0.00213581575184162,6.19316496530851e-05,0.00843432939687222,0.0467217376262958
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AZU1,Azurocidin,39809,0.0141171438461549,0.0071040845861497,0.000193138057301498,0.0280411496350083,0.0469194240318523
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPR101,Probable G-protein coupled receptor 101,37541,-0.0117364486061505,0.00592200564253607,-0.0233435796655212,-0.000129317546779821,0.0475183952802474
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL20RA,Interleukin-20 receptor subunit alpha,40044,0.00838218661356602,0.00423055545469836,9.02979223572371e-05,0.0166740753047748,0.0475702213174085
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TGM2,Protein-glutamine gamma-glutamyltransferase 2,40333,-0.0134053858400105,0.00677685049802275,-0.0266880128161351,-0.00012275886388596,0.0479330530412608
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UBE2B,Ubiquitin-conjugating enzyme E2 B,37900,0.00514866254891208,0.00260320222721107,4.63861835783876e-05,0.0102509389142458,0.047969522525105
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFNG,Interferon gamma,40044,0.0205215866727109,0.0103878525112132,0.000161395750733061,0.0408817775946887,0.0482248487863652
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EDN1,Endothelin-1,37628,0.00524610389941511,0.00266254398793606,2.75176830604401e-05,0.0104646901157698,0.0488208823528221
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIL1,Nucleotide exchange factor SIL1,37628,0.00576340823811636,0.00292919673152355,2.21826443301907e-05,0.0115046338319025,0.0491381382223742
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OGN,Mimecan,40332,-0.0072922735195819,0.00371899578325689,-0.0145815052547654,-3.0417843983931e-06,0.0499177214191156
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK14,Kallikrein-14,40489,0.00819911161499585,0.00419651202629133,-2.60519565351454e-05,0.0164242751865269,0.0507431803547847
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSME2,Proteasome activator complex subunit 2,40152,0.00658442773211941,0.00338550913108265,-5.11701648025845e-05,0.0132200256290414,0.0518065873050002
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NMI,N-myc-interactor,37857,0.0127388402414604,0.0065506996450514,-0.000100531062840366,0.0255782115457611,0.0518375959457594
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FOLR1,Folate receptor alpha,40299,0.00503186580662658,0.00259184740310124,-4.81551034518541e-05,0.010111886716705,0.0522249908912168
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FDX2,"Ferredoxin-2, mitochondrial",37562,0.0102480897432863,0.00528522674499431,-0.000110954676902558,0.0206071341634751,0.0525219603869766
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,40228,0.0185187912105936,0.00955199285006857,-0.000203114775540837,0.037240697196728,0.0525513198134547
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIE1,Tyrosine-protein kinase receptor Tie-1,40536,0.00734582885596009,0.0037895638683917,-8.17163260876464e-05,0.0147733740380078,0.0525874669752818
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSPG5,Chondroitin sulfate proteoglycan 5,37541,-0.00891177210106859,0.00459952841562215,-0.017926847795688,0.000103303593550824,0.0527008046025425
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEPTIN3,Neuronal-specific septin-3,37959,-0.0130397597260098,0.00674896526438368,-0.0262677316442019,0.000188212192182164,0.0533665168726914
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SUMF1,Formylglycine-generating enzyme,37598,0.0118961515364382,0.00615714048620517,-0.000171843816523938,0.0239641468894003,0.0533698200090468
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HMCN2,Hemicentin-2,37648,-0.0100188137748111,0.00523296596937711,-0.0202754270747903,0.000237799525167991,0.0555705711384152
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDHR1,Cadherin-related family member 1,39961,0.00769391623784096,0.00402370424784951,-0.000192544087944071,0.015580376563626,0.055875674669185
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37959,0.00465628547816962,0.0024397803223616,-0.000125683953659119,0.00943825490999835,0.0563496652385741
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37598,0.00608053997259851,0.00322320301048389,-0.000236937927949925,0.0123980178731469,0.0592509858241664
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37998,0.0061660128650113,0.003270191411793,-0.000243562302102981,0.0125755880321256,0.0593809830827758
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37598,0.00623931763663703,0.00331711938437015,-0.000262236356728475,0.0127408716300025,0.0600015455640587
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HIP1,Huntingtin-interacting protein 1,37562,0.00587592880423879,0.0031267609921769,-0.000252522740427932,0.0120043803489055,0.0602341352557513
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYH7B,Myosin-7B,37482,-0.00787114190459618,0.00419717060488598,-0.0160975962901727,0.000355312480980335,0.0607676540504779
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37959,-0.0050478658220353,0.00269583183574666,-0.0103316962200987,0.000235964576028154,0.0611631146212491
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADRA2A,Alpha-2A adrenergic receptor,37562,-0.0123654472860396,0.00660936488462944,-0.0253198024599133,0.00058890788783407,0.0613814844256087
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UNG,Uracil-DNA glycosylase,37900,0.00579202748418212,0.00310402124310133,-0.000291854152296493,0.0118759091206607,0.0620665509930748
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DOCK9,Dedicator of cytokinesis protein 9,37541,0.0204463807738622,0.0109576905998669,-0.00103069280187686,0.0419234543496012,0.0620722689963857
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37900,-0.0145397542009338,0.00780917317411065,-0.0298457336221907,0.000766225220323078,0.0626416077295258
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFNL1,Interferon lambda-1,39961,-0.00770183511246087,0.00414918815828793,-0.0158342439027052,0.00043057367778348,0.0634401606395503
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37562,-0.010198332619683,0.00550361925744476,-0.0209854263642747,0.000588761124908764,0.0639015287328073
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIAA2013,Uncharacterized protein KIAA2013,37900,0.00975980988503648,0.00526866230883182,-0.000566768240273888,0.0200863880103468,0.0639864941411399
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HYAL1,Hyaluronidase-1,40214,0.00387441271977486,0.00209663366941809,-0.000234989272284603,0.00798381471183433,0.0646325401398656
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DEFB116,Beta-defensin 116,37541,-0.0134016620203105,0.00725517094033016,-0.0276217970633577,0.000818473022736566,0.0647425045817697
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ID4,DNA-binding protein inhibitor ID-4,37714,-0.00770894323174878,0.00417335195548495,-0.0158887130644993,0.000470826601001714,0.0647429352762575
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LCN2,Neutrophil gelatinase-associated lipocalin,39865,-0.00637062657494888,0.00345423451419859,-0.0131409262227781,0.000399673072880351,0.0651593747566969
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DEFB104A_DEFB104B,Beta-defensin 104,37541,0.00953274217625216,0.00520020873029124,-0.000659666935118658,0.019725151287623,0.0668035505630619
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEL1L,Protein sel-1 homolog 1,37628,0.00543392991051864,0.0029700532957645,-0.00038737454917979,0.0112552343702171,0.067336368771134
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDH1,Cadherin-1,39806,0.00668744453374562,0.00366416314692132,-0.000494315234220169,0.0138692043017114,0.0680061670983276
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GH2,Growth hormone variant,39980,0.0281655591838694,0.0154357635204915,-0.00208853731629396,0.0584196556840327,0.0680662857631898
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENDOU,Poly(U)-specific endoribonuclease,36973,0.00835292730471103,0.00460701321195223,-0.000676818590715335,0.0173826732001374,0.0698419518810296
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LTO1,Protein LTO1 homolog,40044,0.00678994718191753,0.00376506455743102,-0.000589579350647274,0.0141694737144823,0.0713434734747991
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GSN,Gelsolin,37928,0.00313491997219992,0.00174041866359972,-0.00027630060845553,0.00654614055285538,0.0716866580914558
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD2,T-cell surface antigen CD2,37562,0.00630939674159289,0.00350764621865815,-0.000565589846977084,0.0131843833301629,0.0720804108038206
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40536,0.00481000281180469,0.0026788449461805,-0.000440533282709097,0.0100605389063185,0.0725847135249252
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJA4,DnaJ homolog subfamily A member 4,37942,-0.0116872912355615,0.00652190921748727,-0.0244702333018365,0.00109565083071358,0.0731546340492276
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NECTIN4,Nectin-4,40411,-0.00499339003809453,0.00279162662060866,-0.0104649782144875,0.000478198138298444,0.0736816706635563
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNN,Tenascin-N,37998,0.00713070464927801,0.00400611295527793,-0.000721276743066736,0.0149826860416228,0.0751055784663434
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEP290,Centrosomal protein of 290 kDa,37714,0.00867902019661059,0.00488367549596182,-0.000892983775474568,0.0182510241686957,0.0755666024633874
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CADPS,Calcium-dependent secretion activator 1,37572,-0.00732311979212445,0.00413340661696772,-0.0154245967613812,0.000778357177132278,0.0764690517633737
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SHPK,Sedoheptulokinase,37714,-0.00695489881480915,0.00392810410917102,-0.0146539828687844,0.00074418523916605,0.0766587811224721
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AIDA,"Axin interactor, dorsalization-associated protein",37572,0.0135761361317453,0.00767342192106602,-0.00146377083354412,0.0286160430970347,0.0768768163850239
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL6,Interleukin-6,40305,0.011724962442852,0.00666504835114843,-0.00133853232539895,0.0247884572111029,0.0785676887286812
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL12,Stromal cell-derived factor 1,40044,0.00653233309456221,0.00371374861356737,-0.000746614188029836,0.0138112803771542,0.078604014604659
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37959,0.00781477247650152,0.00444325065637479,-0.000893998809993064,0.0165235437629961,0.0786347677652277
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GBP6,Guanylate-binding protein 6,37562,-0.00765260520705577,0.00436091335566421,-0.0161999953841576,0.000894784970046076,0.0793139598699614
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCDC28A,Coiled-coil domain-containing protein 28A,37572,0.00474728573100798,0.00270600073276691,-0.000556475705215161,0.0100510471672311,0.0793930517787323
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPM1B,Protein phosphatase 1B,37598,0.0101715439236064,0.00582020271111891,-0.00123605339018667,0.0215791412373995,0.0805519683417858
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40471,0.00434601479739464,0.0024960476223721,-0.000546238542454664,0.00923826813724395,0.0816749788053886
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK15,Kallikrein-15,37880,0.00811930078795791,0.00469174489809735,-0.0010765192123129,0.0173151207882287,0.0835549670444187
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGFBPL1,Insulin-like growth factor-binding protein-like 1,40359,0.00533591587474762,0.00308907611092918,-0.000718673302673565,0.0113905050521688,0.0841242209364241
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37900,0.0107893053131546,0.00626363866090518,-0.00148742646221956,0.0230660370885287,0.084996549895062
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NOS1,"Nitric oxide synthase, brain",39961,-0.00784297201995239,0.00456506127233476,-0.0167904921137285,0.00110454807382375,0.0858087142576153
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GKN1,Gastrokine-1,39602,0.00439226391365394,0.00255743567765441,-0.000620310014548705,0.00940483784185659,0.085917703915654
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OSTN,Osteocrin,37572,-0.00675848039639392,0.00394957959083734,-0.0144996563944351,0.000982695601647265,0.0870697138405747
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEMA4C,Semaphorin-4C,40305,0.00442509421340588,0.00258788607277115,-0.000647162489225583,0.00949735091603734,0.0872990880563603
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ICAM2,Intercellular adhesion molecule 2,40536,-0.00485723283310072,0.00284383926007138,-0.0104311577828406,0.00071669211663919,0.0876585506754997
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LMNB1,Lamin-B1,37874,0.00889653298250891,0.00521375666849547,-0.00132243008774221,0.01911549605276,0.0879646648313056
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP5PO,"ATP synthase subunit O, mitochondrial",39961,0.00672680118864292,0.00394591642250691,-0.00100719499947064,0.0144607973767565,0.0882610805047063
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCL2L15,Bcl-2-like protein 15,37598,0.00880234110068908,0.005175407450281,-0.00134145750186168,0.0189461397032398,0.0890039057298201
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BABAM1,BRISC and BRCA1-A complex member 1,37598,0.00458593632768296,0.00270015197981082,-0.000706361552746252,0.00987823420811217,0.0894560817180652
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TYMP,Thymidine phosphorylase,40257,0.0103130791836611,0.00608247290951148,-0.00160856771898136,0.0222347260863037,0.0899926294550941
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",37541,-0.00851212074767051,0.0050501323187788,-0.018410380092477,0.00138613859713593,0.0919112964941742
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD55,Complement decay-accelerating factor,39802,0.00403198138738777,0.00240060437305935,-0.000673203183808555,0.0087371659585841,0.0930614971528805
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OMD,Osteomodulin,40422,-0.00678781452511834,0.00404450967576438,-0.0147150534896165,0.00113942443937985,0.0933122658311122
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPN1,Epsin-1,37714,0.00679705036948469,0.00405305828834981,-0.00114694387568094,0.0147410446146503,0.0935625933156019
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37598,0.00467678678301133,0.00279175452503389,-0.000795052086055106,0.0101486256520778,0.093915998625878
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37635,-0.00741446769711941,0.00444638463012258,-0.0161293815721597,0.00130044617792084,0.0954333548939574
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CFD,Complement factor D,38013,0.00290137334231468,0.00174224660455087,-0.000513430002605032,0.00631617668723439,0.095874864764327
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GGA1,ADP-ribosylation factor-binding protein GGA1,39961,0.0105590172995509,0.00634468947628184,-0.00187657407396153,0.0229946086730633,0.0960868424793169
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDK1,Cyclin-dependent kinase 1,37482,0.00555743015267629,0.00336039034947358,-0.00102893493229192,0.0121437952376445,0.0981912405085336
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NCAM1,Neural cell adhesion molecule 1,40403,0.00415376163052144,0.00252102876946311,-0.000787454757626246,0.00909497801866913,0.0994451403162889
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCN3B,Sodium channel subunit beta-3,37541,0.00689997934046038,0.00421044180712852,-0.00135248660151151,0.0151524452824323,0.101283539849325
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,40359,0.00469540883442142,0.00287692548483484,-0.000943365115854861,0.0103341827846977,0.102679771609225
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA8,Carbonic anhydrase-related protein,37598,-0.00416347789046267,0.00255286214692322,-0.00916708769843217,0.000840131917506845,0.102934135477628
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINA11,Serpin A11,40536,0.00597313139334571,0.00366549245503925,-0.00121123381853122,0.0131574966052226,0.103214596709924
NMR metabolomics,X23503.Total Lipids in Medium VLDL,M6PR,Cation-dependent mannose-6-phosphate receptor,37628,0.0063035863427898,0.00387152412934758,-0.00128460095073145,0.0138917736363111,0.103507994473062
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TAP1,Antigen peptide transporter 1,37714,-0.00917352065932494,0.005651283265182,-0.0202500358590816,0.00190299454043177,0.10455690097372
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLAMF8,SLAM family member 8,39980,0.00792719873952698,0.00489132274333799,-0.00165979383741547,0.0175141913164694,0.105109669722348
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37562,-0.00833506979148265,0.00515076953618355,-0.0184305780824024,0.00176043849943712,0.105639605312337
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACHE,Acetylcholinesterase,37671,-0.00472555673462112,0.0029234596124723,-0.0104555375750668,0.00100442410582458,0.106026058150358
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37562,-0.00497652542388456,0.00307934981709729,-0.0110120510653952,0.00105900021762614,0.106097585190329
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FRMD7,FERM domain-containing protein 7,37572,0.00491736959260776,0.00305431005840996,-0.00106907812187577,0.0109038173070913,0.107426888681939
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,37482,0.00390632418660018,0.00243331289536703,-0.000862969088319203,0.00867561746151957,0.108440553144215
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37562,0.00378257156341021,0.00235691940230967,-0.000836990465116737,0.00840213359193715,0.108544418870551
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PXDNL,Peroxidasin-like protein,37900,0.00861115534806461,0.00536706473289995,-0.00190829152841929,0.0191306022245485,0.108639678868977
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC12A,C-type lectin domain family 12 member A,37598,0.00300890381624608,0.00187682904144836,-0.000669681104992704,0.00668748873748486,0.108917881427523
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP1B4,Protein ATP1B4,37482,-0.00621960417591277,0.00388408428609886,-0.0138324093766665,0.00139320102484099,0.109333590170253
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KRT17,"Keratin, type I cytoskeletal 17",37562,0.00563277939933968,0.00352099302624751,-0.00126836693210543,0.0125339257307848,0.109673688539077
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STC2,Stanniocalcin-2,40309,-0.00396113560258305,0.00247969485799565,-0.00882133752425452,0.000899066319088418,0.110190116579314
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LEG1,Protein LEG1 homolog,37231,-0.0101619760037445,0.00637734722616818,-0.0226615765670342,0.00233762455954509,0.111084287103064
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TXNL1,Thioredoxin-like protein 1,37525,0.0139287890515946,0.00874411538053786,-0.00320967709425964,0.0310672551974488,0.111199421473562
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDCL2,Phosducin-like protein 2,37482,0.00787995458283682,0.00495442802401578,-0.00183072434423412,0.0175906335099078,0.11174927800503
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39980,-0.0111240963558078,0.00701896985112514,-0.024881277264013,0.00263308455239753,0.113018127987054
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSH1,Chorionic somatomammotropin hormone 1,37987,0.00504855702429377,0.00319960006300694,-0.00122265909919983,0.0113197731477874,0.11461855516858
NMR metabolomics,X23503.Total Lipids in Medium VLDL,B4GALT1,"Beta-1,4-galactosyltransferase 1",40422,0.00394115464023209,0.00250079378487677,-0.000960401178126381,0.00884271045859056,0.115054491588198
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL17RA,Interleukin-17 receptor A,40332,0.00629752004449752,0.00400706571077824,-0.00155632874862784,0.0141513688376229,0.116062367353993
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LTBR,Tumor necrosis factor receptor superfamily member 3,40289,-0.00392829124316421,0.00250708879939372,-0.00884218528997589,0.000985602803647472,0.117164219737619
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PFDN4,Prefoldin subunit 4,37482,0.0078153317075067,0.00499284568534672,-0.00197064583577288,0.0176013092507863,0.117535442284856
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HIF1A,Hypoxia-inducible factor 1-alpha,37598,0.00978927204122747,0.00626517432457143,-0.00249046963493254,0.0220690137173875,0.118196677842898
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DENND2B,DENN domain-containing protein 2B,37562,-0.00753194712051435,0.00482142906365921,-0.0169819480852864,0.00191805384425771,0.118269382755956
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD177,CD177 antigen,40316,-0.0182127578275557,0.011670476568009,-0.0410868919008534,0.004661376245742,0.118641907470349
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TXNDC15,Thioredoxin domain-containing protein 15,40411,-0.00386142099048475,0.00248218766973164,-0.00872650882315876,0.00100366684218926,0.119810621111258
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEP152,Centrosomal protein of 152 kDa,37482,0.00592945542822705,0.00381492908505793,-0.00154780557848649,0.0134067164349406,0.120142713115779
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GAMT,Guanidinoacetate N-methyltransferase,37562,-0.00555656485970925,0.00357710613737049,-0.0125676928889554,0.00145456316953691,0.120359204673228
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZNF75D,Zinc finger protein 75D,37714,0.00845700640610365,0.00545254031525564,-0.0022299726117974,0.0191439854240047,0.120920430827766
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SAFB2,Scaffold attachment factor B2,37959,0.00392943580744902,0.00253427243480571,-0.00103773816477018,0.00889660977966822,0.121040591566172
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEP164,Centrosomal protein of 164 kDa,40044,0.0090654957797633,0.00585095961162362,-0.00240238505901899,0.0205333766185456,0.121305111147464
NMR metabolomics,X23503.Total Lipids in Medium VLDL,REXO2,"Oligoribonuclease, mitochondrial",37562,-0.00696054673880857,0.00450217851104804,-0.0157848166204627,0.0018637231428456,0.122119116225338
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENOPH1,Enolase-phosphatase E1,37900,0.0080834909599612,0.0052514871124426,-0.0022094237804263,0.0183764057003487,0.1237603242234
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZP4,Zona pellucida sperm-binding protein 4,37482,-0.00459039688517562,0.00298950901772914,-0.0104498345599247,0.00126904078957349,0.124684861800488
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSRP3,Cysteine and glycine-rich protein 3,37562,-0.0136166199118431,0.00887799409750569,-0.0310174883429543,0.00378424851926802,0.12511539638203
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KITLG,Kit ligand,40359,-0.00507448942440416,0.00332071986144985,-0.0115831003528459,0.00143412150403754,0.126500313343243
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPVL,Probable serine carboxypeptidase CPVL,40465,0.00564417426924723,0.00370333291426422,-0.00161435824271064,0.0129027067812051,0.127508567736809
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL15,Interleukin-15,40341,-0.00456285180636781,0.00299448686167406,-0.010432046055249,0.00130634244251335,0.127590871294803
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRHR1,Corticotropin-releasing factor receptor 1,40042,0.00884720137466836,0.00580732964797921,-0.0025351647353709,0.0202295674847076,0.127665366812666
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC4D,C-type lectin domain family 4 member D,40341,0.00848868747674042,0.00558863262317329,-0.00246503246467924,0.0194424074181601,0.128802458059807
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARG1,Arginase-1,40227,0.00733062320131768,0.00483220064939911,-0.00214049007150457,0.0168017364741399,0.12927758846425
NMR metabolomics,X23503.Total Lipids in Medium VLDL,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37959,0.00606375174709988,0.0039996641874249,-0.00177559006025292,0.0139030935544527,0.129526264227984
NMR metabolomics,X23503.Total Lipids in Medium VLDL,JUN,Transcription factor AP-1,40044,0.0071518204471793,0.00474089254376728,-0.00214032893860457,0.0164439698329632,0.1314369403259
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37901,0.00702836437770271,0.00466925107287884,-0.00212336772513982,0.0161800964805452,0.132284718721126
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MN1,Transcriptional activator MN1,37572,-0.00821715548784921,0.00547585094827693,-0.018949823346472,0.00251551237077357,0.133478693170596
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPINT1,Kunitz-type protease inhibitor 1,40278,0.00349262654030955,0.00233779049498116,-0.00108944282985352,0.00807469591047263,0.135199184861887
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB44,Ras-related protein Rab-44,37900,0.00542742028220091,0.00364785125180106,-0.00172236817132916,0.012577208735731,0.136816448440555
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VIM,Vimentin,40042,0.0160982312586623,0.0108242252955089,-0.00511725032053514,0.0373137128378598,0.136971404472031
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PGLYRP4,Peptidoglycan recognition protein 4,37562,0.00859555514469932,0.00578181964556638,-0.00273681136061079,0.0199279216500094,0.137130730037195
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,40330,0.00424746561488464,0.00287645327948239,-0.00139038281290084,0.00988531404267011,0.139793893169271
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BSND,Barttin,37482,-0.00464652539837242,0.00315047572415007,-0.0108214578177066,0.00152840702096173,0.140273086187057
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37572,-0.00660011651110984,0.00449814230295462,-0.0154164754249009,0.00221624240268122,0.142318898494036
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RELB,Transcription factor RelB,37598,0.00693706615532576,0.0047317028153712,-0.0023370713628018,0.0162112036734533,0.142649761842455
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZPR1,Zinc finger protein ZPR1,37541,0.0130077766266186,0.00891559751302481,-0.00446679449891005,0.0304823477521472,0.144591578213772
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PROK1,Prokineticin-1,40341,-0.00917609602398834,0.00629126786763625,-0.0215069810445554,0.00315478899657872,0.144710202765603
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMPD3,AMP deaminase 3,37942,0.00962197787466539,0.0066355285693032,-0.00338365812116889,0.0226276138704997,0.147062376030196
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFNW1,Interferon omega-1,37562,-0.00490160181421069,0.00338102165057683,-0.0115284042493413,0.0017252006209199,0.147155000076289
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37562,0.0117732158739229,0.00814700868525276,-0.00419492114917253,0.0277413528970183,0.148454609351774
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LEO1,RNA polymerase-associated protein LEO1,37959,0.00409047825290326,0.00283522423991352,-0.00146656125732723,0.00964751776313376,0.14911822391896
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPHA2,Glycoprotein hormone alpha-2,37901,0.0064643069977027,0.00448715737393803,-0.00233052145521584,0.0152591354506212,0.149714190766156
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OMG,Oligodendrocyte-myelin glycoprotein,40305,0.00821947871191545,0.005749470972033,-0.00304948439326922,0.0194884418171001,0.152849812543215
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGB5,Integrin beta-5,40411,0.00481813438219002,0.00338360138888676,-0.00181372434002802,0.0114499931044081,0.154475776124192
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL5A1,Collagen alpha-1(V) chain,37671,-0.00517627818583073,0.00363846444691159,-0.0123076685017774,0.00195511213011598,0.154859904168481
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1GALT1C1,C1GALT1-specific chaperone 1,37562,0.00428093098047097,0.00301333246661736,-0.00162520065409906,0.010187062615041,0.155438436050018
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPARCL1,SPARC-like protein 1,40346,-0.00356782995656375,0.00251836750963927,-0.00850383027545672,0.00136817036232922,0.156583437968143
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DEFB118,Beta-defensin 118,37541,0.00756967574765196,0.00534457615669653,-0.00290569351947324,0.0180450450147772,0.156703132364779
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPRING1,SREBP regulating gene protein,37482,0.00744016187161807,0.00529124095759699,-0.00293067040527203,0.0178109941485082,0.159709976231102
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40502,0.00486779728935734,0.00346504846922271,-0.00192369771031917,0.0116592922890338,0.160091768384927
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TK1,"Thymidine kinase, cytosolic",37714,0.00574864963477528,0.00409560779612514,-0.00227874164562999,0.0137760409151805,0.160457442180364
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEPTIN8,Septin-8,37921,0.00408216167170367,0.00291404749355454,-0.00162937141566322,0.00979369475907056,0.161280098999953
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSMA1,Proteasome subunit alpha type-1,39980,-0.00592820048677035,0.00425815259698722,-0.0142741795768653,0.00241777860332461,0.163881748633376
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",37482,0.00645838042559906,0.00464713063203895,-0.00264999561319729,0.0155667564643954,0.164626547121057
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37959,0.00877947199883501,0.00632365295268139,-0.00361488778842051,0.0211738317860905,0.165052021708037
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",37541,0.00735118189320289,0.00531186650732869,-0.00306007646116134,0.0177624402475671,0.166407494979841
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37959,0.0143316002085621,0.0104266715298176,-0.00610467598988044,0.0347678764070047,0.169305142415112
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEP350,Centrosome-associated protein 350,37482,0.00472857516917113,0.00344326480984831,-0.00202022385813155,0.0114773741964738,0.16968818243038
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCUN1D2,DCN1-like protein 2,37482,0.0101786862370642,0.00743112048573644,-0.00438630991497923,0.0247436823891076,0.170792384205359
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RETN,Resistin,40283,-0.0051712324084082,0.00378277664652618,-0.0125854746355995,0.00224300981878311,0.171630072550689
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAD51,DNA repair protein RAD51 homolog 1,37714,0.00679657157516196,0.00497815281429217,-0.0029606079408507,0.0165537510911746,0.172188276995458
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,40042,0.00608815657897852,0.00446252097190233,-0.00265838452595005,0.0148346976839071,0.17249714449053
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MORF4L2,Mortality factor 4-like protein 2,37482,-0.00454790040244896,0.00334479441535499,-0.0111036974565447,0.00200789665164681,0.173949973135636
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GUK1,Guanylate kinase,37562,-0.00500691767387399,0.0036890783312324,-0.0122375112030895,0.00222367585534152,0.174732376243662
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD33,Myeloid cell surface antigen CD33,40411,0.0098091716223184,0.00725008205958798,-0.00440098921447403,0.0240193324591108,0.176083142384509
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NAPRT,Nicotinate phosphoribosyltransferase,37942,0.00409830622079248,0.00302968304147398,-0.00183987254049652,0.0100364849820815,0.176168468910017
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TEX101,Testis-expressed protein 101,37572,0.00487362355653762,0.00360535814617577,-0.0021928784099669,0.0119401255230421,0.176471446350108
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TOP1MT,"DNA topoisomerase I, mitochondrial",37482,-0.00613503507137306,0.00454931330038956,-0.0150516891401366,0.00278161899739048,0.177500846912047
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCTPP1,dCTP pyrophosphatase 1,40359,0.00390333135553717,0.00289506163029776,-0.00177098943984645,0.00957765215092078,0.177590020497948
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINB5,Serpin B5,40042,-0.00600376016476585,0.00446279077360078,-0.0147508300810234,0.00274330975149167,0.178550274293108
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF5A,Eukaryotic translation initiation factor 5A-1,40044,0.00359232178200617,0.00267337400106626,-0.0016474912600837,0.00883213482409604,0.179051764962363
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SUSD4,Sushi domain-containing protein 4,37900,-0.00548924291784835,0.00408583863013779,-0.0134974866329184,0.00251900079722172,0.179139232346553
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HDAC8,Histone deacetylase 8,37598,0.0077035582723812,0.00574098621359337,-0.0035487747062618,0.0189558912510242,0.179666913160803
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MMP8,Neutrophil collagenase,40442,-0.0089536803135462,0.00668614771692099,-0.0220585298387113,0.00415116921161894,0.180544503039563
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LYPLA2,Acyl-protein thioesterase 2,37541,0.0132616133131317,0.0099214931058487,-0.00618451317433173,0.0327077398005952,0.181358511647434
NMR metabolomics,X23503.Total Lipids in Medium VLDL,YY1,Transcriptional repressor protein YY1,37598,0.00344237624265279,0.00257715780880064,-0.00160885306259647,0.00849360554790204,0.181662028873274
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GLI2,Zinc finger protein GLI2,37598,-0.00411721699668979,0.0030893097368502,-0.0101722640809162,0.0019378300875366,0.182643391810234
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NLGN1,Neuroligin-1,37572,-0.00852386259669855,0.00639726815877863,-0.0210625081879047,0.00401478299450757,0.182744607497701
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDAN1,Codanin-1,37942,0.00283229496393145,0.00212612895036677,-0.00133491777878743,0.00699950770665032,0.182837689964419
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENG,Endoglin,40536,-0.0020712050126742,0.00155561632137967,-0.00512021300257834,0.000977802977229954,0.183064155736862
NMR metabolomics,X23503.Total Lipids in Medium VLDL,S100A3,Protein S100-A3,37900,0.00560144678144589,0.00420739429749806,-0.00264504604165031,0.0138479396045421,0.183101726291072
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SUSD5,Sushi domain-containing protein 5,37604,-0.00416798839094491,0.00313319712524391,-0.010309054756423,0.00197307797453315,0.183453418569453
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BRME1,Break repair meiotic recombinase recruitment factor 1,37541,-0.00503587465241806,0.00378568114649104,-0.0124558096995405,0.00238406039470438,0.183461501275299
NMR metabolomics,X23503.Total Lipids in Medium VLDL,THAP12,52 kDa repressor of the inhibitor of the protein kinase,37457,0.0108866207960475,0.00818565913532584,-0.0051572711091911,0.0269305127012862,0.183553906422983
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC1A,C-type lectin domain family 1 member A,40042,-0.0039895710210786,0.00302090690199756,-0.00991054854899383,0.00193140650683662,0.186636339188442
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37714,-0.00891196470562368,0.00676007267320679,-0.022161707145109,0.00433777773386163,0.187418044121688
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL21,C-C motif chemokine 21,40422,0.00507899856055772,0.00387881335714249,-0.00252347561944155,0.012681472740557,0.190410716162978
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AGR2,Anterior gradient protein 2 homolog,39839,0.0121137316294535,0.00926630294744213,-0.00604822214753306,0.0302756854064401,0.191134269768495
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MSLNL,Mesothelin-like protein,37572,-0.00450699478510276,0.00345074438697332,-0.0112704537835705,0.00225646421336494,0.191543663762284
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCUN1D1,DCN1-like protein 1,37541,-0.00892192735681581,0.0068586028736008,-0.0223647889890734,0.00452093427544175,0.193337006148734
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHP1,Calcineurin B homologous protein 1,37541,0.00869935654510372,0.00669608340815354,-0.00442496693487722,0.0218236800250847,0.193908177679566
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC44A4,Choline transporter-like protein 4,37572,-0.00835387673758848,0.00643071389213047,-0.0209580759661642,0.00425032249098724,0.193946511672321
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KCNC4,Potassium voltage-gated channel subfamily C member 4,37541,0.00676972843842133,0.00524136744429857,-0.00350335175240387,0.0170428086292465,0.196519948817675
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37572,-0.00601987713922861,0.00466845152244033,-0.0151700421232117,0.00313028784475444,0.19725382715794
NMR metabolomics,X23503.Total Lipids in Medium VLDL,REG1B,Lithostathine-1-beta,40536,-0.00656811345311441,0.00509986808784334,-0.0165638549052874,0.00342762799905854,0.197799758817333
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37714,0.00422356850623988,0.00329591854677056,-0.00223643184543041,0.0106835688579102,0.200056598515246
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TGFBR3,Transforming growth factor beta receptor type 3,40536,-0.00386376095352415,0.00301523538795604,-0.009773622313918,0.00204610040686969,0.200067215009299
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TFRC,Transferrin receptor protein 1,40391,-0.00459225675352025,0.00360926114950939,-0.0116664086065587,0.00248189509951816,0.203266040064819
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TAGLN3,Transgelin-3,37482,-0.00712229687923379,0.00560445852331534,-0.0181070355849318,0.00386244182646427,0.203812909976127
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37572,-0.00488910657253503,0.00387878496870433,-0.0124915251111955,0.00271331196612547,0.207520933800977
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIF20B,Kinesin-like protein KIF20B,37541,0.00899621334588744,0.00716574279801591,-0.00504864253822375,0.0230410692299986,0.209338794159322
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CORO6,Coronin-6,37541,-0.00417437892797224,0.00334183887652109,-0.0107243831259536,0.00237562527000911,0.211641210145421
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39980,0.0137263143858609,0.0110788757009993,-0.00798828198809774,0.0354409107598196,0.215378017728643
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNGB3,Cyclic nucleotide-gated cation channel beta-3,37541,0.00623222139815262,0.00503087574281491,-0.00362829505776461,0.0160927378540698,0.215443811298664
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRP2,Low-density lipoprotein receptor-related protein 2,37572,0.00409841260799782,0.00330894923800824,-0.00238712789849833,0.010583953114494,0.215521641231204
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ART5,Ecto-ADP-ribosyltransferase 5,37541,0.00722133786277011,0.00583843274501581,-0.00422199031746089,0.0186646660430011,0.216160367017056
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL17A,Interleukin-17A,40028,-0.00482429647242908,0.00390216593758623,-0.0124725417100981,0.00282394876523993,0.216361073881593
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SDC1,Syndecan-1,40359,0.004514246994224,0.00365209976111237,-0.00264386853755624,0.0116723625260042,0.216451199751505
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PALM3,Paralemmin-3,37562,0.00823043566396003,0.00666000950027551,-0.00482318295657997,0.0212840542845,0.216555285183948
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37562,0.00517957942924849,0.00419622672999987,-0.00304502496155125,0.0134041838200482,0.217097568982199
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37628,-0.0022945465297985,0.00187550731191628,-0.00597054086115441,0.00138144780155741,0.221190290035505
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,37541,-0.00645134961783052,0.00528414098606651,-0.0168082659505209,0.00390556671485983,0.222150041015392
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PON1,Serum paraoxonase/arylesterase 1,37987,0.00288511346683736,0.00236900851684772,-0.00175814322618417,0.0075283701598589,0.223299571330529
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MRPL24,"39S ribosomal protein L24, mitochondrial",37562,0.0044552349333195,0.00367914517008249,-0.00275588960004218,0.0116663594666812,0.225939096231956
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIGLEC5,Sialic acid-binding Ig-like lectin 5,40332,-0.013134732533025,0.0108812677923401,-0.0344620174060116,0.00819255233996163,0.22741323604665
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL2RG,Cytokine receptor common subunit gamma,37900,0.00426351073158794,0.0035380083359686,-0.00267098560691051,0.0111980070700864,0.228201518971324
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPIE,Peptidyl-prolyl cis-trans isomerase E,37714,0.00711905292109086,0.00591010060889012,-0.00446474427233377,0.0187028501145155,0.228395869887963
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37598,0.00392418540622301,0.00333045608285266,-0.0026035085161682,0.0104518793286142,0.238709244427537
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GNPDA1,Glucosamine-6-phosphate isomerase 1,37628,0.0035319165238155,0.00299867390845198,-0.00234548433675039,0.00940931738438138,0.238887197026265
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDH4,Cadherin-4,37541,0.00534103933741158,0.00454266988477402,-0.0035625936367455,0.0142446723115687,0.239716597544882
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39708,0.00400636871274304,0.00341681141020663,-0.00269058165126196,0.010703319076748,0.240996204678647
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAPPA,Pappalysin-1,40044,0.00502199488152272,0.00430111205558031,-0.00340818474741469,0.0134521745104601,0.242984461722592
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PNMA2,Paraneoplastic antigen Ma2,37541,0.0046405851607478,0.00398460068626564,-0.00316923218433286,0.0124504025058285,0.244190054887044
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NBL1,Neuroblastoma suppressor of tumorigenicity 1,40411,0.00280748076620572,0.00242087262348224,-0.00193742957581946,0.00755239110823091,0.246189197416874
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMY2A,Pancreatic alpha-amylase,39695,0.00497511228112002,0.00430905179250968,-0.00347062923219895,0.013420853794439,0.248283673413015
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANXA10,Annexin A10,39961,-0.00869771408158669,0.00755637114083484,-0.023508201517623,0.00611277335444961,0.24973196599108
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37572,-0.00695793189240152,0.00604738899984766,-0.0188108143321029,0.00489495054729991,0.24993099908498
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TP53INP1,Tumor protein p53-inducible nuclear protein 1,40042,0.00345161140615452,0.00300914831441793,-0.00244631929010463,0.00934954210241367,0.251382977704129
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL20,Interleukin-20,40044,0.00533069069657876,0.00466702309243339,-0.00381667456459069,0.0144780559577482,0.25338692888985
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCN2A,Sodium channel protein type 2 subunit alpha,37541,0.00521729040670237,0.00456969723784306,-0.00373931617947003,0.0141738969928748,0.253593524153379
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RTKN2,Rhotekin-2,37562,-0.00550063249539224,0.00484002112354513,-0.0149870738975407,0.0039858089067562,0.25577259053854
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COPE,Coatomer subunit epsilon,39961,0.00502487866225771,0.00442530192056695,-0.00364871310205351,0.0136984704265689,0.25618831828598
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCAR2,Cell cycle and apoptosis regulator protein 2,37942,0.00586667876331284,0.00516929093188314,-0.00426513146317812,0.0159984889898038,0.256433292157182
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CALY,Neuron-specific vesicular protein calcyon,37562,-0.00397185385713673,0.00351501075503914,-0.0108612749370134,0.00291756722274,0.258509880080807
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NLGN2,Neuroligin-2,37541,-0.0049955013867696,0.00443021586996874,-0.0136787244919083,0.00368772171836912,0.25951051258997
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACTN4,Alpha-actinin-4,40044,0.00334786128527656,0.00297193500343386,-0.0024771313214538,0.00917285389200691,0.259974622140987
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLK,STE20-like serine/threonine-protein kinase,37714,0.00802119534357591,0.00712189544267556,-0.00593771972406819,0.02198011041122,0.26007055233592
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TP73,Tumor protein p73,37572,0.00360979367020397,0.00320938094483291,-0.00268059298166854,0.00990018032207648,0.260709957285533
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNTNAP2,Contactin-associated protein-like 2,40341,0.00412246051686991,0.00366694994584793,-0.00306476137699204,0.0113096824107319,0.260936453646797
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SHH,Sonic hedgehog protein,37598,-0.00448139317561118,0.00398816630043883,-0.0122981991244713,0.00333541277324892,0.26117246550334
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDH22,Cadherin-22,37714,-0.00303288769321436,0.00270207113880365,-0.00832894712526951,0.00226317173884078,0.261699662947366
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,40341,-0.00867948208935916,0.00778299461587347,-0.0239341515364712,0.00657518735775284,0.26478784075522
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEMA7A,Semaphorin-7A,40490,0.00273667042244273,0.00245558145368966,-0.00207626922678901,0.00754961007167447,0.26509455957381
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37562,-0.00538937099706717,0.00484931374514851,-0.0148940259375583,0.00411528394342391,0.266430460890639
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LSM8,U6 snRNA-associated Sm-like protein LSm8,37714,0.00928013951484482,0.00839794015543858,-0.0071798231898148,0.0257401022195044,0.269158190914682
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GAD1,Glutamate decarboxylase 1,37482,-0.00262293685386937,0.00237507269408966,-0.00727807933428511,0.00203220562654637,0.269457110705981
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RYR1,Ryanodine receptor 1,37562,-0.00350463453291086,0.00317469670105831,-0.00972704006698515,0.00271777100116343,0.269644912862267
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PI16,Peptidase inhibitor 16,37987,-0.00248772277005653,0.00225444735753353,-0.00690643959082224,0.00193099405070918,0.269841239765845
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ALMS1,Alstrom syndrome protein 1,37714,0.00455657662070261,0.00413071722259111,-0.00353962913557597,0.0126527823769812,0.270005601429648
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BEX3,Protein BEX3,37482,-0.00483831742534665,0.00438832580090308,-0.0134394359951167,0.00376280114442339,0.270246084882175
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRPV3,Transient receptor potential cation channel subfamily V member 3,37562,-0.0051551792662185,0.00468742468224459,-0.0143425316434179,0.00403217311098091,0.271444152550836
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C9orf40,Uncharacterized protein C9orf40,37901,-0.00827502222021086,0.00754449749412104,-0.0230622373086881,0.00651219286826637,0.272735871290162
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KDM3A,Lysine-specific demethylase 3A,37598,-0.00927310304508043,0.00850108099874387,-0.0259352218026184,0.00738901571245755,0.27537447504693
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPRKB,EKC/KEOPS complex subunit TPRKB,37482,-0.00642785617281901,0.00589524501033132,-0.0179825363930684,0.00512682404743038,0.275580970153464
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD70,CD70 antigen,40341,0.00413742065984959,0.00379798384756916,-0.00330662768138596,0.0115814690010851,0.27600600074481
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMPRSS5,Transmembrane protease serine 5,40159,0.00374686195826182,0.00345389432663364,-0.00302277092194011,0.0105164948384637,0.278016969312706
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39961,-0.00460761523858798,0.00424805525489278,-0.0129338035381778,0.00371857306100187,0.278097513298661
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPESP1,Sperm equatorial segment protein 1,37990,0.00272870464019089,0.00252606970451208,-0.0022223919806528,0.00767980126103457,0.280064591263339
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MEGF11,Multiple epidermal growth factor-like domains protein 11,37562,0.00322172322303071,0.00298425968349562,-0.00262742575662071,0.00907087220268212,0.28035267210923
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MSMB,Beta-microseminoprotein,40236,0.00681580685874622,0.00631903837960825,-0.00556950836528596,0.0192011220827784,0.280776066602919
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHIT1,Chitotriosidase-1,40398,0.0146665129700576,0.013635597478507,-0.0120592580878161,0.0413922840279313,0.282120350512577
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNTNAP4,Contactin-associated protein-like 4,37572,0.00990311801396496,0.00931848641027622,-0.00836111535017643,0.0281673513781063,0.287919934219174
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCLRE1C,Protein artemis,37482,-0.00309924752006406,0.00291741421984055,-0.00881737939095154,0.00261888435082343,0.288107007916298
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MKI67,Proliferation marker protein Ki-67,37598,0.003678262428915,0.00346290928146782,-0.00310903976276193,0.0104655646205919,0.288169629887778
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39961,0.00658336055116664,0.00619806688192813,-0.0055648505374125,0.0187315716397458,0.288177995519512
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDX39A,ATP-dependent RNA helicase DDX39A,37598,0.00218051561025703,0.00205310501170127,-0.00184357021267746,0.00620460143319151,0.288229084789521
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FBN2,Fibrillin-2,37572,0.00591405472377171,0.00559202756688882,-0.00504631930733038,0.0168744287548738,0.290263319725267
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37671,-0.00371371814605374,0.00351752779491585,-0.0106080726240888,0.00318063633198132,0.291090286320545
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRRT3,Proline-rich transmembrane protein 3,37628,0.00363303044374161,0.00344235251286281,-0.0031139804814695,0.0103800413689527,0.291265545453945
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RALB,Ras-related protein Ral-B,37598,0.00286672700221737,0.00271681259968621,-0.00245822569316761,0.00819167969760235,0.29136228599351
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DUOX2,Dual oxidase 2,40042,0.00697158645566592,0.00663029935371267,-0.00602380027761092,0.0199669731889428,0.293057306369716
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TSLP,Thymic stromal lymphopoietin,40042,0.00584697010956237,0.00557068370833688,-0.00507156995877791,0.0167655101779027,0.293919938102067
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL24,Interleukin-24,40044,0.0047321818346934,0.00451274156326388,-0.00411279162930381,0.0135771552986906,0.294366160800353
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC12A2,Solute carrier family 12 member 2,37562,-0.00273408486992419,0.00262663521714564,-0.00788228989552964,0.00241412015568126,0.297937574699345
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL20RB,Interleukin-20 receptor subunit beta,37598,0.00406487669430421,0.00391666108499228,-0.00361177903228066,0.0117415324208891,0.299362551418449
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KRT8,"Keratin, type II cytoskeletal 8",37541,-0.00584847698769104,0.00564192007077463,-0.0169066403264093,0.00520968635102724,0.299936286716941
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OTOA,Otoancorin,37541,-0.00520656950619254,0.00502694199690391,-0.0150593758201242,0.00464623680773913,0.300345876282093
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSP90B1,Endoplasmin,39878,-0.00659677569815025,0.00642518734310349,-0.0191901428906331,0.00599659149433259,0.304575219710136
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PADI2,Protein-arginine deiminase type-2,40044,0.00526223952655696,0.00512903665028494,-0.00479067230800152,0.0153151513611154,0.304921476479586
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGFBP7,Insulin-like growth factor-binding protein 7,40536,-0.00275944451343132,0.00269193999833202,-0.00803564691016207,0.00251675788329943,0.305342494895322
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PILRB,Paired immunoglobulin-like type 2 receptor beta,40359,-0.00537418628723323,0.0052446820330448,-0.015653763072001,0.00490539049753458,0.305523890280928
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,40341,0.014072650695956,0.0137417016994269,-0.0128610846349207,0.0410063860268327,0.305811403023202
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PHLDB2,Pleckstrin homology-like domain family B member 2,37482,-0.0089109845760118,0.00876587014760856,-0.0260920900653246,0.00827012091330097,0.309384292464882
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RPGR,X-linked retinitis pigmentosa GTPase regulator,37572,0.00398231224969279,0.00393653045803806,-0.0037332874480618,0.0116979119474474,0.311733659036385
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCNE1,G1/S-specific cyclin-E1,37598,0.00869597601189885,0.00859667289248095,-0.0081535028573638,0.0255454548811615,0.311771237791977
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSMC3,26S proteasome regulatory subunit 6A,37482,-0.00279211634703907,0.00277330737935981,-0.0082277988105843,0.00264356611650616,0.314058173061592
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DOC2B,Double C2-like domain-containing protein beta,37572,0.00330438915701345,0.00330593627061307,-0.00317524593338817,0.00978402424741506,0.317555469907681
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC11A,C-type lectin domain family 11 member A,40296,0.00436968181082221,0.00437864344363085,-0.00421245933869426,0.0129518229603387,0.318317229838284
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NRN1,Neuritin,37959,-0.00330182998795616,0.00335416592204019,-0.00987599519515493,0.00327233521924262,0.324938114444001
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37900,0.00430496014246194,0.00438263368774791,-0.00428500188552397,0.0128949221704478,0.3259810878429
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD164L2,CD164 sialomucin-like 2 protein,37572,0.00331851760330437,0.00338143052943072,-0.00330908623437983,0.00994612144098857,0.326416292890298
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ABO,Histo-blood group ABO system transferase,37987,0.0129575417467152,0.0132038087687673,-0.0129219234400687,0.0388370069334991,0.326438311407803
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FAM171A2,Protein FAM171A2,37959,0.0144418331141495,0.0147278154931588,-0.0144246852524418,0.0433083514807409,0.32681639887705
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRAME,Melanoma antigen preferentially expressed in tumors,37482,-0.0022945441309653,0.00234639786960168,-0.00689348395538459,0.00230439569345399,0.328141591557955
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL33,Interleukin-33,40044,0.00345786258667289,0.00353824675558323,-0.00347710105427025,0.010392826227616,0.328445042839932
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37572,0.00700766733733865,0.00719781404816271,-0.00710004819706026,0.0211153828717376,0.330281721656152
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BTLA,B- and T-lymphocyte attenuator,37482,0.00791249291283638,0.00816242648800614,-0.00808586300365565,0.0239108488293284,0.332373624963631
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL15RA,Interleukin-15 receptor subunit alpha,40044,0.00315353300642353,0.0032573352403796,-0.00323084406472048,0.00953791007756755,0.332993079590446
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TCN2,Transcobalamin-2,40497,0.00263707695387548,0.00272519443933948,-0.00270430414722991,0.00797845805498086,0.333225981265017
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMPD3,Sphingomyelin phosphodiesterase 3,37598,0.00519172132811062,0.00537577398068178,-0.00534479567402567,0.0157282383302469,0.334180764585683
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37562,-0.00620604384267099,0.00648374029390487,-0.0189141748187245,0.00650208713338256,0.338498939703135
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FSTL3,Follistatin-related protein 3,40293,0.00272032156971435,0.00285101277523345,-0.00286766346974322,0.00830830660917191,0.340017356579946
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CST7,Cystatin-F,40376,0.00801285142562104,0.00840147175760994,-0.00845403321929444,0.0244797360705365,0.340227830797856
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TGFBR1,TGF-beta receptor type-1,37598,0.00188473604088031,0.00197640332828619,-0.00198901448256062,0.00575848656432123,0.340293997898879
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37714,0.0055140546211015,0.00578329931389936,-0.00582121203414124,0.0168493212763442,0.340382307243837
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PILRA,Paired immunoglobulin-like type 2 receptor alpha,40332,-0.00365735954541467,0.00384420710113818,-0.0111920054636455,0.00387728637281616,0.341418360128788
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LELP1,Late cornified envelope-like proline-rich protein 1,37541,0.00658802207713323,0.00693135506281842,-0.00699743384599088,0.0201734780002573,0.34189272286776
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC6A,C-type lectin domain family 6 member A,39980,-0.00406572268850027,0.00427923118141831,-0.0124530158040802,0.00432157042707963,0.342073245056924
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLIN3,Perilipin-3,40359,0.00365332254492465,0.003872032915061,-0.00393586196859491,0.0112425070584442,0.34543169021223
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WNT9A,Protein Wnt-9a,40044,0.00245811080337952,0.00262241365293494,-0.00268181995637297,0.00759804156313201,0.348594762879677
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HTR1B,5-hydroxytryptamine receptor 1B,37541,-0.00365658658191912,0.00390228434060675,-0.0113050638895083,0.0039918907256701,0.348756581267244
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCARB1,Scavenger receptor class B member 1,39961,0.00507416659145116,0.00542819593768745,-0.00556509744641624,0.0157134306293186,0.349916471141285
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OSBPL2,Oxysterol-binding protein-related protein 2,37942,0.00341267882361104,0.00365193819427214,-0.00374512003716234,0.0105704776843844,0.350070869129829
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SOD3,Extracellular superoxide dismutase,37987,-0.00505698927499348,0.00541179194757219,-0.015664101492235,0.00555012294224802,0.350094175316884
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CASP4,Caspase-4,37714,-0.0146027239779475,0.0156579347651938,-0.0452922761177274,0.0160868281618324,0.351039090452788
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RICTOR,Rapamycin-insensitive companion of mTOR,37598,0.00431547544399843,0.00463346910388929,-0.00476612399962457,0.0133970748876214,0.351679159386986
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBP7,Retinoid-binding protein 7,37901,-0.00497303949786495,0.00534845020582125,-0.0154560019012746,0.0055099229055447,0.352486445535303
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GAGE2A,G antigen 2A,37482,0.00528806320763382,0.00572191636781172,-0.00592689287327716,0.0165030192885448,0.355411309320651
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AKR1B10,Aldo-keto reductase family 1 member B10,37572,0.00512339821377928,0.00554599917263062,-0.00574676016457673,0.0159935565921353,0.355607052081051
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RGS8,Regulator of G-protein signaling 8,40044,0.00561253274786875,0.00608163141103745,-0.00630746481776465,0.0175325303135021,0.35609115890955
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EVI2B,Protein EVI2B,37482,0.00356837688352783,0.00387130313365995,-0.00401937725844567,0.0111561310255013,0.356675625436261
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNTN4,Contactin-4,40332,-0.00204487707182966,0.00222015098726929,-0.00639637300687746,0.00230661886321815,0.357036667656776
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNASE1,Ribonuclease pancreatic,37987,0.00203531798804004,0.00221015197814876,-0.00229657988913152,0.0063672158652116,0.357121642849479
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37671,-0.00339505097565705,0.00369619233989093,-0.0106395879618433,0.00384948601052918,0.358359999548046
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DBH,Dopamine beta-hydroxylase,37967,0.00886304000102807,0.00966159196879123,-0.0100736802578027,0.0277997602598589,0.358976793726773
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37562,0.00398902456567195,0.00435977837722869,-0.00455614105369628,0.0125341901850402,0.360229247774522
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL3RA,Interleukin-3 receptor subunit alpha,40044,-0.00265880193270287,0.00291379677669687,-0.00836984361502873,0.003052239749623,0.361526472263456
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",37482,-0.00467897155366301,0.00515823713052092,-0.014789116329484,0.00543117322215799,0.364377391264019
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF20,Fibroblast growth factor 20,37598,0.00372159218260551,0.00410350447463841,-0.00432127658768577,0.0117644609528968,0.364460326726568
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GSTM4,Glutathione S-transferase Mu 4,37562,-0.00596312607739365,0.00658141932286193,-0.018862707950203,0.00693645579541574,0.364923538826292
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDI2,Protein DDI1 homolog 2,37671,0.00647420550558611,0.00715701515752101,-0.00755354420315506,0.0205019552143273,0.365696072361517
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NGFR,Tumor necrosis factor receptor superfamily member 16,37990,-0.00243750653806815,0.00270216017395164,-0.00773374047901337,0.00285872740287707,0.367041843798972
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NCLN,Nicalin,40044,-0.00439345602212715,0.00488635067452366,-0.0139707033441935,0.00518379129993921,0.368598227389939
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDCD6,Programmed cell death protein 6,40359,-0.00568999677919129,0.00637077759231489,-0.0181767208601285,0.00679672730174589,0.371795675599129
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GID8,Glucose-induced degradation protein 8 homolog,37959,0.00275998761701469,0.00309759242094707,-0.00331129352804156,0.00883126876207094,0.372939365686782
NMR metabolomics,X23503.Total Lipids in Medium VLDL,B2M,Beta-2-microglobulin,38013,0.00257860561459375,0.00290238728792158,-0.00311007346973254,0.00826728469892005,0.374318271987432
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,37457,-0.00419295753948306,0.00472030774105911,-0.0134447607119589,0.0050588456329928,0.374406289655792
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NRTN,Neurturin,40044,0.00401221107445529,0.00452841806486877,-0.0048634883326875,0.0128879104815981,0.37562730401398
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMIGO1,Amphoterin-induced protein 1,37572,0.00405904830855268,0.0045844805671136,-0.00492653360298998,0.0130446302200953,0.375963131404075
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CAPN3,Calpain-3,37900,0.00301152422127685,0.0034014180913715,-0.00365525523781129,0.00967830368036499,0.375971243693214
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPINK4,Serine protease inhibitor Kazal-type 4,40341,-0.00527670154553553,0.00596665334686787,-0.0169713421053965,0.00641793901432549,0.376512396741801
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PGLYRP1,Peptidoglycan recognition protein 1,40451,-0.00345196310372426,0.00390561467732399,-0.0111069678712793,0.00420304166383075,0.376792466905525
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MET,Hepatocyte growth factor receptor,40375,0.00161676197360593,0.00183321259206467,-0.00197633470684082,0.00520985865405268,0.377828921684685
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGFL4,Insulin growth factor-like family member 4,37598,-0.00636946267612589,0.00722470319657591,-0.0205298809414147,0.00779095558916289,0.377996968895646
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC1A4,Neutral amino acid transporter A,37572,-0.00424106978604006,0.00482177189873944,-0.0136917427075694,0.00520960313548924,0.379110218136038
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL10,Interleukin-10,40044,-0.006918430943965,0.00786803293552746,-0.0223397754975988,0.00850291360966881,0.379247393039542
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNR,Tenascin-R,40228,0.00340991916866045,0.0038800745127384,-0.00419502687630681,0.0110148652136277,0.379507780998841
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPE,Carboxypeptidase E,40360,-0.00306575005546404,0.00349309203267272,-0.00991221043950257,0.00378071032857448,0.380141061340238
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL25,Interleukin-25,37429,0.00280665628544543,0.00320738814148578,-0.0034798244718667,0.00909313704275757,0.381557587670176
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERVV_1,,37562,-0.00387175725210469,0.00444120885567151,-0.0125765266092209,0.00483301210501147,0.383344347873475
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PYDC1,Pyrin domain-containing protein 1,37628,-0.0033932553575826,0.00390983766723683,-0.0110565371853668,0.00427002647020159,0.385477873288038
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37900,0.00514785768766462,0.00595246377816712,-0.00651897131754294,0.0168146866928722,0.387148594989246
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPPP2,Tubulin polymerization-promoting protein family member 2,37714,-0.00652072612995506,0.00755766004601032,-0.0213337398201353,0.00829228756022517,0.38826471141407
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LY6D,Lymphocyte antigen 6D,40268,0.00294411134222734,0.00341397477096527,-0.0037472792088646,0.00963550189331928,0.388496709745664
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,37482,-0.00677100772274822,0.0079078764316807,-0.0222704455288424,0.00872843008334594,0.391883052321075
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37901,-0.013454311307767,0.0158850451622814,-0.0445889998258386,0.0176803772103046,0.397021489295882
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FLT3,Receptor-type tyrosine-protein kinase FLT3,39980,-0.00239550540255682,0.00282943742697388,-0.00794120275942562,0.00315019195431199,0.397210730833799
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL1A1,Collagen alpha-1(I) chain,40536,-0.0019944323707055,0.00237070249197374,-0.00664100925497403,0.00265214451356302,0.400201761841421
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CREB3,Cyclic AMP-responsive element-binding protein 3,37482,-0.00444594309738254,0.00528751587532832,-0.014809474213026,0.00591758801826097,0.400454249796873
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39980,0.00273681464216191,0.00326027543713632,-0.00365332521462527,0.0091269544989491,0.401233815172989
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL18RAP,Interleukin-18 receptor accessory protein,40128,0.0134224559863561,0.0159902973389699,-0.017918526798025,0.0447634387707371,0.401250654230202
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRDX2,Peroxiredoxin-2,37763,-0.00481635268558397,0.00574627868251498,-0.0160790589033133,0.00644635353214539,0.401950842073664
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37572,-0.00398852781809016,0.00479046035285121,-0.0133778301096785,0.00540077447349822,0.405086629514824
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RRP15,RRP15-like protein,37541,-0.00692705117336039,0.00836170268210672,-0.0233159884302896,0.00946188608356878,0.407444441884799
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MTR,Methionine synthase,37562,0.00496732426573938,0.00601221793271067,-0.00681662288237352,0.0167512714138523,0.408702871508292
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BATF,Basic leucine zipper transcriptional factor ATF-like,37572,0.00654465047544049,0.00795236299599823,-0.00904198099671604,0.022131281947597,0.410533267946869
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGAX,Integrin alpha-X,37714,0.00415204439579103,0.00506316652025995,-0.00577176198391848,0.0140758507755005,0.412202939830615
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAMA1,Laminin subunit alpha-1,37562,-0.0042215406707441,0.00515722030228287,-0.0143296924632185,0.00588661112173033,0.413047237577783
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37562,-0.00467800208515136,0.0057526363882571,-0.0159531694061353,0.00659716523583257,0.416122335015798
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL36A,Interleukin-36 alpha,37598,-0.00440896236133927,0.00542650523550644,-0.0150449126229319,0.00622698790025336,0.416527230372829
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANKRA2,Ankyrin repeat family A protein 2,37482,0.00421291533431874,0.00518643740586028,-0.00595250198116741,0.0143783326498049,0.416637421933956
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OFD1,Oral-facial-digital syndrome 1 protein,37714,0.0050446288143013,0.00622996919186931,-0.00716611080176255,0.0172553684303651,0.418106590879619
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPHA4,Ephrin type-A receptor 4,37671,0.00208137683190075,0.00258008450707703,-0.00297558880197023,0.00713834246577173,0.419848796199569
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AKAP12,A-kinase anchor protein 12,37671,-0.00160224698261025,0.0019962184219855,-0.00551483508970183,0.00231034112448133,0.422196626216777
NMR metabolomics,X23503.Total Lipids in Medium VLDL,METAP1,Methionine aminopeptidase 1,39961,0.00225650378842615,0.00281258749810464,-0.00325616770785894,0.00776917528471123,0.422398965389771
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTLA4,Cytotoxic T-lymphocyte protein 4,37998,0.00215824827797378,0.00270421690021971,-0.00314201684645686,0.00745851340240442,0.424823712262914
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KRT6C,"Keratin, type II cytoskeletal 6C",37562,-0.00301860504619944,0.00378279537189979,-0.010432883975123,0.00439567388272414,0.424895016713735
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DLGAP5,Disks large-associated protein 5,37959,-0.00392442548590881,0.00492172984397482,-0.0135710159800995,0.00572216500828183,0.425251873467209
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIRREL1,Kin of IRRE-like protein 1,37541,0.00450622371460822,0.00566271081000121,-0.00659268947299416,0.0156051369022106,0.426179307379359
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC4C,C-type lectin domain family 4 member C,40341,0.00331028331052632,0.00417028337608683,-0.00486347210660386,0.0114840387276565,0.427335962137589
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC39A14,Zinc transporter ZIP14,39961,0.00242718163536994,0.00305796446635414,-0.00356642871868417,0.00842079198942405,0.42736791699037
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERCC1,DNA excision repair protein ERCC-1,37482,0.00244640532106308,0.00308609772595347,-0.00360234622180571,0.00849515686393188,0.42795655395242
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MORF4L1,Mortality factor 4-like protein 1,37714,-0.00296782171691574,0.00374632444953548,-0.0103106176380053,0.00437497420417379,0.428260807870504
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HMBS,Porphobilinogen deaminase,40489,0.00328301365445009,0.00415161064359196,-0.00485414320699014,0.0114201705158903,0.429083656421238
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARHGEF5,Rho guanine nucleotide exchange factor 5,37541,-0.00535037249458689,0.00677170091538004,-0.0186229062887318,0.00792216129955798,0.429479233745401
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYL6B,Myosin light chain 6B,37572,-0.00670325915843022,0.00849204680419629,-0.0233476708946549,0.0099411525777945,0.429917468161405
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UPK3A,Uroplakin-3a,37541,0.00362059438320852,0.00459235412101272,-0.00538041969397642,0.0126216084603935,0.430479290811746
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGA11,Integrin alpha-11,40341,0.00244169638696294,0.00311071145167189,-0.00365529805831397,0.00853869083223984,0.432505250012863
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GFRA3,GDNF family receptor alpha-3,40194,0.00204806138106924,0.00261046612470857,-0.00306845222335955,0.00716457498549804,0.432724726497412
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEND1,Cell cycle exit and neuronal differentiation protein 1,37541,0.00414756399156719,0.00529550056777063,-0.00623161712126326,0.0145267451043976,0.433509659850351
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BHLHE40,Class E basic helix-loop-helix protein 40,37541,-0.00509193205939684,0.00650900495087401,-0.0178495817631099,0.00766571764431621,0.434058081421222
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IMPG1,Interphotoreceptor matrix proteoglycan 1,37541,0.00215051014020363,0.00275037227011358,-0.00324021950921899,0.00754123978962625,0.434288757316227
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",37541,-0.00329176393096529,0.00421058831234402,-0.0115445170231596,0.00496098916122899,0.434356593912334
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TJP3,Tight junction protein ZO-3,37541,-0.00313742041238954,0.00403096983286083,-0.0110381212847968,0.00476328046001769,0.436389197547466
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC7A,C-type lectin domain family 7 member A,40516,0.0041454676798926,0.0053498600313004,-0.00634025798145617,0.0146311933412414,0.438425495981315
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLXDC2,Plexin domain-containing protein 2,37942,0.00188112353085708,0.00244590436605858,-0.00291284902661775,0.0066750960883319,0.441852635145492
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTNNA1,Catenin alpha-1,37541,-0.00254994335376056,0.00332757690851314,-0.00907199409444632,0.0039721073869252,0.4435078534819
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADGRE5,Adhesion G protein-coupled receptor E5,40451,0.00208499167977977,0.00272481636342755,-0.00325564839253823,0.00742563175209778,0.444172006386538
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GIPR,Gastric inhibitory polypeptide receptor,37598,0.00341936066986402,0.00449082691952077,-0.00538266009239669,0.0122213814321247,0.446425855361523
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40536,0.00189864252292252,0.00250463479215992,-0.00301044166971092,0.00680772671555596,0.448431172797332
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37714,0.00305693578634586,0.00403403678933957,-0.00484977632075969,0.0109636478934514,0.448592690373808
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNPO1,Transportin-1,37714,0.00246238873265212,0.00325215115137885,-0.00391182752405043,0.00883660498935466,0.448969310779955
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJA1,DnaJ homolog subfamily A member 1,37482,-0.003255984541059,0.00431632238400596,-0.0117159764137107,0.00520400733159269,0.450657342860576
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL21R,Interleukin-21 receptor,37598,0.00387476000244371,0.00514085446341312,-0.006201314745846,0.0139508347507334,0.451031432488301
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRYBB2,Beta-crystallin B2,37942,-0.00473953684356179,0.00629491467089787,-0.0170775695985216,0.00759849591139805,0.451514021137804
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPINK5,Serine protease inhibitor Kazal-type 5,40332,-0.00223220311482303,0.00296794377654189,-0.00804937291684514,0.00358496668719908,0.451999518276046
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TSPAN7,Tetraspanin-7,37541,0.00631397648713663,0.00840313880862596,-0.0101561755777702,0.0227841285520435,0.452435639777615
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCDC50,Coiled-coil domain-containing protein 50,37959,-0.00539038029670366,0.00718157940601205,-0.0194662759324873,0.00868551533907996,0.45291598579186
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,40042,0.00218078667877741,0.00293198203278949,-0.00356589810548998,0.0079274714630448,0.457013138354336
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DEFA1_DEFA1B,Neutrophil defensin 1,40009,0.00351139582516434,0.00472096166192942,-0.00574168903221733,0.012764480682546,0.457015821329951
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDSN,Corneodesmosin,40456,0.0029131698596402,0.00394249629607005,-0.00481412288065709,0.0106404625999375,0.459969417577746
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEZ6L2,Seizure 6-like protein 2,40305,-0.00159826878809722,0.0021698113535122,-0.00585109904098114,0.0026545614647867,0.461380531114789
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MFAP3L,Microfibrillar-associated protein 3-like,37572,0.00451249809719279,0.00616327612884286,-0.00756752311533921,0.0165925193097248,0.464084603140538
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSCA,Prostate stem cell antigen,37901,0.0173196101387548,0.0238138976985825,-0.029355629350467,0.0639948496279766,0.467060970094873
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL5,Interleukin-5,40044,0.00970060971082536,0.0133450866290846,-0.0164557600821804,0.0358569795038311,0.467295089343166
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNXB,Tenascin-X,40332,-0.00168979023870316,0.00232697538981233,-0.00625066200273532,0.002871081525329,0.46774249214452
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VSTM1,V-set and transmembrane domain-containing protein 1,39961,0.0032260743361755,0.00445038806909693,-0.00549668627925448,0.0119488349516055,0.468525967975601
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NENF,Neudesin,37900,0.00716902546250179,0.00991721971587711,-0.0122687251806174,0.0266067761056209,0.469762114634273
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANK2,Ankyrin-2,37562,0.00492564593104005,0.00682137774595357,-0.00844425445102895,0.0182955463131091,0.470252270688835
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL19,Interleukin-19,39924,-0.00446274457575537,0.00619666293602008,-0.0166082039303547,0.00768271477884398,0.471421890305234
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPSD1,Tryptase delta,37959,-0.00251789958700625,0.00349828563524703,-0.00937453943209043,0.00433874025807792,0.471689892056484
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,37541,0.0032599710868886,0.00453678557911978,-0.00563212864818617,0.0121520708219634,0.472422387826506
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TUBB3,Tubulin beta-3 chain,37541,-0.00182962961004481,0.00255030951605166,-0.00682823626150605,0.00316897704141644,0.473131036661596
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FOS,Proto-oncogene c-Fos,37457,-0.00230480261816708,0.00322576851921765,-0.00862730891583367,0.00401770367949952,0.474932602869211
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPSG1,Tryptase gamma,37598,0.00178711382510299,0.00250521430452347,-0.00312310621176301,0.006697333861969,0.475637126326451
NMR metabolomics,X23503.Total Lipids in Medium VLDL,THRAP3,Thyroid hormone receptor-associated protein 3,37562,0.00780496200651544,0.0109777773909469,-0.0137114816797405,0.0293214056927714,0.477110303295163
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,37541,0.00393264703645724,0.00553421263743302,-0.00691440973291148,0.014779703805826,0.477340823967195
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PALLD,Palladin,37598,0.00270315828863374,0.00381063290666451,-0.00476568220842871,0.0101719987856962,0.478105913366974
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,37482,-0.00290404809145545,0.0041012086828101,-0.0109424171097632,0.00513432092685234,0.478898517203293
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NEB,Nebulin,37562,0.0023582288079766,0.00334559640703271,-0.00419914014980751,0.00891559776576072,0.480900264722353
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SHISA5,Protein shisa-5,37998,0.00160014798656343,0.0022755846403148,-0.00285999790845358,0.00606029388158044,0.481955014918887
NMR metabolomics,X23503.Total Lipids in Medium VLDL,H2AP,Huntingtin-interacting protein M,37482,-0.00335991754424305,0.00478763677671695,-0.0127436856266083,0.00602385053812217,0.482822418977752
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37562,0.00346617134223051,0.00496808545720729,-0.00627127615389577,0.0132036188383568,0.485384992432173
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRTAM,Cytotoxic and regulatory T-cell molecule,40228,0.0032121737397241,0.00461429566569119,-0.00583184576503064,0.0122561932444788,0.486354405518651
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TBR1,T-box brain protein 1,37572,0.00307939075327046,0.00447769631351282,-0.00569689402121467,0.0118556755277556,0.491642765011354
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RANGAP1,Ran GTPase-activating protein 1,39980,-0.0031293359440972,0.00455527541357592,-0.012057675754706,0.0057990038665116,0.492112114818735
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCNA,Proliferating cell nuclear antigen,37482,0.00389497476021058,0.00574462378333308,-0.00736448785512226,0.0151544373755434,0.497770506524249
NMR metabolomics,X23503.Total Lipids in Medium VLDL,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37598,-0.00182942078483975,0.00269840454302803,-0.0071182936891747,0.0034594521194952,0.497806534311859
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RLN2,Prorelaxin H2,37643,0.00873485788830897,0.0129061985957898,-0.0165612913594391,0.0340310071360571,0.498547544063743
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37714,0.00429633939438299,0.00636590526132261,-0.00818083491780934,0.0167735137065753,0.499752070583874
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TOP1,DNA topoisomerase 1,37901,0.00659858993872492,0.0097789372305711,-0.0125681270331944,0.0257653069106443,0.499829833477451
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLHL41,Kelch-like protein 41,37959,0.0029337505865932,0.00434824541731607,-0.0055888104313463,0.0114563116045327,0.499879481045709
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WFDC12,WAP four-disulfide core domain protein 12,40465,-0.00393673115663732,0.00583511457003726,-0.0153735557139103,0.00750009340063571,0.499900153784933
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MMP13,Collagenase 3,39961,-0.00203478679007272,0.00301798402935061,-0.00795003548759992,0.00388046190745448,0.500181168559491
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HK2,Hexokinase-2,40042,-0.00170419379148546,0.00253009020266617,-0.00666317058871115,0.00325478300574023,0.500594482145793
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,40332,-0.00161906433404437,0.00241695727374858,-0.00635630059059158,0.00311817192250284,0.502945877952402
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UBQLN3,Ubiquilin-3,37562,-0.002765414718422,0.00414596609493369,-0.010891508264492,0.00536067882764803,0.504775347604742
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BOC,Brother of CDO,40042,-0.00143488779065589,0.00215747243807747,-0.00566353376928773,0.00279375818797596,0.506010343592074
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL9,Interleukin-9,37714,0.0034950500292594,0.00526981540188866,-0.00683378815844236,0.0138238882169612,0.507200819869712
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OPTC,Opticin,40305,0.00272638941320707,0.00411783044986459,-0.00534455826852752,0.0107973370949417,0.507920826111213
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAPT,Microtubule-associated protein tau,39961,0.00320205126982945,0.00486482575595157,-0.00633300721183564,0.0127371097514945,0.510416362876457
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37714,-0.00384396458943709,0.00584826265668572,-0.0153065593965411,0.00761863021766692,0.511010265757755
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",37541,0.00196096632331325,0.00298429632258668,-0.00388825446895665,0.00781018711558314,0.511131358871862
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BTNL10,Butyrophilin-like protein 10,37482,0.00252153839518653,0.0038454789396737,-0.00501560032657393,0.010058677116947,0.512019064126108
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL1A,Interleukin-1 alpha,40044,0.00322318836557753,0.00492807041126725,-0.00643582964050627,0.0128822063716613,0.513091342153916
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHL1,Neural cell adhesion molecule L1-like protein,40379,-0.00188875677948622,0.00288969203679259,-0.00755255317159969,0.00377503961262725,0.513366923404659
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EXOSC10,Exosome component 10,37562,0.00376823803987583,0.0057718012296794,-0.00754449237029578,0.0150809684500475,0.513851296524294
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD48,CD48 antigen,40396,0.00174387535191355,0.00267731697270783,-0.0035036659145938,0.00699141661842091,0.51482877539732
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RSPO1,R-spondin-1,40228,0.00209872565825,0.00323778334664034,-0.00424732970116505,0.00844478101766506,0.516866135680224
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HRAS,GTPase Hras,37697,-0.00584629305229156,0.00902328025040862,-0.0235319223430925,0.0118393362385093,0.517052992122615
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSAPL1,Proactivator polypeptide-like 1,37901,0.00297425031501581,0.00463283005924519,-0.00610609660110476,0.0120545972311364,0.520887850693976
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMY2B,Alpha-amylase 2B,39311,0.00280000560863858,0.00440705330986092,-0.00583781887868883,0.011437830095966,0.525212278737955
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,37482,-0.00353810340038657,0.00557018488065042,-0.0144556657664614,0.00737945896568826,0.525318272914795
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37900,-0.0045012781435754,0.00712658148355969,-0.0184693778513524,0.0094668215642016,0.527647165994648
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UGDH,UDP-glucose 6-dehydrogenase,37562,0.00561346576078684,0.00892905094365016,-0.0118874740887675,0.0231144056103412,0.529573192662886
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37628,-0.0023388352687537,0.00372558881759062,-0.00964098935123132,0.00496331881372391,0.53016156585777
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNF168,E3 ubiquitin-protein ligase RNF168,37598,-0.00236380335173172,0.00376626453856738,-0.00974568184732378,0.00501807514386034,0.530260255556587
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOH,Beta-2-glycoprotein 1,40332,0.00203259946114862,0.00324045995239773,-0.00431870204555093,0.00838390096784818,0.530500152680716
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DPEP2,Dipeptidase 2,40305,0.00163767681432765,0.00262077631417503,-0.00349904476145541,0.00677439839011071,0.532057282786831
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37990,0.00415133733716767,0.00671244516904643,-0.00900505519416335,0.0173077298684987,0.536286636566628
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL12RB2,Interleukin-12 receptor subunit beta-2,37598,0.00238713461272399,0.0038614051719832,-0.00518121952436308,0.00995548874981105,0.536451841381417
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37998,-0.00139929807404069,0.00228697563872926,-0.00588177032595003,0.00308317417786865,0.540643793595081
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",40305,-0.00233690869805125,0.00382961722768537,-0.00984295846431458,0.00516914106821208,0.541724886438935
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NOTCH2,Neurogenic locus notch homolog protein 2,37998,0.00117624548697181,0.00193833674328187,-0.00262289452986066,0.00497538550380428,0.543972331543195
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FDX1,"Adrenodoxin, mitochondrial",37562,0.00349862860130161,0.00577343734250784,-0.00781730859001375,0.014814565792617,0.544533805131319
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ISM2,Isthmin-2,37998,-0.00246967890649673,0.004082468092868,-0.010471316368518,0.00553195855552456,0.545224007428119
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPRR1B,Cornifin-B,37714,0.00470887295062496,0.00781193735321948,-0.0106025242616852,0.0200202701629351,0.546665926482749
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TLR1,Toll-like receptor 1,37598,-0.00144716362247827,0.00240191649874701,-0.00615491996002241,0.00326059271506587,0.546849280926279
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD99,CD99 antigen,40332,-0.00106236601616108,0.0017738422953803,-0.00453909691510646,0.0024143648827843,0.549243653664101
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NCR1,Natural cytotoxicity triggering receptor 1,40306,0.0019547456256952,0.00328983508749365,-0.00449333114579236,0.00840282239718276,0.552401951772166
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DPEP1,Dipeptidase 1,40192,-0.00275905487797236,0.00464572044957103,-0.0118646669591316,0.00634655720318687,0.552593076541481
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAG,Myelin-associated glycoprotein,37572,0.00254080363084139,0.00427843852399757,-0.00584493587619385,0.0109265431378766,0.552614409511692
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TLR2,Toll-like receptor 2,37714,0.00125026931344976,0.00210665398909417,-0.00287877250517482,0.00537931113207434,0.552866177644256
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VWA5A,von Willebrand factor A domain-containing protein 5A,37482,0.00447301408402842,0.00754292747996323,-0.0103111237766995,0.0192571519447563,0.553186290339274
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MLLT1,Protein ENL,37482,0.00388343898002801,0.00658232031233743,-0.00901790883215335,0.0167847867922094,0.55521412138604
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37562,-0.00237161350539424,0.0040546953988743,-0.0103188164871879,0.00557558947639939,0.558621348477015
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIGLEC1,Sialoadhesin,40422,-0.00229036686516894,0.00395279047217814,-0.0100378361906381,0.00545710246030021,0.562306986697842
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,40228,0.00168700033610394,0.00292367612810216,-0.00404340487497629,0.00741740554718418,0.56393862921784
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPP1,Osteopontin,40497,-0.00247656140979187,0.00434639099338691,-0.0109954877568302,0.00604236493724646,0.568823233587771
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",37482,0.00303088626086744,0.00532153455753372,-0.00739932147189865,0.0134610939936335,0.56899197020384
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37562,-0.00316484880206371,0.00558595015593113,-0.0141133111076887,0.00778361350356131,0.571013990084206
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EDNRB,Endothelin receptor type B,37598,0.00243777781457027,0.00434966008498614,-0.00608755595200257,0.0109631115811431,0.57518038974433
NMR metabolomics,X23503.Total Lipids in Medium VLDL,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37562,0.00103845333536313,0.00185525251678299,-0.00259784159753152,0.00467474826825778,0.575668456305298
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MORC3,MORC family CW-type zinc finger protein 3,37942,-0.00144419469445118,0.00258776782384267,-0.0065162196291828,0.00362783024028045,0.576795528376809
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL1RAP,Interleukin-1 receptor accessory protein,40332,0.00219269479996706,0.00393468818944193,-0.00551929405133912,0.00990468365127325,0.577348894537413
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FABP1,"Fatty acid-binding protein, liver",40357,-0.00471495344676027,0.00847996708201831,-0.0213356889275162,0.0119057820339956,0.578211279780533
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39980,0.00639505942145741,0.0115738735224525,-0.0162897326825494,0.0290798515254643,0.580584535206818
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PITHD1,PITH domain-containing protein 1,37457,-0.00415948415326907,0.00754155959321874,-0.0189409409559778,0.0106219726494397,0.581271905695911
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHGB,Secretogranin-1,40406,-0.00203071491869743,0.00368282545344729,-0.00924905280745411,0.00518762297005926,0.581366299224645
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ESPL1,Separin,37482,-0.00290138817872372,0.00526654771238079,-0.0132238216949901,0.00742104533754262,0.581705549091688
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA3,Carbonic anhydrase 3,40500,-0.00306806016147907,0.00557039322793846,-0.0139860308882385,0.00784991056528031,0.581792288530619
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37562,0.00339453422270804,0.00617337397212326,-0.00870527876265356,0.0154943472080696,0.582420011840843
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCL7A,B-cell CLL/lymphoma 7 protein family member A,37482,0.00320791534257396,0.00585155446594115,-0.00826113141067069,0.0146769620958186,0.583553040496011
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK12,Kallikrein-12,39980,-0.00714762605536866,0.0130954215508794,-0.0328146522950923,0.0185194001843549,0.585203653419117
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MUCL3,Mucin-like protein 3,37482,-0.00226004969999413,0.00414108424304477,-0.0103765748163619,0.00585647541637361,0.585238345489139
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37572,-0.00284335987942115,0.00523577682214888,-0.0131054824508329,0.00741876269199065,0.587095229954019
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HCG22,Protein PBMUCL2,37562,0.00266367540556583,0.00490739679490195,-0.00695482231244199,0.0122821731235736,0.587285099770805
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRP1,Prolow-density lipoprotein receptor-related protein 1,40305,-0.00130456939734551,0.00241296658181179,-0.00603398389769661,0.00342484510300559,0.588756724937294
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANXA5,Annexin A5,39896,-0.00150053395901783,0.00279854481648025,-0.00698568179931913,0.00398461388128347,0.591839358278184
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPBGL,Trophoblast glycoprotein-like,37572,0.00204547069269868,0.00383302399745689,-0.00546725634231683,0.00955819772771418,0.593596822021438
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MFAP3,Microfibril-associated glycoprotein 3,40042,-0.00242871850444404,0.00455356758692129,-0.0113537109748098,0.0064962739659217,0.593787794977715
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGBL1,Integrin beta-like protein 1,37998,0.00169625694938519,0.00319485303983385,-0.00456565500868915,0.00795816890745953,0.595473036933252
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37714,0.00174990382465884,0.00330791570295151,-0.00473361095312612,0.00823341860244381,0.596810860424417
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OLR1,Oxidized low-density lipoprotein receptor 1,40225,-0.00279047883147934,0.00532657904506049,-0.0132305737597979,0.00764961609683923,0.600370594251529
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TP53BP1,TP53-binding protein 1,37598,0.0042444762925475,0.00815900431766866,-0.0117471721700831,0.0202361247551781,0.602919087235282
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TET2,Methylcytosine dioxygenase TET2,37697,-0.00480189795847321,0.00923220591813792,-0.0228970215580235,0.0132932256410771,0.602985385205749
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMC3,Structural maintenance of chromosomes protein 3,37482,0.00266549953058631,0.00512809025703481,-0.00738555737320193,0.0127165564343745,0.603222926136613
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,37541,0.00347981135156411,0.00669858778131745,-0.0096494206998181,0.0166090434029463,0.603431825183891
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UHRF2,E3 ubiquitin-protein ligase UHRF2,37562,-0.0017211314818813,0.00332466969370442,-0.00823748408154196,0.00479522111777936,0.604686831689092
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MMP15,Matrix metalloproteinase-15,37990,0.00231680080182411,0.00456731110035225,-0.00663512895486629,0.0112687305585145,0.611982725780317
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KEL,Kell blood group glycoprotein,39961,-0.00165290050983049,0.00326014113804319,-0.00804277714039515,0.00473697612073417,0.612160100099132
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMED10,Transmembrane emp24 domain-containing protein 10,37562,-0.00242809375269311,0.00479586055290738,-0.0118279804363916,0.00697179293100535,0.612661959594247
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CINP,Cyclin-dependent kinase 2-interacting protein,37714,0.00207964473654168,0.00412120738610443,-0.005997921740223,0.0101572112133064,0.613833962287352
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FZD8,Frizzled-8,37541,0.00207301490527451,0.00411783618650072,-0.0059979440202669,0.0101439738308159,0.614675127006032
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD82,CD82 antigen,37714,0.00192786530286843,0.0038383724778921,-0.00559534475380009,0.00945107535953696,0.615492185642084
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HMMR,Hyaluronan mediated motility receptor,37460,-0.00223399416632071,0.00447623122764698,-0.0110074073725088,0.00653941903986737,0.617731988143579
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHEK2,Serine/threonine-protein kinase Chk2,40042,-0.00152036156235272,0.00308507907374667,-0.0075671165468962,0.00452639342219075,0.622152927240717
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NOS2,"Nitric oxide synthase, inducible",37562,-0.00177824782034817,0.00360929467770365,-0.00885246538864733,0.00529596974795099,0.622242945067146
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CASQ2,Calsequestrin-2,37562,-0.00225573279442788,0.00460721156911654,-0.0112858674698963,0.00677440188104054,0.624418714851373
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC2L,C-type lectin domain family 2 member L,37572,0.00222569244561806,0.00455518049362575,-0.00670246132188841,0.0111538462131245,0.625128220727943
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,40042,-0.000923913785351257,0.0019098954030263,-0.0046673087752828,0.00281948120458029,0.628569397987755
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HNF1A,Hepatocyte nuclear factor 1-alpha,37572,0.00321095084360118,0.00667462968789708,-0.0098713233446771,0.0162932250318795,0.630476183217499
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMED4,Transmembrane emp24 domain-containing protein 4,37562,-0.00253986658124721,0.00532807236405093,-0.012982888414787,0.00790315525229262,0.633587118432
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIRPB1,Signal-regulatory protein beta-1,40335,-0.0019343602314801,0.00409872167042803,-0.00996785470551903,0.00609913424255883,0.636974440171381
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TCL1B,T-cell leukemia/lymphoma protein 1B,40042,0.00344761253631606,0.0073261671982538,-0.0109116751722614,0.0178069002448935,0.637940960979085
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPHS2,Podocin,37598,-0.00449613093292263,0.00962876782408239,-0.0233685158681241,0.0143762540022788,0.640545039677905
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TCP11,T-complex protein 11 homolog,37714,-0.0025883080603026,0.00557144586585327,-0.013508341957375,0.00833172583676981,0.642249430721143
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRG3,Proteoglycan 3,37998,0.00208332687162225,0.0045855305266558,-0.00690431296062311,0.0110709667038676,0.649601307494292
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRR5,Proline-rich protein 5,37598,0.00200656793445634,0.00442782287577622,-0.00667196490206505,0.0106851007709777,0.650431951839102
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC34A3,Sodium-dependent phosphate transport protein 2C,37482,-0.00209928552131252,0.00463290589881607,-0.011179781082992,0.00698121004036697,0.650466273877809
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TSPAN15,Tetraspanin-15,37562,-0.00210776681719347,0.00469040504059283,-0.0113009606967554,0.00708542706236849,0.653166123028663
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KRT14,"Keratin, type I cytoskeletal 14",39530,-0.00117391051656683,0.00261478391751638,-0.00629888699489894,0.00395106596176528,0.65347327411944
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LYPD1,Ly6/PLAUR domain-containing protein 1,39961,-0.00267441666411888,0.00600704001597536,-0.0144482150954306,0.00909938176719283,0.656171522481208
NMR metabolomics,X23503.Total Lipids in Medium VLDL,REST,RE1-silencing transcription factor,37482,-0.00145341019908701,0.0032938892899974,-0.00790943320748192,0.00500261280930789,0.659043395236248
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZNF174,Zinc finger protein 174,37598,-0.00156950907206914,0.00356329780169039,-0.0085535727633823,0.00541455461924403,0.659607373849603
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TEX33,Testis-expressed protein 33,37714,-0.00158483434435188,0.00361930316010569,-0.00867866853815904,0.00550899984945528,0.661477626297439
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OSCAR,Osteoclast-associated immunoglobulin-like receptor,40379,-0.00132874148144572,0.00304826925375239,-0.00730334921880041,0.00464586625590897,0.662914975353842
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPB41L5,Band 4.1-like protein 5,37572,-0.00251522209519638,0.00584618656781969,-0.013973747768123,0.00894330357773021,0.667033261809276
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GJA8,Gap junction alpha-8 protein,37482,0.0024539877474722,0.00572238413159408,-0.00876188515045219,0.0136698606453966,0.66804668818837
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TSPAN8,Tetraspanin-8,37901,0.00407205303140328,0.00951243684418099,-0.0145723231831915,0.022716429245998,0.668602099424563
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OMP,Olfactory marker protein,37541,0.00198752986945375,0.00464603843120361,-0.00711870545570533,0.0110937651946128,0.668810885399174
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCAR,Immunoglobulin alpha Fc receptor,40341,-0.00183644062322758,0.00429722731447263,-0.0102590061595939,0.00658612491313878,0.6691267315156
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AXL,Tyrosine-protein kinase receptor UFO,40403,0.00106218864621858,0.00251092915848359,-0.00385923250440926,0.00598360979684643,0.672281899050082
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSMG4,Proteasome assembly chaperone 4,37598,-0.00218123210976473,0.00517295851427452,-0.0123202307977428,0.00795776657821332,0.673279757499731
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZP3,Zona pellucida sperm-binding protein 3,37628,-0.0101130555298964,0.0240555995556267,-0.0572620306589247,0.0370359195991318,0.674197650051101
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARNT,Aryl hydrocarbon receptor nuclear translocator,40044,0.00144193765931806,0.00343281147836789,-0.005286372838283,0.00817024815691913,0.674457865728126
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL4,Interleukin-4,40044,-0.00333383557973537,0.00821928869605521,-0.0194436414240036,0.0127759702645328,0.685033861187026
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,40332,0.00106969265504494,0.0026409349817995,-0.00410653990928208,0.00624592521937197,0.685451240792666
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF3,Fibroblast growth factor 3,37598,0.00112291015807226,0.00279687325692564,-0.00435896142550201,0.00660478174164652,0.688067632261946
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAP1A,Ras-related protein Rap-1A,37598,0.00256532365720632,0.006398448776492,-0.009975635944718,0.0151062832591306,0.688478915481985
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FZD10,Frizzled-10,37572,0.00221764913889054,0.00559105229489616,-0.00874081335910594,0.013176111636887,0.691637534921626
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DAND5,DAN domain family member 5,37598,-0.00198215926170837,0.00499741124739315,-0.0117770853065989,0.00781276678318221,0.691641446116605
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSF1,Macrophage colony-stimulating factor 1,40422,-0.000974014012108676,0.00247004934592591,-0.00581531073012345,0.0038672827059061,0.69334284587785
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD160,CD160 antigen,40516,0.00163579070729013,0.00417203076093585,-0.00654138958414415,0.0098129709987244,0.695000607058474
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMPRSS11B,Transmembrane protease serine 11B,37541,0.00282366390012,0.00720738252488656,-0.0113028058486577,0.0169501336488977,0.695231706625656
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADGRE2,Adhesion G protein-coupled receptor E2,40422,0.000994367680983899,0.00254026332562721,-0.00398454843724542,0.00597328379921322,0.695475215140792
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIGLEC10,Sialic acid-binding Ig-like lectin 10,40341,0.00119875086636761,0.00306793989158696,-0.00481441132114284,0.00721191305387806,0.695998514895032
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40471,0.00168653835797186,0.00433127204082184,-0.00680275484203894,0.0101758315579827,0.696995519017067
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TFF2,Trefoil factor 2,40396,-0.00201787291684497,0.0052022166077477,-0.0122142174680305,0.00817847163434052,0.698104734253148
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTAG1A_CTAG1B,Cancer/testis antigen 1,37687,0.00177493679162648,0.00463620751002205,-0.00731202992801675,0.0108619035112697,0.701842772585986
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TGOLN2,Trans-Golgi network integral membrane protein 2,37987,-0.00089662402384633,0.00234586650072729,-0.00549452236527182,0.00370127431757916,0.702308321419984
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RASA1,Ras GTPase-activating protein 1,39961,0.00113944669244046,0.00298276399718654,-0.00470677074204516,0.00698566412692607,0.702458928151123
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BRD2,Bromodomain-containing protein 2,37541,0.00120403751927602,0.00316845232123331,-0.00500612903034126,0.0074142040688933,0.703945574584679
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CBLN1,Cerebellin-1,37541,0.00342083502701433,0.00900289408471902,-0.0142248373790349,0.0210665074330636,0.703973407484363
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHRDL2,Chordin-like protein 2,40359,-0.001948752902702,0.00519676068892391,-0.0121344038529929,0.00823689804758886,0.707670096486407
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYOC,Myocilin,40332,-0.00156500484545748,0.00418759866029829,-0.00977269821964213,0.00664268852872717,0.708614883593968
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBM25,RNA-binding protein 25,37482,0.00156377127324444,0.00425684261529245,-0.00677964025272877,0.00990718279921764,0.713360400190949
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37562,-0.00222653841226889,0.00606107572757883,-0.0141062468383234,0.00965317001378562,0.713363615999964
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL13RA2,Interleukin-13 receptor subunit alpha-2,37541,0.000948575904626821,0.00261664274190891,-0.00418004386951464,0.00607719567876828,0.716972024070063
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB6B,Ras-related protein Rab-6B,39961,0.00160457520293359,0.00446639923935387,-0.00714956730619999,0.0103587177120672,0.719409402741359
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HLA_A,,37959,0.00107516204200391,0.00299368974709426,-0.00479246986230084,0.00694279394630866,0.719493897640386
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPLX2,Complexin-2,37482,-0.00102177313104108,0.00284717253511959,-0.00660223129987547,0.00455868503779331,0.719695970786299
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39961,0.00261413817444962,0.00742020376923231,-0.0119294612132457,0.0171577375621449,0.724618036094779
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,40374,-0.0018324560757593,0.00521122993075236,-0.0120464667400339,0.00838155458851532,0.725115912431828
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PGM2,Phosphoglucomutase-2,37572,0.00192958762850656,0.00550599755906313,-0.00886216758725719,0.0127213428442703,0.726005164427046
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DKKL1,Dickkopf-like protein 1,40305,-0.00278336414777141,0.00803608825873558,-0.0185340971348931,0.0129673688393503,0.729078217165358
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37959,0.00134207447422914,0.0039026877280461,-0.00630719347274122,0.00899134242119949,0.730938375472065
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPHA2,Ephrin type-A receptor 2,39759,0.000961369946253631,0.00281565364055386,-0.00455731118923193,0.00648005108173919,0.732778880052898
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37564,0.00119064165167979,0.0035028590819858,-0.00567496214901237,0.00805624545237195,0.733933013568088
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDX1,ATP-dependent RNA helicase DDX1,37901,-0.00158255439780025,0.00474036952164612,-0.0108736786602267,0.00770856986462615,0.738500816533373
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSF2RB,Cytokine receptor common subunit beta,37598,-0.00133001817841435,0.00406392775611437,-0.00929531658039853,0.00663528022356982,0.743465813431804
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37598,0.00145187419183028,0.0044542494751327,-0.00727845477942982,0.0101822031630904,0.744465407091085
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HBZ,Hemoglobin subunit zeta,37990,0.00312825056307656,0.00961126162438224,-0.0157098222207126,0.0219663233468657,0.744824647663476
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLA2G1B,Phospholipase A2,40514,-0.00123942998929387,0.00382574469308466,-0.0087378895877398,0.00625902960915207,0.745964276311997
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZNF830,Zinc finger protein 830,37900,-0.00237705188588694,0.00740134576233354,-0.0168836895800607,0.0121295858082868,0.748090480899329
NMR metabolomics,X23503.Total Lipids in Medium VLDL,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,37482,0.00166555556704643,0.00518673209997511,-0.00850043934890479,0.0118315504829976,0.748125750859067
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FAM3D,Protein FAM3D,37901,0.00241668970704844,0.00753220845154066,-0.0123464388579712,0.0171798182720681,0.748331000954325
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPINK1,Serine protease inhibitor Kazal-type 1,40332,-0.00126901147262654,0.0039588607854291,-0.00902837861206757,0.00649035566681449,0.748555910359973
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCIN,Adseverin,37541,0.00214254865736636,0.00673517151551179,-0.0110583875130368,0.0153434848277695,0.750403955459308
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SHC1,SHC-transforming protein 1,37482,0.00338626476577109,0.0107304061222955,-0.0176453312339281,0.0244178607654702,0.752328977541263
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CGN,Cingulin,37572,0.00119727970992725,0.00385252220189655,-0.00635366380578999,0.00874822322564449,0.755974221011064
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EFNB2,Ephrin-B2,37572,-0.00162463642985927,0.0053148166350469,-0.0120416770345512,0.00879240417483266,0.759852682196025
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNTN1,Contactin-1,40536,-0.000767146899169746,0.00251955563765174,-0.00570547594896715,0.00417118215062766,0.760768404460787
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ECSCR,Endothelial cell-specific chemotaxis regulator,37541,0.00140602946521752,0.0046316470354417,-0.00767199872424822,0.0104840576546833,0.761460273509497
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK1,Kallikrein-1,40209,-0.00347817865409351,0.0116547927258703,-0.0263215723967993,0.0193652150886123,0.765376385569174
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37598,-0.00122313959685049,0.00421177335236131,-0.00947821536747867,0.00703193617377768,0.771507448003089
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD3G,T-cell surface glycoprotein CD3 gamma chain,37598,0.00246487716670857,0.00860856284913199,-0.0144079060175901,0.0193376603510073,0.774631018765856
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GIPC2,PDZ domain-containing protein GIPC2,37942,0.000745382318359361,0.00266693406443653,-0.00448180844793624,0.00597257308465496,0.779872832307547
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPT1,Translationally-controlled tumor protein,40044,0.00169633794339328,0.00608487574713662,-0.0102300185209945,0.013622694407781,0.78041782988854
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD58,Lymphocyte function-associated antigen 3,40335,-0.000448070848026479,0.00161422200066917,-0.00361194596933806,0.0027158042732851,0.781340727449203
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ESR1,Estrogen receptor,37598,0.00145102528657629,0.00534341007379673,-0.0090220584580653,0.0119241090312179,0.785969106802456
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MERTK,Tyrosine-protein kinase Mer,40516,0.000644590825399019,0.00238893014066857,-0.00403771225031138,0.00532689390110942,0.787299079162833
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STEAP4,Metalloreductase STEAP4,37541,0.0018510793602648,0.00690994003486457,-0.0116924031080697,0.0153945618285994,0.788790939077565
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EDDM3B,Epididymal secretory protein E3-beta,37900,0.00102108670474107,0.0039108919895488,-0.00664426159477458,0.00868643500425672,0.794028695296715
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HDAC9,Histone deacetylase 9,37541,-0.00150432075506576,0.00581722492351928,-0.0129060816051636,0.00989744009503204,0.795949754781437
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD209,CD209 antigen,40382,0.000908241805438221,0.00354335054907583,-0.0060367252707504,0.00785320888162684,0.797704844130738
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BLVRB,Flavin reductase,40332,0.00149767957204504,0.00605869722208221,-0.0103773669832361,0.0133727261273262,0.804760521511548
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37562,-0.000846058155314604,0.00347623426619542,-0.00765947731705762,0.00596736100642842,0.807712111972446
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGLON5,IgLON family member 5,37482,0.00208831749641659,0.0086549469871156,-0.01487537859833,0.0190520135911632,0.809337261185375
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDIA2,Protein disulfide-isomerase A2,37482,-0.000907244117922716,0.00382081421431094,-0.00839603997797216,0.00658155174212673,0.812313105678984
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OSMR,Oncostatin-M-specific receptor subunit beta,40424,0.000454598165880125,0.00191647673218006,-0.00330169622919279,0.00421089256095303,0.812500677326801
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BTN1A1,Butyrophilin subfamily 1 member A1,37883,0.000865971679139137,0.00385661354031279,-0.00669299085987393,0.00842493421815221,0.82233901330047
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GUCY2C,Heat-stable enterotoxin receptor,37714,-0.00173562650828445,0.00778153974591886,-0.0169874444102854,0.0135161913937165,0.823504621277196
NMR metabolomics,X23503.Total Lipids in Medium VLDL,INSL3,Insulin-like 3,37942,0.00119200950424231,0.00546483345841958,-0.00951906407426007,0.0119030830827447,0.827336058359329
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADGRB3,Adhesion G protein-coupled receptor B3,40203,-0.000663610018593468,0.00307037782214722,-0.00668155055000201,0.00535433051281508,0.828886863724946
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAC3,Ras-related C3 botulinum toxin substrate 3,37572,-0.00139041150388843,0.00643402406189352,-0.0140010986651997,0.0112202756574229,0.828910869089562
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AOC3,Membrane primary amine oxidase,40403,-0.000598471044291523,0.00277413570628847,-0.00603577702861692,0.00483883494003387,0.829199077257755
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LYPD8,Ly6/PLAUR domain-containing protein 8,39980,0.000969693862432973,0.0047029128881782,-0.0082480153983963,0.0101874031232622,0.836645159880979
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPT1,Palmitoyl-protein thioesterase 1,37572,-0.00145236129171517,0.0071663517459318,-0.0154984107137415,0.0125936881303112,0.839400829425716
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OSM,Oncostatin-M,40268,-0.00134113535835915,0.00662383208525415,-0.0143238462454573,0.011641575528739,0.839550960455843
NMR metabolomics,X23503.Total Lipids in Medium VLDL,S100A16,Protein S100-A16,39934,-0.00114847210772475,0.00569086304679097,-0.0123025636794351,0.0100056194639856,0.840068047386899
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,37541,-0.000585397688621036,0.00290250869552227,-0.00627431473184469,0.00510351935460262,0.840164717419118
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARMCX2,Armadillo repeat-containing X-linked protein 2,37541,0.00123238254109819,0.00611149330619048,-0.0107461443390352,0.0132109094212315,0.840193498104526
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SAP18,Histone deacetylase complex subunit SAP18,37714,0.00137175973872388,0.00684634762945358,-0.0120470816150051,0.0147906010924529,0.841199196898938
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37598,0.000517945395616515,0.0025859042994242,-0.00455042703125492,0.00558631782248795,0.84125245875687
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCARE,Photoreceptor cilium actin regulator,37541,0.0015751080743621,0.0079018328600807,-0.0139124843313961,0.0170627004801203,0.842004172832379
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37572,0.000751941486514856,0.00379249136774926,-0.00668134159427369,0.0081852245673034,0.842836023020239
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LMOD2,Leiomodin-2,37541,0.00117791891624612,0.00596352831031328,-0.0105105965719679,0.0128664344044601,0.84342333114817
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,40357,-0.00067543743895949,0.00350324712280369,-0.00754180179965472,0.00619092692173573,0.847115518004795
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCRL6,Fc receptor-like protein 6,40341,-0.00118629455360523,0.00616868666998922,-0.0132769204267841,0.0109043313195737,0.847502551889519
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRX,Cone-rod homeobox protein,40042,0.0018840010641951,0.00982818044845576,-0.0173792326147782,0.0211472347431684,0.847984574695862
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF7,Fibroblast growth factor 7,37482,0.0014251045229245,0.00744556443638972,-0.0131682017723993,0.0160184108182484,0.84821273082965
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLINT1,Clathrin interactor 1,37482,0.000780031352043781,0.00421961331795714,-0.00749041075115221,0.00905047345523977,0.853342905921912
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL36G,Interleukin-36 gamma,37551,-0.00116532295292432,0.00633138300334578,-0.013574833639482,0.0112441877336334,0.853973125633249
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CYTH3,Cytohesin-3,37482,0.00124732859362349,0.0067778696718395,-0.0120372959631819,0.0145319531504289,0.853993103641714
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TFAP2A,Transcription factor AP-2-alpha,37541,-0.000994443485184237,0.00556325951938122,-0.0118984321431714,0.00990954517280296,0.858135242729895
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VSTM2B,V-set and transmembrane domain-containing protein 2B,37714,0.000660942131209107,0.00377514855415525,-0.00673834903493518,0.00806023329735339,0.861021709981271
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37714,-0.000805287177777859,0.00463460454333796,-0.00988911208272026,0.00827853772716455,0.862060414600276
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",40379,-0.000541793459883062,0.0031313130310069,-0.00667916700065658,0.00559558008089045,0.862634471845111
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL4A4,Collagen alpha-4(IV) chain,37688,0.000825758933017274,0.00481056591798299,-0.00860295026622939,0.0102544681322639,0.863711186821397
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARG2,"Arginase-2, mitochondrial",37900,-0.000685671831764679,0.00407290101634509,-0.00866855782380106,0.00729721416027171,0.866310676166251
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF5,Fibroblast growth factor 5,40044,0.000476041382882805,0.00294982512125691,-0.00530561585478073,0.00625769862054635,0.871796581285336
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,40276,0.000882535372952039,0.00549578974653023,-0.00988921253024721,0.0116542832761513,0.872423182960574
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PODXL2,Podocalyxin-like protein 2,40411,0.000399427404449298,0.00249286276006511,-0.00448658360527831,0.00528543841417691,0.87270318854611
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMED1,Transmembrane emp24 domain-containing protein 1,37714,-0.000793278126137276,0.00498590628645336,-0.0105656544475859,0.0089790981953113,0.873589281773092
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPHA10,Ephrin type-A receptor 10,39961,0.000939884182609161,0.00598410041299153,-0.0107889526268542,0.0126687209920726,0.875196791527904
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEP112,Centrosomal protein of 112 kDa,37562,0.000678065079087677,0.00433612687105406,-0.00782074358817828,0.00917687374635364,0.875739260799477
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD200,OX-2 membrane glycoprotein,40341,-0.00036928680815622,0.00237568648492147,-0.0050256323186023,0.00428705870228986,0.876473074811693
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PMCH,Pro-MCH,37562,-0.00120860965471252,0.00780647857272617,-0.0165093076572558,0.0140920883478308,0.876964532193241
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37959,-0.00046071640378241,0.00300726572373744,-0.00635495722230779,0.00543352441474297,0.878241982206253
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNLZ,DNL-type zinc finger protein,37541,-0.00127918354738135,0.00872640900946512,-0.018382945205933,0.0158245781111703,0.883459781690774
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,37541,-0.000452157096676396,0.00310764860305309,-0.00654314835866046,0.00563883416530767,0.884319823290398
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IKZF2,Zinc finger protein Helios,39980,0.00118700682535805,0.00856836000526538,-0.0156069787849621,0.0179809924356782,0.889820414585575
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATRAID,All-trans retinoic acid-induced differentiation factor,37901,0.000339242168793646,0.00249921046850383,-0.00455921034947386,0.00523769468706115,0.892029065288218
NMR metabolomics,X23503.Total Lipids in Medium VLDL,THSD1,Thrombospondin type-1 domain-containing protein 1,37500,0.000426181486968676,0.0031668570686656,-0.00578085836761591,0.00663322134155326,0.892949560867508
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PFDN6,Prefoldin subunit 6,37572,0.000811629054005716,0.00607018574848594,-0.0110859350130267,0.0127091931210382,0.893635965011021
NMR metabolomics,X23503.Total Lipids in Medium VLDL,S100G,Protein S100-G,37959,0.000543799476621346,0.00407181916840007,-0.00743696609344279,0.00852456504668548,0.893758854840593
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL31,Interleukin-31,37598,0.0007132038347164,0.00534243179491877,-0.00975796248332439,0.0111843701527572,0.893801607817507
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DIPK1C,Divergent protein kinase domain 1C,37572,0.000516177831550432,0.00393954893510723,-0.00720533808125975,0.00823769374436061,0.895757854442668
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARID3A,AT-rich interactive domain-containing protein 3A,37541,-0.000481420166266801,0.00368570463613461,-0.00770540125309064,0.00674256092055704,0.896079338790031
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HTR1A,5-hydroxytryptamine receptor 1A,37541,0.000966651711530962,0.00742150431344051,-0.0135794967428124,0.0155128001658744,0.896370556176282
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADGRV1,Adhesion G-protein coupled receptor V1,37541,0.000844185305916978,0.00651379781729268,-0.0119228584159767,0.0136112290278106,0.896885245838348
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EVPL,Envoplakin,37714,0.000405550823973137,0.00316299566315648,-0.00579392067581356,0.00660502232375984,0.897978938734904
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GAD2,Glutamate decarboxylase 2,37598,0.000547355355154892,0.00434845490834988,-0.00797561626521088,0.00907032697552066,0.899833963456689
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FH,"Fumarate hydratase, mitochondrial",37541,0.000981432225926743,0.00784908329982255,-0.0144027710417254,0.0163656354935789,0.900495533399486
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SHD,SH2 domain-containing adapter protein D,37531,0.000987865668392078,0.00806744438865978,-0.0148243253333811,0.0168000566701653,0.902543826233934
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFNL2,Interferon lambda-2,37541,0.000719102056370468,0.0059398899282887,-0.0109230822030754,0.0123612863158163,0.903642838655494
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HDDC2,5'-deoxynucleotidase HDDC2,37901,-0.000475394030006707,0.00398209797623889,-0.00828030606343494,0.00732951800342152,0.904973865839895
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IZUMO1,Izumo sperm-egg fusion protein 1,37482,-0.000537207080555096,0.00453156446133472,-0.00941907342477114,0.00834465926366095,0.905635436034256
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TXK,Tyrosine-protein kinase TXK,37714,0.00080372494974589,0.00695539780167745,-0.0128288547415419,0.0144363046410337,0.90800766683115
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL17F,Interleukin-17F,40044,-0.000840725698337685,0.00727768187146317,-0.0151049821664055,0.0134235307697301,0.90803359741728
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK3,Prostate-specific antigen,37998,0.000590168708344095,0.00523772366953884,-0.00967576968395202,0.0108561071006402,0.910288651439037
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIT,Mast/stem cell growth factor receptor Kit,40372,0.000287433319784011,0.00270486049672098,-0.00501409325378911,0.00558895989335714,0.915373052257556
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MRPL28,"39S ribosomal protein L28, mitochondrial",37959,-0.000352588180673397,0.00337967212072986,-0.00697674553730392,0.00627156917595713,0.916912075416992
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBP1,Retinol-binding protein 1,37572,-0.000650554081968292,0.00632388987235341,-0.013045378231781,0.0117442700678444,0.918065770933023
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRP2BP,LRP2-binding protein,37572,0.000819401388449629,0.00797369097252811,-0.0148090329177055,0.0164478356946047,0.918152544159873
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KHDC3L,KH domain-containing protein 3,37482,0.000608082573342699,0.00626764491516882,-0.0116765014603882,0.0128926666070736,0.92271255325983
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DHODH,Dihydroorotate dehydrogenase,37562,0.000424461440552467,0.00444140584007639,-0.00828069400599725,0.00912961688710218,0.923864217775427
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HEBP1,Heme-binding protein 1,40042,0.000471287049076112,0.00498281978288635,-0.00929503972538114,0.0102376138235334,0.924647746211255
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CBX2,Chromobox protein homolog 2,37562,0.000342833661274278,0.00377834421163542,-0.00706272099353115,0.00774838831607971,0.927703368005801
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCDC2C,Doublecortin domain-containing protein 2C,37482,-0.000525767208029141,0.00583376114024784,-0.0119599390429149,0.0109084046268566,0.928189338288547
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL3,Interleukin-3,37482,0.000491538307080735,0.00553146497487487,-0.010350133043674,0.0113332096578355,0.929192767362388
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDC123,Cell division cycle protein 123 homolog,37482,0.000511758359847266,0.00589010608338754,-0.0110328495635923,0.0120563662832868,0.930764731054259
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAGEA3,Melanoma-associated antigen 3,37714,-0.000638074130510723,0.00774972353567809,-0.0158275322604398,0.0145513839994183,0.934381499470405
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNTF,Ciliary neurotrophic factor,37541,0.00025280033343985,0.00310672364545293,-0.00583637801164788,0.00634197867852758,0.935147355821559
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MED21,Mediator of RNA polymerase II transcription subunit 21,37562,0.000349800679066646,0.00446832055022305,-0.00840810759937053,0.00910770895750382,0.937602863424645
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TG,Thyroglobulin,37900,-0.000791835476494932,0.0107570682770551,-0.0218756892995229,0.020292018346533,0.941321240512525
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KCNIP4,Kv channel-interacting protein 4,39961,0.000336604265861111,0.00470032537077249,-0.00887603346085298,0.0095492419925752,0.942910840384918
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RUVBL1,RuvB-like 1,39980,-0.000698624077463045,0.00982580941095733,-0.0199572105229394,0.0185599623680133,0.943318352542969
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37562,-0.000317027897272233,0.00452031052090964,-0.00917683651825513,0.00854278072371066,0.944087997608368
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MORN4,MORN repeat-containing protein 4,37482,0.000470842276219334,0.00724877167993105,-0.0137367502164455,0.0146784347688842,0.948211011230445
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLXDC1,Plexin domain-containing protein 1,39980,-0.000194096893773909,0.00310407886383149,-0.00627809146688364,0.00588989767933582,0.950141873909228
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NXPE4,NXPE family member 4,37562,0.000205647458127286,0.00334146472741058,-0.00634362340759746,0.00675491832385203,0.950926827910735
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNF4,E3 ubiquitin-protein ligase RNF4,37714,-0.000366825652097625,0.00616072253218737,-0.0124418418151849,0.0117081905109896,0.95252080514585
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPINT3,Kunitz-type protease inhibitor 3,37901,-0.000698270899625952,0.0117940492972968,-0.0238146075223277,0.0224180657230758,0.952789422467734
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37562,-0.000312035456960625,0.00551023747754459,-0.011112100912948,0.0104880299990268,0.954842142562706
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCN3A,Sodium channel protein type 3 subunit alpha,37572,-0.000198327464957287,0.00356087692543135,-0.00717764623880274,0.00678099130888816,0.955584640947835
NMR metabolomics,X23503.Total Lipids in Medium VLDL,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37942,-0.000187969192328268,0.00343558185926554,-0.00692170963648873,0.00654577125183219,0.956368339517792
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,40341,-0.000186529249839676,0.0035373859764882,-0.00711980576375654,0.00674674726407719,0.957947048275881
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,40451,-0.000149055473610501,0.00316068883577063,-0.00634400559172093,0.00604589464449993,0.96238695463206
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF6,Fibroblast growth factor 6,37598,0.000176631814354241,0.00394847325523549,-0.00756237576590731,0.0079156393946158,0.964319848310445
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATF4,Cyclic AMP-dependent transcription factor ATF-4,37482,0.000140827261378233,0.00317188329944238,-0.00607606400552883,0.00635771852828529,0.964587336943126
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPGN,Epigen,37900,0.000199314955116981,0.00453318697022248,-0.00868573150651907,0.00908436141675303,0.964930601133756
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDC25A,M-phase inducer phosphatase 1,37482,-0.000164704721905743,0.00376346251674159,-0.00754109125471926,0.00721168181090778,0.965093077877926
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDX4,Probable ATP-dependent RNA helicase DDX4,37598,-0.000167901441720446,0.00504009151216187,-0.0100464808055577,0.00971067792211681,0.973425354613417
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNNI3,"Troponin I, cardiac muscle",40042,0.000257710751699388,0.00774406048014931,-0.0149206477893933,0.015436069292792,0.973452921195852
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL13,Interleukin-13,40044,-0.000134164690793901,0.00438860001977152,-0.00873582072954608,0.00846749134795828,0.975611915960673
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SKIV2L,Helicase SKI2W,37562,9.5569533039042e-05,0.00372880084986954,-0.00721288013270526,0.00740401919878335,0.979552768917401
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAPRE3,Microtubule-associated protein RP/EB family member 3,37482,0.000321229982264306,0.0130024736701969,-0.0251636184113216,0.0258060783758503,0.980290407769848
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UPK3BL1,Uroplakin-3b-like protein 1,37692,-0.000112968256411336,0.00510934479887055,-0.0101272840621976,0.00990134754937495,0.982360442392155
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLNS1A,Methylosome subunit pICln,37572,6.78158415428838e-05,0.00308379316982774,-0.00597641877131949,0.00611205045440525,0.982455431431443
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL2,Interleukin-2,40044,-6.26915884029569e-05,0.00286625325423238,-0.00568054796669842,0.0055551647898925,0.982550090371651
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRC1,Protein regulator of cytokinesis 1,37900,-8.50682852443389e-05,0.00427458411144005,-0.00846325314366684,0.00829311657317816,0.984122682440841
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENPEP,Glutamyl aminopeptidase,37562,-7.51986272712997e-05,0.00426107880003468,-0.00842691307533927,0.00827651582079667,0.985920099606307
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADGRE1,Adhesion G protein-coupled receptor E1,37901,7.17824194917672e-05,0.00506100156468279,-0.0098477806472865,0.00999134548627003,0.9886838408326
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL2RB,Interleukin-2 receptor subunit beta,40044,-5.02130422154141e-05,0.0035520759884193,-0.00701228197951724,0.00691185589508641,0.988721459084958
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PGR,Progesterone receptor,37598,0.000125781226263001,0.00950430182193687,-0.0185026503447333,0.0187542127972593,0.989441195973988
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LPA,Apolipoprotein(a),37735,-0.00016462631342584,0.0160780363060297,-0.031677577473244,0.0313483248463923,0.991830592752964
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FOLR3,Folate receptor gamma,40355,-7.53274516863428e-05,0.01683574128196,-0.0330733803643279,0.0329227254609552,0.996430126578116
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KCNH2,Potassium voltage-gated channel subfamily H member 2,37572,2.92907626455154e-05,0.00728261782607952,-0.0142446401764703,0.0143032217017614,0.99679097001743
